Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 papers

DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM


  Vaccines

  Free Subscription


Articles published in Vaccine

Retrieve available abstracts of 2391 articles:
HTML format



Single Articles


    May 2020
  1. JONES OS, Vassie C, Emanuel O, Lechner M, et al
    Targeting key groups using a low-cost strategy to increase HPV awareness and vaccine uptake.
    Vaccine. 2020;38:4059.
    PubMed    


  2. CHERIAN T, Hwang A, Mantel C, Veira C, et al
    Global Vaccine Action Plan lessons learned III: Monitoring and evaluation/accountability framework.
    Vaccine. 2020 May 16. pii: S0264-410X(20)30647.
    PubMed     Abstract available


  3. KOPSIDAS I, Tsopela GC, Maroudi-Manta S, Kourkouni E, et al
    Increasing healthcare workers' uptake of seasonal influenza vaccination in a tertiary-care pediatric hospital in Greece with a low-cost, tailor-made, multifaceted strategy.
    Vaccine. 2020 May 16. pii: S0264-410X(20)30639.
    PubMed     Abstract available


  4. KHODR ZG, Hall C, Chang RN, Bukowinski AT, et al
    Japanese encephalitis vaccination in pregnancy among U.S. active duty military women.
    Vaccine. 2020 May 15. pii: S0264-410X(20)30641.
    PubMed     Abstract available


  5. GORTZ M, Brewer NT, Hansen PR, Ejrnaes M, et al
    The contagious nature of a vaccine scare: How the introduction of HPV vaccination lifted and eroded MMR vaccination in Denmark.
    Vaccine. 2020 May 14. pii: S0264-410X(20)30549.
    PubMed     Abstract available


  6. KURA K, Collyer BS, Toor J, Truscott JE, et al
    Policy implications of the potential use of a novel vaccine to prevent infection with Schistosoma mansoni with or without mass drug administration.
    Vaccine. 2020 May 14. pii: S0264-410X(20)30605.
    PubMed     Abstract available


  7. BUTLER AM, Grabinski VF, Boloker GD, Newland JG, et al
    A qualitative study examining pediatric clinicians' perceptions of delayed vaccine schedules.
    Vaccine. 2020 May 14. pii: S0264-410X(20)30633.
    PubMed     Abstract available


  8. BONNETON M, Antona D, Danis K, Ait-Belghiti F, et al
    Are vaccinated measles cases protected against severe disease?
    Vaccine. 2020 May 14. pii: S0264-410X(20)30611.
    PubMed     Abstract available


  9. STOMA I, Karpov I, Iskrov I, Lendina I, et al
    Clinical efficacy of pneumococcal vaccination in multiple myeloma patients on novel agents: Results of a prospective clinical study.
    Vaccine. 2020 May 14. pii: S0264-410X(20)30643.
    PubMed     Abstract available


  10. BERCE PC, Bernstein RS, MacKinnon GE, Sorum S, et al
    Immunizations at Wisconsin Pharmacies: Results of a statewide vaccine registry analysis and pharmacist survey.
    Vaccine. 2020 May 13. pii: S0264-410X(20)30537.
    PubMed     Abstract available


  11. DUMONTEIL E, Herrera C, Tu W, Goff K, et al
    Safety and immunogenicity of a recombinant vaccine against Trypanosoma cruzi in Rhesus macaques.
    Vaccine. 2020 May 13. pii: S0264-410X(20)30628.
    PubMed     Abstract available


  12. LUISI MLR
    From bad to worse: The representation of the HPV vaccine Facebook.
    Vaccine. 2020 May 13. pii: S0264-410X(20)30634.
    PubMed     Abstract available


  13. SHEEL M, Tippins A, Glass K, Kirk M, et al
    Electronic immunization registers - A tool for mitigating outbreaks of vaccine-preventable diseases in the Pacific.
    Vaccine. 2020 May 12. pii: S0264-410X(20)30588.
    PubMed    


  14. SALL O, Olofsson E, Jacobsson S
    High genomic-based predicted strain coverage among invasive meningococcal isolates when combining Bexsero and Trumenba vaccines.
    Vaccine. 2020 May 12. pii: S0264-410X(20)30591.
    PubMed     Abstract available


  15. NEUFEIND J, Betsch C, Habersaat KB, Eckardt M, et al
    Barriers and drivers to adult vaccination among family physicians - Insights for tailoring the immunization program in Germany.
    Vaccine. 2020 May 11. pii: S0264-410X(20)30546.
    PubMed     Abstract available


  16. XIAO X, Wong RM
    Vaccine hesitancy and perceived behavioral control: A meta-analysis.
    Vaccine. 2020 May 11. pii: S0264-410X(20)30593.
    PubMed     Abstract available


  17. ORTA OR, Hatch EE, Regan AK, Perkins R, et al
    A prospective study of influenza vaccination and time to pregnancy.
    Vaccine. 2020 May 11. pii: S0264-410X(20)30548.
    PubMed     Abstract available


  18. DEAN TC, Gilliland AE, Cameron JE
    Parents' receptiveness to oral health clinic-based vaccination.
    Vaccine. 2020 May 8. pii: S0264-410X(20)30535.
    PubMed     Abstract available


  19. SREEVATSAVA M, Burman AL, Wahdan A, Safdar RM, et al
    Routine immunization coverage in Pakistan: a survey of children under 1 year of age in community-based vaccination areas.
    Vaccine. 2020 May 8. pii: S0264-410X(20)30585.
    PubMed     Abstract available


  20. MORGENROTH A, Jakel V, Hanke-Robinson H, Muller T, et al
    A novel electrophoretic immunoblot as antigen desorption and quantification method for alum-adjuvanted veterinary rabies vaccines.
    Vaccine. 2020 May 8. pii: S0264-410X(20)30561.
    PubMed     Abstract available


  21. KAUR R, Pichichero M
    Comparison of anti-capsular antibody quantity and functionality in children after different primary dose and booster schedules of 13 valent-pneumococcal conjugate vaccine.
    Vaccine. 2020 May 8. pii: S0264-410X(20)30580.
    PubMed     Abstract available


  22. MALTEZOU HC, Asimakopoulos G, Stavrou S, Daskalakis G, et al
    Effectiveness of quadrivalent influenza vaccine in pregnant women and infants, 2018-2019.
    Vaccine. 2020 May 8. pii: S0264-410X(20)30564.
    PubMed     Abstract available


  23. WON G, Senevirathne A, Lee JH
    Salmonella Enteritidis ghost vaccine carrying the hemagglutinin globular head (HA1) domain from H1N1 virus protects against salmonellosis and influenza in chickens.
    Vaccine. 2020 May 8. pii: S0264-410X(20)30594.
    PubMed     Abstract available


  24. WEBBER C, Peyrani P, Balmer P, Serra L, et al
    Persistence of bactericidal antibodies following primary and booster MenACWY-TT vaccination of toddlers: A review of clinical studies.
    Vaccine. 2020 May 7. pii: S0264-410X(20)30260.
    PubMed     Abstract available


  25. LI J, Li X, Ma H, Ren X, et al
    Efficient mucosal vaccination of a novel classical swine fever virus E2-Fc fusion protein mediated by neonatal Fc receptor.
    Vaccine. 2020 May 7. pii: S0264-410X(20)30631.
    PubMed     Abstract available


  26. LIAO Q, Ng TWY, Cowling BJ
    What influenza vaccination programmes are preferred by healthcare personnel? A discrete choice experiment.
    Vaccine. 2020 May 7. pii: S0264-410X(20)30630.
    PubMed     Abstract available


  27. MAURELLI M, Bellinato F, Gisondi P, Girolomoni G, et al
    Persistent localized hypertrichosis in a Caucasian child at sites of DTPa and chickenpox vaccination.
    Vaccine. 2020;38:3808-3809.
    PubMed    


  28. QUIAMBAO BP, Ambas C, Diego S, Bosch Castells V, et al
    Single-visit, 4-site intradermal (ID) rabies vaccination induces robust immune responses 5 years after 1-week, 4-site ID primary post-exposure prophylaxis in the Philippines.
    Vaccine. 2020;38:3740-3746.
    PubMed     Abstract available


  29. SOLASTIE A, Leino T, Ollgren J
    Success ofrotavirus vaccination in Finland, a register based study measuring impact beyond overall effectiveness.
    Vaccine. 2020;38:3766-3772.
    PubMed     Abstract available


  30. WAGNER AL, Gordon A, Tallo VL, Simaku A, et al
    Intent to obtain pediatric influenza vaccine among mothers in four middle income countries.
    Vaccine. 2020 May 6. pii: S0264-410X(20)30508.
    PubMed     Abstract available


  31. ESTEVES-JARAMILLO A, Koehler T, Jeanfreau R, Neveu D, et al
    Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in >/=56-year-olds: A Phase III randomized study.
    Vaccine. 2020 May 6. pii: S0264-410X(20)30584.
    PubMed     Abstract available


  32. PALLIKKUTH S, Bolivar H, Fletcher MA, Babic DZ, et al
    A therapeutic HIV-1 vaccine reduces markers of systemic immune activation and latent infection in patients under highly active antiretroviral therapy.
    Vaccine. 2020 May 6. pii: S0264-410X(20)30485.
    PubMed     Abstract available


  33. BATMUNKH T, Dalmau MT, Munkhsaikhan ME, Khorolsuren T, et al
    A single dose of quadrivalent human papillomavirus (HPV) vaccine is immunogenic and reduces HPV detection rates in young women in Mongolia, six years after vaccination.
    Vaccine. 2020 May 6. pii: S0264-410X(20)30534.
    PubMed     Abstract available


  34. STRONSKY SM, Cooper CL, Steffens J, Van Tongeren S, et al
    Adjuvant selection impacts the correlates of vaccine protection against Ebola infection.
    Vaccine. 2020 May 6. pii: S0264-410X(20)30627.
    PubMed     Abstract available


  35. FRANCIS MJ
    A Veterinary Vaccine Development Process Map to assist in the development of new vaccines.
    Vaccine. 2020 May 6. pii: S0264-410X(20)30613.
    PubMed     Abstract available


  36. NOUATIN O, Ateba Ngoa U, Ibanez J, Dejon-Agobe JC, et al
    Effect of immune regulatory pathways after immunization with GMZ2 malaria vaccine candidate in healthy lifelong malaria-exposed adults.
    Vaccine. 2020 May 5. pii: S0264-410X(20)30540.
    PubMed     Abstract available


  37. SMITH LE, Amlot R, Weinman J, Yiend J, et al
    Why do parents not re-vaccinate their child for influenza? A prospective cohort study.
    Vaccine. 2020 May 5. pii: S0264-410X(20)30509.
    PubMed     Abstract available


  38. CHERIAN T, Arora N, MacDonald NE
    The global vaccine action plan monitoring and evaluation/accountability framework: Perspective.
    Vaccine. 2020 May 4. pii: S0264-410X(20)30529.
    PubMed    


  39. BELL S, Chantler T, Paterson P, Mounier-Jack S, et al
    Is flu vaccination opt-out feasible? Evidence from vaccination programme implementers and managers in the English National Health Service.
    Vaccine. 2020 May 4. pii: S0264-410X(20)30506.
    PubMed     Abstract available


  40. LEI D, Griffiths E, Martin J
    WHO working group meeting to develop WHO Recommendations to assure the quality, safety and efficacy of enterovirus 71 vaccines.
    Vaccine. 2020 May 4. pii: S0264-410X(20)30606.
    PubMed     Abstract available


  41. HAWKSWORTH A, Lockhart R, Crowe J, Maeso R, et al
    Replication of live attenuated influenza vaccine viruses in human nasal epithelial cells is associated with H1N1 vaccine effectiveness.
    Vaccine. 2020 May 3. pii: S0264-410X(20)30462.
    PubMed     Abstract available


  42. NAKASONE M, Lopes MH, Sartori AMC, Sandoval EPN, et al
    Immunogenicity, long term protection and safety of subcutaneous administration of hepatitis A vaccine in patients with hemophilia and other bleeding disorders: A randomized study.
    Vaccine. 2020 May 3. pii: S0264-410X(20)30533.
    PubMed     Abstract available


  43. STOJANOV M, Besancon H, Snaka T, Nardelli-Haefliger D, et al
    Differentially regulated promoters for antigen expression in Salmonella vaccine strains.
    Vaccine. 2020 May 3. pii: S0264-410X(20)30541.
    PubMed     Abstract available


  44. OBI-JEFF C, Rakhshani NS, Bello-Malabu JI, Nwangwu C, et al
    Vaccine indicator and reminder band to improve demand for vaccination in Northern Nigeria: A qualitative evaluation of implementation outcomes.
    Vaccine. 2020 May 3. pii: S0264-410X(20)30505.
    PubMed     Abstract available


  45. POLAND GA
    Tortoises, hares, and vaccines: A cautionary note for SARS-CoV-2 vaccine development.
    Vaccine. 2020 May 1. pii: S0264-410X(20)30590.
    PubMed    


    April 2020
  46. LOFT LH, Pedersen EA, Jacobsen SU, Soborg B, et al
    Using Facebook to increase coverage of HPV vaccination among Danish girls: An assessment of a Danish social media campaign.
    Vaccine. 2020 Apr 30. pii: S0264-410X(20)30512.
    PubMed     Abstract available


  47. BELL GJ, Loop M, Topazian HM, Hudgens M, et al
    Case reduction and cost-effectiveness of the RTS,S/AS01 malaria vaccine alongside bed nets in Lilongwe, Malawi.
    Vaccine. 2020 Apr 30. pii: S0264-410X(20)30511.
    PubMed     Abstract available


  48. IWU CJ, Ngcobo N, McCaul M, Mangqalaza H, et al
    Vaccine stock management in primary health care facilities in OR Tambo District, Eastern Cape, South Africa.
    Vaccine. 2020 Apr 30. pii: S0264-410X(20)30489.
    PubMed     Abstract available


  49. KHAN N, Saggurti N
    Socioeconomic inequality trends in childhood vaccination coverage in India: Findings from multiple rounds of National Family Health Survey.
    Vaccine. 2020 Apr 30. pii: S0264-410X(20)30503.
    PubMed     Abstract available


  50. GEWENIGER A, Abbas KM
    Childhood vaccination coverage and equity impact in Ethiopia by socioeconomic, geographic, maternal, and child characteristics.
    Vaccine. 2020;38:3627-3638.
    PubMed     Abstract available


  51. NGUYEN VH, Vizzotti C, Uruena A, Giglio N, et al
    Cost-effectiveness of introducing an MF59-adjuvanted trivalent influenza vaccine for older adults in Argentina.
    Vaccine. 2020;38:3682-3689.
    PubMed     Abstract available


  52. BERRIE DM, Waters RC, Montoya C, Chatel A, et al
    Development of a high-yield live-virus vaccine production platform using a novel fixed-bed bioreactor.
    Vaccine. 2020;38:3639-3645.
    PubMed     Abstract available


  53. DENG H, Yu S, Guo Y, Gu L, et al
    Development of a multivalent enterovirus subunit vaccine based on immunoinformatic design principles for the prevention of HFMD.
    Vaccine. 2020;38:3671-3681.
    PubMed     Abstract available


  54. ZHANG X, Liu CR, Wang ZZ, Ren ZF, et al
    Effect of a school-based educational intervention on HPV and HPV vaccine knowledge and willingness to be vaccinated among Chinese adolescents : a multi-center intervention follow-up study.
    Vaccine. 2020;38:3665-3670.
    PubMed     Abstract available


  55. LIN J, Wood JG, Bernardo C, Stocks NP, et al
    Herpes zoster vaccine coverage in Australia before and after introduction of a national vaccination program.
    Vaccine. 2020;38:3646-3652.
    PubMed     Abstract available


  56. SANGHA P, McCullough JM
    Trends in school-level vaccination coverage from 2015 to 2018: Increases in exemption rates and declines in herd immunity in Arizona.
    Vaccine. 2020 Apr 29. pii: S0264-410X(20)30510.
    PubMed     Abstract available


  57. GOTTLIEB SL, Ndowa F, Hook EW 3rd, Deal C, et al
    Gonococcal vaccines: Public health value and preferred product characteristics; report of a WHO global stakeholder consultation, January 2019.
    Vaccine. 2020 Apr 28. pii: S0264-410X(20)30317.
    PubMed     Abstract available


  58. CHRAPKOWSKA C, Galanis I, Kark M, Lepp T, et al
    Validation of the new Swedish vaccination register - Accuracy and completeness of register data.
    Vaccine. 2020 Apr 28. pii: S0264-410X(20)30490.
    PubMed     Abstract available


  59. HERST CV, Burkholz S, Sidney J, Sette A, et al
    An effective CTL peptide vaccine for Ebola Zaire Based on Survivors' CD8+ targeting of a particular nucleocapsid protein epitope with potential implications for COVID-19 vaccine design.
    Vaccine. 2020 Apr 28. pii: S0264-410X(20)30518.
    PubMed     Abstract available


  60. SCARINCI IC, Hansen B, Kim YI
    HPV vaccine uptake among daughters of Latinx immigrant mothers: Findings from a cluster randomized controlled trial of a community-based, culturally relevant intervention.
    Vaccine. 2020 Apr 27. pii: S0264-410X(20)30441.
    PubMed     Abstract available


  61. CONREY R, Valencia V, Cioletti A, Williams-Brown MY, et al
    Regional variation in human papillomavirus vaccination uptake and completion among adolescents 13-17 in the state of Texas.
    Vaccine. 2020 Apr 26. pii: S0264-410X(20)30448.
    PubMed     Abstract available


  62. EIZAYAGA JE
    Homeopathic nosodes are not vaccines.
    Vaccine. 2020;38:3517.
    PubMed    


  63. WANG SH, Chen J, Smith D, Cao Z, et al
    A novel combination of intramuscular vaccine adjuvants, nanoemulsion and CpG produces an effective immune response against influenza A virus.
    Vaccine. 2020;38:3537-3544.
    PubMed     Abstract available


  64. FULTON RW, Cook BJ, Payton ME, Burge LJ, et al
    Immune response to bovine viral diarrhea virus (BVDV) vaccines detecting antibodies to BVDV subtypes 1a, 1b, 2a, and 2c.
    Vaccine. 2020 Apr 23. pii: S0264-410X(20)30447.
    PubMed     Abstract available


  65. SAYINZOGA F, Umulisa MC, Sibomana H, Tenet V, et al
    Human papillomavirus vaccine coverage in Rwanda: A population-level analysis by birth cohort.
    Vaccine. 2020 Apr 23. pii: S0264-410X(20)30491.
    PubMed     Abstract available


  66. LEE JH, Hong S, Im JH, Lee JS, et al
    Systematic review and meta-analysis of immune response of double dose of hepatitis B vaccination in HIV-infected patients.
    Vaccine. 2020 Apr 22. pii: S0264-410X(20)30492.
    PubMed     Abstract available


  67. WANLAPAKORN N, Puenpa J, Thongmee T, Srimuan D, et al
    Antibodies to measles, mumps, and rubella virus in Thai children after two-dose vaccination at 9 months and 2.5 years: A longitudinal study.
    Vaccine. 2020 Apr 21. pii: S0264-410X(20)30483.
    PubMed     Abstract available


  68. THOMPSON KM, Orenstein WA, Hinman AR
    An opportunity to incentivize innovation to increase vaccine safety in the United States by improving vaccine delivery using vaccine patches.
    Vaccine. 2020 Apr 21. pii: S0264-410X(20)30538.
    PubMed     Abstract available


  69. OUSMANE S, Kobayashi M, Seidou I, Issaka B, et al
    Characterization of pneumococcal meningitis before and after introduction of 13-valent pneumococcal conjugate vaccine in Niger, 2010-2018.
    Vaccine. 2020 Apr 20. pii: S0264-410X(20)30468.
    PubMed     Abstract available


  70. HOSANGADI D, Warmbrod KL, Martin EK, Adalja A, et al
    Enabling emergency mass vaccination: Innovations in manufacturing and administration during a pandemic.
    Vaccine. 2020 Apr 20. pii: S0264-410X(20)30530.
    PubMed    


  71. LAL M
    Freeze-dried tablets for oral vaccine delivery: Ease of administration and potential for production in existing facilities.
    Vaccine. 2020 Apr 19. pii: S0264-410X(20)30488.
    PubMed    


  72. LI YT, Luo XQ, Zhong XB, Cai LM, et al
    Seroprevalences of antibodies against pertussis, diphtheria, tetanus, measles, mumps and rubella: A cross-sectional study in children following vaccination procedure in Guangzhou, China.
    Vaccine. 2020 Apr 19. pii: S0264-410X(20)30445.
    PubMed     Abstract available


  73. KAUFMAN J, Attwell K, Tuckerman J, O'Sullivan J, et al
    Feasibility and acceptability of the multi-component P3-MumBubVax antenatal intervention to promote maternal and childhood vaccination: A pilot study.
    Vaccine. 2020 Apr 19. pii: S0264-410X(20)30469.
    PubMed     Abstract available


  74. LAZARUS DD, Peta F, Blight D, Van Heerden J, et al
    Efficacy of a foot-and-mouth disease vaccine against a heterologous SAT1 virus challenge in goats.
    Vaccine. 2020 Apr 17. pii: S0264-410X(20)30484.
    PubMed     Abstract available


  75. MUTSAERTS EAML, Nunes MC, Bhikha S, Ikulinda BT, et al
    Short-term immunogenicity and safety of hepatitis-A and varicella vaccines in HIV-exposed uninfected and HIV-unexposed South African children.
    Vaccine. 2020 Apr 16. pii: S0264-410X(20)30433.
    PubMed     Abstract available


  76. JUN JW, Kang JW, Giri SS, Yun S, et al
    Immunostimulation by starch hydrogel-based oral vaccine using formalin-killed cells against edwardsiellosis in Japanese eel, Anguilla japonica.
    Vaccine. 2020 Apr 16. pii: S0264-410X(20)30435.
    PubMed     Abstract available


  77. AVENDANO C, Celis-Giraldo C, Ordonez D, Diaz-Arevalo D, et al
    Evaluating the immunogenicity of chemically-synthesised peptides derived from foot-and-mouth disease VP1, VP2 and VP3 proteins as vaccine candidates.
    Vaccine. 2020 Apr 16. pii: S0264-410X(20)30464.
    PubMed     Abstract available


  78. HOQUE SA, Khandoker N, Thongprachum A, Khamrin P, et al
    Distribution of rotavirus genotypes in Japan from 2015 to 2018: Diversity in genotypes before and after introduction of rotavirus vaccines.
    Vaccine. 2020 Apr 16. pii: S0264-410X(20)30465.
    PubMed     Abstract available


  79. DIB F, le Sage FV, Cohen R, Launay O, et al
    Recommendation of HPV vaccination to boys in France - An unhappy coincidence with the WHO call to pause the implementation of this vaccination in boys.
    Vaccine. 2020 Apr 15. pii: S0264-410X(20)30487.
    PubMed    


  80. MORICONI A, Onnis V, Aggravi M, Parlati C, et al
    A new strategy for preparing a tailored meningococcal ACWY conjugate vaccine for clinical testing.
    Vaccine. 2020 Apr 13. pii: S0264-410X(20)30463.
    PubMed    


  81. CROSS JW, Joy M, McGee C, Akinyemi O, et al
    Adverse events of interest vary by influenza vaccine type and brand: Sentinel network study of eight seasons (2010-2018).
    Vaccine. 2020 Apr 13. pii: S0264-410X(20)30402.
    PubMed     Abstract available


  82. STAPLETON JT, Wagner N, Tuetken R, Bellamy AR, et al
    High dose trivalent influenza vaccine compared to standard dose vaccine in patients with rheumatoid arthritis receiving TNF-alpha inhibitor therapy and healthy controls: Results of the DMID 10-0076 randomized clinical trial.
    Vaccine. 2020 Apr 12. pii: S0264-410X(20)30459.
    PubMed     Abstract available


  83. JALLOH MF, Wallace AS, Bunnell RE, Carter RJ, et al
    Ebola vaccine? Family first! Evidence from using a brief measure on Ebola vaccine demand in a national household survey during the outbreak in Sierra Leone.
    Vaccine. 2020 Apr 11. pii: S0264-410X(20)30423.
    PubMed     Abstract available


  84. VESIKARI T, Forsten A, Laudat F, Li P, et al
    Long-term antibody persistence after a booster dose of quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine in healthy 5-year-old children.
    Vaccine. 2020 Apr 10. pii: S0264-410X(20)30227.
    PubMed     Abstract available


  85. CHANG CY, Cho CY, Lai CC, Lu CY, et al
    Immunogenicity and safety of a quadrivalent inactivated influenza vaccine in healthy subjects aged 3 to 17 years old: A phase III, open label, single-arm study.
    Vaccine. 2020 Apr 10. pii: S0264-410X(20)30437.
    PubMed     Abstract available


  86. TOTTERDELL J, Phillips A, Glover C, Chidwick K, et al
    Safety of live attenuated herpes zoster vaccine in adults 70-79 years: A self-controlled case series analysis using primary care data from Australia's MedicineInsight program.
    Vaccine. 2020 Apr 10. pii: S0264-410X(20)30443.
    PubMed     Abstract available


  87. LI Y, Lin Y, Xin G, Zhou X, et al
    Comparative evaluation of ELPylated virus-like particle vaccine with two commercial PCV2 vaccines by experimental challenge.
    Vaccine. 2020 Apr 10. pii: S0264-410X(20)30460.
    PubMed     Abstract available


  88. TAPIA MD, Doumbia M, Dembele R, Ball K, et al
    Arranging good clinical practices training and trial monitoring for a vaccine efficacy study during a public health emergency of international concern.
    Vaccine. 2020 Apr 10. pii: S0264-410X(20)30359.
    PubMed     Abstract available


  89. STIFTER K, Dekhtiarenko I, Krieger J, Tissot AC, et al
    A tumor-specific neoepitope expressed in homologous/self or heterologous/viral antigens induced comparable effector CD8(+) T-cell responses by DNA vaccination.
    Vaccine. 2020 Apr 9. pii: S0264-410X(20)30461.
    PubMed     Abstract available


  90. KIM JH, Lee H, Shin JY
    Bacillus Calmette-Guerin (BCG) vaccine safety surveillance in the Korea Adverse Event Reporting System using the tree-based scan statistic and conventional disproportionality-based algorithms.
    Vaccine. 2020 Apr 9. pii: S0264-410X(20)30466.
    PubMed     Abstract available


  91. JI YS, Park SK, Ryu S
    Whole leukemia cell vaccines: Past progress and future directions.
    Vaccine. 2020 Apr 9. pii: S0264-410X(20)30421.
    PubMed     Abstract available


  92. GARY E, O'Connor M, Chakhtoura M, Tardif V, et al
    Adenosine deaminase-1 enhances germinal center formation and functional antibody responses to HIV-1 Envelope DNA and protein vaccines.
    Vaccine. 2020 Apr 9. pii: S0264-410X(20)30436.
    PubMed     Abstract available


  93. DODD C, de Ridder M, Weibel D, Mahaux O, et al
    ADVANCE system testing: Estimating the incidence of adverse events following pertussis vaccination in healthcare databases with incomplete exposure data.
    Vaccine. 2020 Apr 9. pii: S0264-410X(20)30439.
    PubMed     Abstract available


  94. WANG S, Yang G, Nie J, Yang R, et al
    Recombinant E(rns)-E2 protein vaccine formulated with MF59 and CPG-ODN promotes T cell immunity against bovine viral diarrhea virus infection.
    Vaccine. 2020 Apr 9. pii: S0264-410X(20)30373.
    PubMed     Abstract available


  95. SINGH AK, Wang X, Sun W
    Oral vaccination with live attenuated Yersinia pseudotuberculosis strains delivering a FliC180-LcrV fusion antigen confers protection against pulmonary Y. Pestis infection.
    Vaccine. 2020 Apr 8. pii: S0264-410X(20)30444.
    PubMed     Abstract available


  96. MEITES E, Markowitz LE, Kempe A, O'Leary ST, et al
    Primary care physician support for harmonizing HPV vaccination recommendations across genders - United States, 2018.
    Vaccine. 2020 Apr 7. pii: S0264-410X(20)30417.
    PubMed     Abstract available


  97. SUGISHITA Y, Nakayama T, Sugawara T, Ohkusa Y, et al
    Negative effect on immune response of repeated influenza vaccination and waning effectiveness in interseason for elderly people.
    Vaccine. 2020 Apr 7. pii: S0264-410X(20)30378.
    PubMed     Abstract available


  98. SURAGH TA, Hibbs B, Marquez P, McNeil MM, et al
    Age inappropriate influenza vaccination in infants less than 6 months old, 2010-2018.
    Vaccine. 2020 Apr 6. pii: S0264-410X(20)30418.
    PubMed     Abstract available


  99. SAEZ-LLORENS X, Thierry-Carstensen B, Stoey LS, Sorensen C, et al
    Immunogenicity and safety of an adjuvanted inactivated polio vaccine, IPV-Al, following vaccination in children at 2, 4, 6 and at 15-18 months.
    Vaccine. 2020 Apr 6. pii: S0264-410X(20)30295.
    PubMed     Abstract available


  100. SCHMUHL NB, Mooney KE, Zhang X, Cooney LG, et al
    No association between HPV vaccination and infertility in U.S. females 18-33 years old.
    Vaccine. 2020 Apr 3. pii: S0264-410X(20)30414.
    PubMed     Abstract available


  101. GUTIERREZ RL, Porter CK, Jarell A, Alcala A, et al
    A grading system for local skin reactions developed for clinical trials of an intradermal and transcutaneous ETEC vaccine.
    Vaccine. 2020 Apr 3. pii: S0264-410X(20)30323.
    PubMed     Abstract available


    March 2020
  102. AHMED MA, Naus M, Singer J, Valiquette L, et al
    Investigating the association of receipt of seasonal influenza vaccine with occurrence of anesthesia/paresthesia and severe headaches, Canada 2012/13-2016/17, the Canadian Vaccine Safety Network.
    Vaccine. 2020 Mar 27. pii: S0264-410X(20)30371.
    PubMed     Abstract available


  103. CHANG LJ, Hedrick J, Christensen S, Pan J, et al
    A Phase II, randomized, immunogenicity and safety study of a quadrivalent meningococcal conjugate vaccine, MenACYW-TT, in healthy adolescents in the United States.
    Vaccine. 2020 Mar 21. pii: S0264-410X(20)30370.
    PubMed     Abstract available


  104. O'LEARY ST, Cataldi JR, Lindley MC, Hurley LP, et al
    Impact of media reports regarding influenza vaccine on obstetricians' vaccination practices.
    Vaccine. 2020 Mar 21. pii: S0264-410X(20)30263.
    PubMed     Abstract available


  105. DAYAN GH, Langevin E, Gilbert PB, Wu Y, et al
    Assessment of the long-term efficacy of a dengue vaccine against symptomatic, virologically-confirmed dengue disease by baseline dengue serostatus.
    Vaccine. 2020 Mar 20. pii: S0264-410X(20)30384.
    PubMed     Abstract available


  106. SUO L, Lu L, Zhao D, Pang X, et al
    Impact of a 2-dose voluntary vaccination strategy on varicella epidemiology in Beijing, 2011-2017.
    Vaccine. 2020 Mar 20. pii: S0264-410X(20)30140.
    PubMed     Abstract available


  107. WILSON-WELDER JH, Boggiatto P, Nally JE, Wafa EI, et al
    Bovine immune response to leptospira antigen in different novel adjuvants and vaccine delivery platforms.
    Vaccine. 2020 Mar 20. pii: S0264-410X(20)30333.
    PubMed     Abstract available


  108. IKILEZI G, Augusto OJ, Sbarra A, Sherr K, et al
    Determinants of geographical inequalities for DTP3 vaccine coverage in sub-Saharan Africa.
    Vaccine. 2020 Mar 20. pii: S0264-410X(20)30338.
    PubMed     Abstract available


  109. WOESTENBERG PJ, van Benthem BHB, Bogaards JA, King AJ, et al
    HPV infections among young MSM visiting sexual health centers in the Netherlands: Opportunities for targeted HPV vaccination.
    Vaccine. 2020 Mar 19. pii: S0264-410X(20)30330.
    PubMed     Abstract available


  110. SANDO E, Suzuki M, Furumoto A, Asoh N, et al
    Corrigendum to "Impact of the pediatric 13-valent pneumococcal conjugate vaccine on serotype distribution and clinical characteristics of pneumococcal pneumonia in adults: The Japan Pneumococcal Vaccine Effectiveness Study (J-PAVE)" [Vaccine 37 (2019)
    Vaccine. 2020 Mar 19. pii: S0264-410X(20)30397.
    PubMed    


  111. QAMAR FN, Yousafzai MT, Khaliq A, Karim S, et al
    Adverse events following immunization with typhoid conjugate vaccine in an outbreak setting in Hyderabad, Pakistan.
    Vaccine. 2020 Mar 19. pii: S0264-410X(20)30383.
    PubMed     Abstract available


  112. SHI S, Liang Z, Sun B
    Response to comment on: Vaccine adjuvants: Understanding the structure and mechanism of adjuvanticity.
    Vaccine. 2020;38:2759.
    PubMed    


  113. SCHUERMAN L
    Reply to Shuting Shi et al., Vaccine adjuvants: Understanding the structure and mechanism of adjuvanticity (Vaccine 2019;37 (24):3167-3178).
    Vaccine. 2020;38:2758.
    PubMed    


  114. LANE MC, Gordon JL, Jiang C, Leitner WW, et al
    Workshop report: Optimization of animal models to better predict influenza vaccine efficacy.
    Vaccine. 2020;38:2751-2757.
    PubMed     Abstract available


  115. NEUMANN G, Kawaoka Y
    Optimization of animal models to better predict influenza vaccine efficacy (VA).
    Vaccine. 2020;38:2749-2750.
    PubMed    


  116. MURAKAMI K, Fujii Y, Someya Y
    Effects of the thermal denaturation of Sabin-derived inactivated polio vaccines on the D-antigenicity and the immunogenicity in rats.
    Vaccine. 2020 Mar 17. pii: S0264-410X(20)30380.
    PubMed     Abstract available


  117. ASANTE KP, Ansong D, Kaali S, Adjei S, et al
    Immunogenicity and safety of the RTS,S/AS01 malaria vaccine co-administered with measles, rubella and yellow fever vaccines in Ghanaian children: A phase IIIb, multi-center, non-inferiority, randomized, open, controlled trial.
    Vaccine. 2020 Mar 16. pii: S0264-410X(20)30358.
    PubMed     Abstract available


  118. BENZAKEN CL, Miller JD, Onono M, Young SL, et al
    Development of a cumulative metric of vaccination adherence behavior and its application among a cohort of 12-month-olds in western Kenya.
    Vaccine. 2020 Mar 14. pii: S0264-410X(20)30355.
    PubMed     Abstract available


  119. RUANSIT W, Charerntantanakul W
    Oral supplementation of quercetin in PRRSV-1 modified-live virus vaccinated pigs in response to HP-PRRSV-2 challenge.
    Vaccine. 2020 Mar 14. pii: S0264-410X(20)30372.
    PubMed     Abstract available


  120. FEYSSAGUET M, Berthold V, Helle L, Povey M, et al
    Comparison of a glycoprotein E-based ELISA with a varicella-zoster whole-virus ELISA for the quantification of varicella vaccine immune responses in young children.
    Vaccine. 2020 Mar 14. pii: S0264-410X(20)30352.
    PubMed     Abstract available


  121. SUNDARAM AK, Ewing D, Blevins M, Liang Z, et al
    Comparison of purified psoralen-inactivated and formalin-inactivated dengue vaccines in mice and nonhuman primates.
    Vaccine. 2020 Mar 14. pii: S0264-410X(20)30351.
    PubMed     Abstract available


  122. HUANG K, Tao S, Zhou X, Mo J, et al
    Incidence rates of health outcomes of interest among Chinese children exposed to selected vaccines in Yinzhou Electronic Health Records: A population-based retrospective cohort study.
    Vaccine. 2020 Mar 13. pii: S0264-410X(20)30357.
    PubMed     Abstract available


  123. YANG YT, Pendo E, Reiss DR
    The Americans with disabilities act and healthcare employer-mandated vaccinations.
    Vaccine. 2020 Mar 13. pii: S0264-410X(20)30356.
    PubMed    


  124. OESTERREICH S, Lindemann M, Goldblatt D, Horn PA, et al
    Humoral response to a 13-valent pneumococcal conjugate vaccine in kidney transplant recipients.
    Vaccine. 2020 Mar 13. pii: S0264-410X(20)30335.
    PubMed     Abstract available


  125. DIAMOS AG, Pardhe MD, Sun H, Hunter JGL, et al
    Codelivery of improved immune complex and virus-like particle vaccines containing Zika virus envelope domain III synergistically enhances immunogenicity.
    Vaccine. 2020 Mar 12. pii: S0264-410X(20)30337.
    PubMed     Abstract available


  126. COLRAIN P, Chang Blanc D, Grundy J, Kone S, et al
    The binomial nature of immunization session size distributions and the implications for vaccine wastage.
    Vaccine. 2020 Mar 11. pii: S0264-410X(20)30292.
    PubMed     Abstract available


  127. RUSCIO B, Bolster A, Bresee J
    Shaping meeting to explore the value of a coordinated work plan for epidemic and pandemic influenza vaccine preparedness.
    Vaccine. 2020 Mar 11. pii: S0264-410X(20)30247.
    PubMed     Abstract available


  128. BARTSCH SM, Stokes-Cawley OJ, Buekens P, Asti L, et al
    The potential economic value of a therapeutic Chagas disease vaccine for pregnant women to prevent congenital transmission.
    Vaccine. 2020 Mar 11. pii: S0264-410X(20)30322.
    PubMed     Abstract available


  129. KUTER BJ, Offit P
    Celebrating the Centennial of the Birth of the World's Greatest Vaccinologist, Maurice R. Hilleman, 1919-2005.
    Vaccine. 2020 Mar 11. pii: S0264-410X(20)30303.
    PubMed    


  130. BRAEYE T, Emborg HD, Llorente-Garcia A, Huerta C, et al
    Age-specific vaccination coverage estimates for influenza, human papillomavirus and measles containing vaccines from seven population-based healthcare databases from four EU countries - The ADVANCE project.
    Vaccine. 2020 Mar 11. pii: S0264-410X(20)30326.
    PubMed     Abstract available


  131. LACOUR M, Davis T
    Vaccine skepticism reflects basic cognitive differences in mortality-related event frequency estimation.
    Vaccine. 2020 Mar 10. pii: S0264-410X(20)30264.
    PubMed     Abstract available


  132. CHO HK, Kang YM, Kim HM, Lee CH, et al
    Sales and immunogenicity of commercial vaccines to H9N2 low pathogenic avian influenza virus in Korea from 2007 to 2017.
    Vaccine. 2020 Mar 10. pii: S0264-410X(20)30328.
    PubMed     Abstract available


  133. CARIAS C, Hills SL, Kahn EB, Adhikari BB, et al
    Comparative economic analysis of strategies for Japanese encephalitis vaccination of U.S. travelers.
    Vaccine. 2020 Mar 10. pii: S0264-410X(20)30229.
    PubMed     Abstract available


  134. BERAN J, Leroux-Roels G, Van Damme P, de Hoon J, et al
    Safety and immunogenicity of fully liquid and lyophilized formulations of an investigational trivalent group B streptococcus vaccine in healthy non-pregnant women: Results from a randomized comparative phase II trial.
    Vaccine. 2020 Mar 10. pii: S0264-410X(20)30331.
    PubMed     Abstract available


  135. BARTHOLOMEUS E, De Neuter N, Suls A, Elias G, et al
    Transcriptomic profiling of different responder types in adults after a Priorix(R) vaccination.
    Vaccine. 2020 Mar 9. pii: S0264-410X(20)30336.
    PubMed     Abstract available


  136. DANCHIN MH, Bines JE, Watts E, Cowley D, et al
    Rotavirus specific maternal antibodies and immune response to RV3-BB rotavirus vaccine in central java and yogyakarta, Indonesia.
    Vaccine. 2020 Mar 9. pii: S0264-410X(20)30334.
    PubMed     Abstract available


  137. YU H, Karunakaran KP, Jiang X, Chan Q, et al
    Comparison of Chlamydia outer membrane complex to recombinant outer membrane proteins as vaccine.
    Vaccine. 2020 Mar 6. pii: S0264-410X(20)30282.
    PubMed     Abstract available


  138. MCCLYMONT E, Ogilvie G, Albert A, Johnston A, et al
    Impact of quadrivalent HPV vaccine dose spacing on immunologic response in women living with HIV.
    Vaccine. 2020 Mar 5. pii: S0264-410X(20)30319.
    PubMed     Abstract available


  139. AHMED N, Giorgakoudi K, Usuf E, Okomo U, et al
    Potential cost-effectiveness of a maternal Group B streptococcal vaccine in The Gambia.
    Vaccine. 2020 Mar 5. pii: S0264-410X(20)30302.
    PubMed     Abstract available


  140. MENZIES R, Heron L, Lampard J, McMillan M, et al
    A randomised controlled trial of SMS messaging and calendar reminders to improve vaccination timeliness in infants.
    Vaccine. 2020 Mar 5. pii: S0264-410X(20)30257.
    PubMed     Abstract available


  141. MOUNIER-JACK S, Bell S, Chantler T, Edwards A, et al
    Organisational factors affecting performance in delivering influenza vaccination to staff in NHS Acute Hospital Trusts in England: A qualitative study.
    Vaccine. 2020 Mar 5. pii: S0264-410X(20)30321.
    PubMed     Abstract available


  142. BELONGIA EA, Levine MZ, Olaiya O, Gross FL, et al
    Clinical trial to assess immunogenicity of high-dose, adjuvanted, and recombinant influenza vaccines against cell-grown A(H3N2) viruses in adults 65 to 74 years, 2017-2018.
    Vaccine. 2020 Mar 4. pii: S0264-410X(20)30278.
    PubMed     Abstract available


  143. LIU M, Zhong Y, Chen J, Liu Y, et al
    Oral immunization of mice with a multivalent therapeutic subunit vaccine protects against Helicobacter pylori infection.
    Vaccine. 2020 Mar 2. pii: S0264-410X(20)30245.
    PubMed     Abstract available


  144. MORAN EB, Wagner AL, Asiedu-Bekoe F, Abdul-Karim A, et al
    Socioeconomic characteristics associated with the introduction of new vaccines and full childhood vaccination in Ghana, 2014.
    Vaccine. 2020 Mar 2. pii: S0264-410X(20)30293.
    PubMed     Abstract available


    February 2020
  145. SONG Y, Yang Y, Lin X, Li X, et al
    In-situ and sensitive stability study of emulsion and aluminum adjuvanted inactivated foot-and-mouth disease virus vaccine by differential scanning fluorimetry analysis.
    Vaccine. 2020 Feb 29. pii: S0264-410X(20)30297.
    PubMed     Abstract available


  146. LIN Y, Lin Z, He F, Chen H, et al
    HPV vaccination intent and willingness to pay for 2-,4-, and 9-valent HPV vaccines: A study of adult women aged 27-45 years in China.
    Vaccine. 2020 Feb 29. pii: S0264-410X(20)30254.
    PubMed     Abstract available


  147. SHU J, Shen W, Liu H, Zhou Y, et al
    The immunologic dominance of an epitope within a rationally designed poly-epitope vaccine is influenced by multiple factors.
    Vaccine. 2020 Feb 29. pii: S0264-410X(20)30298.
    PubMed     Abstract available


  148. CHASE-TOPPING M, Xie J, Pooley C, Trus I, et al
    New insights about vaccine effectiveness: Impact of attenuated PRRS-strain vaccination on heterologous strain transmission.
    Vaccine. 2020 Feb 28. pii: S0264-410X(20)30188.
    PubMed     Abstract available


  149. UTAZI CE, Wagai J, Pannell O, Cutts FT, et al
    Geospatial variation in measles vaccine coverage through routine and campaign strategies in Nigeria: Analysis of recent household surveys.
    Vaccine. 2020 Feb 28. pii: S0264-410X(20)30301.
    PubMed     Abstract available


  150. ARIS E, Montourcy M, Esterberg E, Kurosky SK, et al
    The adult vaccination landscape in the United States during the Affordable Care Act era: Results from a large retrospective database analysis.
    Vaccine. 2020 Feb 27. pii: S0264-410X(20)30280.
    PubMed     Abstract available


  151. NABER SK, Bruijning-Verhagen PCJL, de Hoog MLA, van Giessen A, et al
    Cost-effectiveness of inactivated influenza vaccination in children with medical risk conditions in the Netherlands.
    Vaccine. 2020 Feb 27. pii: S0264-410X(20)30084.
    PubMed     Abstract available


  152. SELVEY LA, Roux F, Burns S
    Potential process improvements to increase coverage of human papillomavirus vaccine in schools - A focus on schools with low vaccine uptake.
    Vaccine. 2020 Feb 27. pii: S0264-410X(20)30259.
    PubMed     Abstract available


  153. FERREIRA VM, Ferreira IE, Chang HY, Nunes AMPB, et al
    Meningococcal carriage in young adults six years after meningococcal C conjugate (MCC) vaccine catch-up campaign in Salvador, Brazil.
    Vaccine. 2020 Feb 27. pii: S0264-410X(20)30262.
    PubMed     Abstract available


  154. KALLIGEROS M, Shehadeh F, Mylona EK, Dapaah-Afriyie C, et al
    Influenza vaccine effectiveness against influenza-associated hospitalization in children: A systematic review and meta-analysis.
    Vaccine. 2020 Feb 27. pii: S0264-410X(20)30261.
    PubMed     Abstract available


  155. ZAHN T, Akhras S, Spengler C, Murra RO, et al
    A new approach for therapeutic vaccination against chronic HBV infections.
    Vaccine. 2020 Feb 26. pii: S0264-410X(20)30291.
    PubMed     Abstract available


  156. ELKIN LE, Pullon SRH, Stubbe MH
    'Should I vaccinate my child?' comparing the displayed stances of vaccine information retrieved from Google, Facebook and YouTube.
    Vaccine. 2020 Feb 25. pii: S0264-410X(20)30253.
    PubMed     Abstract available


  157. HASAN AZ, Saha S, Saha SK, Sahakyan G, et al
    Corrigendum to "Using pneumococcal and rotavirus surveillance in vaccine decision-making: A series of case studies in Bangladesh, Armenia and the Gambia" [Vaccine 36 (2018) 4939-4943].
    Vaccine. 2020 Feb 25. pii: S0264-410X(20)30230.
    PubMed    


  158. LEIDNER AJ, Fisun H, Trimble S, Lucas P, et al
    Evaluation of temperature stability among different types and grades of vaccine storage units: Data from continuous temperature monitoring devices.
    Vaccine. 2020 Feb 25. pii: S0264-410X(20)30255.
    PubMed     Abstract available


  159. JOHNSON DM, Jokinen JD, Wang M, Pfeffer T, et al
    Bivalent Junin & Machupo experimental vaccine based on alphavirus RNA replicon vector.
    Vaccine. 2020 Feb 25. pii: S0264-410X(20)30265.
    PubMed     Abstract available


  160. WHITBY PW, Morton DJ, Mussa HJ, Mirea L, et al
    A bacterial vaccine polypeptide protective against nontypable Haemophilus influenzae.
    Vaccine. 2020 Feb 25. pii: S0264-410X(20)30277.
    PubMed     Abstract available


  161. ASHBAUGH HR, Cherry JD, Hoff NA, Doshi RH, et al
    Measles antibody levels among vaccinated and unvaccinated children 6-59months of age in the Democratic Republic of the Congo, 2013-2014.
    Vaccine. 2020;38:2258-2265.
    PubMed     Abstract available


  162. ANDREWS N, Stowe J, Walker J, Thomas S, et al
    Response to Letter to the editor by Signe Sorup re: The risk of non-specific hospitalised infections following MMR vaccination given with and without inactivated vaccines in the second year of life. Comparative self-controlled case-series study in Eng
    Vaccine. 2020;38:2116.
    PubMed    


  163. SORUP S
    Careful consideration of hypotheses and model assumptions in study of non-specific effects of vaccines.
    Vaccine. 2020;38:2115.
    PubMed    


  164. BLYTH CC, Cheng AC, Crawford NW, Clark JE, et al
    The impact of new universal child influenza programs in Australia: Vaccine coverage, effectiveness and disease epidemiology in hospitalised children in 2018.
    Vaccine. 2020 Feb 24. pii: S0264-410X(20)30228.
    PubMed     Abstract available


  165. MUELLER S, Stauft CB, Kalkeri R, Koidei F, et al
    A codon-pair deoptimized live-attenuated vaccine against respiratory syncytial virus is immunogenic and efficacious in non-human primates.
    Vaccine. 2020 Feb 24. pii: S0264-410X(20)30279.
    PubMed     Abstract available


  166. DUDLEY MZ, Limaye RJ, Omer SB, O'Leary ST, et al
    Factors associated with referring close contacts to an app with individually-tailored vaccine information.
    Vaccine. 2020 Feb 22. pii: S0264-410X(20)30206.
    PubMed     Abstract available


  167. COLEY KC, Gessler C, McGivney M, Richardson R, et al
    Increasing adult vaccinations at a regional supermarket chain pharmacy: A multi-site demonstration project.
    Vaccine. 2020 Feb 21. pii: S0264-410X(20)30252.
    PubMed     Abstract available


  168. KASEREKA MC, Ericson AD, Conroy AL, Tumba L, et al
    Prior vaccination with recombinant Vesicular Stomatitis Virus - Zaire Ebolavirus vaccine is associated with improved survival among patients with Ebolavirus infection.
    Vaccine. 2020 Feb 21. pii: S0264-410X(20)30256.
    PubMed     Abstract available


  169. QIU Y, Zhao Y, Liu F, Ye B, et al
    Evaluation of Plasmodium vivax HAP2 as a transmission-blocking vaccine candidate.
    Vaccine. 2020 Feb 21. pii: S0264-410X(20)30184.
    PubMed     Abstract available


  170. HU D, Martin C, Dredze M, Broniatowski DA, et al
    Chinese social media suggest decreased vaccine acceptance in China: An observational study on Weibo following the 2018 Changchun Changsheng vaccine incident.
    Vaccine. 2020 Feb 21. pii: S0264-410X(20)30224.
    PubMed     Abstract available


  171. LOCKYER K, Gao F, Francis RJ, Eastwood D, et al
    Higher mass meningococcal group C-tetanus toxoid vaccines conjugated with carbodiimide correlate with greater immunogenicity.
    Vaccine. 2020 Feb 20. pii: S0264-410X(20)30185.
    PubMed     Abstract available


  172. MCDONALD SL, Weldon WC, Wei L, Chen Q, et al
    Neutralization capacity of highly divergent type 2 vaccine-derived polioviruses from immunodeficient patients.
    Vaccine. 2020 Feb 20. pii: S0264-410X(20)30244.
    PubMed     Abstract available


  173. KABORE L, Meda CZ, Sawadogo F, Bengue MM, et al
    Quality and reliability of vaccination documentation in the routine childhood immunization program in Burkina Faso: Results from a cross-sectional survey.
    Vaccine. 2020 Feb 20. pii: S0264-410X(20)30220.
    PubMed     Abstract available


  174. GORMAN DR, Bielecki K, Larson HJ, Willocks LJ, et al
    Comparing vaccination hesitancy in Polish migrant parents who accept or refuse nasal flu vaccination for their children.
    Vaccine. 2020 Feb 20. pii: S0264-410X(20)30225.
    PubMed     Abstract available


  175. ALBERSHARDT TC, Parsons AJ, Reeves RS, Flynn PA, et al
    Therapeutic efficacy of PD1/PDL1 blockade in B16 melanoma is greatly enhanced by immunization with dendritic cell-targeting lentiviral vector and protein vaccine.
    Vaccine. 2020 Feb 19. pii: S0264-410X(20)30243.
    PubMed     Abstract available


  176. CHURCH JA, Chasekwa B, Rukobo S, Govha M, et al
    Predictors of oral rotavirus vaccine immunogenicity in rural Zimbabwean infants.
    Vaccine. 2020 Feb 19. pii: S0264-410X(20)30150.
    PubMed     Abstract available


  177. ZHOU Y, Lin YF, Meng X, Duan Q, et al
    Anal human papillomavirus among men who have sex with men in three metropolitan cities in southern China: implications for HPV vaccination.
    Vaccine. 2020 Feb 19. pii: S0264-410X(20)30176.
    PubMed     Abstract available


  178. VODICKA E, Zimmermann M, Lopez AL, Silva MW, et al
    Japanese encephalitis vaccination in the Philippines: A cost-effectiveness analysis comparing alternative delivery strategies.
    Vaccine. 2020 Feb 18. pii: S0264-410X(20)30205.
    PubMed     Abstract available


  179. TRETYAKOVA I, Plante KS, Rossi SL, Lawrence HWS, et al
    Venezuelan equine encephalitis vaccine with rearranged genome resists reversion and protects non-human primates from viremia after aerosol challenge.
    Vaccine. 2020 Feb 18. pii: S0264-410X(20)30173.
    PubMed     Abstract available


  180. DAVIS H, Dow T, Isopi L, Blue JT, et al
    Examination of the effect of agitation on the potency of the Ebola Zaire vaccine rVSVDeltaG-ZEBOV-GP.
    Vaccine. 2020 Feb 18. pii: S0264-410X(20)30155.
    PubMed     Abstract available


  181. LANGSAM D, Anis E, Haas EJ, Gosinov R, et al
    Tdap vaccination during pregnancy interrupts a twenty-year increase in the incidence of pertussis.
    Vaccine. 2020 Feb 15. pii: S0264-410X(20)30148.
    PubMed     Abstract available


  182. MADHI SA, Izu A, Violari A, Cotton MF, et al
    Effect of HIV-exposure and timing of antiretroviral treatment initiation in children living with HIV on antibody persistence and memory responses to Haemophilus influenzae type b and pneumococcal polysaccharide-protein conjugate vaccines.
    Vaccine. 2020 Feb 15. pii: S0264-410X(20)30223.
    PubMed     Abstract available


  183. SOMPAGDEE N, Anuwutnavin S, Phongsamart W, Senawong S, et al
    Seroprevalence of Bordetella pertussis antibodies and anti-pertussis antibody response after a single dose of reduced-antigen combined diphtheria, tetanus, and acellular pertussis vaccine (Tdap) in pregnant Thai women.
    Vaccine. 2020 Feb 15. pii: S0264-410X(20)30116.
    PubMed     Abstract available


  184. HOSCHLER K, Maharjan S, Whitaker H, Southern J, et al
    Use of traditional serological methods and oral fluids to assess immunogenicity in children aged 2-16 years after successive annual vaccinations with LAIV.
    Vaccine. 2020 Feb 15. pii: S0264-410X(20)30221.
    PubMed     Abstract available


  185. MOHAMMED H, Roberts CT, Grzeskowiak LE, Giles L, et al
    Psychosocial determinants of pertussis and influenza vaccine uptake in pregnant women: A prospective study.
    Vaccine. 2020 Feb 15. pii: S0264-410X(20)30217.
    PubMed     Abstract available


  186. KOIVUMAGI K, Toompere K, Soeorg H, Kallas E, et al
    Acute gastroenteritis hospitalizations after implementation of universal mass vaccination against rotavirus.
    Vaccine. 2020 Feb 14. pii: S0264-410X(20)30151.
    PubMed     Abstract available


  187. XU Q, Cao Q, Yang W, Liu X, et al
    Interchangeability of two Enterovirus 71 inactivated vaccines in Chinese children: A phase IV, open-label, and randomized controlled trial.
    Vaccine. 2020 Feb 14. pii: S0264-410X(20)30186.
    PubMed     Abstract available


  188. SIGURDSSON S, Eythorsson E, Erlendsdottir H, Hrafnkelsson B, et al
    Impact of the 10-valent pneumococcal conjugate vaccine on hospital admissions in children under three years of age in Iceland.
    Vaccine. 2020 Feb 13. pii: S0264-410X(20)30147.
    PubMed     Abstract available


  189. VAN DEN BOOGAARD J, Rots NY, van der Klis F, de Melker HE, et al
    Is there an association between socioeconomic status and immune response to infant and childhood vaccination in the Netherlands?
    Vaccine. 2020 Feb 13. pii: S0264-410X(20)30113.
    PubMed     Abstract available


  190. STEINICHE MM, Thysen SM, Jensen AKG, Rodrigues A, et al
    The effect of early measles vaccination on morbidity and growth: A randomised trial from Guinea-Bissau.
    Vaccine. 2020 Feb 12. pii: S0264-410X(20)30149.
    PubMed     Abstract available


  191. DI LELLO FA, Blejer J, Alter A, Bartoli S, et al
    Hepatitis B surface antibodies seroprevalence among people born before and after implementation of universal HBV vaccination.
    Vaccine. 2020 Feb 12. pii: S0264-410X(20)30187.
    PubMed     Abstract available


  192. STURKENBOOM M, Braeye T, van der Aa L, Danieli G, et al
    ADVANCE database characterisation and fit for purpose assessment for multi-country studies on the coverage, benefits and risks of pertussis vaccinations.
    Vaccine. 2020 Feb 12. pii: S0264-410X(20)30153.
    PubMed     Abstract available


  193. SHARON AJ, Yom-Tov E, Baram-Tsabari A
    Vaccine information seeking on social Q&A services.
    Vaccine. 2020 Feb 12. pii: S0264-410X(20)30177.
    PubMed     Abstract available


  194. BRANDON D, Kimmel M, Kuriyakose SO, Kostanyan L, et al
    Corrigendum to 'Antibody persistence and safety and immunogenicity of a second booster dose nine years after a first booster vaccination with a reduced antigen diphtheria-tetanus-acellular pertussis vaccine (Tdap) in adults'. [Vaccine 36 (2018) 6325-6
    Vaccine. 2020 Feb 12. pii: S0264-410X(20)30134.
    PubMed    


  195. YU X, Zhang T, Cui L, Geng X, et al
    Corrigendum to "Epidemiology study of pediatric primary intussusception aged </=24 months in pre-rotavirus vaccine era of Jinan, China" [Vaccine 37(11) (2019) 1436-1442].
    Vaccine. 2020 Feb 11. pii: S0264-410X(20)30111.
    PubMed    


  196. BUTTENHEIM AM, Joyce CM, Ibarra J, Agas J, et al
    Vaccine exemption requirements and parental vaccine attitudes: an online experiment.
    Vaccine. 2020 Feb 11. pii: S0264-410X(20)30050.
    PubMed     Abstract available


  197. SAMY N, Reichhardt D, Schmidt D, Chen LM, et al
    Safety and immunogenicity of novel modified vaccinia Ankara-vectored RSV vaccine: A randomized phase I clinical trial.
    Vaccine. 2020 Feb 11. pii: S0264-410X(20)30081.
    PubMed     Abstract available


  198. OVERTON ET, Lawrence SJ, Stapleton JT, Weidenthaler H, et al
    A randomized phase II trial to compare safety and immunogenicity of the MVA-BN smallpox vaccine at various doses in adults with a history of AIDS.
    Vaccine. 2020 Feb 11. pii: S0264-410X(20)30085.
    PubMed     Abstract available


  199. ESPARZA J
    Three different paths to introduce the smallpox vaccine in early 19th century United States.
    Vaccine. 2020 Feb 11. pii: S0264-410X(20)30119.
    PubMed     Abstract available


  200. LI S, Yang Y, Lin X, Li Z, et al
    Biocompatible cationic solid lipid nanoparticles as adjuvants effectively improve humoral and T cell immune response of foot and mouth disease vaccines.
    Vaccine. 2020 Feb 10. pii: S0264-410X(20)30157.
    PubMed     Abstract available


  201. GARY EN, Kathuria N, Makurumidze G, Curatola A, et al
    CCR10 expression is required for the adjuvant activity of the mucosal chemokine CCL28 when delivered in the context of an HIV-1 Env DNA vaccine.
    Vaccine. 2020 Feb 10. pii: S0264-410X(20)30038.
    PubMed     Abstract available


  202. DE SCHRYVER A, Lambaerts T, Lammertyn N, Francois G, et al
    European survey of hepatitis B vaccination policies for healthcare workers: An updated overview.
    Vaccine. 2020 Feb 10. pii: S0264-410X(20)30156.
    PubMed     Abstract available


  203. JENSEN SK, Jensen TM, Birk NM, Stensballe LG, et al
    Bacille Calmette-Guerin vaccination at birth and differential white blood cell count in infancy. A randomised clinical trial.
    Vaccine. 2020 Feb 10. pii: S0264-410X(20)30171.
    PubMed     Abstract available


  204. BECERRA-CULQUI TA, Sy LS, Ackerson BK, Chen LH, et al
    Safety of MenACWY-CRM vaccine exposure during pregnancy.
    Vaccine. 2020 Feb 10. pii: S0264-410X(20)30175.
    PubMed     Abstract available


  205. FAN J, Cong S, Wang N, Bao H, et al
    Influenza vaccination rate and its association with chronic diseases in China: Results of a national cross-sectional study.
    Vaccine. 2020 Feb 8. pii: S0264-410X(20)30146.
    PubMed     Abstract available


  206. LIU CH, Yeh YC, Huang WT, Chie WC, et al
    Assessment of pre-specified adverse events following varicella vaccine: A population-based self-controlled risk interval study.
    Vaccine. 2020 Feb 8. pii: S0264-410X(20)30143.
    PubMed     Abstract available


  207. JUAN-GINER A, Alsalhani A, Panunzi I, Lambert V, et al
    Evaluation of the stability of measles vaccine out of the cold chain under extended controlled temperature conditions.
    Vaccine. 2020 Feb 8. pii: S0264-410X(20)30158.
    PubMed     Abstract available


  208. BEAL JL, Kadakia NN, Reed JB, Illingworth Plake KS, et al
    Pharmacists' impact on older adults' access to vaccines in the United States.
    Vaccine. 2020 Feb 8. pii: S0264-410X(20)30088.
    PubMed     Abstract available


  209. EMERSON A, Allison M, Kelly PJ, Ramaswamy M, et al
    Barriers and facilitators of implementing a collaborative HPV vaccine program in an incarcerated population: A case study.
    Vaccine. 2020 Feb 8. pii: S0264-410X(20)30138.
    PubMed     Abstract available


  210. YANG H, Fan F, Liu L, Liu J, et al
    A novel amino acid site closely associated with the neurovirulence of live, attenuated Japanese encephalitis vaccine (SA14-14-2 strain).
    Vaccine. 2020 Feb 7. pii: S0264-410X(20)30009.
    PubMed     Abstract available


  211. KUBA Y, Kyan H, Iha Y, Kato T, et al
    Emergent measles-containing vaccination recommendation for aged 6-11 months and detection of vaccine-associated measles during a large measles outbreak in Okinawa, Japan, in 2018.
    Vaccine. 2020 Feb 6. pii: S0264-410X(20)30105.
    PubMed     Abstract available


  212. MATTHIAS KA, Reveille A, Connolly KL, Jerse AE, et al
    Deletion of major porins from meningococcal outer membrane vesicle vaccines enhances reactivity against heterologous serogroup B Neisseria meningitidis strains.
    Vaccine. 2020 Feb 6. pii: S0264-410X(20)30053.
    PubMed     Abstract available


  213. HENDRY AJ, Beard FH, Dey A, Quinn H, et al
    Lower immunity to poliomyelitis viruses in Australian young adults not eligible for inactivated polio vaccine.
    Vaccine. 2020 Feb 6. pii: S0264-410X(20)30122.
    PubMed     Abstract available


  214. PULLAGURA GR, Violette R, Houle SKD, Waite NM, et al
    Shades of gray in vaccination decisions - Understanding community pharmacists' perspectives of, and experiences with, influenza vaccine hesitancy in Ontario, Canada.
    Vaccine. 2020 Feb 6. pii: S0264-410X(20)30137.
    PubMed     Abstract available


  215. MOREIRA C JR, Ferreira MRA, Finger PF, Magalhaes CG, et al
    Protective efficacy of recombinant bacterin vaccine against botulism in cattle.
    Vaccine. 2020 Feb 6. pii: S0264-410X(20)30142.
    PubMed     Abstract available


  216. VANDERVEN HA, Barr I, Reynaldi A, Wheatley AK, et al
    Fc functional antibody responses to adjuvanted versus unadjuvanted seasonal influenza vaccination in community-dwelling older adults.
    Vaccine. 2020 Feb 5. pii: S0264-410X(20)30104.
    PubMed     Abstract available


  217. DURRHEIM DN
    Measuring equitable delivery of vaccines.
    Vaccine. 2020 Feb 5. pii: S0264-410X(20)30152.
    PubMed    


  218. MADHI SA, Moreira M, Koen A, van Niekerk N, et al
    Impact of HIV status and vaccination schedule on bacterial nasopharyngeal carriage following infant immunisation with the pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine in South Africa.
    Vaccine. 2020 Feb 5. pii: S0264-410X(20)30100.
    PubMed     Abstract available


  219. REISS DR, Offit PA
    Improving vaccine policy making: A dose of reality.
    Vaccine. 2020 Feb 5. pii: S0264-410X(20)30051.
    PubMed    


  220. HALES C, Jochems SP, Robinson R, Solorzano C, et al
    Symptoms associated with influenza vaccination and experimental human pneumococcal colonisation of the nasopharynx.
    Vaccine. 2020 Feb 4. pii: S0264-410X(20)30112.
    PubMed     Abstract available


  221. CAMARGOS P, Nascimento-Carvalho CM, Teixeira R, Franca E, et al
    Lower respiratory infections mortality among Brazilians under-five before and after national pneumococcal conjugate vaccine implementation.
    Vaccine. 2020 Feb 4. pii: S0264-410X(20)30136.
    PubMed     Abstract available


  222. MOURATIDOU E, Lambrou A, Andreopoulou A, Gioula G, et al
    Influenza vaccine effectiveness against hospitalization with laboratory-confirmed influenza in Greece: A pooled analysis across six seasons, 2013-2014 to 2018-2019.
    Vaccine. 2020 Feb 4. pii: S0264-410X(20)30135.
    PubMed     Abstract available


  223. PERRY MR, Ionin B, Barnewall RE, Vassar ML, et al
    Development of a guinea pig inhalational anthrax model for evaluation of post-exposure prophylaxis efficacy of anthrax vaccines.
    Vaccine. 2020 Feb 3. pii: S0264-410X(20)30106.
    PubMed     Abstract available


  224. MUHSEN K, Haklai Z, Applbaum Y, Gordon ES, et al
    Effects of rotavirus vaccine on all-cause acute gastroenteritis and rotavirus hospitalizations in Israel: A nationwide analysis.
    Vaccine. 2020 Feb 3. pii: S0264-410X(20)30049.
    PubMed     Abstract available


  225. THOMPSON EL, Wheldon CW, Rosen BL, Maness SB, et al
    Awareness and knowledge of HPV and HPV vaccination among adults ages 27-45 years.
    Vaccine. 2020 Feb 3. pii: S0264-410X(20)30079.
    PubMed     Abstract available


  226. YUFIKA A, Wagner AL, Nawawi Y, Wahyuniati N, et al
    Parents' hesitancy towards vaccination in Indonesia: A cross-sectional study in Indonesia.
    Vaccine. 2020 Feb 1. pii: S0264-410X(20)30114.
    PubMed     Abstract available


  227. BAKER MA, Jankosky C, Yih WK, Gruber S, et al
    The risk of febrile seizures following influenza and 13-valent pneumococcal conjugate vaccines.
    Vaccine. 2020 Feb 1. pii: S0264-410X(20)30072.
    PubMed     Abstract available


  228. BALLARD SB, Tallant A, Guerra RG, Quigley D, et al
    Application of a cost-effectiveness analysis of pathogen-specific vaccines against gastroenteritis to a military population in a developing country setting.
    Vaccine. 2020 Feb 1. pii: S0264-410X(20)30117.
    PubMed     Abstract available


  229. CHAMPREDON D, Shoukat A, Moghadas SM
    Effectiveness and cost-effectiveness of a Clostridium difficile vaccine candidate in a hospital setting.
    Vaccine. 2020 Feb 1. pii: S0264-410X(20)30115.
    PubMed     Abstract available


    January 2020
  230. LU Y, Landreth S, Liu G, Brownlie R, et al
    Innate immunemodulator containing adjuvant formulated HA based vaccine protects mice from lethal infection of highly pathogenic avian influenza H5N1 virus.
    Vaccine. 2020 Jan 31. pii: S0264-410X(20)30077.
    PubMed     Abstract available


  231. DA CUNHA GK, de Matos MB, Trettim JP, Rubin BB, et al
    Thimerosal-containing vaccines and deficit in child development: Population-based study in southern Brazil.
    Vaccine. 2020 Jan 31. pii: S0264-410X(19)31696.
    PubMed     Abstract available


  232. CHOI KY, El-Hamdi NS, McGregor A
    Neutralizing antibodies to gB based CMV vaccine requires full length antigen but reduced virus neutralization on non-fibroblast cells limits vaccine efficacy in the guinea pig model.
    Vaccine. 2020 Jan 31. pii: S0264-410X(20)30101.
    PubMed     Abstract available


  233. AKPALU Y, Sullivan SJ, Regan AK
    Association between health insurance coverage and uptake of seasonal influenza vaccine in Brazos County, Texas.
    Vaccine. 2020 Jan 31. pii: S0264-410X(20)30044.
    PubMed     Abstract available


  234. PETIT B, Epaulard O
    Men having sex with men and the HPV vaccine in France: A low vaccine coverage that may be due to its infrequent proposal by physicians.
    Vaccine. 2020 Jan 30. pii: S0264-410X(20)30075.
    PubMed     Abstract available


  235. BOVAY A, Nassiri S, Maby-El Hajjami H, Marcos Mondejar P, et al
    Minimal immune response to booster vaccination against Yellow Fever associated with pre-existing antibodies.
    Vaccine. 2020 Jan 30. pii: S0264-410X(20)30071.
    PubMed     Abstract available


  236. OKENWA UJ, Dairo MD, Bamgboye E, Ajumobi O, et al
    Maternal knowledge and infant uptake of valid hepatitis B vaccine birth dose at routine immunization clinics in Enugu State - Nigeria.
    Vaccine. 2020 Jan 29. pii: S0264-410X(20)30070.
    PubMed     Abstract available


  237. PILAEV M, Shen Y, Carbonneau J, Venable MC, et al
    Evaluation of pre- and post-fusion Human metapneumovirus F proteins as subunit vaccine candidates in mice.
    Vaccine. 2020 Jan 29. pii: S0264-410X(20)30073.
    PubMed     Abstract available


  238. AVALOS LA, Ferber J, Zerbo O, Naleway AL, et al
    Trivalent inactivated influenza vaccine (IIV3) during pregnancy and six-month infant development.
    Vaccine. 2020 Jan 29. pii: S0264-410X(20)30086.
    PubMed     Abstract available


  239. WANTUCH PL, Sun L, LoPilato RK, Mousa JJ, et al
    Isolation and characterization of new human carrier peptides from two important vaccine immunogens.
    Vaccine. 2020 Jan 28. pii: S0264-410X(20)30103.
    PubMed     Abstract available


  240. LASSETER G, Al-Janabi H, Trotter CL, Carroll FE, et al
    Understanding the role of peace of mind in childhood vaccination: A qualitative study with members of the general public.
    Vaccine. 2020 Jan 28. pii: S0264-410X(19)31651.
    PubMed     Abstract available


  241. NGUYEN TTM, Lafond KE, Nguyen TX, Tran PD, et al
    Acceptability of seasonal influenza vaccines among health care workers in Vietnam in 2017.
    Vaccine. 2020 Jan 27. pii: S0264-410X(19)31699.
    PubMed     Abstract available


  242. KALOK A, Loh SYE, Chew KT, Abdul Aziz NH, et al
    Vaccine hesitancy towards childhood immunisation amongst urban pregnant mothers in Malaysia.
    Vaccine. 2020 Jan 27. pii: S0264-410X(20)30069.
    PubMed     Abstract available


  243. HILLS SL, Fischer M, Biggerstaff BJ
    Perceptions among the U.S. population of value of Japanese encephalitis (JE) vaccination for travel to JE-endemic countries.
    Vaccine. 2020 Jan 25. pii: S0264-410X(20)30074.
    PubMed     Abstract available


  244. KING JP, Hanson KE, Donahue JG, Glanz JM, et al
    Survey of influenza vaccine knowledge, attitudes, and beliefs among pregnant women in the 2016-17 season.
    Vaccine. 2020 Jan 25. pii: S0264-410X(20)30054.
    PubMed     Abstract available


  245. UZIEL Y, Moshe V, Onozo B, Kulcsar A, et al
    Live attenuated MMR/V booster vaccines in children with rheumatic diseases on immunosuppressive therapy are safe: Multicenter, retrospective data collection.
    Vaccine. 2020 Jan 24. pii: S0264-410X(20)30052.
    PubMed     Abstract available


  246. SUNTARATTIWONG P, Vandepitte WP, Singhamatr P, Chotpitayasunondh T, et al
    Seroprotection rate in adults after 1-dose, 2-dose, and 3-dose series of a reduced-diphtheria-tetanus toxoid vaccine (Td) during a diphtheria outbreak in Thailand.
    Vaccine. 2020 Jan 24. pii: S0264-410X(20)30055.
    PubMed     Abstract available


  247. PLOTKIN SA, Offit PA, DeStefano F, Larson HJ, et al
    The science of vaccine safety: Summary of meeting at Wellcome Trust.
    Vaccine. 2020 Jan 24. pii: S0264-410X(20)30039.
    PubMed     Abstract available


  248. KAZAKOVA A, Kakkola L, Ziegler T, Syrjanen R, et al
    Pandemic influenza A(H1N1pdm09) vaccine induced high levels of influenza-specific IgG and IgM antibodies as analyzed by enzyme immunoassay and dual-mode multiplex microarray immunoassay methods.
    Vaccine. 2020 Jan 24. pii: S0264-410X(20)30037.
    PubMed     Abstract available


  249. BETTINGER JA, Liberator P, Halperin SA, Vaudry W, et al
    Estimated susceptibility of Canadian meningococcal B isolates to a meningococcal serogroup B vaccine (MenB-FHbp).
    Vaccine. 2020 Jan 23. pii: S0264-410X(19)31703.
    PubMed     Abstract available


  250. AZIZ AB, Ali M, Basunia AH, Yunus M, et al
    Impact of vaccination on the risk factors for acute rotavirus diarrhea: An analysis of the data of a cluster randomized trial conducted in a rural area of Bangladesh.
    Vaccine. 2020 Jan 23. pii: S0264-410X(20)30056.
    PubMed     Abstract available


  251. DESAI S, Scobie HM, Cherian T, Goodman T, et al
    Use of tetanus-diphtheria (Td) vaccine in children 4-7 years of age: World Health Organization consultation of experts.
    Vaccine. 2020 Jan 23. pii: S0264-410X(20)30033.
    PubMed     Abstract available


  252. SATO R, Belel A
    The effect of performance-based financing on child vaccinations in northern Nigeria.
    Vaccine. 2020 Jan 23. pii: S0264-410X(20)30048.
    PubMed     Abstract available


  253. LAI E, Tan HY, Kunasekaran M, Chughtai AA, et al
    Influenza vaccine coverage and predictors of vaccination among aged care workers in Sydney Australia.
    Vaccine. 2020 Jan 23. pii: S0264-410X(20)30008.
    PubMed     Abstract available


  254. DALY C, Molodecky NA, Sreevatsava M, Belayneh AD, et al
    Needle-free injectors for mass administration of fractional dose inactivated poliovirus vaccine in Karachi, Pakistan: A survey of caregiver and vaccinator acceptability.
    Vaccine. 2020 Jan 23. pii: S0264-410X(19)31723.
    PubMed     Abstract available


  255. CASTILLA J, Portillo ME, Casado I, Pozo F, et al
    Effectiveness of the current and prior influenza vaccinations in Northern Spain, 2018-2019.
    Vaccine. 2020 Jan 22. pii: S0264-410X(20)30043.
    PubMed     Abstract available


  256. BATISTA ICA, Quinan BR, Rocha Alves EA, Jangola STG, et al
    Design and production of dengue virus chimeric proteins useful for developing tetravalent vaccines.
    Vaccine. 2020 Jan 22. pii: S0264-410X(20)30007.
    PubMed     Abstract available


  257. FADLYANA E, Dhamayanti M, Tarigan R, Mulia Sari R, et al
    Immunogenicity and safety profile of a primary dose of bivalent oral polio vaccine given simultaneously with DTwP-Hb-Hib and inactivated poliovirus vaccine at the 4th visit in Indonesian infants.
    Vaccine. 2020 Jan 22. pii: S0264-410X(20)30011.
    PubMed     Abstract available


  258. FAN S, Liao Y, Jiang G, Jiang L, et al
    Study of integrated protective immunity induced in rhesus macaques by the intradermal administration of a bivalent EV71-CA16 inactivated vaccine.
    Vaccine. 2020 Jan 22. pii: S0264-410X(19)31721.
    PubMed     Abstract available


  259. THOMPSON KM, Orenstein WA, Hinman AR
    Performance of the United States Vaccine Injury Compensation Program (VICP): 1988-2019.
    Vaccine. 2020 Jan 22. pii: S0264-410X(20)30057.
    PubMed     Abstract available


  260. MOHANTY S, Joyce CM, Delamater PL, Klein NP, et al
    Homeschooling parents in California: Attitudes, beliefs and behaviors associated with child's vaccination status.
    Vaccine. 2020 Jan 22. pii: S0264-410X(20)30041.
    PubMed     Abstract available


  261. INGUVA S, Barnard M, Ward LM, Yang Y, et al
    Factors influencing Human papillomavirus (HPV) vaccination series completion in Mississippi Medicaid.
    Vaccine. 2020 Jan 21. pii: S0264-410X(19)31672.
    PubMed     Abstract available


  262. PACHECO FC, Franca GVA, Elidio GA, Leal MB, et al
    Measles-containing vaccines in Brazil: Coverage, homogeneity of coverage and associations with contextual factors at municipal level.
    Vaccine. 2020 Jan 21. pii: S0264-410X(20)30045.
    PubMed     Abstract available


  263. BRADSHAW AS, Treise D, Shelton SS, Cretul M, et al
    Propagandizing anti-vaccination: Analysis of Vaccines Revealed documentary series.
    Vaccine. 2020 Jan 21. pii: S0264-410X(19)31669.
    PubMed     Abstract available


  264. LUBOGO M, Mohamed AM, Ali AH, Ali AH, et al
    Oral cholera vaccination coverage in an acute emergency setting in Somalia, 2017.
    Vaccine. 2020 Jan 21. pii: S0264-410X(20)30030.
    PubMed     Abstract available


  265. TILEY K, Tessier E, White JM, Andrews N, et al
    School-based vaccination programmes: An evaluation of school immunisation delivery models in England in 2015/16.
    Vaccine. 2020 Jan 21. pii: S0264-410X(20)30046.
    PubMed     Abstract available


  266. WASKO I, Golebiewska A, Kiedrowska M, Ronkiewicz P, et al
    Genetic variability of Polish serogroup B meningococci (2010-2016) including the 4CMenB vaccine component genes.
    Vaccine. 2020 Jan 21. pii: S0264-410X(20)30036.
    PubMed     Abstract available


  267. MUSA S, Skrijelj V, Kulo A, Habersaat KB, et al
    Identifying barriers and drivers to vaccination: A qualitative interview study with health workers in the Federation of Bosnia and Herzegovina.
    Vaccine. 2020 Jan 21. pii: S0264-410X(20)30040.
    PubMed     Abstract available


  268. YILDIRIM M, Keskinocak P, Pelton S, Pickering L, et al
    Who is at risk of 13-valent conjugated pneumococcal vaccine failure?
    Vaccine. 2020 Jan 20. pii: S0264-410X(19)31724.
    PubMed     Abstract available


  269. OPRIESSNIG T, Karuppannan AK, Halbur PG, Calvert JG, et al
    Porcine circovirus type 2a or 2b based experimental vaccines provide protection against PCV2d/porcine parvovirus 2 co-challenge.
    Vaccine. 2020 Jan 20. pii: S0264-410X(20)30017.
    PubMed     Abstract available


  270. DERBISE A, Guillas C, Gerke C, Carniel E, et al
    Subcutaneous vaccination with a live attenuated Yersinia pseudotuberculosis plague vaccine.
    Vaccine. 2020 Jan 18. pii: S0264-410X(20)30018.
    PubMed     Abstract available


  271. ROY P, Ali AJ, Kobiyama K, Ghosheh Y, et al
    Opportunities for an atherosclerosis vaccine: From mice to humans.
    Vaccine. 2020 Jan 18. pii: S0264-410X(19)31681.
    PubMed     Abstract available


  272. OLSZEWSKI AE
    Dear fears: Vaccines and ebiribiri.
    Vaccine. 2020 Jan 17. pii: S0264-410X(20)30034.
    PubMed    


  273. TOURTELOT E, Quataert S, Glantz JC, Perlis L, et al
    Women who received varicella vaccine versus natural infection have different long-term T cell immunity but similar antibody levels.
    Vaccine. 2020 Jan 17. pii: S0264-410X(20)30003.
    PubMed     Abstract available


  274. IZAC JR, O'Bier NS, Oliver LD Jr, Camire AC, et al
    Development and optimization of OspC chimeritope vaccinogens for Lyme disease.
    Vaccine. 2020 Jan 17. pii: S0264-410X(20)30042.
    PubMed     Abstract available


  275. STINSON JA, Palmer CR, Miller DP, Li AB, et al
    Thin silk fibroin films as a dried format for temperature stabilization of inactivated polio vaccine.
    Vaccine. 2020 Jan 17. pii: S0264-410X(19)31726.
    PubMed     Abstract available


  276. SALAMI K, Gsell PS, Olayinka A, Maiga D, et al
    Meeting report: WHO consultation on accelerating Lassa fever vaccine development in endemic countries, Dakar, 10-11 September 2019.
    Vaccine. 2020 Jan 14. pii: S0264-410X(20)30032.
    PubMed     Abstract available


  277. HALL C, Abramovitz LM, Bukowinski AT, Ricker AA, et al
    Safety of tetanus, diphtheria, and acellular pertussis vaccination among pregnant active duty U.S. military women.
    Vaccine. 2020 Jan 14. pii: S0264-410X(20)30013.
    PubMed     Abstract available


  278. POSUWAN N, Wanlapakorn N, Vongpunsawad S, Sintusek P, et al
    Comparison of hepatitis B surface antibody levels induced by the pentavalent DTwP-HB-Hib versus the hexavalent DTaP-HB-Hib-IPV vaccine, administered to infants at 2, 4, 6, and 18 months of age, following monovalent hepatitis B vaccination at birth.
    Vaccine. 2020 Jan 14. pii: S0264-410X(19)31729.
    PubMed     Abstract available


  279. MANDAL S, Edelstein M, Ramsay M
    Public health leadership in the UK's response to hepatitis A and hepatitis B vaccine shortages.
    Vaccine. 2020 Jan 13. pii: S0264-410X(20)30014.
    PubMed    


  280. MA P, Luo Z, Qian J, Yan Z, et al
    Decreased ratio of influenza-specific IgG versus IgM in response to influenza vaccination in antiretroviral-treated HIV-infected African Americans compared to Caucasians, and its direct correlation with the percentages of peripheral Tfh cells.
    Vaccine. 2020 Jan 13. pii: S0264-410X(20)30004.
    PubMed     Abstract available


  281. HUANG C, Fu X, Zhou Y, Mi F, et al
    Comparison of the immunogenicity and safety of quadrivalent and tetravalent influenza vaccines in children and adolescents.
    Vaccine. 2020 Jan 13. pii: S0264-410X(19)31625.
    PubMed     Abstract available


  282. TIAN KY, Guo HF, Li N, Zhang YH, et al
    Protection of chickens against hepatitis-hydropericardium syndrome and Newcastle disease with a recombinant Newcastle disease virus vaccine expressing the fowl adenovirus serotype 4 fiber-2 protein.
    Vaccine. 2020 Jan 13. pii: S0264-410X(20)30010.
    PubMed     Abstract available


  283. XU L, Qin Z, Qiao L, Wen J, et al
    Characterization of thermostable Newcastle disease virus recombinants expressing the hemagglutinin of H5N1 avian influenza virus as bivalent vaccine candidates.
    Vaccine. 2020 Jan 11. pii: S0264-410X(19)31718.
    PubMed     Abstract available


  284. JARVIS JR, Dorey RB, Warricker FDM, Alwan NA, et al
    The effectiveness of influenza vaccination in pregnancy in relation to child health outcomes: Systematic review and meta-analysis.
    Vaccine. 2020 Jan 10. pii: S0264-410X(19)31720.
    PubMed     Abstract available


  285. VAN DER MEEREN O, Jongert E, Seaton KE, Koutsoukos M, et al
    Persistence of vaccine-elicited immune response up to 14 years post-HIV gp120-NefTat/AS01B vaccination.
    Vaccine. 2020 Jan 10. pii: S0264-410X(19)31722.
    PubMed     Abstract available


  286. GALOR I, Perry Markovich M, Wolf D, Haber M, et al
    Population seroprotection against hepatitis a virus in Israel 18 years after introduction of inactivated vaccine into the routine childhood vaccination schedule.
    Vaccine. 2020 Jan 10. pii: S0264-410X(19)31693.
    PubMed     Abstract available


  287. SANDHU SK, Hua W, MaCurdy TE, Franks RL, et al
    Comparison of alpha-spending plans for near real-time monitoring for Guillain-Barre after influenza vaccination during the 2010/11 influenza season.
    Vaccine. 2020 Jan 10. pii: S0264-410X(19)31674.
    PubMed     Abstract available


  288. ESPUL C, Cuello H, Lo Castro I, Bravo C, et al
    Statistical modeling alongside observational data predicts long-term immunogenicity of one dose and two doses of pediatric hepatitis A vaccine in the Mendoza province of Argentina.
    Vaccine. 2020 Jan 9. pii: S0264-410X(19)31701.
    PubMed     Abstract available


  289. TRUCAS M
    The Falconi's needle against anti-vaccination: A minimally invasive tool in the nineteenth century.
    Vaccine. 2020 Jan 9. pii: S0264-410X(19)31727.
    PubMed     Abstract available


  290. ORTEGA-SANCHEZ R, Camacho-Nuez M, Castaneda-Ortiz JE, Martinez-Benitez MB, et al
    Vaccine efficacy of recombinant BmVDAC on Rhipicephalus microplus fed on Babesia bigemina-infected and uninfected cattle.
    Vaccine. 2020 Jan 9. pii: S0264-410X(19)31692.
    PubMed     Abstract available


  291. ULZIIBAT G, Maygmarsuren O, Khishgee B, Basan G, et al
    Immunogenicity of imported foot-and-mouth vaccines in different species in Mongolia.
    Vaccine. 2020 Jan 9. pii: S0264-410X(19)31717.
    PubMed     Abstract available


  292. POH ZW, Wang Z, Kumar SR, Yong HY, et al
    Modification of neutralizing epitopes of hemagglutinin for the development of broadly protective H9N2 vaccine.
    Vaccine. 2020 Jan 7. pii: S0264-410X(19)31634.
    PubMed     Abstract available


  293. FOMBONNE E, Goin-Kochel RP, O'Roak BJ
    Beliefs in vaccine as causes of autism among SPARK cohort caregivers.
    Vaccine. 2020 Jan 7. pii: S0264-410X(19)31668.
    PubMed     Abstract available


  294. HANSEN PR, Schmidtblaicher M, Brewer NT
    Resilience of HPV vaccine uptake in Denmark: Decline and recovery.
    Vaccine. 2020 Jan 6. pii: S0264-410X(19)31661.
    PubMed     Abstract available


  295. HAGEDORN BL, Gauld J, Feasey N, Hu H, et al
    Cost-effectiveness of using environmental surveillance to target the roll-out typhoid conjugate vaccine.
    Vaccine. 2020 Jan 6. pii: S0264-410X(19)31725.
    PubMed    


  296. JIA R, Yan L, Guo J
    Enhancing the immunogenicity of a DNA vaccine against Streptococcus mutans by attenuating the inhibition of endogenous miR-9.
    Vaccine. 2020 Jan 6. pii: S0264-410X(19)31637.
    PubMed     Abstract available


  297. BURKHARD J, Ciurea A, Gabay C, Hasler P, et al
    Long-term immunogenicity after yellow fever vaccination in immunosuppressed and healthy individuals.
    Vaccine. 2020 Jan 3. pii: S0264-410X(19)31694.
    PubMed     Abstract available


  298. PUENTE-MASSAGUER E, Lecina M, Godia F
    Application of advanced quantification techniques in nanoparticle-based vaccine development with the Sf9 cell baculovirus expression system.
    Vaccine. 2020 Jan 3. pii: S0264-410X(19)31647.
    PubMed     Abstract available


  299. JO SK, Ahn BE, Choi EH, Kang JE, et al
    Evaluation of the protective efficacy of recombinant protective antigen vaccine (GC1109)-immunized human sera using passive immunization in a mouse model.
    Vaccine. 2020 Jan 3. pii: S0264-410X(19)31700.
    PubMed     Abstract available


  300. STERRETT S, Peng BJ, Burton RL, LaFon DC, et al
    Peripheral CD4 T follicular cells induced by a conjugated pneumococcal vaccine correlate with enhanced opsonophagocytic antibody responses in younger individuals.
    Vaccine. 2020 Jan 3. pii: S0264-410X(19)31665.
    PubMed     Abstract available


  301. ABDELLRAZEQ GS, Fry LM, Elnaggar MM, Bannantine JP, et al
    Simultaneous cognate epitope recognition by bovine CD4 and CD8 T cells is essential for primary expansion of antigen-specific cytotoxic T-cells following ex vivo stimulation with a candidate Mycobacterium avium subsp. paratuberculosis peptide vaccine.
    Vaccine. 2020 Jan 2. pii: S0264-410X(19)31704.
    PubMed     Abstract available


    December 2019
  302. DELACRUZ WP, Savona MR, Thornton JA, Danaher PJ, et al
    Evidence of vaccinia dissemination despite lack of major reaction following smallpox vaccination.
    Vaccine. 2019 Dec 31. pii: S0264-410X(19)31698.
    PubMed     Abstract available


  303. DUTHIE MS, Frevol A, Day T, Coler RN, et al
    A phase 1 antigen dose escalation trial to evaluate safety, tolerability and immunogenicity of the leprosy vaccine candidate LepVax (LEP-F1 + GLA-SE) in healthy adults.
    Vaccine. 2019 Dec 30. pii: S0264-410X(19)31702.
    PubMed     Abstract available


  304. KIM J, Kim T, Hong JK, Lee HS, et al
    The interference effect of maternally-derived antibodies on the serological performance of pigs immunized with a foot-and-mouth disease oil emulsion vaccine.
    Vaccine. 2019 Dec 28. pii: S0264-410X(19)31695.
    PubMed     Abstract available


  305. JIANG L, Wang J, Zhang C, He W, et al
    Effectiveness of enterovirus A71 vaccine in severe hand, foot, and mouth disease cases in Guangxi, China.
    Vaccine. 2019 Dec 28. pii: S0264-410X(19)31667.
    PubMed     Abstract available


  306. LUTZ CS, Fink RV, Cloud AJ, Stevenson J, et al
    Factors associated with perceptions of influenza vaccine safety and effectiveness among adults, United States, 2017-2018.
    Vaccine. 2019 Dec 27. pii: S0264-410X(19)31644.
    PubMed     Abstract available


  307. STOECKER C, Kobayashi M, Matanock A, Cho BH, et al
    Cost-effectiveness of continuing pneumococcal conjugate vaccination at age 65 in the context of indirect effects from the childhood immunization program.
    Vaccine. 2019 Dec 27. pii: S0264-410X(19)31671.
    PubMed     Abstract available


  308. MCILHONE KA, Best EJ, Petousis-Harris H, Howe AS, et al
    Impact of rotavirus vaccine on paediatric rotavirus hospitalisation and intussusception in New Zealand: A retrospective cohort study.
    Vaccine. 2019 Dec 27. pii: S0264-410X(19)31697.
    PubMed     Abstract available


  309. HABER P, Moro PL, Ng C, Dores GM, et al
    Safety review of tetanus toxoid, reduced diphtheria toxoid, acellular pertussis vaccines (Tdap) in adults aged >/=65years, Vaccine Adverse Event reporting System (VAERS), United States, September 2010-December 2018.
    Vaccine. 2019 Dec 26. pii: S0264-410X(19)31628.
    PubMed     Abstract available


  310. NAKANO S, Fujisawa T, Ito Y, Chang B, et al
    Nationwide surveillance of paediatric invasive and non-invasive pneumococcal disease in Japan after the introduction of the 13-valent conjugated vaccine, 2015-2017.
    Vaccine. 2019 Dec 24. pii: S0264-410X(19)31664.
    PubMed     Abstract available


  311. SHAIKH H, Lynch J, Kim J, Excler JL, et al
    Current and future cholera vaccines.
    Vaccine. 2019 Dec 24. pii: S0264-410X(19)31653.
    PubMed     Abstract available


  312. COUDEVILLE L, Baurin N, Shepard DS
    The potential impact of dengue vaccination with, and without, pre-vaccination screening.
    Vaccine. 2019 Dec 23. pii: S0264-410X(19)31654.
    PubMed     Abstract available


  313. CHOWDHURY F, Bhuiyan TR, Akter A, Bhuiyan MS, et al
    Augmented immune responses to a booster dose of oral cholera vaccine in Bangladeshi children less than 5 years of age: Revaccination after an interval of over three years of primary vaccination with a single dose of vaccine.
    Vaccine. 2019 Dec 23. pii: S0264-410X(19)31676.
    PubMed     Abstract available


  314. LUANA C, Teresa S, Sarah E, Klara F, et al
    Vaccination rate and immunity of children and adolescents with inflammatory bowel disease or autoimmune hepatitis in Germany.
    Vaccine. 2019 Dec 23. pii: S0264-410X(19)31666.
    PubMed     Abstract available


  315. BEYER WEP, Palache AM, Reperant LA, Boulfich M, et al
    Association between vaccine adjuvant effect and pre-seasonal immunity. Systematic review and meta-analysis of randomised immunogenicity trials comparing squalene-adjuvanted and aqueous inactivated influenza vaccines.
    Vaccine. 2019 Dec 23. pii: S0264-410X(19)31679.
    PubMed     Abstract available


  316. OLWAGEN CP, Adrian PV, Madhi SA
    Evaluation of the impact of HIV-1 infection and density of common nasopharyngeal bacterial colonizers in South African children immunized with 7-valent pneumococcal conjugate vaccine.
    Vaccine. 2019 Dec 21. pii: S0264-410X(19)31675.
    PubMed     Abstract available


  317. BEREZIN EN, Jarovsky D, Cardoso MRA, Mantese OC, et al
    Invasive pneumococcal disease among hospitalized children in Brazil before and after the introduction of a pneumococcal conjugate vaccine.
    Vaccine. 2019 Dec 21. pii: S0264-410X(19)31680.
    PubMed     Abstract available


  318. SU JR, Haber P, Ng CS, Marquez PL, et al
    Erythema multiforme, Stevens Johnson syndrome, and toxic epidermal necrolysis reported after vaccination, 1999-2017.
    Vaccine. 2019 Dec 20. pii: S0264-410X(19)31670.
    PubMed     Abstract available


  319. WHITWORTH HS, Gallagher KE, Howard N, Mounier-Jack S, et al
    Efficacy and immunogenicity of a single dose of human papillomavirus vaccine compared to no vaccination or standard three and two-dose vaccination regimens: A systematic review of evidence from clinical trials.
    Vaccine. 2019 Dec 20. pii: S0264-410X(19)31659.
    PubMed     Abstract available


  320. ANWARI P, Debellut F, Vodicka E, Clark A, et al
    Potential health impact and cost-effectiveness of bivalent human papillomavirus (HPV) vaccination in Afghanistan.
    Vaccine. 2019 Dec 20. pii: S0264-410X(19)31655.
    PubMed     Abstract available


  321. ORUMAA M, Kjaer SK, Dehlendorff C, Munk C, et al
    The impact of HPV multi-cohort vaccination: Real-world evidence of faster control of HPV-related morbidity.
    Vaccine. 2019 Dec 20. pii: S0264-410X(19)31658.
    PubMed     Abstract available


  322. LAI SW
    Effectiveness of the herpes zoster vaccine Zostavax.
    Vaccine. 2019 Dec 19. pii: S0264-410X(19)31677.
    PubMed    


  323. ACCROMBESSI M, Adetola CV, Bacharou S, Dossou Y, et al
    Assessment of the anti-HBs antibody response in Beninese infants following 4 doses of HBV vaccine, including administration at birth, compared to the standard 3 doses regime; a cross-sectional survey.
    Vaccine. 2019 Dec 19. pii: S0264-410X(19)31673.
    PubMed     Abstract available


  324. GIESE H, Neth H, Moussaid M, Betsch C, et al
    The echo in flu-vaccination echo chambers: Selective attention trumps social influence.
    Vaccine. 2019 Dec 18. pii: S0264-410X(19)31563.
    PubMed     Abstract available


  325. MARKKULA J, Hemming-Harlo M, Vesikari T
    Shedding of oral pentavalent bovine-human reassortant rotavirus vaccine indicates high uptake rate of vaccine and prominence of G-type G1.
    Vaccine. 2019 Dec 17. pii: S0264-410X(19)31649.
    PubMed     Abstract available


  326. MORSE-BRADY J, Marie Hart A
    Prevalence and types of vaccination errors from 2009 to 2018: A systematic review of the medical literature.
    Vaccine. 2019 Dec 17. pii: S0264-410X(19)31632.
    PubMed     Abstract available


  327. RAO S, Ziniel SI, Khan I, Dempsey A, et al
    Be inFLUential: Evaluation of a multifaceted intervention to increase influenza vaccination rates among pediatric inpatients.
    Vaccine. 2019 Dec 17. pii: S0264-410X(19)31652.
    PubMed     Abstract available


  328. BERTRAN K, Criado MF, Lee DH, Killmaster L, et al
    Protection of White Leghorn chickens by recombinant fowlpox vector vaccine with an updated H5 insert against Mexican H5N2 avian influenza viruses.
    Vaccine. 2019 Dec 17. pii: S0264-410X(19)31626.
    PubMed     Abstract available


  329. DHAMAYANTI M, Tarigan R, Fadlyana E, Prasetyo D, et al
    Immunogenicity and safety of Quadrivalent Influenza HA vaccine in Indonesian children: An open-labeled, bridging, clinical study.
    Vaccine. 2019 Dec 17. pii: S0264-410X(19)31650.
    PubMed     Abstract available


  330. LEVILLAIN F, Kim H, Woong Kwon K, Clark S, et al
    Preclinical assessment of a new live attenuated Mycobacterium tuberculosis Beijing-based vaccine for tuberculosis.
    Vaccine. 2019 Dec 17. pii: S0264-410X(19)31639.
    PubMed     Abstract available


  331. OFFEDDU V, Low MSF, Surendran S, Kembhavi G, et al
    Acceptance and feasibility of school-based seasonal influenza vaccination in Singapore: A qualitative study.
    Vaccine. 2019 Dec 17. pii: S0264-410X(19)31662.
    PubMed     Abstract available


  332. PECENKA C, Debellut F, Bar-Zeev N, Anwari P, et al
    Cost-effectiveness analysis for rotavirus vaccine decision-making: How can we best inform evolving and complex choices in vaccine product selection?
    Vaccine. 2019 Dec 16. pii: S0264-410X(19)31656.
    PubMed    


  333. NNAJI CA, Shey MS, Adetokunboh OO, Wiysonge CS, et al
    Immunogenicity and safety of fractional dose yellow fever vaccination: A systematic review and meta-analysis.
    Vaccine. 2019 Dec 16. pii: S0264-410X(19)31660.
    PubMed     Abstract available


  334. DE HOOG MLA, Venekamp RP, Meijer A, Sanders EAM, et al
    Inactivated influenza vaccine does not reduce all cause respiratory illness in children with pre-existing medical conditions.
    Vaccine. 2019 Dec 16. pii: S0264-410X(19)31640.
    PubMed     Abstract available


  335. HADJIPANAYIS A, van Esso D, Del Torso S, Dornbusch HJ, et al
    Vaccine confidence among parents: Large scale study in eighteen European countries.
    Vaccine. 2019 Dec 14. pii: S0264-410X(19)31622.
    PubMed     Abstract available


  336. ZAMAN K, Kingma R, Yunus M, van Straaten I, et al
    Corrigendum to "Safety, immunogenicity and lot-to-lot consistency of a new Bivalent Oral Polio Vaccine (bOPV) in healthy Infants: Results of a Phase III, observer blind, randomized, controlled clinical study" [Vaccine 37 (2019) 4275-4280].
    Vaccine. 2019 Dec 14. pii: S0264-410X(19)31646.
    PubMed    


  337. CONSTABLE C, Caplan A
    Comparison of the implementation of human papillomavirus and hepatitis B vaccination programs in the United States: Implications for future vaccines.
    Vaccine. 2019 Dec 13. pii: S0264-410X(19)31627.
    PubMed     Abstract available


  338. PASTURAL E, McNeil SA, MacKinnon-Cameron D, Ye L, et al
    Safety and immunogenicity of a 30-valent M protein-based group a streptococcal vaccine in healthy adult volunteers: A randomized, controlled phase I study.
    Vaccine. 2019 Dec 13. pii: S0264-410X(19)31645.
    PubMed     Abstract available


  339. TRICOU V, Low JG, Oh HM, Leo YS, et al
    Safety and immunogenicity of a single dose of a tetravalent dengue vaccine with two different serotype-2 potencies in adults in Singapore: A phase 2, double-blind, randomised, controlled trial.
    Vaccine. 2019 Dec 13. pii: S0264-410X(19)31615.
    PubMed     Abstract available


  340. PULIDO MR, Garcia-Quintanilla M, Pachon J, McConnell MJ, et al
    A lipopolysaccharide-free outer membrane vesicle vaccine protects against Acinetobacter baumannii infection.
    Vaccine. 2019 Dec 13. pii: S0264-410X(19)31572.
    PubMed     Abstract available


  341. CLARKE E, Bashorun AO, Okoye M, Umesi A, et al
    Safety and immunogenicity of a novel 10-valent pneumococcal conjugate vaccine candidate in adults, toddlers, and infants in The Gambia-Results of a phase 1/2 randomized, double-blinded, controlled trial.
    Vaccine. 2019 Dec 13. pii: S0264-410X(19)31148.
    PubMed     Abstract available


  342. WHITING G, Vipond C, Facchetti A, Chan H, et al
    Measurement of surface protein antigens, PorA and PorB, in Bexsero vaccine using quantitative mass spectrometry.
    Vaccine. 2019 Dec 12. pii: S0264-410X(19)31636.
    PubMed     Abstract available


  343. SALGADO VR, Fukutani KF, Fukutani E, Lima JV, et al
    Effects of 10-valent pneumococcal conjugate (PCV10) vaccination on the nasopharyngeal microbiome.
    Vaccine. 2019 Dec 12. pii: S0264-410X(19)31633.
    PubMed     Abstract available


  344. MANGTANI P, Evans SJW, Lange B, Oberle D, et al
    Safety profile of rubella vaccine administered to pregnant women: A systematic review of pregnancy related adverse events following immunisation, including congenital rubella syndrome and congenital rubella infection in the foetus or infant.
    Vaccine. 2019 Dec 12. pii: S0264-410X(19)31624.
    PubMed     Abstract available


  345. PERRY M, McGowan A, Roberts R, Cottrell S, et al
    Timeliness and equity of infant pertussis vaccination in wales: Analysis of the three dose primary course.
    Vaccine. 2019 Dec 12. pii: S0264-410X(19)31641.
    PubMed     Abstract available


  346. PORTER RM, Goldin S, Lafond KE, Hedman L, et al
    Does having a seasonal influenza program facilitate pandemic preparedness? An analysis of vaccine deployment during the 2009 pandemic.
    Vaccine. 2019 Dec 12. pii: S0264-410X(19)31548.
    PubMed     Abstract available


  347. ESPARZA J
    Early vaccine advocacy: Medals honoring Edward Jenner issued during the 19th century.
    Vaccine. 2019 Dec 12. pii: S0264-410X(19)31631.
    PubMed     Abstract available


  348. DUDLEY MZ, Privor-Dumm L, Dube E, MacDonald NE, et al
    Words matter: Vaccine hesitancy, vaccine demand, vaccine confidence, herd immunity and mandatory vaccination.
    Vaccine. 2019 Dec 10. pii: S0264-410X(19)31598.
    PubMed    


  349. GRODELAND G, Fossum E, Bogen B
    Targeting of HA to chemokine receptors induces strong and cross-reactive T cell responses after DNA vaccination in pigs.
    Vaccine. 2019 Dec 10. pii: S0264-410X(19)31638.
    PubMed     Abstract available


  350. NGUYEN-HUU NH, Thilly N, Derrough T, Sdona E, et al
    Human papillomavirus vaccination coverage, policies, and practical implementation across Europe.
    Vaccine. 2019 Dec 10. pii: S0264-410X(19)31635.
    PubMed     Abstract available


  351. LI Y, Zhu P, Wu M, Zhang Y, et al
    Immunogenicity and safety of human papillomavirus vaccine coadministered with other vaccines in individuals aged 9-25years: A systematic review and meta-analysis.
    Vaccine. 2019 Dec 9. pii: S0264-410X(19)31481.
    PubMed     Abstract available


  352. KURATA T, Kanbayashi D, Egawa K, Kinoshita M, et al
    A measles outbreak from an index case with immunologically confirmed secondary vaccine failure.
    Vaccine. 2019 Dec 9. pii: S0264-410X(19)31629.
    PubMed     Abstract available


  353. ECARNOT F, Pedone C, Cesari M, Maggi S, et al
    Knowledge about vaccines and vaccination in older people: Results of a national survey by the Italian Society for Gerontology & Geriatrics.
    Vaccine. 2019 Dec 7. pii: S0264-410X(19)31619.
    PubMed     Abstract available


  354. LACONI A, Weerts EAWS, Bloodgood JCG, Deniz Marrero JP, et al
    Attenuated live infectious bronchitis virus QX vaccine disseminates slowly to target organs distant from the site of inoculation.
    Vaccine. 2019 Dec 7. pii: S0264-410X(19)31618.
    PubMed     Abstract available


  355. SUN X, Wagner AL, Ji J, Huang Z, et al
    A conjoint analysis of stated vaccine preferences in Shanghai, China.
    Vaccine. 2019 Dec 7. pii: S0264-410X(19)31616.
    PubMed     Abstract available


  356. SAUL A, Podda A, Rappuoli R
    The use and abuse of a 4-fold increase in antibody response to assess immunogenicity in early stage vaccine clinical trials.
    Vaccine. 2019 Dec 7. pii: S0264-410X(19)31621.
    PubMed    


  357. TAVARES-DA-SILVA F, Miranda M, Dessart C, Herve C, et al
    Review of the initial post-marketing safety surveillance for the recombinant zoster vaccine.
    Vaccine. 2019 Dec 6. pii: S0264-410X(19)31600.
    PubMed     Abstract available


  358. GAO Z, Robinson K, Skowronski DM, De Serres G, et al
    Quantification of the total neuraminidase content of recent commercially-available influenza vaccines: Introducing a neuraminidase titration reagent.
    Vaccine. 2019 Dec 6. pii: S0264-410X(19)31570.
    PubMed     Abstract available


  359. ENTICOTT G, Maye D, Naylor R, Brunton L, et al
    An assessment of risk compensation and spillover behavioural adaptions associated with the use of vaccines in animal disease management.
    Vaccine. 2019 Dec 5. pii: S0264-410X(19)31562.
    PubMed     Abstract available


  360. YAN X, Zhou M, Yu S, Jin Z, et al
    An overview of biodegradable nanomaterials and applications in vaccines.
    Vaccine. 2019 Dec 5. pii: S0264-410X(19)31556.
    PubMed     Abstract available


  361. MACK I, Erlanger TE, Lang P, Sinniger P, et al
    Dose-dependent effectiveness of acellular pertussis vaccine in infants: A population-based case-control study.
    Vaccine. 2019 Dec 5. pii: S0264-410X(19)31623.
    PubMed     Abstract available


  362. DUONG TN, Thiem VD, Anh DD, Cuong NP, et al
    A Phase 2/3 double blinded, randomized, placebo-controlled study in healthy adult participants in Vietnam to examine the safety and immunogenicity of an inactivated whole virion, alum adjuvanted, A(H5N1) influenza vaccine (IVACFLU-A/H5N1).
    Vaccine. 2019 Dec 4. pii: S0264-410X(19)31601.
    PubMed     Abstract available


  363. PAN SC, Hsu WT, Lee WS, Wang NC, et al
    A double-blind, randomized controlled trial to evaluate the safety and immunogenicity of an intranasally administered trivalent inactivated influenza vaccine with the adjuvant LTh(alphaK): A phase II study.
    Vaccine. 2019 Dec 4. pii: S0264-410X(19)31589.
    PubMed     Abstract available


  364. KO MK, Jo HE, Choi JH, You SH, et al
    Improved foot-and-mouth disease vaccine with O PanAsia-2 strain protect pigs against O/Jincheon/SKR/2014 originated from South Korea.
    Vaccine. 2019 Dec 3. pii: S0264-410X(19)31554.
    PubMed     Abstract available


  365. WILSON R, Zaytseva A, Bocquier A, Nokri A, et al
    Vaccine hesitancy and self-vaccination behaviors among nurses in southeastern France.
    Vaccine. 2019 Dec 3. pii: S0264-410X(19)31541.
    PubMed     Abstract available


  366. LAMA Y, Hancock GR, Freimuth VS, Jamison AM, et al
    Using classification and regression tree analysis to explore parental influenza vaccine decisions.
    Vaccine. 2019 Dec 2. pii: S0264-410X(19)31568.
    PubMed     Abstract available


  367. FRASCELLA B, Oradini-Alacreu A, Balzarini F, Signorelli C, et al
    Effectiveness of email-based reminders to increase vaccine uptake: a systematic review.
    Vaccine. 2019 Dec 2. pii: S0264-410X(19)31478.
    PubMed     Abstract available


    November 2019
  368. MALLORY RM, Nyborg A, Kalyani RN, Yuan Y, et al
    A study to evaluate the immunogenicity and shedding of live attenuated influenza vaccine strains in children 24-<48 months of age.
    Vaccine. 2019 Nov 30. pii: S0264-410X(19)31597.
    PubMed     Abstract available


  369. SCHNEIDER R, Reinau D, Schur N, Blozik E, et al
    Coverage rates and timeliness of nationally recommended vaccinations in Swiss preschool children: A descriptive analysis using claims data.
    Vaccine. 2019 Nov 30. pii: S0264-410X(19)31599.
    PubMed     Abstract available


  370. RINTA-KOKKO H, Auranen K, Toropainen M, Nuorti JP, et al
    Effectiveness of 10-valent pneumococcal conjugate vaccine estimated with three parallel study designs among vaccine-eligible children in Finland.
    Vaccine. 2019 Nov 29. pii: S0264-410X(19)31591.
    PubMed     Abstract available


  371. ONELLO E, Friedrichsen S, Krafts K, Simmons G Jr, et al
    First year allopathic medical student attitudes about vaccination and vaccine hesitancy.
    Vaccine. 2019 Nov 29. pii: S0264-410X(19)31494.
    PubMed     Abstract available


  372. IM JH, Woo H, Ha BM, Lee JS, et al
    Effectiveness of a single dose of the quadrivalent meningococcal conjugate vaccine, MenACWY-CRM, in the Korean Armed Forces.
    Vaccine. 2019 Nov 29. pii: S0264-410X(19)31538.
    PubMed     Abstract available


  373. LEE WN, Stuck D, Konty K, Rivers C, et al
    Large-scale influenza vaccination promotion on a mobile app platform: A randomized controlled trial.
    Vaccine. 2019 Nov 29. pii: S0264-410X(19)31595.
    PubMed     Abstract available


  374. WALLER J, Forster A, Ryan M, Richards R, et al
    Decision-making about HPV vaccination in parents of boys and girls: A population-based survey in England and Wales.
    Vaccine. 2019 Nov 28. pii: S0264-410X(19)31588.
    PubMed     Abstract available


  375. JIANG M, Li P, Wang W, Zhao M, et al
    Cost-effectiveness of quadrivalent versus trivalent influenza vaccine for elderly population in China.
    Vaccine. 2019 Nov 28. pii: S0264-410X(19)31587.
    PubMed     Abstract available


  376. REINDERS S, Romero C, Carcamo C, Tinoco Y, et al
    A community-based survey on influenza and vaccination knowledge, perceptions and practices in Peru.
    Vaccine. 2019 Nov 28. pii: S0264-410X(19)31539.
    PubMed     Abstract available


  377. TOP KA, Esteghamati A, Kervin M, Henaff L, et al
    Governing off-label vaccine use: An environmental scan of the Global National Immunization Technical Advisory Group Network.
    Vaccine. 2019 Nov 27. pii: S0264-410X(19)31558.
    PubMed     Abstract available


  378. CHUA GT, Ho FK, Tung KT, Wong RS, et al
    Sexual behaviors and intention for cervical screening among HPV-vaccinated young Chinese females.
    Vaccine. 2019 Nov 27. pii: S0264-410X(19)31573.
    PubMed     Abstract available


  379. PENTA MA, Craciun IC, Baban A
    The power of anticipated regret: Predictors of HPV vaccination and seasonal influenza vaccination acceptability among young Romanians.
    Vaccine. 2019 Nov 27. pii: S0264-410X(19)31571.
    PubMed     Abstract available


  380. HIBBS BF, Ng CS, Museru O, Moro PL, et al
    Reports of atypical shoulder pain and dysfunction following inactivated influenza vaccine, Vaccine Adverse Event Reporting System (VAERS), 2010-2017.
    Vaccine. 2019 Nov 26. pii: S0264-410X(19)31546.
    PubMed     Abstract available


  381. GUISO N, Meade BD, Wirsing von Konig CH
    Pertussis vaccines: The first hundred years.
    Vaccine. 2019 Nov 25. pii: S0264-410X(19)31545.
    PubMed     Abstract available


  382. GOSS MD, Temte JL, Barlow S, Temte E, et al
    An assessment of parental knowledge, attitudes, and beliefs regarding influenza vaccination.
    Vaccine. 2019 Nov 25. pii: S0264-410X(19)31569.
    PubMed     Abstract available


  383. HESSE EM, Atanasoff S, Hibbs BF, Adegoke OJ, et al
    Shoulder Injury Related to Vaccine Administration (SIRVA): Petitioner claims to the National Vaccine Injury Compensation Program, 2010-2016.
    Vaccine. 2019 Nov 23. pii: S0264-410X(19)31557.
    PubMed     Abstract available


  384. DEGIUSEPPE JI, Stupka JA
    Genotype distribution of Group A rotavirus in children before and after massive vaccination in Latin America and the Caribbean: Systematic review.
    Vaccine. 2019 Nov 23. pii: S0264-410X(19)31540.
    PubMed     Abstract available


  385. DOCHEZ C, Al Awaidy S, Mohsni E, Fahmy K, et al
    Strengthening national teams of experts to support HPV vaccine introduction in Eastern Mediterranean countries: Lessons learnt and recommendations from an international workshop.
    Vaccine. 2019 Nov 23. pii: S0264-410X(19)31552.
    PubMed     Abstract available


  386. GEREND MA, Murdock C, Grove K
    An intervention for increasing HPV vaccination on a university campus.
    Vaccine. 2019 Nov 23. pii: S0264-410X(19)31553.
    PubMed     Abstract available


  387. GUZMAN-HOLST A, DeAntonio R, Prado-Cohrs D, Juliao P, et al
    Barriers to vaccination in Latin America: A systematic literature review.
    Vaccine. 2019 Nov 22. pii: S0264-410X(19)31477.
    PubMed     Abstract available


  388. WARD K, Mugenyi K, MacNeil A, Luzze H, et al
    Financial cost analysis of a strategy to improve the quality of administrative vaccination data in Uganda.
    Vaccine. 2019 Nov 22. pii: S0264-410X(19)31555.
    PubMed     Abstract available


  389. FURER V, Zisman D, Kaufman I, Arad U, et al
    Immunogenicity and safety of vaccination against seasonal influenza vaccine in patients with psoriatic arthritis treated with secukinumab.
    Vaccine. 2019 Nov 22. pii: S0264-410X(19)31470.
    PubMed     Abstract available


  390. FRADE J, Nunes C, Mesquita JR, Nascimento MSJ, et al
    Mumps antibodies in the cord blood: Association with maternal recall of mumps. Possible consequences for vaccination strategies.
    Vaccine. 2019 Nov 22. pii: S0264-410X(19)31536.
    PubMed     Abstract available


  391. PLOTKIN SA
    Updates on immunologic correlates of vaccine-induced protection.
    Vaccine. 2019 Nov 22. pii: S0264-410X(19)31426.
    PubMed     Abstract available


  392. WELLIVER RC, Papin JF, Preno A, Ivanov V, et al
    Maternal immunization with RSV fusion glycoprotein vaccine and substantial protection of neonatal baboons against respiratory syncytial virus pulmonary challenge.
    Vaccine. 2019 Nov 21. pii: S0264-410X(19)31510.
    PubMed     Abstract available


  393. MALTEZOU HC, Karantoni H, Petrikkos P, Georgota P, et al
    Vaccination coverage and immunity levels against vaccine-preventable diseases in male Air Force recruits in Greece.
    Vaccine. 2019 Nov 21. pii: S0264-410X(19)31544.
    PubMed     Abstract available


  394. NOWAK GJ, Evans NJ, Wojdynski BW, Ahn SJG, et al
    Using immersive virtual reality to improve the beliefs and intentions of influenza vaccine avoidant 18-to-49-year-olds: Considerations, effects, and lessons learned.
    Vaccine. 2019 Nov 21. pii: S0264-410X(19)31516.
    PubMed     Abstract available


  395. KIELY M, Boulianne N, Talbot D, Ouakki M, et al
    Children vaccination coverage surveys: Impact of multiple sources of information and multiple contact attempts.
    Vaccine. 2019 Nov 20. pii: S0264-410X(19)31537.
    PubMed     Abstract available


  396. VILA-CORCOLES A, Hospital I, Ochoa-Gondar O, Satue E, et al
    Clinical effectiveness of 13-valent and 23-valent pneumococcal vaccination in middle-aged and older adults: The EPIVAC cohort study, 2015-2016.
    Vaccine. 2019 Nov 20. pii: S0264-410X(19)31526.
    PubMed     Abstract available


  397. D'SOUZA MP, Rele S, Haynes BF, Hu DJ, et al
    Engineering immunity for next generation HIV vaccines: The intersection of bioengineering and immunology.
    Vaccine. 2019 Nov 20. pii: S0264-410X(19)31409.
    PubMed     Abstract available


  398. BIFFAR L, Blunt L, Atkins W, Anderson P, et al
    Evaluating the sensitivity of the bovine BCG challenge model using a prime boost Ad85A vaccine regimen.
    Vaccine. 2019 Nov 20. pii: S0264-410X(19)31512.
    PubMed     Abstract available


  399. MADLON-KAY DJ, Smith ER
    Interpreters' knowledge and perceptions of childhood vaccines: Effect of an educational session.
    Vaccine. 2019 Nov 19. pii: S0264-410X(19)31517.
    PubMed     Abstract available


  400. FLOREK K, Mutschler J, McLean HQ, King JP, et al
    Antibody-dependent cell-mediated cytotoxicity antibody responses to inactivated and live-attenuated influenza vaccination in children during 2014-15.
    Vaccine. 2019 Nov 18. pii: S0264-410X(19)31440.
    PubMed     Abstract available


  401. ZENG W, Horrocks KJ, Tan ACL, Wong CY, et al
    Modular platforms for the assembly of self-adjuvanting lipopeptide-based vaccines for use in an out-bred population.
    Vaccine. 2019 Nov 15. pii: S0264-410X(19)31435.
    PubMed     Abstract available


  402. INSULANDER M, Lindh G, Stenkvist J, Samuelson A, et al
    Long-term follow-up of a vaccination program for infants born to HBsAg-positive mothers in Stockholm County, Sweden.
    Vaccine. 2019 Nov 15. pii: S0264-410X(19)31502.
    PubMed     Abstract available


  403. WANG Y, Zhou Y, Zhang J, Wang X, et al
    iTRAQ-based proteomic analysis of Mycoplasma bovis NM-28 strain from two generations for vaccine screening.
    Vaccine. 2019 Nov 15. pii: S0264-410X(19)31441.
    PubMed     Abstract available


  404. PATEL MM, Davis W, Beacham L, Spencer S, et al
    Priming with MF59 adjuvanted versus nonadjuvanted seasonal influenza vaccines in children - A systematic review and a meta-analysis.
    Vaccine. 2019 Nov 14. pii: S0264-410X(19)31433.
    PubMed     Abstract available


  405. TSUZUKI S, Baguelin M, Pebody R, van Leeuwen E, et al
    Modelling the optimal target age group for seasonal influenza vaccination in Japan.
    Vaccine. 2019 Nov 14. pii: S0264-410X(19)31508.
    PubMed     Abstract available


  406. WILKIE M, Satti I, Minhinnick A, Harris S, et al
    A phase I trial evaluating the safety and immunogenicity of a candidate tuberculosis vaccination regimen, ChAdOx1 85A prime - MVA85A boost in healthy UK adults.
    Vaccine. 2019 Nov 14. pii: S0264-410X(19)31504.
    PubMed     Abstract available


  407. RAFFERTY ERS, McDonald W, Osgood ND, Qian W, et al
    Seeking the optimal schedule for chickenpox vaccination in Canada: Using an agent-based model to explore the impact of dose timing, coverage and waning of immunity on disease outcomes.
    Vaccine. 2019 Nov 14. pii: S0264-410X(19)31445.
    PubMed     Abstract available


  408. BIRCH CPD, Chambers MA, Lesellier S
    A combined measure of tuberculous lesions for assessing the efficacy of vaccination against tuberculosis (Mycobacterium bovis) in European badgers (Meles meles) supports the 3Rs principle of reduction.
    Vaccine. 2019 Nov 13. pii: S0264-410X(19)31468.
    PubMed     Abstract available


  409. NUNEZ IA, Ross TM
    Human COBRA 2 vaccine contains two major epitopes that are responsible for eliciting neutralizing antibody responses against heterologous clades of viruses.
    Vaccine. 2019 Nov 13. pii: S0264-410X(19)31497.
    PubMed     Abstract available


  410. VEKEMANS J, Brennan MJ, Hatherill M, Schrager L, et al
    Preferred product characteristics for therapeutic vaccines to improve tuberculosis treatment outcomes: Key considerations from World Health Organization consultations.
    Vaccine. 2019 Nov 13. pii: S0264-410X(19)31461.
    PubMed     Abstract available


  411. JAMISON AM, Broniatowski DA, Dredze M, Wood-Doughty Z, et al
    Vaccine-related advertising in the Facebook Ad Archive.
    Vaccine. 2019 Nov 12. pii: S0264-410X(19)31446.
    PubMed     Abstract available


  412. HUGHES SL, Bolotin S, Khan S, Li Y, et al
    The effect of time since measles vaccination and age at first dose on measles vaccine effectiveness - A systematic review.
    Vaccine. 2019 Nov 12. pii: S0264-410X(19)31479.
    PubMed     Abstract available


  413. HARALAMBIEVA IH, Ovsyannikova IG, Kennedy RB, Goergen KM, et al
    Rubella virus-specific humoral immune responses and their interrelationships before and after a third dose of measles-mumps-rubella vaccine in women of childbearing age.
    Vaccine. 2019 Nov 12. pii: S0264-410X(19)31511.
    PubMed     Abstract available


  414. STEIGERWALD R, Brake DA, Barrera J, Schutta CJ, et al
    Evaluation of modified Vaccinia Ankara-based vaccines against foot-and-mouth disease serotype A24 in cattle.
    Vaccine. 2019 Nov 9. pii: S0264-410X(19)31505.
    PubMed     Abstract available


  415. TSUNEKUNI R, Tanikawa T, Nakaya T, Saito T, et al
    Improvement of a recombinant avian avulavirus serotype 10 vectored vaccine by the addition of untranslated regions.
    Vaccine. 2019 Nov 9. pii: S0264-410X(19)31500.
    PubMed     Abstract available


  416. SILVEIRA MF, Buffarini R, Bertoldi AD, Santos IS, et al
    The emergence of vaccine hesitancy among upper-class Brazilians: Results from four birth cohorts, 1982-2015.
    Vaccine. 2019 Nov 9. pii: S0264-410X(19)31459.
    PubMed     Abstract available


  417. TADOUNT F, Doyon-Plourde P, Quach C
    Is there a difference in the immune response, efficacy, effectiveness and safety of seasonal influenza vaccine in males and females? - A systematic review.
    Vaccine. 2019 Nov 8. pii: S0264-410X(19)31480.
    PubMed     Abstract available


  418. MITILIAN E, Malli F, Verger P
    Image of the new vaccination obligation through the media.
    Vaccine. 2019 Nov 8. pii: S0264-410X(19)31458.
    PubMed     Abstract available


  419. OTIENO L, Guerra Mendoza Y, Adjei S, Agbenyega T, et al
    Safety and immunogenicity of the RTS,S/AS01 malaria vaccine in infants and children identified as HIV-infected during a randomized trial in sub-Saharan Africa.
    Vaccine. 2019 Nov 7. pii: S0264-410X(19)31466.
    PubMed     Abstract available


  420. HAWKSWORTH A, Jayachander M, Hester S, Mohammed S, et al
    Proteomics as a tool for live attenuated influenza vaccine characterisation.
    Vaccine. 2019 Nov 7. pii: S0264-410X(19)31471.
    PubMed     Abstract available


  421. DAUDEL L, Mary J, Epaulard O
    Perception of mandatory infant vaccines and trust in vaccination among first-year healthcare students: An opportunity window for the training of future healthcare workers.
    Vaccine. 2019 Nov 7. pii: S0264-410X(19)31501.
    PubMed     Abstract available


  422. MARIN-LOPEZ A, Barreiro-Pineiro N, Utrilla-Trigo S, Barriales D, et al
    Cross-protective immune responses against African horse sickness virus after vaccination with protein NS1 delivered by avian reovirus muNS microspheres and modified vaccinia virus Ankara.
    Vaccine. 2019 Nov 7. pii: S0264-410X(19)31476.
    PubMed     Abstract available


  423. KONGCHANAGUL A, Samnuan K, Wirachwong P, Surichan S, et al
    A live attenuated H5N2 prime- inactivated H5N1 boost vaccination induces influenza virus hemagglutinin stalk specific antibody responses.
    Vaccine. 2019 Nov 7. pii: S0264-410X(19)31473.
    PubMed     Abstract available


  424. GILBERT SS, Bulula N, Yohana E, Thompson J, et al
    The impact of an integrated electronic immunization registry and logistics management information system (EIR-eLMIS) on vaccine availability in three regions in Tanzania: A pre-post and time-series analysis.
    Vaccine. 2019 Nov 7. pii: S0264-410X(19)31439.
    PubMed     Abstract available


  425. GANCZAK M, Kalinowski P, Drozd-Dabrowska M, Biesiada D, et al
    School life and influenza immunization: A cross-sectional study on vaccination coverage and influencing determinants among Polish teachers.
    Vaccine. 2019 Nov 6. pii: S0264-410X(19)31447.
    PubMed     Abstract available


  426. KIM E, Won G, Lee JH
    Construction of a novel tetravalent dengue vaccine with a Salmonella Typhimurium bacterial ghost and evaluation of its immunogenicity and protective efficacy using a murine model.
    Vaccine. 2019 Nov 6. pii: S0264-410X(19)31464.
    PubMed     Abstract available


  427. HARMON SHE, Faour D, MacDonald NE, Graham J, et al
    Strengthening vaccination frameworks: Findings of a study on the legal foundations of National Immunization Technical Advisory Groups (NITAGs).
    Vaccine. 2019 Nov 6. pii: S0264-410X(19)31474.
    PubMed     Abstract available


  428. CACHEIRO-LLAGUNO C, Parody N, Renshaw-Calderon A, Osuna C, et al
    Vaccination with LetiFend(R) reduces circulating immune complexes in dogs experimentally infected with L. infantum.
    Vaccine. 2019 Nov 6. pii: S0264-410X(19)31467.
    PubMed     Abstract available


  429. BROWNE SK, Beeler JA, Roberts JN
    Summary of the Vaccines and Related Biological Products Advisory Committee meeting held to consider evaluation of vaccine candidates for the prevention of respiratory syncytial virus disease in RSV-naive infants.
    Vaccine. 2019 Nov 6. pii: S0264-410X(19)31428.
    PubMed     Abstract available


  430. MOTTRAM L, Lundgren A, Svennerholm AM, Leach S, et al
    Booster vaccination with a fractional dose of an oral cholera vaccine induces comparable vaccine-specific antibody avidity as a full dose: A randomised clinical trial.
    Vaccine. 2019 Nov 5. pii: S0264-410X(19)31430.
    PubMed     Abstract available


  431. YU Q, Li Y, Dimitrov K, Afonso CL, et al
    Genetic stability of a Newcastle disease virus vectored infectious laryngotracheitis virus vaccine after serial passages in chicken embryos.
    Vaccine. 2019 Nov 5. pii: S0264-410X(19)31463.
    PubMed     Abstract available


  432. BRAVO LC, Carlos JC, Gatchalian SR, Montellano MEB, et al
    Immunogenicity and safety of an adjuvanted inactivated polio vaccine, IPV-Al, compared to standard IPV: A phase 3 observer-blinded, randomised, controlled trial in infants vaccinated at 6, 10, 14weeks and 9months of age.
    Vaccine. 2019 Nov 5. pii: S0264-410X(19)31444.
    PubMed     Abstract available


  433. LUU LDW, Octavia S, Aitken C, Zhong L, et al
    Surfaceome analysis of Australian epidemic Bordetella pertussis reveals potential vaccine antigens.
    Vaccine. 2019 Nov 5. pii: S0264-410X(19)31442.
    PubMed     Abstract available


  434. MANTEL C, Chu SY, Hyde TB, Lambach P, et al
    Seasonal influenza vaccination in middle-income countries: Assessment of immunization practices in Belarus, Morocco, and Thailand.
    Vaccine. 2019 Nov 4. pii: S0264-410X(19)31401.
    PubMed     Abstract available


  435. CHEN W, Stoecker C
    Mass media coverage and influenza vaccine uptake.
    Vaccine. 2019 Nov 4. pii: S0264-410X(19)31382.
    PubMed     Abstract available


  436. HESTER MM, Lee CK, Abraham A, Khoshkenar P, et al
    Protection of mice against experimental cryptococcosis using glucan particle-based vaccines containing novel recombinant antigens.
    Vaccine. 2019 Nov 4. pii: S0264-410X(19)31431.
    PubMed     Abstract available


  437. ZAIDI S, Riaz A, Hussain SS, Omer SB, et al
    Applying a governance barometer to vaccine delivery systems: Lessons from a rural district of Pakistan.
    Vaccine. 2019 Nov 4. pii: S0264-410X(19)31432.
    PubMed     Abstract available


  438. SONG JY, Noh JY, Lee JS, Wie SH, et al
    Effectiveness of repeated influenza vaccination among the elderly population with high annual vaccine uptake rates during the three consecutive A/H3N2 epidemics.
    Vaccine. 2019 Nov 2. pii: S0264-410X(19)31375.
    PubMed     Abstract available


  439. PEBODY RG, Whitaker H, Ellis J, Andrews N, et al
    End of season influenza vaccine effectiveness in primary care in adults and children in the United Kingdom in 2018/19.
    Vaccine. 2019 Nov 1. pii: S0264-410X(19)31460.
    PubMed     Abstract available


    October 2019
  440. OTTEN G, Matassa V, Ciarlet M, Leav B, et al
    A phase 1, randomized, observer blind, antigen and adjuvant dosage finding clinical trial to evaluate the safety and immunogenicity of an adjuvanted, trivalent subunit influenza vaccine in adults>/=65 years of age.
    Vaccine. 2019 Oct 31. pii: S0264-410X(19)31438.
    PubMed     Abstract available


  441. IKILEZI G, Augusto OJ, Dieleman JL, Sherr K, et al
    Effect of donor funding for immunization from Gavi and other development assistance channels on vaccine coverage: Evidence from 120 low and middle income recipient countries.
    Vaccine. 2019 Oct 31. pii: S0264-410X(19)31437.
    PubMed     Abstract available


  442. SHEN AK, Warnock R, Selna W, MaCurdy TE, et al
    Characteristics of vaccinating providers reported through Medicare claims in office-based settings: Volume of influenza and pneumococcal vaccinations.
    Vaccine. 2019 Oct 31. pii: S0264-410X(19)31402.
    PubMed     Abstract available


  443. FELDSTEIN LR, Fox G, Shefer A, Conklin LM, et al
    School-based delivery of routinely recommended vaccines and opportunities to check vaccination status at school, a global summary, 2008-2017.
    Vaccine. 2019 Oct 31. pii: S0264-410X(19)31434.
    PubMed     Abstract available


  444. EMBORG HD, Kahlert J, Braeye T, Bauwens J, et al
    ADVANCE system testing: Can coverage of pertussis vaccination be estimated in European countries using electronic healthcare databases: An example.
    Vaccine. 2019 Oct 31. pii: S0264-410X(19)30930.
    PubMed     Abstract available


  445. STURKENBOOM M, Bahri P, Chiucchiuini A, Grove Krause T, et al
    Why we need more collaboration in Europe to enhance post-marketing surveillance of vaccines.
    Vaccine. 2019 Oct 31. pii: S0264-410X(19)31002.
    PubMed     Abstract available


  446. BOLLAERTS K, de Smedt T, McGee C, Emborg HD, et al
    ADVANCE: Towards near real-time monitoring of vaccination coverage, benefits and risks using European electronic health record databases.
    Vaccine. 2019 Oct 31. pii: S0264-410X(19)31051.
    PubMed     Abstract available


  447. TIN TIN HTAR M, de Ridder M, Braeye T, Correa A, et al
    Advance system testing: Vaccine benefit studies using multi-country electronic health data - The example of pertussis vaccination.
    Vaccine. 2019 Oct 31. pii: S0264-410X(19)31167.
    PubMed     Abstract available


  448. BOLLAERTS K, Ledent E, de Smedt T, Weibel D, et al
    ADVANCE system testing: Benefit-risk analysis of a marketed vaccine using multi-criteria decision analysis and individual-level state transition modelling.
    Vaccine. 2019 Oct 31. pii: S0264-410X(19)31243.
    PubMed     Abstract available


  449. WEIBEL D, Dodd C, Mahaux O, Haguinet F, et al
    ADVANCE system testing: Can safety studies be conducted using electronic healthcare data? An example using pertussis vaccination.
    Vaccine. 2019 Oct 31. pii: S0264-410X(19)30802.
    PubMed     Abstract available


  450. HAVERS FP, Cho BH, Walker JW, Hariri S, et al
    Economic impact of implementing decennial tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccination in adults in the United States.
    Vaccine. 2019 Oct 29. pii: S0264-410X(19)31348.
    PubMed     Abstract available


  451. GRAFL B, Berger E, Wernsdorf P, Hess M, et al
    Successful reproduction of adenoviral gizzard erosion in 20-week-old SPF layer-type chickens and efficacious prophylaxis due to live vaccination with an apathogenic fowl adenovirus serotype 1 strain (CELO).
    Vaccine. 2019 Oct 28. pii: S0264-410X(19)31412.
    PubMed     Abstract available


  452. SHIODA K, de Oliveira LH, Sanwogou J, Rey-Benito G, et al
    Identifying signatures of the impact of rotavirus vaccines on hospitalizations using sentinel surveillance data from Latin American countries.
    Vaccine. 2019 Oct 28. pii: S0264-410X(19)31373.
    PubMed     Abstract available


  453. ORIJE MRP, Maertens K, Corbiere V, Wanlapakorn N, et al
    The effect of maternal antibodies on the cellular immune response after infant vaccination: A review.
    Vaccine. 2019 Oct 28. pii: S0264-410X(19)31398.
    PubMed     Abstract available


  454. PALLAS SW, Ahmeti A, Morgan W, Preza I, et al
    Program cost analysis of influenza vaccination of health care workers in Albania.
    Vaccine. 2019 Oct 25. pii: S0264-410X(19)31400.
    PubMed     Abstract available


  455. KANG YM, Cho HK, Kim HM, Lee MH, et al
    Protective efficacy of vaccines of the Korea national antigen bank against the homologous H5Nx clade 2.3.2.1 and clade 2.3.4.4 highly pathogenic avian influenza viruses.
    Vaccine. 2019 Oct 25. pii: S0264-410X(19)31417.
    PubMed     Abstract available


  456. NG TWY, Cowling BJ, So HC, Ip DKM, et al
    Testing an integrative theory of health behavioural change for predicting seasonal influenza vaccination uptake among healthcare workers.
    Vaccine. 2019 Oct 24. pii: S0264-410X(19)31414.
    PubMed     Abstract available


  457. OHORI J, Iuchi H, Maseda Y, Kurono Y, et al
    Phosphorylcholine intranasal immunization with a 13-valent pneumococcal conjugate vaccine can boost immune response against Streptococcus pneumoniae.
    Vaccine. 2019 Oct 24. pii: S0264-410X(19)31416.
    PubMed     Abstract available


  458. MAHUMUD RA, Gow J, Alam K, Keramat SA, et al
    Cost-effectiveness of the introduction of two-dose bi-valent (Cervarix) and quadrivalent (Gardasil) HPV vaccination for adolescent girls in Bangladesh.
    Vaccine. 2019 Oct 24. pii: S0264-410X(19)31410.
    PubMed     Abstract available


  459. REYES MSGL, Lee KMG, Pedron AML, Pimentel JMT, et al
    Factors associated with the willingness of primary caregivers to avail of a dengue vaccine for their 9 to 14-year-olds in an urban community in the Philippines.
    Vaccine. 2019 Oct 24. pii: S0264-410X(19)31337.
    PubMed     Abstract available


  460. KOLB EA, Buterbaugh RE, Rinehart CL, Ensley D, et al
    Protection against bovine respiratory syncytial virus in calves vaccinated with adjuvanted modified live vaccine administered in the face of maternal antibody.
    Vaccine. 2019 Oct 24. pii: S0264-410X(19)31378.
    PubMed     Abstract available


  461. SINGH S, Wilson JC, Cripps AW, Massa H, et al
    Immunological characterisation of truncated lipooligosaccharide-outer membrane protein based conjugate vaccine against Moraxella catarrhalis and nontypeable Haemophilus influenzae.
    Vaccine. 2019 Oct 23. pii: S0264-410X(19)31377.
    PubMed     Abstract available


  462. FRAWLEY JE, McManus K, McIntyre E, Seale H, et al
    Uptake of funded influenza vaccines in young Australian children in 2018; parental characteristics, information seeking and attitudes.
    Vaccine. 2019 Oct 23. pii: S0264-410X(19)31406.
    PubMed     Abstract available


  463. PEBODY R, Whitaker H, Zhao H, Andrews N, et al
    Protection provided by influenza vaccine against influenza-related hospitalisation in >/=65 year olds: Early experience of introduction of a newly licensed adjuvanted vaccine in England in 2018/19.
    Vaccine. 2019 Oct 22. pii: S0264-410X(19)31405.
    PubMed     Abstract available


  464. GAJEWSKA M, Gorynski P, Paradowska-Stankiewicz I, Lewtak K, et al
    Monitoring of community-acquired pneumonia hospitalisations before the introduction of pneumococcal conjugate vaccine into Polish National Immunisation Programme (2009-2016): A nationwide retrospective database analysis.
    Vaccine. 2019 Oct 22. pii: S0264-410X(19)31404.
    PubMed     Abstract available


  465. PEBODY RG, Zhao H, Whitaker HJ, Ellis J, et al
    Effectiveness of influenza vaccine in children in preventing influenza associated hospitalisation, 2018/19, England.
    Vaccine. 2019 Oct 21. pii: S0264-410X(19)31408.
    PubMed     Abstract available


  466. AABY P, Benn CS
    Stopping live vaccines after disease eradication may increase mortality.
    Vaccine. 2019 Oct 21. pii: S0264-410X(19)31407.
    PubMed     Abstract available


  467. BECERRA-CULQUI TA, Sy LS, Ackerson BK, Slezak JM, et al
    Safety of quadrivalent meningococcal conjugate vaccine in infants and toddlers 2 to 23-months old.
    Vaccine. 2019 Oct 21. pii: S0264-410X(19)31387.
    PubMed     Abstract available


  468. FERNANDES EG, Sartori AMC, de Soarez PC, Amaku M, et al
    Cost-effectiveness analysis of universal adult immunization with tetanus-diphtheria-acellular pertussis vaccine (Tdap) versus current practice in Brazil.
    Vaccine. 2019 Oct 21. pii: S0264-410X(19)31344.
    PubMed     Abstract available


  469. SAUVAGEAU C, Gilca V, Donken R, Fan SY, et al
    The immune response to a two-dose schedule of quadrivalent HPV vaccine in 9-13year-old girls: Is it influenced by age, menarche status or body mass index?
    Vaccine. 2019 Oct 21. pii: S0264-410X(19)31331.
    PubMed     Abstract available


  470. KOC OM, Damoiseaux J, van Loo IHM, Masquillier HIL, et al
    Case report of delayed seroprotection rather than non-response after primary three-dose hepatitis B vaccination.
    Vaccine. 2019 Oct 21. pii: S0264-410X(19)31385.
    PubMed     Abstract available


  471. ESSINK B, Fierro C, Rosen J, Figueroa AL, et al
    Immunogenicity and safety of MF59-adjuvanted quadrivalent influenza vaccine versus standard and alternate B strain MF59-adjuvanted trivalent influenza vaccines in older adults.
    Vaccine. 2019 Oct 18. pii: S0264-410X(19)31384.
    PubMed     Abstract available


  472. KNODLSEDER JM, Fell SF, Straubinger RK
    A study with a commercial vaccine against Lyme borreliosis in horses using two different vaccination schedules: Characterization of the humoral immune response.
    Vaccine. 2019 Oct 18. pii: S0264-410X(19)31329.
    PubMed     Abstract available


  473. AUN MV, Almeida FM, Saraiva-Romanholo BM, Martins MA, et al
    Diphteria-tetanus-pertussis vaccine reduces specific IgE, inflammation and remodelling in an animal model of mite-induced respiratory allergy.
    Vaccine. 2019 Oct 17. pii: S0264-410X(19)31338.
    PubMed     Abstract available


  474. MANDON ED, Pizzorno A, Traversier A, Champagne A, et al
    Novel calixarene-based surfactant enables low dose split inactivated vaccine protection against influenza infection.
    Vaccine. 2019 Oct 17. pii: S0264-410X(19)31381.
    PubMed     Abstract available


  475. BARRENECHEA GG, Bastos LS
    Evaluation of impact of one dose varicella vaccine on the incidence of chickenpox in Argentina.
    Vaccine. 2019 Oct 17. pii: S0264-410X(19)31362.
    PubMed     Abstract available


  476. MASSEREY SPICHER V, Weiss MG
    Policy and socio-cultural differences between cantons in Switzerland with high and low adolescent vaccination coverage for hepatitis B and HPV.
    Vaccine. 2019 Oct 17. pii: S0264-410X(19)31327.
    PubMed     Abstract available


  477. NEWALL AT, Wood JG, Chen C, McIntyre P, et al
    Reply to letter: Retrospective cost-effectiveness of the 23-valent pneumococcal polysaccharide vaccination program in Australia.
    Vaccine. 2019 Oct 17. pii: S0264-410X(19)31365.
    PubMed    


  478. KYDD JH, Hannant D, Robinson RS, Bryant N, et al
    Vaccination of foals with a modified live, equid herpesvirus-1 gM deletion mutant (RacHDeltagM) confers partial protection against infection.
    Vaccine. 2019 Oct 16. pii: S0264-410X(19)31360.
    PubMed     Abstract available


  479. HAMMITT LL, Campbell JC, Borys D, Weatherholtz RC, et al
    Efficacy, safety and immunogenicity of a pneumococcal protein-based vaccine co-administered with 13-valent pneumococcal conjugate vaccine against acute otitis media in young children: A phase IIb randomized study.
    Vaccine. 2019 Oct 16. pii: S0264-410X(19)31304.
    PubMed     Abstract available


  480. SALERNO-GONCALVES R, Tettelin H, Luo D, Guo Q, et al
    Differential functional patterns of memory CD4(+) and CD8(+) T-cells from volunteers immunized with Ty21a typhoid vaccine observed using a recombinant Escherichia coli system expressing S. Typhi proteins.
    Vaccine. 2019 Oct 16. pii: S0264-410X(19)31383.
    PubMed     Abstract available


  481. MCCLENAHAN SJ, Kormos CM, Gunnell M, Hambuchen MD, et al
    Design, synthesis and biological evaluation of a bi-specific vaccine against alpha-pyrrolidinovalerophenone (alpha-PVP) and 3,4-methylenedioxypyrovalerone (MDPV) in rats.
    Vaccine. 2019 Oct 16. pii: S0264-410X(19)31371.
    PubMed     Abstract available


  482. GIDDING HF, Flack LK, Sheridan S, Liu B, et al
    Infant, maternal and demographic predictors of delayed vaccination: A population-based cohort study.
    Vaccine. 2019 Oct 15. pii: S0264-410X(19)31333.
    PubMed     Abstract available


  483. HARMON SHE, MacDonald NE
    National immunization programme development and vaccine legislation.
    Vaccine. 2019 Oct 15. pii: S0264-410X(19)31346.
    PubMed    


  484. GRANTZ KH, Claudot P, Kambala M, Kouyate M, et al
    Factors influencing participation in an Ebola vaccine trial among front-line workers in Guinea.
    Vaccine. 2019 Oct 14. pii: S0264-410X(19)31336.
    PubMed     Abstract available


  485. MALTEZOU HC, Botelho-Nevers E, Brantsaeter AB, Carlsson RM, et al
    Vaccination of healthcare personnel in Europe: Update to current policies.
    Vaccine. 2019 Oct 14. pii: S0264-410X(19)31285.
    PubMed     Abstract available


  486. DULL P, Friede M, Hwang A, Hall BF, et al
    Meeting report: Global vaccine and immunization research forum, 2018.
    Vaccine. 2019 Oct 14. pii: S0264-410X(19)31374.
    PubMed     Abstract available


  487. KAMEN AA, Lua LHL, Mukhopadhyay TK
    Vaccine Technology VII: Beyond the "decade of vaccines".
    Vaccine. 2019 Oct 14. pii: S0264-410X(19)31325.
    PubMed    


  488. SATO R
    Differential determinants and reasons for the non- and partial vaccination of children among Nigerian caregivers.
    Vaccine. 2019 Oct 12. pii: S0264-410X(19)31341.
    PubMed     Abstract available


  489. SUZUKI M, Morimoto K
    Pneumonia endpoints must be standardized for adult pneumococcal vaccine trials.
    Vaccine. 2019 Oct 12. pii: S0264-410X(19)31376.
    PubMed    


  490. SHAHBARI NAE, Gesser-Edelsburg A, Mesch GS
    Perceived trust in the health system among mothers and nurses and its relationship to the issue of vaccinations among the Arab population of Israel: A qualitative research study.
    Vaccine. 2019 Oct 11. pii: S0264-410X(19)31340.
    PubMed     Abstract available


  491. SAADEH K, Park I, Gargano JW, Whitney E, et al
    Prevalence of human papillomavirus (HPV)-vaccine types by race/ethnicity and sociodemographic factors in women with high-grade cervical intraepithelial neoplasia (CIN2/3/AIS), Alameda County, California, United States.
    Vaccine. 2019 Oct 11. pii: S0264-410X(19)31347.
    PubMed     Abstract available


  492. BERNSTEIN DI, Morello CS, Cardin RD, Bravo FJ, et al
    A vaccine containing highly purified virus particles in adjuvant provides high level protection against genital infection and disease in guinea pigs challenged intravaginally with homologous and heterologous strains of herpes simplex virus type 2.
    Vaccine. 2019 Oct 11. pii: S0264-410X(19)31332.
    PubMed     Abstract available


  493. GARG H, Mehmetoglu-Gurbuz T, Ruddy GM, Joshi A, et al
    Capsid containing virus like particle vaccine against Zika virus made from a stable cell line.
    Vaccine. 2019 Oct 10. pii: S0264-410X(19)31335.
    PubMed     Abstract available


  494. COWLEY D, Sari RM, Handley A, Watts E, et al
    Immunogenicity of four doses of oral poliovirus vaccine when co-administered with the human neonatal rotavirus vaccine (RV3-BB).
    Vaccine. 2019 Oct 10. pii: S0264-410X(19)31299.
    PubMed     Abstract available


  495. LEE B, Dickson DM, Alam M, Afreen S, et al
    The effect of increased inoculum on oral rotavirus vaccine take among infants in Dhaka, Bangladesh: A double-blind, parallel group, randomized, controlled trial.
    Vaccine. 2019 Oct 10. pii: S0264-410X(19)31330.
    PubMed     Abstract available


  496. BALL C, Forrester A, Herrmann A, Lemiere S, et al
    Comparative protective immunity provided by live vaccines of Newcastle disease virus or avian metapneumovirus when co-administered alongside classical and variant strains of infectious bronchitis virus in day-old broiler chicks.
    Vaccine. 2019 Oct 10. pii: S0264-410X(19)31323.
    PubMed     Abstract available


  497. ROBERTS NJ JR
    Respiratory syncytial virus suppression of the antiviral immune response: Implications for evaluation of candidate vaccines.
    Vaccine. 2019 Oct 10. pii: S0264-410X(19)31339.
    PubMed     Abstract available


  498. CONSTENLA D, Liu T
    Estimating the economic impact of pneumococcal conjugate, Haemophilus influenzae type b and rotavirus vaccines in India: National and state-level analyses.
    Vaccine. 2019 Oct 10. pii: S0264-410X(19)31326.
    PubMed     Abstract available


  499. WOLFF GG
    Influenza vaccination and respiratory virus interference among Department of Defense personnel during the 2017-2018 influenza season.
    Vaccine. 2019 Oct 10. pii: S0264-410X(19)31364.
    PubMed     Abstract available


  500. TAVOSCHI L, Quattrone F, De Vita E, Lopalco PL, et al
    Impact of mandatory law on vaccine hesitancy spectrum: The case of measles vaccine catch-up activities in Tuscany, Italy.
    Vaccine. 2019 Oct 9. pii: S0264-410X(19)31334.
    PubMed    


  501. VAN AALST R, Gravenstein S, Mor V, Mahmud SM, et al
    Comparative effectiveness of high dose versus adjuvanted influenza vaccine: A retrospective cohort study.
    Vaccine. 2019 Oct 9. pii: S0264-410X(19)31349.
    PubMed     Abstract available


  502. LIU Z, Behloul N, Baha S, Wei W, et al
    Design and immunogenicity analysis of the combined vaccine against zoonotic hepatitis E and foot-and-mouth disease.
    Vaccine. 2019 Oct 8. pii: S0264-410X(19)31245.
    PubMed     Abstract available


  503. MANCA TA, Graham JE, Dube E, Kervin M, et al
    Developing product label information to support evidence-informed use of vaccines in pregnancy.
    Vaccine. 2019 Oct 5. pii: S0264-410X(19)31291.
    PubMed     Abstract available


  504. HILL K, Arsic N, Nordstrom S, Griebel PJ, et al
    Immune memory induced by intranasal vaccination with a modified-live viral vaccine delivered to colostrum fed neonatal calves.
    Vaccine. 2019 Oct 4. pii: S0264-410X(19)31322.
    PubMed     Abstract available


  505. DE NORONHA TG, de Lourdes de Sousa Maia M, Geraldo Leite Ribeiro J, Campos Lemos JA, et al
    Duration of post-vaccination humoral immunity against yellow fever in children.
    Vaccine. 2019 Oct 4. pii: S0264-410X(19)31260.
    PubMed     Abstract available


  506. KOIKE ME, Gattas VL, Lucchesi MBB, Moura de Oliveira MM, et al
    Pharmacovigilance capacity strengthening for WHO prequalification: The case of the trivalent influenza vaccine manufactured by Instituto Butantan.
    Vaccine. 2019 Oct 4. pii: S0264-410X(19)31324.
    PubMed     Abstract available


  507. KIM SH, Chung DR, Song JH, Baek JY, et al
    Changes in serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates from adult patients in Asia: Emergence of drug-resistant non-vaccine serotypes.
    Vaccine. 2019 Oct 4. pii: S0264-410X(19)31293.
    PubMed     Abstract available


  508. MODANLOO S, Stacey D, Dunn S, Choueiry J, et al
    Parent resources for early childhood vaccination: An online environmental scan.
    Vaccine. 2019 Oct 4. pii: S0264-410X(19)31303.
    PubMed     Abstract available


  509. VILLENA R, Valenzuela MT, Bastias M, Santolaya ME, et al
    Meningococcal invasive disease by serogroup W and use of ACWY conjugate vaccines as control strategy in Chile.
    Vaccine. 2019 Oct 1. pii: S0264-410X(19)31259.
    PubMed     Abstract available


  510. HEINIMAKI S, Hankaniemi MM, Sioofy-Khojine AB, Laitinen OH, et al
    Combination of three virus-derived nanoparticles as a vaccine against enteric pathogens; enterovirus, norovirus and rotavirus.
    Vaccine. 2019 Oct 1. pii: S0264-410X(19)31300.
    PubMed     Abstract available


  511. CAPEDING MR, Alberto E, Sil A, Saluja T, et al
    Immunogenicity, safety and reactogenicity of a Phase II trial of Vi-DT typhoid conjugate vaccine in healthy Filipino infants and toddlers: A preliminary report.
    Vaccine. 2019 Oct 1. pii: S0264-410X(19)31302.
    PubMed     Abstract available


  512. GOODMAN RM, Bridges CB, Kim D, Pike J, et al
    Billing and payment of commercial and Medicaid health plan adult vaccination claims in Michigan since the Affordable Care Act.
    Vaccine. 2019 Oct 1. pii: S0264-410X(19)31251.
    PubMed     Abstract available


    September 2019
  513. AN SH, Lee CY, Hong SM, Choi JG, et al
    Bioengineering a highly productive vaccine strain in embryonated chicken eggs and mammals from a non-pathogenic clade 2.3.4.4 H5N8 strain.
    Vaccine. 2019;37:6154-6161.
    PubMed     Abstract available


  514. TIPTON M, Daly W, Senders S, Block SL, et al
    MenACWY-CRM conjugate vaccine booster dose given 4-6years after priming: Results from a phase IIIb, multicenter, open label study in adolescents and adults.
    Vaccine. 2019;37:6171-6179.
    PubMed     Abstract available


  515. YARNOFF B, Khavjou O, King G, Bates L, et al
    Analysis of the profitability of adult vaccination in 13 private provider practices in the United States.
    Vaccine. 2019;37:6180-6185.
    PubMed     Abstract available


  516. SMITH D, Streatfield SJ, Acosta H, Ganesan S, et al
    A nanoemulsion-adjuvanted intranasal H5N1 influenza vaccine protects ferrets against homologous and heterologous H5N1 lethal challenge.
    Vaccine. 2019;37:6162-6170.
    PubMed     Abstract available


  517. THOMPSON A, Lamberth E, Severs J, Scully I, et al
    Phase 1 trial of a 20-valent pneumococcal conjugate vaccine in healthy adults.
    Vaccine. 2019;37:6201-6207.
    PubMed     Abstract available


  518. SITT T, Kenney M, Barrera J, Pandya M, et al
    Duration of protection and humoral immunity induced by an adenovirus-vectored subunit vaccine for foot-and-mouth disease (FMD) in Holstein steers.
    Vaccine. 2019;37:6221-6231.
    PubMed     Abstract available


  519. KAUFFMANN F, Van Damme P, Leroux-Roels G, Vandermeulen C, et al
    Clinical trials with GMO-containing vaccines in Europe: Status and regulatory framework.
    Vaccine. 2019;37:6144-6153.
    PubMed     Abstract available


  520. LUO J, Zhang Y, He H, Liu Q, et al
    Artesunate enhances the immune response of rabies vaccine as an adjuvant.
    Vaccine. 2019 Sep 30. pii: S0264-410X(19)31305.
    PubMed     Abstract available


  521. WIDDICE LE, Bernstein DI, Franco EL, Ding L, et al
    Decline in vaccine-type human papillomavirus prevalence in young men from a Midwest metropolitan area of the United States over the six years after vaccine introduction.
    Vaccine. 2019 Sep 30. pii: S0264-410X(19)31126.
    PubMed     Abstract available


  522. BIGGERSTAFF M, Cohen C, Reed C, Tempia S, et al
    A cost-effectiveness analysis of antenatal influenza vaccination among HIV-infected and HIV-uninfected pregnant women in South Africa.
    Vaccine. 2019 Sep 28. pii: S0264-410X(19)31283.
    PubMed     Abstract available


  523. MASSORA S, Lessa FC, Moiane B, Pimenta FC, et al
    Invasive disease potential of Streptococcus pneumoniae serotypes before and after 10-valent pneumococcal conjugate vaccine introduction in a rural area, southern Mozambique.
    Vaccine. 2019 Sep 28. pii: S0264-410X(19)31319.
    PubMed     Abstract available


  524. PASMANS H, Schurink-Van't Klooster TM, Bogaard MJM, van Rooijen DM, et al
    Long-term HPV-specific immune response after one versus two and three doses of bivalent HPV vaccination in Dutch girls.
    Vaccine. 2019 Sep 28. pii: S0264-410X(19)31294.
    PubMed     Abstract available


  525. VITORIANO-SOUZA J, Siqueira Mathias FA, Moreira NDD, Aguiar-Soares RDO, et al
    Effect on cellular recruitment and the innate immune response by combining saponin, monophosphoryl lipid-A and Incomplete Freund's Adjuvant with Leishmania (Viannia) braziliensis antigens for a vaccine formulation.
    Vaccine. 2019 Sep 28. pii: S0264-410X(19)31295.
    PubMed     Abstract available


  526. MOURA SILVEIRA M, McBride AJA, Trotter CL
    Health impact and cost-effectiveness of introducing the vaccine (Bexsero) against MenB disease into the Brazilian immunization programme.
    Vaccine. 2019 Sep 27. pii: S0264-410X(19)31286.
    PubMed     Abstract available


  527. WILKINSON K, Righolt CH, Kwong JC, Schwartz KL, et al
    A nested case-control study measuring pertussis vaccine effectiveness and duration of protection in Manitoba, Canada, 1992-2015: A Canadian Immunization Research Network Study.
    Vaccine. 2019 Sep 26. pii: S0264-410X(19)31292.
    PubMed     Abstract available


  528. NAPOLITANO F, Bianco A, D'Alessandro A, Papadopoli R, et al
    Healthcare workers' knowledge, beliefs, and coverage regarding vaccinations in critical care units in Italy.
    Vaccine. 2019 Sep 26. pii: S0264-410X(19)31275.
    PubMed     Abstract available


  529. WALLACE AS, Peetosutan K, Untung A, Ricardo M, et al
    Home-based records and vaccination appointment stickers as parental reminders to reduce vaccination dropout in Indonesia: A cluster-randomized controlled trial.
    Vaccine. 2019 Sep 26. pii: S0264-410X(19)31249.
    PubMed     Abstract available


  530. KIRTLAND KA, Lin X, Kroger AT, Myerburg S, et al
    Frequency and cost of live vaccines administered too soon after prior live vaccine in children aged 12months through 6years, 2014-2017.
    Vaccine. 2019 Sep 25. pii: S0264-410X(19)31282.
    PubMed     Abstract available


  531. VAN ZANDVOORT K, Checchi F, Diggle E, Eggo RM, et al
    Pneumococcal conjugate vaccine use during humanitarian crises.
    Vaccine. 2019 Sep 24. pii: S0264-410X(19)31247.
    PubMed     Abstract available


  532. ALASHKAR F, Vance C, Herich-Terhurne D, Turki AT, et al
    Serologic response to meningococcal vaccination in patients with cold agglutinin disease (CAD) in the novel era of complement inhibition.
    Vaccine. 2019 Sep 24. pii: S0264-410X(19)31242.
    PubMed     Abstract available


  533. CHOW EPF, Tabrizi SN, Fairley CK, Wigan R, et al
    Prevalence of human papillomavirus in teenage heterosexual males following the implementation of female and male school-based vaccination in Australia: 2014-2017.
    Vaccine. 2019 Sep 24. pii: S0264-410X(19)31261.
    PubMed     Abstract available


  534. GIDENGIL C, Chen C, Parker AM, Nowak S, et al
    Beliefs around childhood vaccines in the United States: A systematic review.
    Vaccine. 2019 Sep 24. pii: S0264-410X(19)31144.
    PubMed     Abstract available


  535. MARUYAMA J, Mateer EJ, Manning JT, Sattler R, et al
    Adenoviral vector-based vaccine is fully protective against lethal Lassa fever challenge in Hartley guinea pigs.
    Vaccine. 2019 Sep 24. pii: S0264-410X(19)31230.
    PubMed     Abstract available


  536. MOSTAFAPOUR M, Meyer SB, Scholer A
    Exploring the effect of risk and benefit information provision on vaccination decision-making.
    Vaccine. 2019 Sep 23. pii: S0264-410X(19)31172.
    PubMed     Abstract available


  537. TATE J, Aguado T, Belie J, Holt D, et al
    The life-course approach to vaccination: Harnessing the benefits of vaccination throughout life.
    Vaccine. 2019 Sep 23. pii: S0264-410X(19)31204.
    PubMed     Abstract available


  538. HAJIZADEH M
    Decomposing socioeconomic inequality in child vaccination in the Gambia, the Kyrgyz Republic and Namibia.
    Vaccine. 2019 Sep 23. pii: S0264-410X(19)31276.
    PubMed     Abstract available


  539. LIN Y, Lin Z, He F, Hu Z, et al
    Factors influencing intention to obtain the HPV vaccine and acceptability of 2-, 4- and 9-valent HPV vaccines: A study of undergraduate female health sciences students in Fujian, China.
    Vaccine. 2019 Sep 20. pii: S0264-410X(19)31226.
    PubMed     Abstract available


  540. MCNEIL MM, Paradowska-Stankiewicz I, Miller ER, Marquez PL, et al
    Adverse events following adenovirus type 4 and type 7 vaccine, live, oral in the Vaccine Adverse Event Reporting System (VAERS), United States, October 2011-July 2018.
    Vaccine. 2019 Sep 20. pii: S0264-410X(19)31188.
    PubMed     Abstract available


  541. GROOM HC, Smith N, Irving SA, Koppolu P, et al
    Uptake and safety of hepatitis A vaccination during pregnancy: A Vaccine Safety Datalink study.
    Vaccine. 2019 Sep 20. pii: S0264-410X(19)31252.
    PubMed     Abstract available


  542. KUMRU OS, Saleh-Birdjandi S, Antunez LR, Sayeed E, et al
    Stabilization and formulation of a recombinant Human Cytomegalovirus vector for use as a candidate HIV-1 vaccine.
    Vaccine. 2019 Sep 20. pii: S0264-410X(19)31227.
    PubMed     Abstract available


  543. CUTRELL JB, Drechsler H, Bedimo R, Alvarez CA, et al
    Statin use and medically attended acute respiratory illness among influenza vaccine recipients.
    Vaccine. 2019 Sep 19. pii: S0264-410X(19)31224.
    PubMed     Abstract available


  544. DETOC M, Launay O, Duale C, Mutter C, et al
    Barriers and motivations for participation in preventive vaccine clinical trials: Experience of 5 clinical research sites.
    Vaccine. 2019 Sep 19. pii: S0264-410X(19)31257.
    PubMed     Abstract available


  545. GUCLU OA, Demirci H, Ocakoglu G, Guclu Y, et al
    Relationship of pneumococcal and influenza vaccination frequency with health literacy in the rural population in Turkey.
    Vaccine. 2019 Sep 18. pii: S0264-410X(19)31258.
    PubMed     Abstract available


  546. YITBAREK A, Astill J, Hodgins DC, Parkinson J, et al
    Commensal gut microbiota can modulate adaptive immune responses in chickens vaccinated with whole inactivated avian influenza virus subtype H9N2.
    Vaccine. 2019 Sep 18. pii: S0264-410X(19)31255.
    PubMed     Abstract available


  547. TEO LM, Smith HE, Lwin MO, Tang WE, et al
    Attitudes and perception of influenza vaccines among older people in Singapore: A qualitative study.
    Vaccine. 2019 Sep 18. pii: S0264-410X(19)31246.
    PubMed     Abstract available


  548. DONAHUE JG, Kieke BA, King JP, Mascola MA, et al
    Inactivated influenza vaccine and spontaneous abortion in the Vaccine Safety Datalink in 2012-13, 2013-14, and 2014-15.
    Vaccine. 2019 Sep 17. pii: S0264-410X(19)31244.
    PubMed     Abstract available


  549. KARRAS J, Dube E, Danchin M, Kaufman J, et al
    A scoping review examining the availability of dialogue-based resources to support healthcare providers engagement with vaccine hesitant individuals.
    Vaccine. 2019 Sep 17. pii: S0264-410X(19)31248.
    PubMed     Abstract available


  550. ETO A, Fujita M, Nishiyama Y, Saito T, et al
    Profiling of the antibody response to attenuated LC16m8 smallpox vaccine using protein array analysis.
    Vaccine. 2019 Sep 17. pii: S0264-410X(19)31194.
    PubMed     Abstract available


  551. GILES ML, Buttery J, Davey MA, Wallace E, et al
    Pregnant women's knowledge and attitude to maternal vaccination including group B streptococcus and respiratory syncytial virus vaccines.
    Vaccine. 2019 Sep 17. pii: S0264-410X(19)31173.
    PubMed     Abstract available


  552. MALIK A, Haldar P, Ray A, Shet A, et al
    Introducing rotavirus vaccine in the Universal Immunization Programme in India: From evidence to policy to implementation.
    Vaccine. 2019;37:5817-5824.
    PubMed     Abstract available


  553. RIECKMANN A, Meyle KD, Rod NH, Baker JL, et al
    Smallpox and BCG vaccination in childhood and cutaneous malignant melanoma in Danish adults followed from 18 to 49 years.
    Vaccine. 2019 Sep 16. pii: S0264-410X(19)31223.
    PubMed     Abstract available


  554. OPRIESSNIG T, Castro AMMG, Karuppanan AK, Gauger PC, et al
    A Porcine circovirus type 2b (PCV2b)-based experimental vaccine is effective in the PCV2b-Mycoplasma hyopneumoniae coinfection pig model.
    Vaccine. 2019 Sep 16. pii: S0264-410X(19)31229.
    PubMed     Abstract available


  555. WILLER DO, Oostvogels L, Cunningham AL, Gervais P, et al
    Efficacy of the adjuvanted recombinant zoster vaccine (RZV) by sex, geographic region, and geographic ancestry/ethnicity: A post-hoc analysis of the ZOE-50 and ZOE-70 randomized trials.
    Vaccine. 2019 Sep 16. pii: S0264-410X(19)31228.
    PubMed     Abstract available


  556. MOKOMANE M, Esona MD, Bowen MD, Tate JE, et al
    Diversity of Rotavirus Strains Circulating in Botswana before and after introduction of the Monovalent Rotavirus Vaccine.
    Vaccine. 2019 Sep 14. pii: S0264-410X(19)31222.
    PubMed     Abstract available


  557. AUTUMN SMILEY M, Sanford DC, Triplett CA, Callahan D, et al
    Comparative immunogenicity and efficacy of thermostable (lyophilized) and liquid formulation of anthrax vaccine candidate AV7909.
    Vaccine. 2019 Sep 14. pii: S0264-410X(19)31203.
    PubMed     Abstract available


  558. CONNOCHIE D, Tingler RC, Bauermeister JA
    Young men who have sex with men's awareness, acceptability, and willingness to participate in HIV vaccine trials: Results from a nationwide online pilot study.
    Vaccine. 2019 Sep 13. pii: S0264-410X(19)31152.
    PubMed     Abstract available


  559. IHARA H, Kikuchi K, Taniguchi H, Fujita S, et al
    23-valent pneumococcal polysaccharide vaccine improves survival in dialysis patients by preventing cardiac events.
    Vaccine. 2019 Sep 13. pii: S0264-410X(19)31190.
    PubMed     Abstract available


  560. ACOSTA D, Hendrickx S, McKune S
    The livestock vaccine supply chain: Why it matters and how it can help eradicate peste des petits Ruminants, based on findings in Karamoja, Uganda.
    Vaccine. 2019 Sep 13. pii: S0264-410X(19)31199.
    PubMed     Abstract available


  561. TAN HY, Lai E, Kunasekaran M, Chughtai AA, et al
    Prevalence and predictors of influenza vaccination among residents of long-term care facilities.
    Vaccine. 2019 Sep 13. pii: S0264-410X(19)31221.
    PubMed     Abstract available


  562. DU L, Yu X, Hou L, Zhang D, et al
    Identification of mechanisms conferring an enhanced immune response in mice induced by CVC1302-adjuvanted killed serotype O foot-and-mouth virus vaccine.
    Vaccine. 2019 Sep 13. pii: S0264-410X(19)31202.
    PubMed     Abstract available


  563. NOAD RJ, Simpson K, Fooks AR, Hewson R, et al
    UK vaccines network: Mapping priority pathogens of epidemic potential and vaccine pipeline developments.
    Vaccine. 2019 Sep 12. pii: S0264-410X(19)31197.
    PubMed     Abstract available


  564. MCLAUGHLIN JM, Jiang Q, Gessner BD, Swerdlow DL, et al
    Pneumococcal conjugate vaccine against serotype 3 pneumococcal pneumonia in adults: A systematic review and pooled analysis.
    Vaccine. 2019 Sep 12. pii: S0264-410X(19)31135.
    PubMed     Abstract available


  565. FOUGERE Y, El Houss S, Suris JC, Rouvenaz-Defago S, et al
    Single doses of diphtheria-tetanus-pertussis and poliomyelitis vaccines are sufficient to generate a booster-type response to tetanus in most migrant children.
    Vaccine. 2019 Sep 12. pii: S0264-410X(19)31192.
    PubMed     Abstract available


  566. CHOW EPF, Danielewski JA, Murray GL, Fehler G, et al
    Anal human papillomavirus infections in young unvaccinated men who have sex with men attending a sexual health clinic for HPV vaccination in Melbourne, Australia.
    Vaccine. 2019 Sep 11. pii: S0264-410X(19)31142.
    PubMed     Abstract available


  567. BURNETT EM, Francois J, Sreenivasan N, Wannemuehler K, et al
    Oral cholera vaccination coverage after the first global stockpile deployment in Haiti, 2014.
    Vaccine. 2019 Sep 11. pii: S0264-410X(19)31218.
    PubMed     Abstract available


  568. WIYEH AB, Cooper S, Jaca A, Mavundza E, et al
    Social media and HPV vaccination: Unsolicited public comments on a Facebook post by the Western Cape Department of Health provide insights into determinants of vaccine hesitancy in South Africa.
    Vaccine. 2019 Sep 11. pii: S0264-410X(19)31219.
    PubMed     Abstract available


  569. COSTANTINO V, MacIntyre CR, Trent M
    Modelling of optimal timing for influenza vaccination as a function of intraseasonal waning of immunity and vaccine coverage.
    Vaccine. 2019 Sep 11. pii: S0264-410X(19)31145.
    PubMed     Abstract available


  570. JACOBSEN KH, McCoy JD, Painter JE
    Authors' Response "Perceptions of vaccination within a Christian homeschooling community in Pennsylvania".
    Vaccine. 2019;37:5667.
    PubMed    


  571. LI XR, Yang YK, Wang RB, An FL, et al
    A scale-down model of 4000-L cell culture process for inactivated foot-and-mouth disease vaccine production.
    Vaccine. 2019 Sep 10. pii: S0264-410X(19)31201.
    PubMed     Abstract available


  572. YU X, Zhang T, Cui L, Geng X, et al
    Corrigendum to "Epidemiology study of pediatric primary intussusception aged </=24months in pre-rotavirus vaccine era of Jinan, China" [Vaccine (37) 1436-1442].
    Vaccine. 2019 Sep 10. pii: S0264-410X(19)31070.
    PubMed    


  573. PEZZOLI L
    Global oral cholera vaccine use, 2013-2018.
    Vaccine. 2019 Sep 10. pii: S0264-410X(19)31185.
    PubMed     Abstract available


  574. ZEEVAT F, van der Schans J, Boersma WG, Boersma C, et al
    Cost-effectiveness analysis on elderly pneumococcal vaccination in the Netherlands: Challenging the Dutch Health Council's advice.
    Vaccine. 2019 Sep 9. pii: S0264-410X(19)31125.
    PubMed     Abstract available


  575. XU J, Hiramatsu R, Suhaimi H, Kato T, et al
    Neospora caninum antigens displaying virus-like particles as a bivalent vaccine candidate against neosporosis.
    Vaccine. 2019 Sep 9. pii: S0264-410X(19)31187.
    PubMed     Abstract available


  576. WANG LY, Chen CF, Wu TW, Lai SK, et al
    Response to hepatitis B vaccination is co-determined by HLA-DPA1 and -DPB1.
    Vaccine. 2019 Sep 9. pii: S0264-410X(19)31186.
    PubMed     Abstract available


  577. QUATTROCCHI A, Mereckiene J, Fitzgerald M, Cotter S, et al
    Determinants of influenza and pertussis vaccine uptake in pregnant women in Ireland: A cross-sectional survey in 2017/18 influenza season.
    Vaccine. 2019 Sep 9. pii: S0264-410X(19)31196.
    PubMed     Abstract available


  578. ARYA DP, Said MA, Izurieta HS, Perez-Vilar S, et al
    Surveillance for Guillain-Barre syndrome after 2015-2016 and 2016-2017 influenza vaccination of Medicare beneficiaries.
    Vaccine. 2019 Sep 9. pii: S0264-410X(19)31109.
    PubMed     Abstract available


  579. TORRES JR, Falleiros-Arlant LH, Gessner BD, Delrieu I, et al
    Updated recommendations of the International Dengue Initiative expert group for CYD-TDV vaccine implementation in Latin America.
    Vaccine. 2019 Sep 9. pii: S0264-410X(19)31198.
    PubMed     Abstract available


  580. BERNSTEIN DI, Cardin RD, Bravo FJ, Hamouda T, et al
    Intranasal nanoemulsion-adjuvanted HSV-2 subunit vaccine is effective as a prophylactic and therapeutic vaccine using the guinea pig model of genital herpes.
    Vaccine. 2019 Sep 9. pii: S0264-410X(19)31153.
    PubMed     Abstract available


  581. UMTHONG S, Dunn JR, Cheng HH
    Towards a mechanistic understanding of the synergistic response induced by bivalent Marek's disease vaccines to prevent lymphomas.
    Vaccine. 2019 Sep 9. pii: S0264-410X(19)31189.
    PubMed     Abstract available


  582. KEITEL WA, Potter GE, Diemert D, Bethony J, et al
    A phase 1 study of the safety, reactogenicity, and immunogenicity of a Schistosoma mansoni vaccine with or without glucopyranosyl lipid A aqueous formulation (GLA-AF) in healthy adults from a non-endemic area.
    Vaccine. 2019 Sep 9. pii: S0264-410X(19)31151.
    PubMed     Abstract available


  583. ELAISH M, Xia M, Ngunjiri JM, Ghorbani A, et al
    Protective immunity against influenza virus challenge by norovirus P particle-M2e and HA2-AtCYN vaccines in chickens.
    Vaccine. 2019 Sep 7. pii: S0264-410X(19)31171.
    PubMed     Abstract available


  584. SAKURAI A, Ogawa T, Matsumoto J, Kihira T, et al
    Regulatory aspects of quality and safety for live recombinant viral vaccines against infectious diseases in Japan.
    Vaccine. 2019 Sep 7. pii: S0264-410X(19)31095.
    PubMed     Abstract available


  585. SALMON DA, Limaye RJ, Dudley MZ, Oloko OK, et al
    MomsTalkShots: An individually tailored educational application for maternal and infant vaccines.
    Vaccine. 2019 Sep 7. pii: S0264-410X(19)31169.
    PubMed     Abstract available


  586. GOMES RR, Antunes DE, Dos Santos DF, Sabino EFP, et al
    BCG vaccine and leprosy household contacts: Protective effect and probability to becoming sick during follow-up.
    Vaccine. 2019 Sep 6. pii: S0264-410X(19)31143.
    PubMed     Abstract available


  587. CHAN J, Nguyen CD, Dunne EM, Kim Mulholland E, et al
    Using pneumococcal carriage studies to monitor vaccine impact in low- and middle-income countries.
    Vaccine. 2019 Sep 6. pii: S0264-410X(19)31149.
    PubMed     Abstract available


  588. NAKAMURA K, Harada Y, Takahashi H, Trusheim H, et al
    Systematic evaluation of suspension MDCK cells, adherent MDCK cells, and LLC-MK2 cells for preparing influenza vaccine seed virus.
    Vaccine. 2019 Sep 6. pii: S0264-410X(19)31140.
    PubMed     Abstract available


  589. CHEN JY, Wu CM, Liao CM, Chen KC, et al
    The impact of porcine circovirus associated diseases on live attenuated classical swine fever vaccine in field farm applications.
    Vaccine. 2019 Sep 6. pii: S0264-410X(19)31103.
    PubMed     Abstract available


  590. CHERIAN T, Morales KF, Mantel C, Lambach P, et al
    Factors and considerations for establishing and improving seasonal influenza vaccination of health workers: Report from a WHO meeting, January 16-17, Berlin, Germany.
    Vaccine. 2019 Sep 6. pii: S0264-410X(19)31000.
    PubMed     Abstract available


  591. VESTJENS SMT, Sanders EAM, Vlaminckx BJ, de Melker HE, et al
    Twelve years of pneumococcal conjugate vaccination in the Netherlands: Impact on incidence and clinical outcomes of invasive pneumococcal disease.
    Vaccine. 2019 Sep 6. pii: S0264-410X(19)31075.
    PubMed     Abstract available


  592. ROLLENHAGEN JE, Woods CM, O'Dowd A, Poole ST, et al
    Evaluation of transcutaneous immunization as a delivery route for an enterotoxigenic E. coli adhesin-based vaccine with CfaE, the colonization factor antigen 1 (CFA/I) tip adhesin.
    Vaccine. 2019 Sep 3. pii: S0264-410X(19)31131.
    PubMed     Abstract available


    August 2019
  593. BAR-PELED Y, Huang J, Nunez IA, Pierce SR, et al
    Structural and antigenic characterization of a computationally-optimized H5 hemagglutinin influenza vaccine.
    Vaccine. 2019 Aug 31. pii: S0264-410X(19)31138.
    PubMed     Abstract available


  594. PARENKY AC, Akalkotkar A, Mulla NS, D'Souza MJ, et al
    Harnessing T-cell activity against prostate cancer: A therapeutic microparticulate oral cancer vaccine.
    Vaccine. 2019 Aug 30. pii: S0264-410X(19)31097.
    PubMed     Abstract available


  595. POUDEL A, Lau ETL, Deldot M, Campbell C, et al
    Pharmacist role in vaccination: Evidence and challenges.
    Vaccine. 2019 Aug 29. pii: S0264-410X(19)31136.
    PubMed     Abstract available


  596. NICCOLAI LM, Yakely AE, Hansen CE
    Up-to-date coverage with meningococcal vaccine among adolescents age 17years: Patterns and correlates in the United States, 2017.
    Vaccine. 2019 Aug 28. pii: S0264-410X(19)31065.
    PubMed     Abstract available


  597. FATHIMA P, Snelling TL, Gibbs RA
    Effectiveness of rotavirus vaccines in an Australian population: A case-control study.
    Vaccine. 2019 Aug 28. pii: S0264-410X(19)31111.
    PubMed     Abstract available


  598. LIM ASE, Lim RBT
    Facilitators and barriers of human papillomavirus vaccine uptake in young females 18-26years old in Singapore: A qualitative study.
    Vaccine. 2019 Aug 28. pii: S0264-410X(19)31127.
    PubMed     Abstract available


  599. RAJ SM, Chughtai AA, Sharma A, Tan TC, et al
    Cost-benefit analysis of a national influenza vaccination program in preventing hospitalisation costs in Australian adults aged 50-64years old.
    Vaccine. 2019 Aug 28. pii: S0264-410X(19)31092.
    PubMed     Abstract available


  600. COOK E, Russell G, Grant D, Mutisya C, et al
    A randomised vaccine field trial in Kenya demonstrates protection against wildebeest-associated malignant catarrhal fever in cattle.
    Vaccine. 2019 Aug 28. pii: S0264-410X(19)31104.
    PubMed     Abstract available


  601. FELETTO M, Sharkey AB
    Broadening the perspective on gender equity in immunization: The unique contributions of Human Papillomavirus vaccination.
    Vaccine. 2019 Aug 28. pii: S0264-410X(19)31099.
    PubMed    


  602. MOKOENA NB, Moetlhoa B, Rutkowska DA, Mamputha S, et al
    Plant-produced Bluetongue chimaeric VLP vaccine candidates elicit serotype-specific immunity in sheep.
    Vaccine. 2019 Aug 27. pii: S0264-410X(19)31106.
    PubMed     Abstract available


  603. CARLSON SJ, Scanlan C, Marshall HS, Blyth CC, et al
    Attitudes about and access to influenza vaccination experienced by parents of children hospitalised for influenza in Australia.
    Vaccine. 2019 Aug 27. pii: S0264-410X(19)31071.
    PubMed     Abstract available


  604. DORAIVELU K, Boulet SL, Biswas HH, Adams JC, et al
    Predictors of tetanus, diphtheria, acellular pertussis and influenza vaccination during pregnancy among full-term deliveries in a medically underserved population.
    Vaccine. 2019 Aug 27. pii: S0264-410X(19)31108.
    PubMed     Abstract available


  605. CHEN P, Ding L, Jiang Y, Zeng X, et al
    Protective efficacy in farmed ducks of a duck enteritis virus-vectored vaccine against H5N1, H5N6, and H5N8 avian influenza viruses.
    Vaccine. 2019 Aug 27. pii: S0264-410X(19)31088.
    PubMed     Abstract available


  606. DANOVARO-HOLLIDAY MC
    Comments on ''Redefining vaccination coverage and timeliness measures using electronic immunization registry data in low- and middle-income countries".
    Vaccine. 2019 Aug 27. pii: S0264-410X(19)31028.
    PubMed    


  607. HANKANIEMI MM, Stone VM, Sioofy-Khojine AB, Heinimaki S, et al
    A comparative study of the effect of UV and formalin inactivation on the stability and immunogenicity of a Coxsackievirus B1 vaccine.
    Vaccine. 2019 Aug 27. pii: S0264-410X(19)31101.
    PubMed     Abstract available


  608. ZHAO R, Yu P, Shan Y, Thirumeni N, et al
    Rabies virus glycoprotein serology ELISA for measurement of neutralizing antibodies in sera of vaccinated human subjects.
    Vaccine. 2019 Aug 27. pii: S0264-410X(19)31107.
    PubMed     Abstract available


  609. HAGEDORN BL, Dabbagh A, McCarthy KA
    The cost saving opportunity of introducing a card review into measles-containing vaccination campaigns.
    Vaccine. 2019 Aug 27. pii: S0264-410X(19)31113.
    PubMed     Abstract available


  610. SREENIVASAN N, Li A, Shiferaw M, Tran CH, et al
    Overview of rabies post-exposure prophylaxis access, procurement and distribution in selected countries in Asia and Africa, 2017-2018.
    Vaccine. 2019 Aug 27. pii: S0264-410X(19)30475.
    PubMed     Abstract available


  611. LAN H, Hosomi K, Kunisawa J
    Clostridium perfringens enterotoxin-based protein engineering for the vaccine design and delivery system.
    Vaccine. 2019 Aug 26. pii: S0264-410X(19)31096.
    PubMed     Abstract available


  612. PINDYCK T, Tate JE, Bonkoungou IJO, Armah G, et al
    Timeliness of rotavirus vaccination at sentinel sites in four early-adopter African countries.
    Vaccine. 2019 Aug 24. pii: S0264-410X(19)31047.
    PubMed     Abstract available


  613. PARK BJ, Ahn HS, Han SH, Go HJ, et al
    Evaluation of the protective effects of a nanogel-based vaccine against rabbit hepatitis E virus.
    Vaccine. 2019 Aug 24. pii: S0264-410X(19)31093.
    PubMed     Abstract available


  614. ZUK P, Zuk P
    One of the recent attacks of smallpox in Europe: A massive vaccination campaign during the epidemic in Wroclaw in 1963.
    Vaccine. 2019 Aug 24. pii: S0264-410X(19)31102.
    PubMed     Abstract available


  615. ROZBROJ T, Lyons A, Lucke J
    The mad leading the blind: Perceptions of the vaccine-refusal movement among Australians who support vaccination.
    Vaccine. 2019 Aug 23. pii: S0264-410X(19)31073.
    PubMed     Abstract available


  616. HOQUE SA, Iizuka I, Kobayashi M, Takanashi S, et al
    Determining effectiveness of rotavirus vaccine by immunochromatography and reverse transcriptase polymerase chain reaction: A comparison.
    Vaccine. 2019 Aug 22. pii: S0264-410X(19)31012.
    PubMed     Abstract available


  617. EVANS DR, Yemeke TT, Kiracho EE, Mutebi A, et al
    Trust in vaccines and medicines in Uganda.
    Vaccine. 2019 Aug 22. pii: S0264-410X(19)30913.
    PubMed     Abstract available


  618. WILKINSON TMA, Schembri S, Brightling C, Bakerly ND, et al
    Non-typeable Haemophilus influenzae protein vaccine in adults with COPD: A phase 2 clinical trial.
    Vaccine. 2019 Aug 22. pii: S0264-410X(19)31021.
    PubMed     Abstract available


  619. PAGLIUSI S, Che Y, Dong S
    The art of partnerships for vaccines.
    Vaccine. 2019 Aug 22. pii: S0264-410X(19)31009.
    PubMed     Abstract available


  620. BRUXVOORT KJ, Luo Y, Ackerson B, Tanenbaum HC, et al
    Comparison of vaccine effectiveness against influenza hospitalization of cell-based and egg-based influenza vaccines, 2017-2018.
    Vaccine. 2019 Aug 21. pii: S0264-410X(19)31074.
    PubMed     Abstract available


  621. NEALON J, Lim WY, Moureau A, Linus Lojikip S, et al
    Feasibility of case-control and test-negative designs to evaluate dengue vaccine effectiveness in Malaysia.
    Vaccine. 2019 Aug 21. pii: S0264-410X(19)31004.
    PubMed     Abstract available


  622. FATHIMA P, Gidding HF, Snelling TL, McIntyre PB, et al
    Timeliness and factors associated with rotavirus vaccine uptake among Australian Aboriginal and non-Aboriginal children: A record linkage cohort study.
    Vaccine. 2019 Aug 20. pii: S0264-410X(19)31063.
    PubMed     Abstract available


  623. STREZOVA A, Lal H, Enweonye I, Campora L, et al
    The adjuvanted recombinant zoster vaccine co-administered with a tetanus, diphtheria and pertussis vaccine in adults aged >/=50 years: A randomized trial.
    Vaccine. 2019 Aug 20. pii: S0264-410X(19)31026.
    PubMed     Abstract available


  624. DAS M, Singh H, Girish Kumar CP, John D, et al
    Non-vaccine strategies for cholera prevention and control: India's preparedness for the global roadmap.
    Vaccine. 2019 Aug 20. pii: S0264-410X(19)31049.
    PubMed     Abstract available


  625. XIA R, Sun S, Shen M, Zhang L, et al
    Targeted hepatitis E vaccination for women of childbearing age is cost-effective in China.
    Vaccine. 2019 Aug 20. pii: S0264-410X(19)31040.
    PubMed     Abstract available


  626. PACKNETT E, Irwin DE, Novy P, Watson PS, et al
    Meningococcal-group B (MenB) vaccine series completion and adherence to dosing schedule in the United States: A retrospective analysis by vaccine and payer type.
    Vaccine. 2019 Aug 20. pii: S0264-410X(19)30842.
    PubMed     Abstract available


  627. KOFF WC, Schenkelberg T
    The future of vaccine development.
    Vaccine. 2019 Aug 20. pii: S0264-410X(19)31022.
    PubMed     Abstract available


  628. HYER RN, Janssen RS
    Immunogenicity and safety of a 2-dose hepatitis B vaccine, HBsAg/CpG 1018, in persons with diabetes mellitus aged 60-70years.
    Vaccine. 2019 Aug 17. pii: S0264-410X(19)31044.
    PubMed     Abstract available


  629. CHANG LJ, Meng Y, Janosczyk H, Landolfi V, et al
    Safety and immunogenicity of high-dose quadrivalent influenza vaccine in adults >/=65years of age: A phase 3 randomized clinical trial.
    Vaccine. 2019 Aug 17. pii: S0264-410X(19)31066.
    PubMed     Abstract available


  630. HILKE J, Strobel H, Woelke S, Stoeter M, et al
    A comparison of different vaccination schemes used in sheep combining inactivated bluetongue vaccines against serotypes 4 and 8.
    Vaccine. 2019 Aug 17. pii: S0264-410X(19)31050.
    PubMed     Abstract available


  631. COSTANTINO C, Restivo V, Amodio E, Colomba GME, et al
    A mid-term estimate of 2018/2019 vaccine effectiveness to prevent laboratory confirmed A(H1N1)pdm09 and A(H3N2) influenza cases in Sicily (Italy).
    Vaccine. 2019 Aug 16. pii: S0264-410X(19)31064.
    PubMed     Abstract available


  632. PERRETT SE, Cottrell S, Shankar AG
    Hepatitis B vaccine coverage in short and long stay prisons in Wales, UK 2013-2017 and the impact of the global vaccine shortage.
    Vaccine. 2019;37:4872-4876.
    PubMed     Abstract available


  633. BELINGHERI M, De Vito G, Riva MA
    Italian midwives and influenza vaccination: problems in adherence and perception.
    Vaccine. 2019;37:4851.
    PubMed    


  634. INNIS BL, Scorza FB, Blum JS, Jain VK, et al
    Convening on the influenza human viral challenge model for universal influenza vaccines, Part 2: Methodologic considerations.
    Vaccine. 2019;37:4830-4834.
    PubMed     Abstract available


  635. INNIS BL, Berlanda Scorza F, Blum JS, Jain VK, et al
    Meeting report: Convening on the influenza human viral challenge model for universal influenza vaccines, Part 1: Value; challenge virus selection; regulatory, industry and ethical considerations; increasing standardization, access and capacity.
    Vaccine. 2019;37:4823-4829.
    PubMed     Abstract available


  636. ZHANG W, Wang Q
    The failure of news coverage supportive of human papillomavirus vaccination: The investigation of the effects of online comments on female college students' vaccination intention.
    Vaccine. 2019 Aug 14. pii: S0264-410X(19)31046.
    PubMed     Abstract available


  637. CATALDI JR, Sevick C, Pyrzanowski J, Wagner N, et al
    Addressing personal parental values in decisions about childhood vaccination: Measure development.
    Vaccine. 2019 Aug 14. pii: S0264-410X(19)31048.
    PubMed     Abstract available


  638. VAN WIJHE M, de Boer PT, de Jong HJ, van Vliet H, et al
    Trends in governmental expenditure on vaccination programmes in the Netherlands, a historical analysis.
    Vaccine. 2019 Aug 13. pii: S0264-410X(19)31018.
    PubMed     Abstract available


  639. LAUPEZE B, Herve C, Di Pasquale A, Tavares Da Silva F, et al
    Adjuvant Systems for vaccines: 13years of post-licensure experience in diverse populations have progressed the way adjuvanted vaccine safety is investigated and understood.
    Vaccine. 2019 Aug 13. pii: S0264-410X(19)31019.
    PubMed     Abstract available


  640. PATEL N, Massare MJ, Tian JH, Guebre-Xabier M, et al
    Respiratory syncytial virus prefusogenic fusion (F) protein nanoparticle vaccine: Structure, antigenic profile, immunogenicity, and protection.
    Vaccine. 2019 Aug 12. pii: S0264-410X(19)31010.
    PubMed     Abstract available


  641. BOWEN W, Batra L, Pulsifer AR, Yolcu ES, et al
    Robust Th1 cellular and humoral responses generated by the Yersinia pestis rF1-V subunit vaccine formulated to contain an agonist of the CD137 pathway do not translate into increased protection against pneumonic plague.
    Vaccine. 2019 Aug 12. pii: S0264-410X(19)31024.
    PubMed     Abstract available


  642. PATON DJ, Reeve R, Capozzo AV, Ludi A, et al
    Estimating the protection afforded by foot-and-mouth disease vaccines in the laboratory.
    Vaccine. 2019 Aug 9. pii: S0264-410X(19)31023.
    PubMed     Abstract available


  643. PANDA S, Chatterjee P, Deb A, Kanungo S, et al
    Preventing cholera in India: Synthesizing evidences through a systematic review for policy discussion on the use of oral cholera vaccine.
    Vaccine. 2019 Aug 9. pii: S0264-410X(19)30920.
    PubMed     Abstract available


  644. THYSEN SM, Byberg S, Martins JSD, Kallestrup P, et al
    Household costs of seeking BCG vaccination in rural Guinea-Bissau.
    Vaccine. 2019 Aug 9. pii: S0264-410X(19)31041.
    PubMed     Abstract available


  645. SOUSA M, Fenge C, Rupprecht J, Tappe A, et al
    Process intensification for Peste des Petites Ruminants Virus vaccine production.
    Vaccine. 2019 Aug 8. pii: S0264-410X(19)30887.
    PubMed     Abstract available


  646. MACINTYRE CR, Shaw PJ, Mackie FE, Boros C, et al
    Long term follow up of persistence of immunity following quadrivalent Human Papillomavirus (HPV) vaccine in immunocompromised children.
    Vaccine. 2019 Aug 8. pii: S0264-410X(19)30993.
    PubMed     Abstract available


  647. WHITE JA, Lal M
    Technical product attributes in development of an oral enteric vaccine for infants.
    Vaccine. 2019;37:4800-4804.
    PubMed     Abstract available


  648. GIERSING BK, Porter CK, Kotloff K, Neels P, et al
    How can controlled human infection models accelerate clinical development and policy pathways for vaccines against Shigella?
    Vaccine. 2019;37:4778-4783.
    PubMed     Abstract available


  649. WIERZBA TF
    Implications and measurement of herd protection (indirect effects) for enteric vaccine development.
    Vaccine. 2019;37:4775-4777.
    PubMed     Abstract available


  650. BARRY E, Cassels F, Riddle M, Walker R, et al
    Vaccines Against Shigella and Enterotoxigenic Escherichia coli: A summary of the 2018 VASE Conference.
    Vaccine. 2019;37:4768-4774.
    PubMed     Abstract available


  651. GUO A, Lindley MC, Hurley LP, Allen JA, et al
    Ten years of experience with herpes zoster vaccine in primary care- how attitudes and practices have changed and what it may mean for a new zoster vaccine.
    Vaccine. 2019 Aug 7. pii: S0264-410X(19)31027.
    PubMed     Abstract available


  652. OZAWA S, Yemeke TT, Evans DR, Pallas SE, et al
    Defining hard-to-reach populations for vaccination.
    Vaccine. 2019 Aug 7. pii: S0264-410X(19)30858.
    PubMed     Abstract available


  653. ASTHAGIRI ARUNKUMAR G, McMahon M, Pavot V, Aramouni M, et al
    Vaccination with viral vectors expressing NP, M1 and chimeric hemagglutinin induces broad protection against influenza virus challenge in mice.
    Vaccine. 2019 Aug 6. pii: S0264-410X(19)31016.
    PubMed     Abstract available


  654. SOUZA IEL, Fernandes FF, Schiavoni MCL, Silva CL, et al
    Therapeutic effect of DNA vaccine encoding the 60-kDa-heat shock protein from Paracoccidoides brasiliensis on experimental paracoccidioidomycosis in mice.
    Vaccine. 2019 Aug 6. pii: S0264-410X(19)31011.
    PubMed     Abstract available


  655. HUNG MC, Cho CY, Chen CJ, Lai CC, et al
    Immunogenicity and safety of an inactivated enterovirus A71 vaccine in children 3-6years and 2-35months of age- an open-label, randomized phase IIb clinical trial.
    Vaccine. 2019 Aug 6. pii: S0264-410X(19)31017.
    PubMed     Abstract available


  656. GEBAUER M, Hurlimann HC, Behrens M, Wolff T, et al
    Subunit vaccines based on recombinant yeast protect against influenza A virus in a one-shot vaccination scheme.
    Vaccine. 2019 Aug 6. pii: S0264-410X(19)31015.
    PubMed     Abstract available


  657. ZHAO F, Zhai Y, Zhu J, Xiao P, et al
    Enhancement of autophagy as a strategy for development of new DNA vaccine candidates against Japanese encephalitis.
    Vaccine. 2019 Aug 6. pii: S0264-410X(19)31014.
    PubMed     Abstract available


  658. HASSAN WS, Giaretta PR, Rech R, Ollivault-Shiflett M, et al
    Enhanced protective efficacy of Borrelia burgdorferi BB0172 derived-peptide based vaccine to control Lyme disease.
    Vaccine. 2019 Aug 3. pii: S0264-410X(19)31013.
    PubMed     Abstract available


  659. CHEN TH, Liu WC, Chen IC, Liu CC, et al
    Recombinant hemagglutinin produced from Chinese Hamster Ovary (CHO) stable cell clones and a PELC/CpG combination adjuvant for H7N9 subunit vaccine development.
    Vaccine. 2019 Aug 2. pii: S0264-410X(19)30247.
    PubMed     Abstract available


  660. STARK FC, Akache B, Ponce A, Dudani R, et al
    Archaeal glycolipid adjuvanted vaccines induce strong influenza-specific immune responses through direct immunization in young and aged mice or through passive maternal immunization.
    Vaccine. 2019 Aug 2. pii: S0264-410X(19)30888.
    PubMed     Abstract available


  661. ROMIJNDERS KAGJ, van Seventer SL, Scheltema M, van Osch L, et al
    A deliberate choice? Exploring factors related to informed decision-making about childhood vaccination among acceptors, refusers, and partial acceptors.
    Vaccine. 2019 Aug 2. pii: S0264-410X(19)30968.
    PubMed     Abstract available


  662. ROSS TM, DiNapoli J, Giel-Moloney M, Bloom CE, et al
    Corrigendum to "A computationally designed H5 antigen shows immunological breadth of coverage and protects against drifting avian strains" [Vaccine 37 (2019) 2369-2376].
    Vaccine. 2019 Aug 2. pii: S0264-410X(19)30966.
    PubMed    


  663. GERRITZEN MJH, Salverda MLM, Martens DE, Wijffels RH, et al
    Spontaneously released Neisseria meningitidis outer membrane vesicles as vaccine platform: production and purification.
    Vaccine. 2019 Aug 2. pii: S0264-410X(19)30161.
    PubMed     Abstract available


  664. PASSWELL JH, Ashkenazi S, Banet-Levi Y, Ramon-Saraf R, et al
    Erratum to 'Age-related efficacy of Shigella O-specific polysaccharide conjugates in 1-4-year-old Israeli children' [Vaccine 28 (2010) 2231-2235].
    Vaccine. 2019 Aug 1. pii: S0264-410X(19)30986.
    PubMed    


    July 2019
  665. RAY A, Sarkar K, Haldar P, Ghosh R, et al
    Oral cholera vaccine delivery strategy in India: Routine or campaign?-A scoping review.
    Vaccine. 2019 Jul 31. pii: S0264-410X(19)31003.
    PubMed     Abstract available


  666. WILDER-SMITH A, Smith PG, Luo R, Kelly-Cirino C, et al
    Pre-vaccination screening strategies for the use of the CYD-TDV dengue vaccine: A meeting report.
    Vaccine. 2019 Jul 31. pii: S0264-410X(19)30894.
    PubMed     Abstract available


  667. YAN R, He H, Zhou Y, Xie S, et al
    Study on factors associated with seroprotection after measles vaccination in children of 6-14years in Eastern China.
    Vaccine. 2019 Jul 31. pii: S0264-410X(19)30996.
    PubMed     Abstract available


  668. CHEN CH, Su LH, Li HC, Hsu MH, et al
    Evaluation of the impact of 13-valent pneumococcal conjugate vaccine immunization in children by surveillance of culture-confirmed pneumococcal disease: A prospective clinical microbiological study.
    Vaccine. 2019 Jul 31. pii: S0264-410X(19)30994.
    PubMed     Abstract available


  669. NOH JY, Jang YS, Lee SN, Choi MJ, et al
    Randomized, single-blind, active-controlled phase I clinical trial to evaluate the immunogenicity and safety of GC3114 (high-dose, quadrivalent influenza vaccine) in healthy adults.
    Vaccine. 2019 Jul 31. pii: S0264-410X(19)30997.
    PubMed     Abstract available


  670. CARTER ED, Tam Y, Walker N
    Impact of vaccination delay on deaths averted by pneumococcal conjugate vaccine: Modeled effects in 8 country scenarios.
    Vaccine. 2019 Jul 30. pii: S0264-410X(19)30971.
    PubMed     Abstract available


  671. MUNOZ FM, Anderson EJ, Bernstein DI, Harrison CJ, et al
    Safety and immunogenicity of unadjuvanted subvirion monovalent inactivated influenza H3N2 variant (H3N2v) vaccine in children and adolescents.
    Vaccine. 2019 Jul 30. pii: S0264-410X(19)31006.
    PubMed     Abstract available


  672. GUIDRY JPD, Carlyle KE, Perrin PB, LaRose JG, et al
    A path model of psychosocial constructs predicting future Zika vaccine uptake intent.
    Vaccine. 2019 Jul 30. pii: S0264-410X(19)30972.
    PubMed     Abstract available


  673. O'NEILL LM, Keane OM, Ross PJ, Nally JE, et al
    Evaluation of protective and immune responses following vaccination with recombinant MIP and CPAF from Chlamydia abortus as novel vaccines for enzootic abortion of ewes.
    Vaccine. 2019 Jul 30. pii: S0264-410X(19)30879.
    PubMed     Abstract available


  674. ANDREWS N, Stowe J, Thomas SL, Walker JL, et al
    The risk of non-specific hospitalised infections following MMR vaccination given with and without inactivated vaccines in the second year of life. Comparative self-controlled case-series study in England.
    Vaccine. 2019 Jul 30. pii: S0264-410X(19)30967.
    PubMed     Abstract available


  675. DALAL J, Rana R, Harale K, Hanif S, et al
    Development and pre-clinical evaluation of a synthetic oligosaccharide-protein conjugate vaccine against Neisseria meningitidis serogroup C.
    Vaccine. 2019 Jul 29. pii: S0264-410X(19)30951.
    PubMed     Abstract available


  676. KWAK HW, Park HJ, Ko HL, Park H, et al
    Cricket paralysis virus internal ribosome entry site-derived RNA promotes conventional vaccine efficacy by enhancing a balanced Th1/Th2 response.
    Vaccine. 2019 Jul 29. pii: S0264-410X(19)30991.
    PubMed     Abstract available


  677. GILCA V, Sauvageau C, De Serres G
    A mixed vaccination schedule of HPV vaccine induces a 100% seropositivity to all 9 HPV types included in 9vHPV vaccine.
    Vaccine. 2019;37:4422-4423.
    PubMed    


  678. ROSBERGER Z, Steben M, Norris T, McFadyen A, et al
    A mixed two-dose vaccination schedule: Not enough evidence to support a policy change in Quebec.
    Vaccine. 2019;37:4421.
    PubMed    


  679. HADJ MB, Bouguerra H, Saffar F, Chelly S, et al
    Corrigendum to 'Observational study of vaccine effectiveness 20years after the introduction of universal hepatitis B vaccination in Tunisia' [Vaccine 36 (2018) 5858-5864].
    Vaccine. 2019 Jul 25. pii: S0264-410X(19)30321.
    PubMed    


  680. SPITTELER MA, Romo A, Magi N, Seo MG, et al
    Validation of a high performance liquid chromatography method for quantitation of foot-and-mouth disease virus antigen in vaccines and vaccine manufacturing.
    Vaccine. 2019 Jul 25. pii: S0264-410X(19)30949.
    PubMed     Abstract available


  681. CHEN XX, Wagner AL, Zheng XB, Xie JY, et al
    Hepatitis E vaccine in China: Public health professional perspectives on vaccine promotion and strategies for control.
    Vaccine. 2019 Jul 25. pii: S0264-410X(19)30988.
    PubMed     Abstract available


  682. ESTEBAN-VASALLO MD, Dominguez-Berjon MF, Garcia-Riolobos C, Zoni AC, et al
    Effect of mobile phone text messaging for improving the uptake of influenza vaccination in patients with rare diseases.
    Vaccine. 2019 Jul 25. pii: S0264-410X(19)30970.
    PubMed     Abstract available


  683. YAO PP, Miao ZP, Xu F, Lu HJ, et al
    An adult gerbil model for evaluating potential coxsackievirus A16 vaccine candidates.
    Vaccine. 2019 Jul 24. pii: S0264-410X(19)30937.
    PubMed     Abstract available


  684. CHANTLER T, Letley L, Paterson P, Yarwood J, et al
    Optimising informed consent in school-based adolescent vaccination programmes in England: A multiple methods analysis.
    Vaccine. 2019 Jul 24. pii: S0264-410X(19)30969.
    PubMed     Abstract available


  685. BRANDILEONE MC, Zanella RC, Almeida SCG, Cassiolato AP, et al
    Long-term effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae in children in Brazil.
    Vaccine. 2019 Jul 24. pii: S0264-410X(19)30934.
    PubMed     Abstract available


  686. LUCERO MS, Richetta M, Chimeno Zoth S, Jaton J, et al
    Plant-based vaccine candidate against Infectious bursal disease: An alternative to inactivated vaccines for breeder hens.
    Vaccine. 2019 Jul 24. pii: S0264-410X(19)30990.
    PubMed     Abstract available


  687. REED L, Tarini BA, Andreae MC
    Vaccine administration error rates at a large academic medical center and its affiliated clinics - Familiarity matters.
    Vaccine. 2019 Jul 23. pii: S0264-410X(19)30918.
    PubMed     Abstract available


  688. HAN B, Wang S, Wan Y, Liu J, et al
    Has the public lost confidence in vaccines because of a vaccine scandal in China.
    Vaccine. 2019 Jul 22. pii: S0264-410X(19)30950.
    PubMed     Abstract available


  689. CARRYN S, Feyssaguet M, Povey M, Di Paolo E, et al
    Long-term immunogenicity of measles, mumps and rubella-containing vaccines in healthy young children: A 10-year follow-up.
    Vaccine. 2019 Jul 22. pii: S0264-410X(19)30940.
    PubMed     Abstract available


  690. NEVES FPG, Cardoso NT, Cardoso CAA, Teixeira LM, et al
    Direct effect of the 13-valent pneumococcal conjugate vaccine use on pneumococcal colonization among children in Brazil.
    Vaccine. 2019 Jul 20. pii: S0264-410X(19)30954.
    PubMed     Abstract available


  691. GIDUDU JF, Shaum A, Habersaat K, Wilhelm E, et al
    An approach for preparing and responding to adverse events following immunization reported after hepatitis B vaccine birth dose administration.
    Vaccine. 2019 Jul 20. pii: S0264-410X(19)30932.
    PubMed     Abstract available


  692. FABIANI M, Volpe E, Faraone M, Bella A, et al
    Influenza vaccine uptake in the elderly population: Individual and general practitioner's determinants in Central Italy, Lazio region, 2016-2017 season.
    Vaccine. 2019 Jul 19. pii: S0264-410X(19)30952.
    PubMed     Abstract available


  693. SIMOES EAF, Nunes MC, Carosone-Link P, Madimabe R, et al
    Trivalent influenza vaccination randomized control trial of pregnant women and adverse fetal outcomes.
    Vaccine. 2019 Jul 19. pii: S0264-410X(19)30915.
    PubMed     Abstract available


  694. EICKHOFF CS, Blazevic A, Killoran EA, Morris MS, et al
    Induction of mycobacterial protective immunity by sublingual BCG vaccination.
    Vaccine. 2019 Jul 19. pii: S0264-410X(19)30925.
    PubMed     Abstract available


  695. SUSARLA SK, Gupta M, Mantan M, Dhongade R, et al
    Immunogenicity and safety of a liquid Pentavalent (DTwP-Hb-Hib) combination vaccine manufactured by Human Biologicals Institute in 6-8weeks old healthy infants: A phase III, randomized, single blind, non-inferiority study.
    Vaccine. 2019 Jul 19. pii: S0264-410X(19)30844.
    PubMed     Abstract available


  696. VAN SCHALKWYK C, Moodley J, Welte A, Johnson LF, et al
    Estimated impact of human papillomavirus vaccines on infection burden: The effect of structural assumptions.
    Vaccine. 2019 Jul 19. pii: S0264-410X(19)30774.
    PubMed     Abstract available


  697. KENNEDY EM, Dowall SD, Salguero FJ, Yeates P, et al
    A vaccine based on recombinant modified Vaccinia Ankara containing the nucleoprotein from Lassa virus protects against disease progression in a guinea pig model.
    Vaccine. 2019 Jul 19. pii: S0264-410X(19)30914.
    PubMed     Abstract available


  698. GUPTA S, Chaudhary S, Bubber P, Ray P, et al
    Epidemiology and genetic diversity of group A rotavirus in acute diarrhea patients in pre-vaccination era in Himachal Pradesh, India.
    Vaccine. 2019 Jul 19. pii: S0264-410X(19)30928.
    PubMed     Abstract available


  699. GESSNER BD, Theilacker C, Jodar L
    Rethinking results from the Japanese 23-valent pneumococcal polysaccharide vaccine randomized clinical trial.
    Vaccine. 2019 Jul 18. pii: S0264-410X(19)30931.
    PubMed     Abstract available


  700. SAFADI MAP, Martinon-Torres F, Weckx LY, Moreira ED Junior, et al
    Immunogenicity of the pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) administered concomitantly with the meningococcal serogroup B (4CMenB) vaccine in infants: A post-hoc analysis in a phase 3b, randomised, cont
    Vaccine. 2019 Jul 18. pii: S0264-410X(19)30912.
    PubMed     Abstract available


  701. MADEDDU G, Vroling H, Oordt-Speets A, Babudieri S, et al
    Vaccinations in prison settings: A systematic review to assess the situation in EU/EEA countries and in other high income countries.
    Vaccine. 2019 Jul 18. pii: S0264-410X(19)30892.
    PubMed     Abstract available


  702. DAUGHERTY MA, Hinman AR, Cochi SL, Garon JR, et al
    The Global Vaccine Action Plan - insights into its utility, application, and ways to strengthen future plans.
    Vaccine. 2019 Jul 17. pii: S0264-410X(19)30933.
    PubMed     Abstract available


  703. LEE H, Park SY, Clark A, Debellut F, et al
    Cost-effectiveness analysis of the implementation of a National Immunization Program for rotavirus vaccination in a country with a low rotavirus gastroenteritis-related mortality: A South Korean study.
    Vaccine. 2019 Jul 17. pii: S0264-410X(19)30921.
    PubMed     Abstract available


  704. WAMBURA G, Mwatondo A, Muturi M, Nasimiyu C, et al
    Rabies vaccine and immunoglobulin supply and logistics: Challenges and opportunities for rabies elimination in Kenya.
    Vaccine. 2019 Jul 17. pii: S0264-410X(19)30659.
    PubMed     Abstract available


  705. LEHRER AT, Wong TS, Lieberman MM, Johns L, et al
    Recombinant subunit vaccines protect guinea pigs from lethal Ebola virus challenge.
    Vaccine. 2019 Jul 16. pii: S0264-410X(19)30797.
    PubMed     Abstract available


  706. ZHAO B, Marciniuk K, Gibbs E, Yousefi M, et al
    Therapeutic vaccines for amyotrophic lateral sclerosis directed against disease specific epitopes of superoxide dismutase 1.
    Vaccine. 2019 Jul 16. pii: S0264-410X(19)30935.
    PubMed     Abstract available


  707. VOLCKMAR J, Knop L, Stegemann-Koniszewski S, Schulze K, et al
    The STING activator c-di-AMP exerts superior adjuvant properties than the formulation poly(I:C)/CpG after subcutaneous vaccination with soluble protein antigen or DEC-205-mediated antigen targeting to dendritic cells.
    Vaccine. 2019 Jul 15. pii: S0264-410X(19)30910.
    PubMed     Abstract available


  708. DE GROOT C, Musken M, Bleckmann M, Ebensen T, et al
    Novel colloidal associations of soyasaponins and lipid components (DPPC, cholesterol) as potential adjuvants for vaccines.
    Vaccine. 2019 Jul 15. pii: S0264-410X(19)30911.
    PubMed     Abstract available


  709. SARKISSIAN CA, Alteri CJ, Mobley HLT
    UTI patients have pre-existing antigen-specific antibody titers against UTI vaccine antigens.
    Vaccine. 2019 Jul 15. pii: S0264-410X(19)30922.
    PubMed     Abstract available


  710. GOODING E, Spiliotopoulou E, Yadav P
    Impact of vaccine stockouts on immunization coverage in Nigeria.
    Vaccine. 2019 Jul 15. pii: S0264-410X(19)30765.
    PubMed     Abstract available


  711. GOCKO X, Poulteau S, Beyens MN, Bertholon P, et al
    Case report: Recurrent peripheral facial paralysis following two influenza vaccinations in 2009 and 2016.
    Vaccine. 2019 Jul 13. pii: S0264-410X(19)30916.
    PubMed     Abstract available


  712. MAC KEON S, Bentivegna S, Levy EM, Marks MS, et al
    Syngeneic B16-F1 cells are more efficient than allogeneic Cloudman cells as antigen source in DC-based vaccination in the B16-F1 murine melanoma model.
    Vaccine. 2019 Jul 13. pii: S0264-410X(19)30909.
    PubMed     Abstract available


  713. REID MC, Peebles K, Stansfield SE, Goodreau SM, et al
    Models to predict the public health impact of vaccine resistance: A systematic review.
    Vaccine. 2019 Jul 12. pii: S0264-410X(19)30891.
    PubMed     Abstract available


  714. DE SERRES G, Billard MN, Gariepy MC, Roy MC, et al
    Nephrotic syndrome following four-component meningococcal B vaccination: Epidemiologic investigation of a surveillance signal.
    Vaccine. 2019 Jul 12. pii: S0264-410X(19)30901.
    PubMed     Abstract available


  715. SEALE AC, Baker CJ, Berkley JA, Madhi SA, et al
    Vaccines for maternal immunization against Group B Streptococcus disease: WHO perspectives on case ascertainment and case definitions.
    Vaccine. 2019 Jul 11. pii: S0264-410X(19)30890.
    PubMed     Abstract available


  716. BRIDGES CB, Watson TL, Nelson NP, Chavez-Torres M, et al
    Challenges with hepatitis B vaccination of high risk adults - A pilot program.
    Vaccine. 2019 Jul 11. pii: S0264-410X(19)30746.
    PubMed     Abstract available


  717. KLEIN NP, Bartlett J, Fireman B, Marks MA, et al
    Long-term effectiveness of zoster vaccine live for postherpetic neuralgia prevention.
    Vaccine. 2019 Jul 10. pii: S0264-410X(19)30882.
    PubMed     Abstract available


  718. DECKER MD, Greenberg DP, Johnson DR, Pool V, et al
    Randomized study of immune responses to two Tdap vaccines among adolescents primed with DTaP and comparison with results among adolescents primed with DTwP.
    Vaccine. 2019 Jul 10. pii: S0264-410X(19)30893.
    PubMed     Abstract available


  719. SHELDENKAR A, Lim F, Yung CF, Lwin MO, et al
    Acceptance and uptake of influenza vaccines in Asia: A systematic review.
    Vaccine. 2019 Jul 10. pii: S0264-410X(19)30889.
    PubMed     Abstract available


  720. ISLAM MT, Chowdhury F, Qadri F, Sur D, et al
    Trials of the killed oral cholera vaccine (Shanchol) in India and Bangladesh: Lessons learned and way forward.
    Vaccine. 2019 Jul 10. pii: S0264-410X(19)30870.
    PubMed     Abstract available


  721. SI S, Zomer E, Fletcher S, Lee J, et al
    Cost-effectiveness of meningococcal polysaccharide serogroups A, C, W-135 and Y conjugate vaccine in Australian adolescents.
    Vaccine. 2019 Jul 10. pii: S0264-410X(19)30886.
    PubMed     Abstract available


  722. GUNARATNE K, Coomes EA, Haghbayan H
    Temporal trends in anti-vaccine discourse on Twitter.
    Vaccine. 2019 Jul 9. pii: S0264-410X(19)30876.
    PubMed     Abstract available


  723. GROVES PJ, Williamson SL, Sharpe SM, Gerber PF, et al
    Uptake and spread of infectious laryngotracheitis vaccine virus within meat chicken flocks following drinking water vaccination.
    Vaccine. 2019 Jul 9. pii: S0264-410X(19)30877.
    PubMed     Abstract available


  724. BOGLER L, Jantos N, Barnighausen T, Vollmer S, et al
    Estimating the effect of measles vaccination on child growth using 191 DHS from 65 low- and middle-income countries.
    Vaccine. 2019 Jul 9. pii: S0264-410X(19)30816.
    PubMed     Abstract available


  725. MACINTYRE CR, Ridda I, Trent MJ, McIntyre P, et al
    Persistence of immunity to conjugate and polysaccharide pneumococcal vaccines in frail, hospitalised older adults in long-term follow up.
    Vaccine. 2019 Jul 9. pii: S0264-410X(19)30883.
    PubMed     Abstract available


  726. SIRDAR MM, Fosgate GT, Blignaut B, Gummow B, et al
    A novel method for performing antigenic vaccine matching for foot-and-mouth disease in absence of the homologous virus.
    Vaccine. 2019 Jul 8. pii: S0264-410X(19)30880.
    PubMed     Abstract available


  727. ABBOTT S, Christensen H, Lalor MK, Zenner D, et al
    Exploring the effects of BCG vaccination in patients diagnosed with tuberculosis: Observational study using the Enhanced Tuberculosis Surveillance system.
    Vaccine. 2019 Jul 8. pii: S0264-410X(19)30818.
    PubMed     Abstract available


  728. BRESEE JS, Lafond KE, McCarron M, Azziz-Baumgartner E, et al
    The partnership for influenza vaccine introduction (PIVI): Supporting influenza vaccine program development in low and middle-income countries through public-private partnerships.
    Vaccine. 2019 Jul 6. pii: S0264-410X(19)30811.
    PubMed     Abstract available


  729. SHEN CF, Guilbault C, Li X, Elahi SM, et al
    Development of suspension adapted Vero cell culture process technology for production of viral vaccines.
    Vaccine. 2019 Jul 6. pii: S0264-410X(19)30881.
    PubMed     Abstract available


  730. ORK V, Woodring J, Shafiqul Hossain M, Wasley A, et al
    Hepatitis B surface antigen seroprevalence among pre- and post-vaccine cohorts in Cambodia, 2017.
    Vaccine. 2019 Jul 5. pii: S0264-410X(19)30850.
    PubMed     Abstract available


  731. MALTEZOU HC, Ledda C, Rapisarda V
    Mandatory vaccinations for children in Italy: The need for a stable frame.
    Vaccine. 2019 Jul 4. pii: S0264-410X(19)30768.
    PubMed    


  732. MOSER MJ, Hatta Y, Gabaglia C, Sanchez A, et al
    Single-replication BM2SR vaccine provides sterilizing immunity and cross-lineage influenza B virus protection in mice.
    Vaccine. 2019 Jul 4. pii: S0264-410X(19)30805.
    PubMed     Abstract available


  733. DILOKTHORNSAKUL P, Kengkla K, Saokaew S, Permsuwan U, et al
    An updated cost-effectiveness analysis of pneumococcal conjugate vaccine among children in Thailand.
    Vaccine. 2019 Jul 4. pii: S0264-410X(19)30776.
    PubMed     Abstract available


  734. HOES J, Knol MJ, Mollema L, Buisman A, et al
    Comparison of antibody response between boys and girls after infant and childhood vaccinations in the Netherlands.
    Vaccine. 2019 Jul 4. pii: S0264-410X(19)30817.
    PubMed     Abstract available


  735. PARKER L, Ritter L, Wu W, Maeso R, et al
    Haemagglutinin stability was not the primary cause of the reduced effectiveness of live attenuated influenza vaccine against A/H1N1pdm09 viruses in the 2013-2014 and 2015-2016 seasons.
    Vaccine. 2019 Jul 3. pii: S0264-410X(19)30777.
    PubMed     Abstract available


  736. WILLIAMS M, Ewing D, Blevins M, Sun P, et al
    Enhanced immunogenicity and protective efficacy of a tetravalent dengue DNA vaccine using electroporation and intradermal delivery.
    Vaccine. 2019 Jul 3. pii: S0264-410X(19)30871.
    PubMed     Abstract available


  737. KLEIN NP, Block SL, Essink B, Barbi S, et al
    Antibody persistence and booster response following MenACWY-CRM vaccination in children as assessed by two different assay methods.
    Vaccine. 2019 Jul 3. pii: S0264-410X(19)30853.
    PubMed     Abstract available


  738. BRIGGS L, Fronek P, Quinn V, Wilde T, et al
    Perceptions of influenza and pneumococcal vaccine uptake by older persons in Australia.
    Vaccine. 2019 Jul 2. pii: S0264-410X(19)30856.
    PubMed     Abstract available


  739. TANIGUCHI M, Ueda Y, Yagi A, Ikeda S, et al
    Cervical cancer screening rate differs by HPV vaccination status: An interim analysis.
    Vaccine. 2019 Jul 1. pii: S0264-410X(19)30839.
    PubMed     Abstract available


  740. ANDREWS N, Kent A, Amin-Chowdhury Z, Sheppard C, et al
    Effectiveness of the seven-valent and thirteen-valent pneumococcal conjugate vaccines in England: The indirect cohort design, 2006-2018.
    Vaccine. 2019 Jul 1. pii: S0264-410X(19)30848.
    PubMed     Abstract available


    June 2019
  741. OZGEN MH, Blume S
    The continuing search for an addiction vaccine.
    Vaccine. 2019 Jun 29. pii: S0264-410X(19)30851.
    PubMed     Abstract available


  742. ADRIEN N, Hyde TB, Gacic-Dobo M, Hombach J, et al
    Differences between coverage of yellow fever vaccine and the first dose of measles-containing vaccine: A desk review of global data sources.
    Vaccine. 2019 Jun 29. pii: S0264-410X(19)30838.
    PubMed     Abstract available


  743. DABANCH J, Gonzalez C, Cerda J, Acevedo J, et al
    Chile's National Advisory Committee on Immunization (CAVEI): Evidence-based recommendations for public policy decision-making on vaccines and immunization.
    Vaccine. 2019 Jun 29. pii: S0264-410X(19)30846.
    PubMed     Abstract available


  744. D'OFFAY JM, Fulton RW, Fishbein M, Eberle R, et al
    Isolation of a naturally occurring vaccine/wild-type recombinant bovine herpesvirus type 1 (BoHV-1) from an aborted bovine fetus.
    Vaccine. 2019 Jun 29. pii: S0264-410X(19)30821.
    PubMed     Abstract available


  745. VAN AALST R, Russo EM, Neupane N, Mahmud SM, et al
    Economic assessment of a high-dose versus a standard-dose influenza vaccine in the US Veteran population: Estimating the impact on hospitalization cost for cardio-respiratory disease.
    Vaccine. 2019 Jun 28. pii: S0264-410X(19)30843.
    PubMed     Abstract available


  746. PEYRAUD N, Zehrung D, Jarrahian C, Frivold C, et al
    Potential use of microarray patches for vaccine delivery in low- and middle- income countries.
    Vaccine. 2019 Jun 28. pii: S0264-410X(19)30357.
    PubMed     Abstract available


  747. DURO TORRIJOS JL, Tuells J
    The beginnings of smallpox vaccination in Spain seen through the correspondence of Ignacio Maria Ruiz de Luzuriaga (1801-1802).
    Vaccine. 2019 Jun 28. pii: S0264-410X(19)30735.
    PubMed     Abstract available


  748. YU XY, Chen ZP, Wang SY, Pan HR, et al
    Safety and immunogenicity of hepatitis E vaccine in elderly people older than 65years.
    Vaccine. 2019 Jun 28. pii: S0264-410X(19)30444.
    PubMed     Abstract available


  749. BRYDEN GM, Browne M, Rockloff M, Unsworth C, et al
    The privilege paradox: Geographic areas with highest socio-economic advantage have the lowest rates of vaccination.
    Vaccine. 2019 Jun 28. pii: S0264-410X(19)30822.
    PubMed     Abstract available


  750. VOM STEEG LG, Flores-Garcia Y, Zavala F, Klein SL, et al
    Irradiated sporozoite vaccination induces sex-specific immune responses and protection against malaria in mice.
    Vaccine. 2019 Jun 28. pii: S0264-410X(19)30852.
    PubMed     Abstract available


  751. ALMUDEVAR A, Kaur R, Pichichero M
    Statistical projection of post-vaccination antibody kinetics between dosing schedules.
    Vaccine. 2019 Jun 28. pii: S0264-410X(19)30778.
    PubMed     Abstract available


  752. SAULSBERRY L, Fowler EF, Nagler RH, Gollust SE, et al
    Perceptions of politicization and HPV vaccine policy support.
    Vaccine. 2019 Jun 28. pii: S0264-410X(19)30699.
    PubMed     Abstract available


  753. STUDHOLME L, Sutherland J, Desai T, Hockley J, et al
    Evaluation of the monocyte activation test for the safety testing of meningococcal B vaccine Bexsero: A collaborative study.
    Vaccine. 2019;37:3761-3769.
    PubMed     Abstract available


  754. VIPOND C, Sutherland J, Nordgren K, Kemp G, et al
    Development and validation of a monocyte activation test for the control/safety testing of an OMV-based meningococcal B vaccine.
    Vaccine. 2019;37:3747-3753.
    PubMed     Abstract available


  755. BRUUN T, Watle SSV, Tveteraas IH, Flem E, et al
    Intussusception among Norwegian children: What to expect after introduction of rotavirus vaccination?
    Vaccine. 2019 Jun 26. pii: S0264-410X(19)30820.
    PubMed     Abstract available


  756. HAUSER MI, Muscatello DJ, Soh ACY, Dwyer DE, et al
    An indirect comparison meta-analysis of AS03 and MF59 adjuvants in pandemic influenza A(H1N1)pdm09 vaccines.
    Vaccine. 2019 Jun 25. pii: S0264-410X(19)30801.
    PubMed     Abstract available


  757. CONSTABLE C, Chapman CR
    Bolstering trust in the human papillomavirus vaccine through improved communication in the vaccine information statement.
    Vaccine. 2019 Jun 25. pii: S0264-410X(19)30766.
    PubMed    


  758. TSHILWANE SI, Thema N, Steyn HC, van Kleef M, et al
    A multi-epitope DNA vaccine co-administered with monophosphoryl lipid A adjuvant provides protection against tick transmitted Ehrlichia ruminantium in sheep.
    Vaccine. 2019 Jun 25. pii: S0264-410X(19)30788.
    PubMed     Abstract available


  759. BELLAN SE, Eggo RM, Gsell PS, Kucharski AJ, et al
    An online decision tree for vaccine efficacy trial design during infectious disease epidemics: The InterVax-Tool.
    Vaccine. 2019 Jun 24. pii: S0264-410X(19)30780.
    PubMed     Abstract available


  760. RUSS SM, Brackney M, Meek J, Niccolai LM, et al
    Missed Opportunities for HPV Vaccination Among Vaccine-Eligible Women with High Grade Cervical Lesions.
    Vaccine. 2019 Jun 24. pii: S0264-410X(19)30836.
    PubMed     Abstract available


  761. HEWITT JS, Karuppannan AK, Tan S, Gauger P, et al
    A prime-boost concept using a T-cell epitope-driven DNA vaccine followed by a whole virus vaccine effectively protected pigs in the pandemic H1N1 pig challenge model.
    Vaccine. 2019 Jun 24. pii: S0264-410X(19)30806.
    PubMed     Abstract available


  762. SOBEY KG, Jamieson SE, Walpole AA, Rosatte RC, et al
    ONRAB(R) oral rabies vaccine is shed from, but does not persist in, captive mammals.
    Vaccine. 2019 Jun 24. pii: S0264-410X(19)30808.
    PubMed     Abstract available


  763. KNEZEVIC I
    1st WHO International Standard antiserum to RSV: Availability and benefits for RSV vaccine development (Commentary on the collaborative study report published in the vaccine journal (Vaccine 2018 36: 7641-7649)).
    Vaccine. 2019 Jun 24. pii: S0264-410X(19)30783.
    PubMed    


  764. RENSON P, Fablet C, Andraud M, Normand V, et al
    Maternally-derived neutralizing antibodies reduce vaccine efficacy against porcine reproductive and respiratory syndrome virus infection.
    Vaccine. 2019 Jun 24. pii: S0264-410X(19)30807.
    PubMed     Abstract available


  765. DECEUNINCK G, Lefebvre B, Tsang R, Betala-Belinga JF, et al
    Impact of a mass vaccination campaign against Serogroup B meningococcal disease in the Saguenay-Lac-Saint-Jean region of Quebec four years after its launch.
    Vaccine. 2019 Jun 22. pii: S0264-410X(19)30782.
    PubMed     Abstract available


  766. LI AJ, Peiris TSR, Sanderson C, Lochlainn LN, et al
    Opportunities to improve vaccination coverage in a country with a fledgling health system: Findings from an assessment of missed opportunities for vaccination among health center attendees-Timor Leste, 2016.
    Vaccine. 2019 Jun 22. pii: S0264-410X(19)30803.
    PubMed     Abstract available


  767. SINGH G, Zholobko O, Pillatzki A, Webb B, et al
    An amphiphilic invertible polymer as a delivery vehicle for a M2e-HA2-HA1 peptide vaccine against an Influenza A virus in pigs.
    Vaccine. 2019 Jun 21. pii: S0264-410X(19)30792.
    PubMed     Abstract available


  768. RAMANATHAN R, Stibitz S, Pratt D, Roberts J, et al
    Use of controlled human infection models (CHIMs) to support vaccine development: US regulatory considerations.
    Vaccine. 2019 Jun 21. pii: S0264-410X(19)30770.
    PubMed     Abstract available


  769. ZAMAN K, Kingma R, Yunus M, van Straaten I, et al
    Safety, immunogenicity and lot-to-lot consistency of a new Bivalent Oral Polio Vaccine (bOPV) in healthy Infants: Results of a Phase III, observer blind, randomized, controlled clinical study.
    Vaccine. 2019 Jun 21. pii: S0264-410X(19)30810.
    PubMed     Abstract available


  770. DOWELL AC, Menning L, MacDonald N, Turner N, et al
    An evolution in thinking to support the post 2020 global vaccine strategy: The application of complexity and implementation science.
    Vaccine. 2019 Jun 21. pii: S0264-410X(19)30790.
    PubMed    


  771. BLOM K, Yin L, Arnheim-Dahlstrom L
    Effectiveness of the herpes zoster vaccine Zostavax(R) in Stockholm County, Sweden.
    Vaccine. 2019 Jun 20. pii: S0264-410X(19)30769.
    PubMed     Abstract available


  772. MANI S, Toapanta FR, McArthur MA, Qadri F, et al
    Role of antigen specific T and B cells in systemic and mucosal immune responses in ETEC and Shigella infections, and their potential to serve as correlates of protection in vaccine development.
    Vaccine. 2019 Jun 20. pii: S0264-410X(19)30372.
    PubMed     Abstract available


  773. TAMBYAH PA, Oon J, Asli R, Kristanto W, et al
    An inactivated enterovirus 71 vaccine is safe and immunogenic in healthy adults: A phase I, double blind, randomized, placebo-controlled, study of two dosages.
    Vaccine. 2019 Jun 20. pii: S0264-410X(19)30784.
    PubMed     Abstract available


  774. SONG S, Li P, Zhang R, Chen J, et al
    Oral vaccine of recombinant Lactococcus lactis expressing the VP1 protein of duck hepatitis A virus type 3 induces mucosal and systemic immune responses.
    Vaccine. 2019 Jun 18. pii: S0264-410X(19)30787.
    PubMed     Abstract available


  775. NANDI A, Shet A, Behrman JR, Black MM, et al
    Anthropometric, cognitive, and schooling benefits of measles vaccination: Longitudinal cohort analysis in Ethiopia, India, and Vietnam.
    Vaccine. 2019 Jun 18. pii: S0264-410X(19)30786.
    PubMed     Abstract available


  776. MANARA C, Brazzoli M, Piccioli D, Taccone M, et al
    Co-administration of GM-CSF expressing RNA is a powerful tool to enhance potency of SAM-based vaccines.
    Vaccine. 2019 Jun 18. pii: S0264-410X(19)30479.
    PubMed     Abstract available


  777. KWONG JC, Buchan SA, Chung H, Campitelli MA, et al
    Can routinely collected laboratory and health administrative data be used to assess influenza vaccine effectiveness? Assessing the validity of the Flu and Other Respiratory Viruses Research (FOREVER) Cohort.
    Vaccine. 2019 Jun 17. pii: S0264-410X(19)30772.
    PubMed     Abstract available


  778. MANSOUR Z, Brandt L, Said R, Fahmy K, et al
    Home-based records' quality and validity of caregivers' recall of children's vaccination in Lebanon.
    Vaccine. 2019 Jun 17. pii: S0264-410X(19)30656.
    PubMed     Abstract available


  779. MUNGWIRA RG, Maure CG, Zuber PLF
    Economic and immunisation safety surveillance characteristics of countries implementing no-fault compensation programmes for vaccine injuries.
    Vaccine. 2019 Jun 15. pii: S0264-410X(19)30779.
    PubMed     Abstract available


  780. MURTI M, Otterstatter M, Orth A, Balshaw R, et al
    Measuring the impact of a mandatory province-wide vaccinate-or-mask policy on healthcare worker absenteeism in British Columbia, Canada.
    Vaccine. 2019 Jun 13. pii: S0264-410X(19)30767.
    PubMed     Abstract available


  781. GUO Z, Bai L, Gong S
    Some comments on the scandal of rabies vaccine in China.
    Vaccine. 2019 Jun 13. pii: S0264-410X(19)30732.
    PubMed    


  782. MURTI M, Otterstatter M, Orth A, Balshaw R, et al
    Measuring the impact of influenza vaccination on healthcare worker absenteeism in the context of a province-wide mandatory vaccinate-or-mask policy.
    Vaccine. 2019 Jun 13. pii: S0264-410X(19)30775.
    PubMed     Abstract available


  783. GENG F, Guo J, Guo QQ, Xie Y, et al
    A DNA vaccine expressing an optimized secreted FAPalpha induces enhanced anti-tumor activity by altering the tumor microenvironment in a murine model of breast cancer.
    Vaccine. 2019 Jun 12. pii: S0264-410X(19)30773.
    PubMed     Abstract available


  784. HUIJBERS EJM, van Beijnum JR, Le CT, Langman S, et al
    Corrigendum to "An improved conjugate vaccine technology; induction of antibody responses to the tumor vasculature" [Vaccine 36(21) 3054-3060].
    Vaccine. 2019 Jun 12. pii: S0264-410X(19)30771.
    PubMed    


  785. WILKINSON TA, Dixon BE, Xiao S, Tu W, et al
    Physician clinical decision support system prompts and administration of subsequent doses of HPV vaccine: A randomized clinical trial.
    Vaccine. 2019 Jun 11. pii: S0264-410X(19)30595.
    PubMed     Abstract available


  786. DEMARCUS L, Shoubaki L, Federinko S
    Comparing influenza vaccine effectiveness between cell-derived and egg-derived vaccines, 2017-2018 influenza season.
    Vaccine. 2019 Jun 11. pii: S0264-410X(19)30763.
    PubMed     Abstract available


  787. MULAMA DH, Mutsvunguma LZ, Totonchy J, Ye P, et al
    A multivalent Kaposi sarcoma-associated herpesvirus-like particle vaccine capable of eliciting high titers of neutralizing antibodies in immunized rabbits.
    Vaccine. 2019 Jun 11. pii: S0264-410X(19)30559.
    PubMed     Abstract available


  788. XIA M, Huang P, Jiang X, Tan M, et al
    Immune response and protective efficacy of the S particle presented rotavirus VP8* vaccine in mice.
    Vaccine. 2019 Jun 11. pii: S0264-410X(19)30712.
    PubMed     Abstract available


  789. NORDIN JD, Vazquez-Benitez G, Olsen A, Kuckler LC, et al
    Safety of guidelines recommending live attenuated influenza vaccine for routine use in children and adolescents with asthma.
    Vaccine. 2019 Jun 10. pii: S0264-410X(19)30718.
    PubMed     Abstract available


  790. NARAYANAN N, Elsaid MI, NeMoyer RE, Trivedi N, et al
    Disparities in hepatitis A virus (HAV) vaccination coverage among adult travelers to intermediate or high-risk countries: The role of birthplace and race/ethnicity.
    Vaccine. 2019 Jun 10. pii: S0264-410X(19)30708.
    PubMed     Abstract available


  791. TEIXEISRA AF, Fernandes LGV, Cavenague MF, Takahashi MB, et al
    Adjuvanted leptospiral vaccines: Challenges and future development of new leptospirosis vaccines.
    Vaccine. 2019 Jun 8. pii: S0264-410X(19)30734.
    PubMed     Abstract available


  792. SHINJOH M, Sugaya N, Furuichi M, Araki E, et al
    Effectiveness of inactivated influenza vaccine in children by vaccine dose, 2013-18.
    Vaccine. 2019 Jun 8. pii: S0264-410X(19)30747.
    PubMed     Abstract available


  793. MURALIDHARAN A, Russell MS, Larocque L, Gravel C, et al
    Chitosan alters inactivated respiratory syncytial virus vaccine elicited immune responses without affecting lung histopathology in mice.
    Vaccine. 2019 Jun 8. pii: S0264-410X(19)30753.
    PubMed     Abstract available


  794. LIAO Q, Lam WWT, Wong CKH, Lam C, et al
    The relative effects of determinants on Chinese adults' decision for influenza vaccination choice: What is the effect of priming?
    Vaccine. 2019 Jun 8. pii: S0264-410X(19)30709.
    PubMed     Abstract available


  795. LOH FK, Nathan S, Chow SC, Fang CM, et al
    Vaccination challenges and strategies against long-lived Toxoplasma gondii.
    Vaccine. 2019 Jun 8. pii: S0264-410X(19)30730.
    PubMed     Abstract available


  796. MULLER C, Ulrich R, Schinkothe J, Muller M, et al
    Characterization of protective humoral and cellular immune responses against RHDV2 induced by a new vaccine based on recombinant baculovirus.
    Vaccine. 2019 Jun 7. pii: S0264-410X(19)30537.
    PubMed     Abstract available


  797. YANG H, Luo G, Zeng Y, Li Y, et al
    The distinct impact of maternal antibodies on the immunogenicity of live and recombinant rotavirus vaccines.
    Vaccine. 2019 Jun 7. pii: S0264-410X(19)30733.
    PubMed     Abstract available


  798. BORG K, Sutton K, Beasley M, Tull F, et al
    Reply to letter to the editor in response to the article "Communication-based interventions for increasing influenza vaccination rates among Aboriginal children: A randomised controlled trial".
    Vaccine. 2019;37:3382.
    PubMed    


  799. ELLA R, Babji S, Ciarlet M, Blackwelder WC, et al
    A randomized, open-labelled, non-inferiority phase 4 clinical trial to evaluate the immunogenicity and safety of the live, attenuated, oral rotavirus vaccine, ROTAVAC(R) in comparison with a licensed rotavirus vaccine in healthy infants.
    Vaccine. 2019 Jun 6. pii: S0264-410X(19)30706.
    PubMed     Abstract available


  800. HOU H, Liu X, Peng Q
    The advances in brucellosis vaccines.
    Vaccine. 2019 Jun 5. pii: S0264-410X(19)30731.
    PubMed     Abstract available


  801. GERMAN EL, Solorzano C, Sunny S, Dunne F, et al
    Protective effect of PCV vaccine against experimental pneumococcal challenge in adults is primarily mediated by controlling colonisation density.
    Vaccine. 2019 Jun 5. pii: S0264-410X(19)30717.
    PubMed     Abstract available


  802. HWANG CS, Smith LC, Wenthur CJ, Ellis B, et al
    Heroin vaccine: Using titer, affinity, and antinociception as metrics when examining sex and strain differences.
    Vaccine. 2019 Jun 5. pii: S0264-410X(19)30698.
    PubMed     Abstract available


  803. ANDRASIK M, Grove D, Broder G, Scott H, et al
    A descriptive analysis of transgender participants in phase 1-2a trials of the HIV Vaccine Trials Network (HVTN) in the United States and Peru.
    Vaccine. 2019 Jun 5. pii: S0264-410X(19)30630.
    PubMed     Abstract available


  804. VON MOLLENDORF C, Dunne EM, La Vincente S, Ulziibayar M, et al
    Pneumococcal carriage in children in Ulaanbaatar, Mongolia before and one year after the introduction of the 13-valent pneumococcal conjugate vaccine.
    Vaccine. 2019 Jun 4. pii: S0264-410X(19)30715.
    PubMed     Abstract available


  805. JIANG J, Ramos SJ, Bangalore P, Fisher P, et al
    Integration of needle-free jet injection with advanced electroporation delivery enhances the magnitude, kinetics, and persistence of engineered DNA vaccine induced immune responses.
    Vaccine. 2019 Jun 4. pii: S0264-410X(19)30691.
    PubMed     Abstract available


  806. SUNAY MME, Martins KAO, Steffens JT, Gregory M, et al
    Glucopyranosyl lipid adjuvant enhances immune response to Ebola virus-like particle vaccine in mice.
    Vaccine. 2019 Jun 4. pii: S0264-410X(19)30640.
    PubMed     Abstract available


  807. HONG DT, Hien ND, Thao PTP, Anh DD, et al
    Immunogenicity of the AIK-C measles vaccine in infants aged <9months in Vietnam.
    Vaccine. 2019 Jun 4. pii: S0264-410X(19)30476.
    PubMed     Abstract available


  808. CHANG J, Hou Z, Fang H, Meng Q, et al
    Are providers' recommendation and knowledge associated with uptake of optional vaccinations among children? A multilevel analysis in three provinces of China.
    Vaccine. 2019 Jun 4. pii: S0264-410X(19)30707.
    PubMed     Abstract available


  809. LIU X, Adams LJ, Zeng X, Lin J, et al
    Evaluation of in ovo vaccination of DNA vaccines for Campylobacter control in broiler chickens.
    Vaccine. 2019 Jun 3. pii: S0264-410X(19)30729.
    PubMed     Abstract available


  810. CAMACHO LAB
    Duration of immunity in recipients of two doses of 17DD yellow fever vaccine.
    Vaccine. 2019 Jun 3. pii: S0264-410X(19)30672.
    PubMed     Abstract available


  811. FAWOLE OA, Srivastava T, Feemster KA
    Student health administrator perspectives on college vaccine policy development and implementation.
    Vaccine. 2019 Jun 1. pii: S0264-410X(19)30710.
    PubMed     Abstract available


  812. BEISSBARTH J, Smith-Vaughan HC, Harris TM, Binks MJ, et al
    Use of the 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) in an Australian Indigenous paediatric population does not alter the prevalence of nontypeable Haemophilus influenzae without the protein D gene.
    Vaccine. 2019 Jun 1. pii: S0264-410X(19)30716.
    PubMed     Abstract available


  813. ALVIM RGF, Itabaiana I Jr, Castilho LR
    Zika virus-like particles (VLPs): Stable cell lines and continuous perfusion processes as a new potential vaccine manufacturing platform.
    Vaccine. 2019 Jun 1. pii: S0264-410X(19)30701.
    PubMed     Abstract available


  814. BELL CA, Russell ML, Drews SJ, Simmonds KA, et al
    Acellular pertussis vaccine effectiveness and waning immunity in Alberta, Canada: 2010-2015, a Canadian Immunization Research Network (CIRN) study.
    Vaccine. 2019 Jun 1. pii: S0264-410X(19)30704.
    PubMed     Abstract available


  815. ZHANG J, Liu N, Lu Y, Huang Z, et al
    Phosphorothioated antisense oligodeoxynucleotide suppressing interleukin-10 is a safe and potent vaccine adjuvant.
    Vaccine. 2019 Jun 1. pii: S0264-410X(19)30713.
    PubMed     Abstract available


    May 2019
  816. NG Y, Nandar K, Chua LAV, Mak TM, et al
    Evaluating the effectiveness of the influenza vaccine during respiratory outbreaks in Singapore's long term care facilities, 2017.
    Vaccine. 2019 May 31. pii: S0264-410X(19)30388.
    PubMed     Abstract available


  817. KEITEL WA, Voronca DC, Atmar RL, Paust S, et al
    Effect of recent seasonal influenza vaccination on serum antibody responses to candidate pandemic influenza A/H5N1 vaccines: A meta-analysis.
    Vaccine. 2019 May 31. pii: S0264-410X(19)30554.
    PubMed     Abstract available


  818. MARKOWITZ LE, Naleway AL, Lewis RM, Crane B, et al
    Declines in HPV vaccine type prevalence in women screened for cervical cancer in the United States: Evidence of direct and herd effects of vaccination.
    Vaccine. 2019 May 31. pii: S0264-410X(19)30626.
    PubMed     Abstract available


  819. NOSAN G, Paro-Panjan D, Ihan A, Kopitar AN, et al
    Vaccine immune response, autoimmunity and morbidity after neonatal blood exchange transfusion.
    Vaccine. 2019 May 31. pii: S0264-410X(19)30714.
    PubMed     Abstract available


  820. CABRERA G, Marcipar I
    Vaccines and the regulatory arm of the immune system. An overview from the Trypanosoma cruzi infection model.
    Vaccine. 2019 May 30. pii: S0264-410X(19)30629.
    PubMed     Abstract available


  821. GRANADILLO M, Batte A, Alfonso AB, Blanco A, et al
    Impact on antitumor response using a new adjuvant preparation as a component of a human papillomavirus type 16 therapeutic vaccine candidate.
    Vaccine. 2019 May 30. pii: S0264-410X(19)30697.
    PubMed     Abstract available


  822. YAKUBOGULLARI N, Genc R, Coven F, Nalbantsoy A, et al
    Development of adjuvant nanocarrier systems for seasonal influenza A (H3N2) vaccine based on Astragaloside VII and gum tragacanth (APS).
    Vaccine. 2019 May 30. pii: S0264-410X(19)30662.
    PubMed     Abstract available


  823. SHAH SFA, Ginossar T, Weiss D
    "This is a Pakhtun disease": Pakhtun health journalists' perceptions of the barriers and facilitators to polio vaccine acceptance among the high-risk Pakhtun community in Pakistan.
    Vaccine. 2019 May 30. pii: S0264-410X(19)30653.
    PubMed     Abstract available


  824. NICOLODI C, Groiss F, Kiselev O, Wolschek M, et al
    Safety and immunogenicity of a replication-deficient H5N1 influenza virus vaccine lacking NS1.
    Vaccine. 2019 May 30. pii: S0264-410X(19)30627.
    PubMed     Abstract available


  825. MORO PL, Arana J, Marquez PL, Ng C, et al
    Is there any harm in administering extra-doses of vaccine to a person? Excess doses of vaccine reported to the Vaccine Adverse Event Reporting System (VAERS), 2007-2017.
    Vaccine. 2019 May 30. pii: S0264-410X(19)30576.
    PubMed     Abstract available


  826. GESSNER BD, Jiang Q, Van Werkhoven CH, Sings HL, et al
    A post-hoc analysis of serotype-specific vaccine efficacy of 13-valent pneumococcal conjugate vaccine against clinical community acquired pneumonia from a randomized clinical trial in the Netherlands.
    Vaccine. 2019 May 30. pii: S0264-410X(19)30702.
    PubMed     Abstract available


  827. ESPANA PP, Uranga A, Ruiz LA, Quintana JM, et al
    Evolution of serotypes in bacteremic pneumococcal adult pneumonia in the period 2001-2014, after introduction of the pneumococcal conjugate vaccine in bizkaia (spain).
    Vaccine. 2019 May 29. pii: S0264-410X(19)30689.
    PubMed     Abstract available


  828. HOSHI SL, Seposo X, Shono A, Okubo I, et al
    Cost-effectiveness of Recombinant Zoster Vaccine (RZV) and Varicella Vaccine Live (VVL) against herpes zoster and post-herpetic neuralgia among adults aged 65 and over in Japan.
    Vaccine. 2019 May 29. pii: S0264-410X(19)30599.
    PubMed     Abstract available


  829. VAZ-DE-LIMA LRA, Sato HK, Fernandes EG, Sato APS, et al
    Association between the timing of maternal vaccination and newborns' anti-pertussis toxin antibody levels.
    Vaccine. 2019 May 29. pii: S0264-410X(19)30567.
    PubMed     Abstract available


  830. ZIMMERMANN P, Donath S, Perrett KP, Messina NL, et al
    The influence of neonatal Bacille Calmette-Guerin (BCG) immunisation on heterologous vaccine responses in infants.
    Vaccine. 2019 May 29. pii: S0264-410X(19)30327.
    PubMed     Abstract available


  831. AWASTHI S, Hook LM, Swaminathan G, Cairns TM, et al
    Antibody responses to crucial functional epitopes as a novel approach to assess immunogenicity of vaccine adjuvants.
    Vaccine. 2019 May 29. pii: S0264-410X(19)30705.
    PubMed     Abstract available


  832. RAPPUOLI R
    Towards animal free and science based measures of critical quality attributes for vaccine quality control and release.
    Vaccine. 2019 May 28. pii: S0264-410X(19)30663.
    PubMed    


  833. LIM SI, Choe S, Kim KS, Jeoung HY, et al
    Assessment of the efficacy of an attenuated live marker classical swine fever vaccine (Flc-LOM-BE(rns)) in pregnant sows.
    Vaccine. 2019 May 28. pii: S0264-410X(19)30564.
    PubMed     Abstract available


  834. CAWLFIELD A, Genito CJ, Beck Z, Bergmann-Leitner ES, et al
    Safety, toxicity and immunogenicity of a malaria vaccine based on the circumsporozoite protein (FMP013) with the adjuvant army liposome formulation containing QS21 (ALFQ).
    Vaccine. 2019 May 28. pii: S0264-410X(19)30696.
    PubMed     Abstract available


  835. KANG CK, Kim NH, Kim CJ, Rhie GE, et al
    Immunogenicity and safety of a novel recombinant protective antigen anthrax vaccine (GC1109), a randomized, single-blind, placebo controlled phase II clinical study.
    Vaccine. 2019 May 28. pii: S0264-410X(19)30694.
    PubMed     Abstract available


  836. VAN BUYNDER P, Cripps AW
    Retrospective cost-effectiveness of the 23-valent pneumococcal polysaccharide vaccination program in Australia.
    Vaccine. 2019;37:3141.
    PubMed    


  837. KIM H, Kim AY, Kim JS, Lee JM, et al
    A simple and rapid assay to evaluate purity of foot-and-mouth disease vaccine before animal experimentation.
    Vaccine. 2019 May 25. pii: S0264-410X(19)30690.
    PubMed     Abstract available


  838. GOLDSTEIN ND, LeVasseur MT, Tran NK, Purtle J, et al
    Modeling HPV vaccination scale-up among urban young men who have sex with men in the context of HIV.
    Vaccine. 2019 May 25. pii: S0264-410X(19)30671.
    PubMed     Abstract available


  839. GRANDESSO F, Kasambara W, Page AL, Debes AK, et al
    Effectiveness of oral cholera vaccine in preventing cholera among fishermen in Lake Chilwa, Malawi: A case-control study.
    Vaccine. 2019 May 24. pii: S0264-410X(19)30668.
    PubMed     Abstract available


  840. BEZERRA IPS, Costa-Souza BLS, Carneiro G, Ferreira LAM, et al
    Nanoencapsulated retinoic acid as a safe tolerogenic adjuvant for intranasal vaccination against cutaneous leishmaniasis.
    Vaccine. 2019 May 24. pii: S0264-410X(19)30667.
    PubMed     Abstract available


  841. KADDAR M, Saxenian H, Senouci K, Mohsni E, et al
    Vaccine procurement in the Middle East and North Africa region: Challenges and ways of improving program efficiency and fiscal space.
    Vaccine. 2019 May 23. pii: S0264-410X(19)30480.
    PubMed     Abstract available


  842. BA-NGUZ A, Shah A, Bresee JS, Lafond KE, et al
    Supporting national immunization technical advisory groups (NITAGs) in resource-constrained settings. New strategies and lessons learned from the Task Force for Global Health's Partnership for influenza vaccine introduction.
    Vaccine. 2019 May 23. pii: S0264-410X(19)30670.
    PubMed     Abstract available


  843. TASHANI M, Badahdah AM, Alfelali M, Barasheed O, et al
    Effect on meningococcal serogroup W immunogenicity when Tdap was administered prior, concurrent or subsequent to the quadrivalent (ACWY) meningococcal CRM197-conjugate vaccine in adult Hajj pilgrims: A randomised controlled trial.
    Vaccine. 2019 May 22. pii: S0264-410X(19)30639.
    PubMed     Abstract available


  844. GILLARD P, Benninghoff B
    Response to: A Phase III open-label, randomized, active controlled clinical study to assess safety, immunogenicity and lot-to-lot consistency of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants.
    Vaccine. 2019;37:2990.
    PubMed    


  845. LAESTADIUS A, Ingelman-Sundberg HM, Myrberg IH, Verme A, et al
    Altered proportions of circulating CXCR5+ helper T cells do not dampen influenza vaccine responses in children with rheumatic disease.
    Vaccine. 2019 May 21. pii: S0264-410X(19)30661.
    PubMed     Abstract available


  846. STANTON SE, Gad E, Corulli LR, Lu H, et al
    Tumor-associated antigens identified early in mouse mammary tumor development can be effective vaccine targets.
    Vaccine. 2019 May 21. pii: S0264-410X(19)30638.
    PubMed     Abstract available


  847. JINA A, Wang TL, Seyferth ER, Cohen A, et al
    Increasing antepartum Tdap vaccine administration: A quality improvement initiative.
    Vaccine. 2019 May 20. pii: S0264-410X(19)30669.
    PubMed     Abstract available


  848. FESTJENS N, Vandewalle K, Houthuys E, Plets E, et al
    SapM mutation to improve the BCG vaccine: Genomic, transcriptomic and preclinical safety characterization.
    Vaccine. 2019 May 20. pii: S0264-410X(19)30636.
    PubMed     Abstract available


  849. CHOI WS, Choi JH, Jung DS, Choi HJ, et al
    Immunogenicity and safety of a new live attenuated herpes zoster vaccine (NBP608) compared to Zostavax(R) in healthy adults aged 50 years and older.
    Vaccine. 2019 May 20. pii: S0264-410X(19)30510.
    PubMed     Abstract available


  850. TRAUCHESSEC M, Lambert O, Bonnafous P, Berard Y, et al
    Complementary use of mass spectrometry and cryo-electron microscopy to assess the maturity of live attenuated dengue vaccine viruses.
    Vaccine. 2019 May 20. pii: S0264-410X(19)30624.
    PubMed     Abstract available


  851. LI J, Zhang Y, Yang Y, Liang Z, et al
    Effectiveness of Lanzhou lamb rotavirus vaccine in preventing gastroenteritis among children younger than 5years of age.
    Vaccine. 2019 May 20. pii: S0264-410X(19)30418.
    PubMed     Abstract available


  852. NIEMINEN H, Rinta-Kokko H, Jokinen J, Puumalainen T, et al
    Effectiveness of the 10-valent pneumococcal conjugate vaccine among girls, boys, preterm and low-birth-weight infants - Results from a randomized, double-blind vaccine trial.
    Vaccine. 2019 May 20. pii: S0264-410X(19)30657.
    PubMed     Abstract available


  853. PEREZ-VILAR S, Wernecke M, Arya D, Lo AC, et al
    Surveillance for Guillain-Barre syndrome after influenza vaccination among U.S. Medicare beneficiaries during the 2017-2018 season.
    Vaccine. 2019 May 20. pii: S0264-410X(19)30665.
    PubMed     Abstract available


  854. FORRO B, Marton S, Kecskemeti S, Hornyak A, et al
    Vaccine-associated rabies in red fox, Hungary.
    Vaccine. 2019 May 17. pii: S0264-410X(19)30628.
    PubMed     Abstract available


  855. ORTIZ-BRIZUELA E, Leal-Vega F, Cuellar-Rodriguez J, Bobadilla-Del-Valle M, et al
    Vaccine-derived varicella zoster infection in a kidney transplant recipient after zoster vaccine live administration.
    Vaccine. 2019 May 17. pii: S0264-410X(19)30631.
    PubMed     Abstract available


  856. BARTSCH SM, Bottazzi ME, Asti L, Strych U, et al
    Economic value of a therapeutic Chagas vaccine for indeterminate and Chagasic cardiomyopathy patients.
    Vaccine. 2019 May 16. pii: S0264-410X(19)30652.
    PubMed     Abstract available


  857. KOUL PA, Bali NK, Koul HP
    Influenza vaccination for Hajj for the next decade: A case for quadrivalent SH vaccine.
    Vaccine. 2019 May 16. pii: S0264-410X(19)30602.
    PubMed    


  858. O'LEARY ST, Pyrzanowski J, Brewer SE, Sevick C, et al
    Effectiveness of a multimodal intervention to increase vaccination in obstetrics/gynecology settings.
    Vaccine. 2019 May 15. pii: S0264-410X(19)30658.
    PubMed     Abstract available


  859. MANNING J, Dunne EM, Wang N, Pedersen JS, et al
    Effect of a pneumococcal whole cell vaccine on influenza A-induced pneumococcal otitis media in infant mice.
    Vaccine. 2019 May 15. pii: S0264-410X(19)30324.
    PubMed     Abstract available


  860. BERNSTEIN DI, Flechtner JB, McNeil LK, Heineman T, et al
    Therapeutic HSV-2 vaccine decreases recurrent virus shedding and recurrent genital herpes disease.
    Vaccine. 2019 May 15. pii: S0264-410X(19)30621.
    PubMed     Abstract available


  861. RATNAPRIYA S, Keerti, Sahasrabuddhe AA, Dube A, et al
    Visceral leishmaniasis: An overview of vaccine adjuvants and their applications.
    Vaccine. 2019 May 15. pii: S0264-410X(19)30600.
    PubMed     Abstract available


  862. OSOWICKI J, Azzopardi KI, Baker C, Waddington CS, et al
    Controlled human infection for vaccination against Streptococcus pyogenes (CHIVAS): Establishing a group A Streptococcus pharyngitis human infection study.
    Vaccine. 2019 May 14. pii: S0264-410X(19)30405.
    PubMed     Abstract available


  863. KO EJ, Lee Y, Lee YT, Jung YJ, et al
    Flagellin-expressing virus-like particles exhibit adjuvant effects on promoting IgG isotype-switched long-lasting antibody induction and protection of influenza vaccines in CD4-deficient mice.
    Vaccine. 2019 May 14. pii: S0264-410X(19)30632.
    PubMed     Abstract available


  864. KESHERWANI V, Tarang S
    An immunoinformatic approach to universal therapeutic vaccine design against BK virus.
    Vaccine. 2019 May 13. pii: S0264-410X(19)30616.
    PubMed     Abstract available


  865. ZHOU M, Qu S, Zhao L, Kong N, et al
    Trust collapse caused by the Changsheng vaccine crisis in China.
    Vaccine. 2019 May 13. pii: S0264-410X(19)30634.
    PubMed     Abstract available


  866. LIANG B, Li H, Li L, Omange RW, et al
    Current advances in HIV vaccine preclinical studies using Macaque models.
    Vaccine. 2019 May 11. pii: S0264-410X(19)30603.
    PubMed     Abstract available


  867. DAVIES J, Lokuge K, Glass K
    Routine and pulse vaccination for Lassa virus could reduce high levels of endemic disease: A mathematical modelling study.
    Vaccine. 2019 May 11. pii: S0264-410X(19)30622.
    PubMed     Abstract available


  868. BRUXVOORT KJ, Liang AS, Harpaz R, Qian L, et al
    Patient report of herpes zoster pain: Incremental benefits of zoster vaccine live.
    Vaccine. 2019 May 11. pii: S0264-410X(19)30615.
    PubMed     Abstract available


  869. FELDMAN RA, Fuhr R, Smolenov I, Mick Ribeiro A, et al
    mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials.
    Vaccine. 2019 May 9. pii: S0264-410X(19)30562.
    PubMed     Abstract available


  870. MASTERS NB, Wagner AL, Ding Y, Zhang Y, et al
    Assessing measles vaccine failure in Tianjin, China.
    Vaccine. 2019 May 8. pii: S0264-410X(19)30598.
    PubMed     Abstract available


  871. XIE L, Zai J, Yi K, Li Y, et al
    Intranasal immunization with recombinant Vaccinia virus Tiantan harboring Zaire Ebola virus gp elicited systemic and mucosal neutralizing antibody in mice.
    Vaccine. 2019 May 7. pii: S0264-410X(19)30558.
    PubMed     Abstract available


  872. SAMBALA EZ, Wiyeh AB, Ngcobo N, Machingaidze S, et al
    New vaccine introductions in Africa before and during the decade of vaccines - Are we making progress?
    Vaccine. 2019 May 7. pii: S0264-410X(19)30593.
    PubMed     Abstract available


  873. KLEYNHANS J, Cohen C, McMorrow M, Tempia S, et al
    Can pneumococcal meningitis surveillance be used to assess the impact of pneumococcal conjugate vaccine on total invasive pneumococcal disease? A case-study from South Africa, 2005-2016.
    Vaccine. 2019 May 7. pii: S0264-410X(19)30590.
    PubMed     Abstract available


  874. WANG L, Zhang X, Zhang Q, Zhang S, et al
    Understanding medical students' practices and perceptions towards vaccination in China: A qualitative study in a medical university.
    Vaccine. 2019 May 7. pii: S0264-410X(19)30387.
    PubMed     Abstract available


  875. TRETYAKOVA I, Tibbens A, Jokinen JD, Johnson DM, et al
    Novel DNA-launched Venezuelan equine encephalitis virus vaccine with rearranged genome.
    Vaccine. 2019 May 6. pii: S0264-410X(19)30560.
    PubMed     Abstract available


  876. TORCEL-PAGNON L, Bauchau V, Mahy P, Tin Tin Htar M, et al
    Guidance for the governance of public-private collaborations in vaccine post-marketing settings in Europe.
    Vaccine. 2019 May 6. pii: S0264-410X(19)30561.
    PubMed     Abstract available


  877. AWAD S, Abdo N, Yusef D, Jawarneh A, et al
    Knowledge, attitudes and practices related to influenza illness and vaccination in children: Role of awareness campaigns in changing parents' attitudes toward influenza vaccination in Jordan.
    Vaccine. 2019 May 6. pii: S0264-410X(19)30571.
    PubMed     Abstract available


  878. KOCHHAR S, Edwards KM, Ropero Alvarez AM, Moro PL, et al
    Introduction of new vaccines for immunization in pregnancy - Programmatic, regulatory, safety and ethical considerations.
    Vaccine. 2019 May 6. pii: S0264-410X(19)30563.
    PubMed     Abstract available


  879. VEDHARA K, Ayling K, Sunger K, Caldwell DM, et al
    Psychological interventions as vaccine adjuvants: A systematic review.
    Vaccine. 2019 May 6. pii: S0264-410X(19)30591.
    PubMed     Abstract available


  880. MASCARO V, Pileggi C, Curra A, Bianco A, et al
    HPV vaccination coverage and willingness to be vaccinated among 18-30year-old students in Italy.
    Vaccine. 2019 May 4. pii: S0264-410X(19)30569.
    PubMed     Abstract available


  881. HECHTER RC, Qian L, Tartof SY, Sy LS, et al
    Vaccine safety in HIV-infected adults within the Vaccine Safety Datalink Project.
    Vaccine. 2019 May 4. pii: S0264-410X(19)30568.
    PubMed     Abstract available


  882. KUMAR A, Gupta VK, Mandil R, Rahal A, et al
    Interplay of oxidative stress and antioxidant bio markers in oil adjuvant Brucella melitensis vaccinated and challenged mice.
    Vaccine. 2019 May 4. pii: S0264-410X(19)30536.
    PubMed     Abstract available


  883. SALAS A, Pardo-Seco J, Cebey-Lopez M, Martinon-Martinez JM, et al
    Impact of rotavirus vaccination on childhood hospitalizations for seizures: Heterologous or unforeseen direct vaccine effects?
    Vaccine. 2019 May 4. pii: S0264-410X(19)30574.
    PubMed     Abstract available


  884. BONOMO ME, Kim RY, Deem MW
    Modular epitope binding predicts influenza quasispecies dominance and vaccine effectiveness: Application to 2018/19 season.
    Vaccine. 2019 May 3. pii: S0264-410X(19)30417.
    PubMed     Abstract available


  885. KRUBINER CB, Faden RR, Karron RA, Little MO, et al
    Pregnant women & vaccines against emerging epidemic threats: Ethics guidance for preparedness, research, and response.
    Vaccine. 2019 May 3. pii: S0264-410X(19)30045.
    PubMed     Abstract available


  886. ANTONUCCI R, Frassetto R, Vacca N, Mura D, et al
    Poor vaccine-related immunity against HBV in children with autoimmune diseases: Early or late sign of immunological disorder?
    Vaccine. 2019;37:2527-2528.
    PubMed    


    April 2019
  887. TUNG WC, Lu M, Qiu X, Ervin S, et al
    Human papillomavirus knowledge, attitudes, and vaccination among Chinese college students in the United States.
    Vaccine. 2019 Apr 29. pii: S0264-410X(19)30572.
    PubMed     Abstract available


  888. DOYON-PLOURDE P, Fakih I, Tadount F, Fortin E, et al
    Impact of influenza vaccination on healthcare utilization - A systematic review.
    Vaccine. 2019 Apr 29. pii: S0264-410X(19)30525.
    PubMed     Abstract available


  889. DORA EG, Rossi SL, Weaver SC, Tucker SN, et al
    An adjuvanted adenovirus 5-based vaccine elicits neutralizing antibodies and protects mice against chikungunya virus-induced footpad swelling.
    Vaccine. 2019 Apr 29. pii: S0264-410X(19)30557.
    PubMed     Abstract available


  890. PATO TP, Souza MCO, Mattos DA, Caride E, et al
    Purification of yellow fever virus produced in Vero cells for inactivated vaccine manufacture.
    Vaccine. 2019 Apr 29. pii: S0264-410X(19)30565.
    PubMed     Abstract available


  891. ELIKAEE S, Mohebali M, Rezaei S, Eslami H, et al
    Leishmania major p27 gene knockout as a novel live attenuated vaccine candidate: Protective immunity and efficacy evaluation against cutaneous and visceral leishmaniasis in BALB/c mice.
    Vaccine. 2019 Apr 29. pii: S0264-410X(19)30556.
    PubMed     Abstract available


  892. SHI S, Zhu H, Xia X, Liang Z, et al
    Vaccine adjuvants: Understanding the structure and mechanism of adjuvanticity.
    Vaccine. 2019 Apr 29. pii: S0264-410X(19)30529.
    PubMed     Abstract available


  893. JOOSTEN SA, Ottenhoff THM, Lewinsohn DM, Hoft DF, et al
    Harnessing donor unrestricted T-cells for new vaccines against tuberculosis.
    Vaccine. 2019 Apr 27. pii: S0264-410X(19)30524.
    PubMed     Abstract available


  894. FRANCIS MR, Nuorti JP, Kompithra RZ, Larson H, et al
    Vaccination coverage and factors associated with routine childhood vaccination uptake in rural Vellore, southern India, 2017.
    Vaccine. 2019 Apr 27. pii: S0264-410X(19)30534.
    PubMed     Abstract available


  895. ZENG Y, Luo M, Chen J, He H, et al
    An economic evaluation of the current measles vaccination program: A case study in Zhejiang Province, east China.
    Vaccine. 2019 Apr 27. pii: S0264-410X(19)30533.
    PubMed     Abstract available


  896. HABER M, Lopman BA, Tate JE, Shi M, et al
    Effect of propensity of seeking medical care on the bias of the estimated effectiveness of rotavirus vaccines from studies using a test-negative case-control design.
    Vaccine. 2019 Apr 26. pii: S0264-410X(19)30541.
    PubMed     Abstract available


  897. RODRIGUEZ SA, Savas LS, Loomba P, Vernon SW, et al
    Low-income Hispanic parent recall of daughters' HPV vaccination status: Correlates of accurate reporting of daughters' HPV-vaccine naive status compared with electronic health records.
    Vaccine. 2019 Apr 26. pii: S0264-410X(19)30540.
    PubMed     Abstract available


  898. ATKINSON KM, Wilson K, Murphy MSQ, El-Halabi S, et al
    Effectiveness of digital technologies at improving vaccine uptake and series completion - A systematic review and meta-analysis of randomized controlled trials.
    Vaccine. 2019 Apr 26. pii: S0264-410X(19)30412.
    PubMed     Abstract available


  899. MOLLER J, Kraner M, Sonnewald U, Sangal V, et al
    Proteomics of diphtheria toxoid vaccines reveals multiple proteins that are immunogenic and may contribute to protection of humans against Corynebacterium diphtheriae.
    Vaccine. 2019 Apr 26. pii: S0264-410X(19)30535.
    PubMed     Abstract available


  900. JIANG HY, Shi YD, Zhang X, Pan LY, et al
    Human papillomavirus vaccination and the risk of autoimmune disorders: A systematic review and meta-analysis.
    Vaccine. 2019 Apr 26. pii: S0264-410X(19)30523.
    PubMed     Abstract available


  901. VEKEMANS J, Crofts J, Baker CJ, Goldblatt D, et al
    The role of immune correlates of protection on the pathway to licensure, policy decision and use of group B Streptococcus vaccines for maternal immunization: considerations from World Health Organization consultations.
    Vaccine. 2019 Apr 25. pii: S0264-410X(19)30501.
    PubMed     Abstract available


  902. COHET C, van der Most R, Bauchau V, Bekkat-Berkani R, et al
    Safety of AS03-adjuvanted influenza vaccines: A review of the evidence.
    Vaccine. 2019 Apr 25. pii: S0264-410X(19)30522.
    PubMed     Abstract available


  903. FEATHERSTONE JD, Bell RA, Ruiz JB
    Relationship of people's sources of health information and political ideology with acceptance of conspiratorial beliefs about vaccines.
    Vaccine. 2019 Apr 25. pii: S0264-410X(19)30539.
    PubMed     Abstract available


  904. JONKER EFF, Uijlings MAC, Visser LG, Soonawala D, et al
    Comparison of the immunogenicity of Dukoral(R) oral cholera vaccine between renal transplant recipients on either a calcineurin inhibitor or mycophenolate - A controlled trial.
    Vaccine. 2019 Apr 24. pii: S0264-410X(19)30448.
    PubMed     Abstract available


  905. VAN DAMME P, Leroux-Roels G, Vandermeulen C, De Ryck I, et al
    Safety and immunogenicity of non-typeable Haemophilus influenzae-Moraxella catarrhalis vaccine.
    Vaccine. 2019 Apr 24. pii: S0264-410X(19)30505.
    PubMed     Abstract available


  906. MWENDA JM, Mandomando I, Jere KC, Cunliffe NA, et al
    Evidence of reduction of rotavirus diarrheal disease after rotavirus vaccine introduction in national immunization programs in the African countries: Report of the 11(th) African rotavirus symposium held in Lilongwe, Malawi.
    Vaccine. 2019 Apr 24. pii: S0264-410X(19)30381.
    PubMed     Abstract available


  907. KARPPINEN S, Toivonen L, Schuez-Havupalo L, Teros-Jaakkola T, et al
    Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against all respiratory tract infections in children under two years of age.
    Vaccine. 2019 Apr 23. pii: S0264-410X(19)30477.
    PubMed     Abstract available


  908. DELLEPIANE N, Pagliusi S
    Opportunities for improving access to vaccines in emerging countries through efficient and aligned registration procedures: An industry perspective.
    Vaccine. 2019 Apr 23. pii: S0264-410X(19)30347.
    PubMed     Abstract available


  909. JIANG B, Patel M, Glass RI
    Polio endgame: Lessons for the global rotavirus vaccination program.
    Vaccine. 2019 Apr 23. pii: S0264-410X(19)30474.
    PubMed     Abstract available


  910. XEUATVONGSA A, Mott JA, Khanthamaly V, Patthammavong C, et al
    Progress toward sustainable influenza vaccination in the Lao Peoples' Democratic Republic, 2012-2018.
    Vaccine. 2019 Apr 23. pii: S0264-410X(19)30511.
    PubMed     Abstract available


  911. MING M, Bernardo L, Williams K, Kolattukudy P, et al
    An in vitro functional assay to measure the biological activity of TB vaccine candidate H4-IC31.
    Vaccine. 2019 Apr 19. pii: S0264-410X(19)30486.
    PubMed     Abstract available


  912. BETTAMPADI D, Boulton ML, Power LE, Hutton DW, et al
    Are community health workers cost-effective for childhood vaccination in India?
    Vaccine. 2019 Apr 19. pii: S0264-410X(19)30500.
    PubMed     Abstract available


  913. NGUYEN A, Schwalbe N
    Apples and oranges? Can second generation vaccines become as low cost as generic medicines?
    Vaccine. 2019 Apr 19. pii: S0264-410X(19)30457.
    PubMed     Abstract available


  914. BOILESEN DR, Ragonnaud E, Laursen H, Andersson AC, et al
    CD8+ T cells induced by adenovirus-vectored vaccine are capable of preventing establishment of latent murine gamma-herpesvirus 68 infection.
    Vaccine. 2019 Apr 18. pii: S0264-410X(19)30485.
    PubMed     Abstract available


  915. KIM JH, Chun BC, Song JY, Kim HY, et al
    Direct effectiveness of pneumococcal polysaccharide vaccine against invasive pneumococcal disease and non-bacteremic pneumococcal pneumonia in elderly population in the era of pneumococcal conjugate vaccine: A case-control study.
    Vaccine. 2019 Apr 17. pii: S0264-410X(19)30458.
    PubMed     Abstract available


  916. PARKER KH, Kemp TJ, Isaacs-Soriano K, Abrahamsen M, et al
    HPV-specific antibodies at the oral cavity up to 30months after the start of vaccination with the quadrivalent HPV vaccine among mid-adult aged men.
    Vaccine. 2019 Apr 17. pii: S0264-410X(19)30413.
    PubMed     Abstract available


  917. BERCOVICH S, Anis E, Kassem E, Rubinstein U, et al
    Validation of parental reports of rotavirus vaccination of their children compared to the national immunization registry.
    Vaccine. 2019 Apr 16. pii: S0264-410X(19)30499.
    PubMed     Abstract available


  918. ABDELLRAZEQ GS, Elnaggar MM, Bannantine JP, Schneider DA, et al
    A peptide-based vaccine for Mycobacterium avium subspecies paratuberculosis.
    Vaccine. 2019 Apr 16. pii: S0264-410X(19)30504.
    PubMed     Abstract available


  919. LACONI A, Catelli E, Cecchinato M, Naylor CJ, et al
    Two similar commercial live attenuated AMPV vaccines prepared by random passage of the identical field isolate, have unrelated sequences.
    Vaccine. 2019 Apr 16. pii: S0264-410X(19)30498.
    PubMed     Abstract available


  920. ATTWELL K, Drislane S, Leask J
    Mandatory vaccination and no fault vaccine injury compensation schemes: An identification of country-level policies.
    Vaccine. 2019 Apr 15. pii: S0264-410X(19)30414.
    PubMed     Abstract available


  921. O'MAHONY JF, Paulden M
    Appraising the cost-effectiveness of vaccines in the UK: Insights from the Department of Health Consultation on the revision of methods guidelines.
    Vaccine. 2019 Apr 15. pii: S0264-410X(19)30421.
    PubMed     Abstract available


  922. ALBERTS CJ, Boyd A, Bruisten SM, Heijman T, et al
    Hepatitis A incidence, seroprevalence, and vaccination decision among MSM in Amsterdam, the Netherlands.
    Vaccine. 2019 Apr 13. pii: S0264-410X(19)30382.
    PubMed     Abstract available


  923. VAN BUYNDER PG, Van Buynder JL, Menton L, Thompson G, et al
    Antigen specific vaccine hesitancy in pregnancy.
    Vaccine. 2019 Apr 13. pii: S0264-410X(19)30472.
    PubMed     Abstract available


  924. PACHECO FC, Franca GVA, Elidio GA, Domingues CMAS, et al
    Trends and spatial distribution of MMR vaccine coverage in Brazil during 2007-2017.
    Vaccine. 2019 Apr 12. pii: S0264-410X(19)30470.
    PubMed     Abstract available


  925. LEROUX-ROELS G, De Boever F, Maes C, Nguyen TL, et al
    Safety and immunogenicity of a respiratory syncytial virus fusion glycoprotein F subunit vaccine in healthy adults: Results of a phase 1, randomized, observer-blind, controlled, dosage-escalation study.
    Vaccine. 2019 Apr 12. pii: S0264-410X(19)30449.
    PubMed     Abstract available


  926. MCGIRR A, Widenmaier R, Curran D, Espie E, et al
    The comparative efficacy and safety of herpes zoster vaccines: A network meta-analysis.
    Vaccine. 2019 Apr 11. pii: S0264-410X(19)30455.
    PubMed     Abstract available


  927. HOFFMAN BL, Felter EM, Chu KH, Shensa A, et al
    It's not all about autism: The emerging landscape of anti-vaccination sentiment on Facebook.
    Vaccine. 2019;37:2216-2223.
    PubMed     Abstract available


  928. HARRIS AM, Millman AJ, Lora M, Osinubi A, et al
    Hepatitis B testing, care linkage, and vaccination coverage within a registry of hepatitis C infected patients.
    Vaccine. 2019;37:2188-2193.
    PubMed     Abstract available


  929. POLAND GA, Hall LL, Powell JA
    Effective and equitable influenza vaccine coverage in older and vulnerable adults: The need for evidence-based innovation and transformation.
    Vaccine. 2019;37:2167-2170.
    PubMed    


  930. FABIANI M, Fano V, Spadea T, Piovesan C, et al
    Comparison of early childhood vaccination coverage and timeliness between children born to Italian women and those born to foreign women residing in Italy: A multi-centre retrospective cohort study.
    Vaccine. 2019;37:2179-2187.
    PubMed     Abstract available


  931. PICAZO JJ, Ruiz-Contreras J, Casado-Flores J, Negreira S, et al
    Impact of 13-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in children under 15years old in Madrid, Spain, 2007 to 2016: The HERACLES clinical surveillance study.
    Vaccine. 2019;37:2200-2207.
    PubMed     Abstract available


  932. AZZARI C, Serranti D, Nieddu F, Moriondo M, et al
    Significant impact of pneumococcal conjugate vaccination on pediatric parapneumonic effusion: Italy 2006-2018.
    Vaccine. 2019 Apr 10. pii: S0264-410X(19)30450.
    PubMed     Abstract available


  933. NEUKAM K, Gutierrez-Valencia A, Llaves-Flores S, Espinosa N, et al
    Response to a reinforced hepatitis B vaccination scheme in HIV-infected patients under real-life conditions.
    Vaccine. 2019 Apr 10. pii: S0264-410X(19)30351.
    PubMed     Abstract available


  934. SHAPIRO SZ
    Lessons for general vaccinology research from attempts to develop an HIV vaccine.
    Vaccine. 2019 Apr 9. pii: S0264-410X(19)30442.
    PubMed     Abstract available


  935. GORMAN DR, Bielecki K, Willocks LJ, Pollock KG, et al
    A qualitative study of vaccination behaviour amongst female Polish migrants in Edinburgh, Scotland.
    Vaccine. 2019 Apr 9. pii: S0264-410X(19)30422.
    PubMed     Abstract available


  936. RIES C, Beer M, Hoffmann B
    BTV antibody longevity in cattle five to eight years post BTV-8 vaccination.
    Vaccine. 2019 Apr 9. pii: S0264-410X(19)30440.
    PubMed     Abstract available


  937. MIHIGO R, Okeibunor J, Cernuschi T, Petu A, et al
    Improving access to affordable vaccines for middle-income countries in the african region.
    Vaccine. 2019 Apr 9. pii: S0264-410X(19)30426.
    PubMed     Abstract available


  938. ODUTOLA A, Ota MOC, Antonio M, Ogundare EO, et al
    Immunogenicity of pneumococcal conjugate vaccine formulations containing pneumococcal proteins, and immunogenicity and reactogenicity of co-administered routine vaccines - A phase II, randomised, observer-blind study in Gambian infants.
    Vaccine. 2019 Apr 8. pii: S0264-410X(19)30355.
    PubMed     Abstract available


  939. SANDO E, Suzuki M, Furumoto A, Asoh N, et al
    Impact of the pediatric 13-valent pneumococcal conjugate vaccine on serotype distribution and clinical characteristics of pneumococcal pneumonia in adults: The Japan Pneumococcal Vaccine Effectiveness Study (J-PAVE).
    Vaccine. 2019 Apr 8. pii: S0264-410X(19)30447.
    PubMed     Abstract available


  940. KEERSMAEKERS N, Ogunjimi B, Van Damme P, Beutels P, et al
    An ODE-based mixed modelling approach for B- and T-cell dynamics induced by Varicella-Zoster Virus vaccines in adults shows higher T-cell proliferation with Shingrix than with Varilrix.
    Vaccine. 2019 Apr 8. pii: S0264-410X(19)30424.
    PubMed     Abstract available


  941. CLARKE RM, Paterson P, Sirota M
    Determinants of satisfaction with information and additional information-seeking behaviour for the pertussis vaccination given during pregnancy.
    Vaccine. 2019 Apr 8. pii: S0264-410X(19)30446.
    PubMed     Abstract available


  942. SCHARTAU S, Heering Holt D, Lutzen T, Rytter D, et al
    On the contextual nature of vaccine safety monitoring: Adverse events reporting after HPV-vaccination in Denmark, 2015.
    Vaccine. 2019 Apr 6. pii: S0264-410X(19)30391.
    PubMed     Abstract available


  943. CHARANIA NA, Gaze N, Kung JY, Brooks S, et al
    Vaccine-preventable diseases and immunisation coverage among migrants and non-migrants worldwide: A scoping review of published literature, 2006 to 2016.
    Vaccine. 2019 Apr 6. pii: S0264-410X(19)30437.
    PubMed     Abstract available


  944. LECOUTURIER V, Bernard MC, Berry C, Carayol S, et al
    Immunogenicity and protection conferred by an optimized purified inactivated Zika vaccine in mice.
    Vaccine. 2019 Apr 6. pii: S0264-410X(19)30451.
    PubMed     Abstract available


  945. CROWCROFT NS, Schwartz KL, Chen C, Johnson C, et al
    Pertussis vaccine effectiveness in a frequency matched population-based case-control Canadian Immunization Research Network study in Ontario, Canada 2009-2015.
    Vaccine. 2019 Apr 6. pii: S0264-410X(19)30254.
    PubMed     Abstract available


  946. INOUE M, Yonemura T, de Solom R, Yamaji M, et al
    A phase 1 randomized study assessing safety and immunogenicity of two 3-dose regimens of a Clostridium difficile vaccine in healthy older Japanese adults.
    Vaccine. 2019 Apr 5. pii: S0264-410X(19)30325.
    PubMed     Abstract available


  947. TAUCHER C, Kollaritsch H, Dubischar KL
    Persistence of the immune response after vaccination with the Japanese encephalitis vaccine, IXIARO(R) in healthy adults: A five year follow-up study.
    Vaccine. 2019 Apr 5. pii: S0264-410X(19)30352.
    PubMed     Abstract available


  948. CHAMBERLAIN AT, Limaye RJ, O'Leary ST, Frew PM, et al
    Development and acceptability of a video-based vaccine promotion tutorial for obstetric care providers.
    Vaccine. 2019 Apr 5. pii: S0264-410X(19)30305.
    PubMed     Abstract available


  949. ECHEVARRIA D, Gutfraind A, Boodram B, Layden J, et al
    Modeling indicates efficient vaccine-based interventions for the elimination of hepatitis C virus among persons who inject drugs in metropolitan Chicago.
    Vaccine. 2019 Apr 5. pii: S0264-410X(19)30319.
    PubMed     Abstract available


  950. KAWADE A, Babji S, Kamath V, Raut A, et al
    Immunogenicity and lot-to-lot consistency of a ready to use liquid bovine-human reassortant pentavalent rotavirus vaccine (ROTASIIL - Liquid) in Indian infants.
    Vaccine. 2019 Apr 4. pii: S0264-410X(19)30416.
    PubMed     Abstract available


  951. EL SAHLY HM, Atmar RL, Patel SM, Bellamy A, et al
    Safety and immunogenicity of an 8 year interval heterologous prime-boost influenza A/H7N7-H7N9 vaccination.
    Vaccine. 2019 Apr 4. pii: S0264-410X(19)30420.
    PubMed     Abstract available


  952. LIMA L, Molina MDGF, Pereira BS, Nadaf MLA, et al
    Acquisition of specific antibodies and their influence on cell-mediated immune response in neonatal cord blood after maternal pertussis vaccination during pregnancy.
    Vaccine. 2019 Apr 4. pii: S0264-410X(19)30419.
    PubMed     Abstract available


  953. GAGNEUR A, Bergeron J, Gosselin V, Farrands A, et al
    A complementary approach to the vaccination promotion continuum: An immunization-specific motivational-interview training for nurses.
    Vaccine. 2019 Apr 3. pii: S0264-410X(19)30425.
    PubMed     Abstract available


  954. HAVERI A, Ikonen N, Kantele A, Anttila VJ, et al
    Seasonal influenza vaccines induced high levels of neutralizing cross-reactive antibody responses against different genetic group influenza A(H1N1)pdm09 viruses.
    Vaccine. 2019 Apr 3. pii: S0264-410X(19)30427.
    PubMed     Abstract available


  955. BRUMMAIER T, Poe Yen Yen S, Keereecharoen D, McGready R, et al
    The natural course of a localized BCG vaccine abscess.
    Vaccine. 2019 Apr 2. pii: S0264-410X(19)30415.
    PubMed    


  956. REGAN AK, Fielding JE, Chilver MB, Carville KS, et al
    Intraseason decline in influenza vaccine effectiveness during the 2016 southern hemisphere influenza season: A test-negative design study and phylogenetic assessment.
    Vaccine. 2019 Apr 2. pii: S0264-410X(19)30222.
    PubMed     Abstract available


  957. FERNANDES EG, Sato APS, Vaz-de-Lima LRA, Rodrigues M, et al
    The effectiveness of maternal pertussis vaccination in protecting newborn infants in Brazil: A case-control study.
    Vaccine. 2019 Apr 1. pii: S0264-410X(19)30383.
    PubMed     Abstract available


    March 2019
  958. MENSAH K, Heraud JM, Takahashi S, Winter AK, et al
    Seasonal gaps in measles vaccination coverage in Madagascar.
    Vaccine. 2019 Mar 30. pii: S0264-410X(19)30276.
    PubMed     Abstract available


  959. PINTO LA, Wilkin TJ, Kemp TJ, Abrahamsen M, et al
    Oral and systemic HPV antibody kinetics post-vaccination among HIV-positive and HIV-negative men.
    Vaccine. 2019 Mar 30. pii: S0264-410X(19)30356.
    PubMed     Abstract available


  960. LUYTEN J, Bruyneel L, van Hoek AJ
    Assessing vaccine hesitancy in the UK population using a generalized vaccine hesitancy survey instrument.
    Vaccine. 2019 Mar 30. pii: S0264-410X(19)30375.
    PubMed     Abstract available


  961. SAWLWIN DC, Graves Jones A, Albano FR
    Modification of the vaccine manufacturing process improves the pyrogenicity profile of inactivated influenza vaccines in young children.
    Vaccine. 2019 Mar 29. pii: S0264-410X(19)30390.
    PubMed     Abstract available


  962. LOPEZ-FAUQUED M, Campora L, Delannois F, El Idrissi M, et al
    Safety profile of the adjuvanted recombinant zoster vaccine: Pooled analysis of two large randomised phase 3 trials.
    Vaccine. 2019 Mar 29. pii: S0264-410X(19)30377.
    PubMed     Abstract available


  963. OSTER NV, Williams EC, Unger JM, Newcomb PA, et al
    Sociodemographic, clinical and birth hospitalization characteristics and infant Hepatitis B vaccination in Washington State.
    Vaccine. 2019 Mar 28. pii: S0264-410X(19)30384.
    PubMed     Abstract available


  964. CASHMAN P, Moberley S, Chee K, Stephenson J, et al
    Participant centred safety surveillance of health care workers receiving influenza vaccination.
    Vaccine. 2019 Mar 28. pii: S0264-410X(19)30320.
    PubMed     Abstract available


  965. XIN H, Glee P, Adams A, Mohiuddin F, et al
    Design of a mimotope-peptide based double epitope vaccine against disseminated candidiasis.
    Vaccine. 2019 Mar 28. pii: S0264-410X(19)30407.
    PubMed     Abstract available


  966. POELLABAUER E, Angermayr R, Behre U, Zhang P, et al
    Seropersistence and booster response following vaccination with FSME-IMMUN in children, adolescents, and young adults.
    Vaccine. 2019 Mar 27. pii: S0264-410X(19)30354.
    PubMed     Abstract available


  967. ARNOLD LD, Luong L, Rebmann T, Chang JJ, et al
    Racial disparities in U.S. maternal influenza vaccine uptake: Results from analysis of Pregnancy Risk Assessment Monitoring System (PRAMS) data, 2012-2015.
    Vaccine. 2019 Mar 27. pii: S0264-410X(19)30208.
    PubMed     Abstract available


  968. GODI A, Panwar K, Haque M, Cocuzza CE, et al
    Durability of the neutralizing antibody response to vaccine and non-vaccine HPV types 7 years following immunization with either Cervarix(R) or Gardasil(R) vaccine.
    Vaccine. 2019 Mar 27. pii: S0264-410X(19)30386.
    PubMed     Abstract available


  969. WENTWORTH D, Hampson K, Thumbi SM, Mwatondo A, et al
    A social justice perspective on access to human rabies vaccines.
    Vaccine. 2019 Mar 27. pii: S0264-410X(19)30150.
    PubMed     Abstract available


  970. SARKAR S, Piepenbrink MS, Basu M, Thakar J, et al
    IL-33 enhances the kinetics and quality of the antibody response to a DNA and protein-based HIV-1 Env vaccine.
    Vaccine. 2019 Mar 26. pii: S0264-410X(19)30378.
    PubMed     Abstract available


  971. LEE BY, Brown ST, Haidari LA, Clark S, et al
    Economic value of vaccinating geographically hard-to-reach populations with measles vaccine: A modeling application in Kenya.
    Vaccine. 2019 Mar 25. pii: S0264-410X(19)30307.
    PubMed     Abstract available


  972. XU Y, Ma S, Huang Y, Chen F, et al
    Virus-like particle vaccines for poliovirus types 1, 2, and 3 with enhanced thermostability expressed in insect cells.
    Vaccine. 2019 Mar 25. pii: S0264-410X(19)30353.
    PubMed     Abstract available


  973. TAYLOR E, Banyard AC, Bourhy H, Cliquet F, et al
    Avoiding preventable deaths: The scourge of counterfeit rabies vaccines.
    Vaccine. 2019 Mar 25. pii: S0264-410X(19)30369.
    PubMed    


  974. EVERETT HE, Aramouni M, Coward V, Ramsay A, et al
    Vaccine-mediated protection of pigs against infection with pandemic H1N1 2009 swine influenza A virus requires a close antigenic match between the vaccine antigen and challenge virus.
    Vaccine. 2019 Mar 23. pii: S0264-410X(19)30316.
    PubMed     Abstract available


  975. WEDLOCK PT, Mitgang EA, Oron AP, Hagedorn BL, et al
    Modeling the economic impact of different vial-opening thresholds for measles-containing vaccines.
    Vaccine. 2019 Mar 23. pii: S0264-410X(19)30328.
    PubMed     Abstract available


  976. BEKELE Y, Lemma M, Bobosha K, Yibeltal D, et al
    Homing defects of B cells in HIV-1 infected children impair vaccination responses.
    Vaccine. 2019 Mar 23. pii: S0264-410X(19)30349.
    PubMed     Abstract available


  977. CHOUDHARY TS, Reddy NS, Apte A, Sinha B, et al
    Delayed vaccination and its predictors among children under 2years in India: Insights from the national family health survey-4.
    Vaccine. 2019 Mar 23. pii: S0264-410X(19)30371.
    PubMed     Abstract available


  978. TING-HUI-LIN, Chia MY, Lin CY, Yeh YQ, et al
    Improving immunogenicity of influenza virus H7N9 recombinant hemagglutinin for vaccine development.
    Vaccine. 2019;37:1897-1903.
    PubMed     Abstract available


  979. DE SOAREZ PC, Silva AB, Randi BA, Azevedo LM, et al
    Systematic review of health economic evaluation studies of dengue vaccines.
    Vaccine. 2019 Mar 22. pii: S0264-410X(19)30348.
    PubMed     Abstract available


  980. DRURY G, Jolliffe S, Mukhopadhyay TK
    Process mapping of vaccines: Understanding the limitations in current response to emerging epidemic threats.
    Vaccine. 2019 Mar 22. pii: S0264-410X(19)30126.
    PubMed     Abstract available


  981. RILEY TV, Lyras D, Douce GR
    Status of vaccine research and development for Clostridium difficile.
    Vaccine. 2019 Mar 19. pii: S0264-410X(19)30259.
    PubMed     Abstract available


  982. ERONDU NA, Ferland L, Haile BH, Abimbola T, et al
    A systematic review of vaccine preventable disease surveillance cost studies.
    Vaccine. 2019 Mar 19. pii: S0264-410X(19)30221.
    PubMed     Abstract available


  983. DUCLOS P, Martinez L, MacDonald N, Asturias E, et al
    Global vaccinology training: Report from an ADVAC workshop.
    Vaccine. 2019 Mar 18. pii: S0264-410X(19)30269.
    PubMed     Abstract available


  984. SELINGER C, Bershteyn A, Dimitrov DT, Adamson BJS, et al
    Targeting and vaccine durability are key for population-level impact and cost-effectiveness of a pox-protein HIV vaccine regimen in South Africa.
    Vaccine. 2019 Mar 16. pii: S0264-410X(19)30291.
    PubMed     Abstract available


  985. FRITZSCHE C, Bergmann L, Loebermann M, Glass A, et al
    Immune response to hepatitis A vaccine in patients with HIV.
    Vaccine. 2019 Mar 16. pii: S0264-410X(19)30271.
    PubMed     Abstract available


  986. QUIAMBAO BP, Ambas C, Diego S, Bosch Castells V, et al
    Intradermal post-exposure rabies vaccination with purified Vero cell rabies vaccine: Comparison of a one-week, 4-site regimen versus updated Thai Red Cross regimen in a randomized non-inferiority trial in the Philippines.
    Vaccine. 2019 Mar 16. pii: S0264-410X(19)30335.
    PubMed     Abstract available


  987. ZERVA I, Katsoni E, Simitzi C, Stratakis E, et al
    Laser micro-structured Si scaffold-implantable vaccines against Salmonella Typhimurium.
    Vaccine. 2019 Mar 15. pii: S0264-410X(19)30318.
    PubMed     Abstract available


  988. CRIADO MF, Bertran K, Lee DH, Killmaster L, et al
    Efficacy of novel recombinant fowlpox vaccine against recent Mexican H7N3 highly pathogenic avian influenza virus.
    Vaccine. 2019 Mar 15. pii: S0264-410X(19)30314.
    PubMed     Abstract available


  989. NORMAN DA, Danchin M, Van Buynder P, Moore HC, et al
    Caregiver's attitudes, beliefs, and experiences for influenza vaccination in Australian children with medical comorbidities.
    Vaccine. 2019 Mar 15. pii: S0264-410X(19)30315.
    PubMed     Abstract available


  990. SCHAFFER SJ, Rand CM, Humiston SG, Concannon C, et al
    Practical considerations in developing a successful school-located influenza vaccination (SLIV) program.
    Vaccine. 2019 Mar 13. pii: S0264-410X(19)30290.
    PubMed    


  991. KASEREKA MC, Sawatzky J, Hawkes MT
    Ebola epidemic in war-torn Democratic Republic of Congo, 2018: Acceptability and patient satisfaction of the recombinant Vesicular Stomatitis Virus - Zaire Ebolavirus Vaccine.
    Vaccine. 2019 Mar 13. pii: S0264-410X(19)30304.
    PubMed     Abstract available


  992. BRUNELLI L, Romanese F, Benetollo PP, Iob A, et al
    Management of reduced vaccine coverage due to 6years of failure to vaccinate: The Codroipo case, Italy.
    Vaccine. 2019 Mar 13. pii: S0264-410X(19)30179.
    PubMed     Abstract available


  993. CHEN T, Zhou X, Qi Y, Mi L, et al
    Feline herpesvirus vectored-rabies vaccine in cats: A dual protection.
    Vaccine. 2019 Mar 13. pii: S0264-410X(19)30310.
    PubMed     Abstract available


  994. LAYTON JB, Butler AM, Brookhart MA, Panozzo CA, et al
    Variation in rotavirus vaccination coding in state US medicaid data.
    Vaccine. 2019 Mar 12. pii: S0264-410X(19)30311.
    PubMed     Abstract available


  995. MERCALDO RA, Bellan SE
    Evaluation of alternative endpoints for ZIKV vaccine efficacy trials.
    Vaccine. 2019 Mar 11. pii: S0264-410X(19)30273.
    PubMed     Abstract available


  996. THORRINGTON D, van Leeuwen E, Ramsay M, Pebody R, et al
    Assessing optimal use of the standard dose adjuvanted trivalent seasonal influenza vaccine in the elderly.
    Vaccine. 2019 Mar 11. pii: S0264-410X(19)30293.
    PubMed     Abstract available


  997. JACOBS AAC, Harks F, Hazenberg L, Hoeijmakers MJH, et al
    Efficacy of a novel inactivated Lawsonia intracellularis vaccine in pigs against experimental infection and under field conditions.
    Vaccine. 2019 Mar 11. pii: S0264-410X(19)30274.
    PubMed     Abstract available


  998. YIANNAKOULIAS N, Slavik C, Chase M
    Expressions of pro- and anti-vaccine sentiment on YouTube.
    Vaccine. 2019 Mar 9. pii: S0264-410X(19)30292.
    PubMed     Abstract available


  999. ABAASA A, Nash S, Mayanja Y, Price M, et al
    Simulated vaccine efficacy trials to estimate HIV incidence for actual vaccine clinical trials in key populations in Uganda.
    Vaccine. 2019 Mar 8. pii: S0264-410X(19)30289.
    PubMed     Abstract available


  1000. SEKIYA T, Mifsud EJ, Ohno M, Nomura N, et al
    Inactivated whole virus particle vaccine with potent immunogenicity and limited IL-6 induction is ideal for influenza.
    Vaccine. 2019 Mar 8. pii: S0264-410X(19)30264.
    PubMed     Abstract available


  1001. VERELST F, Kessels R, Delva W, Beutels P, et al
    Drivers of vaccine decision-making in South Africa: A discrete choice experiment.
    Vaccine. 2019 Mar 8. pii: S0264-410X(19)30263.
    PubMed     Abstract available


  1002. MCCARTY JM, Lock MD, Bennett S, Hunt KM, et al
    Age-related immunogenicity and reactogenicity of live oral cholera vaccine CVD 103-HgR in a randomized, controlled clinical trial.
    Vaccine. 2019;37:1389-1397.
    PubMed     Abstract available


  1003. FOTSO KAMDEM A, Vidal C, Pazart L, Leroux F, et al
    A case-control study of risk factors for intussusception among infants in eastern France after the introduction of the rotavirus vaccine.
    Vaccine. 2019 Mar 7. pii: S0264-410X(19)30260.
    PubMed     Abstract available


  1004. ZHAN Y, Deng Y, Huang B, Song Q, et al
    Humoral and cellular immunity against both ZIKV and poxvirus is elicited by a two-dose regimen using DNA and non-replicating vaccinia virus-based vaccine candidates.
    Vaccine. 2019 Mar 6. pii: S0264-410X(19)30270.
    PubMed     Abstract available


  1005. MOUCHET J, Begaud B
    Hepatitis B vaccination and central demyelination - History, description and observed/expected analyses of 624 cases reported to the French pharmacovigilance over a 20-year period.
    Vaccine. 2019 Mar 6. pii: S0264-410X(19)30253.
    PubMed     Abstract available


  1006. BURNY W, Marchant A, Herve C, Callegaro A, et al
    Inflammatory parameters associated with systemic reactogenicity following vaccination with adjuvanted hepatitis B vaccines in humans.
    Vaccine. 2019 Mar 5. pii: S0264-410X(19)30209.
    PubMed     Abstract available


  1007. PAN SC, Hsieh SM, Lin CF, Hsu YS, et al
    A randomized, double-blind, controlled clinical trial to evaluate the safety and immunogenicity of an intranasally administered trivalent inactivated influenza vaccine with adjuvant LTh(alphaK): A phase I study.
    Vaccine. 2019 Mar 2. pii: S0264-410X(19)30189.
    PubMed     Abstract available


  1008. AINSLIE KEC, Haber M, Orenstein WA
    Bias of influenza vaccine effectiveness estimates from test-negative studies conducted during an influenza pandemic.
    Vaccine. 2019 Mar 1. pii: S0264-410X(19)30241.
    PubMed     Abstract available


    February 2019
  1009. KLEIN NP, Goddard K, Lewis E, Ross P, et al
    Long term risk of developing type 1 diabetes after HPV vaccination in males and females.
    Vaccine. 2019 Feb 28. pii: S0264-410X(19)30258.
    PubMed     Abstract available


  1010. SATOH H, Tanaka-Taya K, Shimizu H, Goto A, et al
    Polio vaccination coverage and seroprevalence of poliovirus antibodies after the introduction of inactivated poliovirus vaccines for routine immunization in Japan.
    Vaccine. 2019 Feb 28. pii: S0264-410X(19)30229.
    PubMed     Abstract available


  1011. GIDUTHURI JG, Purohit V, Maire N, Kudale A, et al
    Influenza vaccination of pregnant women: Engaging clinicians to reduce missed opportunities for vaccination.
    Vaccine. 2019 Feb 28. pii: S0264-410X(19)30240.
    PubMed     Abstract available


  1012. ZHANG D, Zhang Y, Wang Q, Lock J, et al
    The effectiveness of influenza vaccination in preventing hospitalizations in elderly in Beijing, 2016-18.
    Vaccine. 2019 Feb 28. pii: S0264-410X(19)30207.
    PubMed     Abstract available


  1013. ROSSO A, Massimi A, De Vito C, Adamo G, et al
    Knowledge and attitudes on pediatric vaccinations and intention to vaccinate in a sample of pregnant women from the City of Rome.
    Vaccine. 2019 Feb 28. pii: S0264-410X(19)30256.
    PubMed     Abstract available


  1014. ZHOU F, Xu J, Black CL, Ding H, et al
    Trends in Tdap vaccination among privately insured pregnant women in the United States, 2009-2016.
    Vaccine. 2019 Feb 27. pii: S0264-410X(19)30249.
    PubMed     Abstract available


  1015. PORTH JM, Wagner AL, Teklie H, Abeje Y, et al
    Vaccine non-receipt and refusal in Ethiopia: The expanded program on immunization coverage survey, 2012.
    Vaccine. 2019 Feb 27. pii: S0264-410X(19)30252.
    PubMed     Abstract available


  1016. MEYER SB, Violette R, Aggarwal R, Simeoni M, et al
    Vaccine hesitancy and Web 2.0: Exploring how attitudes and beliefs about influenza vaccination are exchanged in online threaded user comments.
    Vaccine. 2019 Feb 27. pii: S0264-410X(19)30223.
    PubMed     Abstract available


  1017. ZEPEDA-CERVANTES J, Cruz-Resendiz A, Sampieri A, Carreon-Napoles R, et al
    Incorporation of ORF2 from Porcine Circovirus Type 2(PCV2) into genetically encoded nanoparticles as a novel vaccine using a self-aggregating peptide.
    Vaccine. 2019 Feb 26. pii: S0264-410X(19)30251.
    PubMed     Abstract available


  1018. NDAWULA C JR, Sabadin GA, Parizi LF, da Silva Vaz I Jr, et al
    Constituting a glutathione S-transferase-cocktail vaccine against tick infestation.
    Vaccine. 2019 Feb 26. pii: S0264-410X(19)30246.
    PubMed     Abstract available


  1019. WALKER EJ, MacDonald NE, Islam N, Le Saux N, et al
    Completeness and timeliness of diphtheria-tetanus-pertussis, measles-mumps-rubella, and polio vaccines in young children with chronic health conditions: A systematic review.
    Vaccine. 2019 Feb 25. pii: S0264-410X(19)30226.
    PubMed     Abstract available


  1020. LEFEVRE H, Samain S, Ibrahim N, Fourmaux C, et al
    HPV vaccination and sexual health in France: Empowering girls to decide.
    Vaccine. 2019 Feb 23. pii: S0264-410X(19)30215.
    PubMed     Abstract available


  1021. MO Z, Ma X, Luo P, Mo Y, et al
    Immunogenicity of pentavalent rotavirus vaccine in Chinese infants.
    Vaccine. 2019 Feb 23. pii: S0264-410X(19)30213.
    PubMed     Abstract available


  1022. DOLAN SB, Carnahan E, Shearer JC, Beylerian EN, et al
    Redefining vaccination coverage and timeliness measures using electronic immunization registry data in low- and middle-income countries.
    Vaccine. 2019 Feb 23. pii: S0264-410X(19)30212.
    PubMed     Abstract available


  1023. MUNYAKA PM, Kommadath A, Fouhse J, Wilkinson J, et al
    Characterization of whole blood transcriptome and early-life fecal microbiota in high and low responder pigs before, and after vaccination for Mycoplasma hyopneumoniae.
    Vaccine. 2019 Feb 23. pii: S0264-410X(19)30211.
    PubMed     Abstract available


  1024. HUANG LM, Chiu CH, Chiu NC, Lin CY, et al
    Immunogenicity, safety, cross-reaction, and immune persistence of an inactivated enterovirus A71 vaccine in children aged from two months to 11 years in Taiwan.
    Vaccine. 2019 Feb 22. pii: S0264-410X(19)30218.
    PubMed     Abstract available


  1025. KROGSGAARD LW, Bech BH, Plana-Ripoll O, Thomsen RW, et al
    Hospital contacts and diagnoses five years prior to HPV vaccination among females referred for suspected adverse vaccine effects: A Danish nationwide case-control study.
    Vaccine. 2019 Feb 22. pii: S0264-410X(19)30224.
    PubMed     Abstract available


  1026. GETAHUN D, Fassett MJ, Peltier MR, Takhar HS, et al
    Association between seasonal influenza vaccination with pre- and postnatal outcomes.
    Vaccine. 2019 Feb 21. pii: S0264-410X(19)30214.
    PubMed     Abstract available


  1027. PERDRIZET JA, Shiau DS, Xie H
    The serological response in dogs inoculated with canine distemper virus vaccine at the acupuncture point governing vessel-14: A randomized controlled trial.
    Vaccine. 2019 Feb 21. pii: S0264-410X(18)31463.
    PubMed     Abstract available


  1028. DOENER F, Hong HS, Meyer I, Tadjalli-Mehr K, et al
    RNA-based adjuvant CV8102 enhances the immunogenicity of a licensed rabies vaccine in a first-in-human trial.
    Vaccine. 2019 Feb 21. pii: S0264-410X(19)30219.
    PubMed     Abstract available


  1029. KENNEDY RB, Ovsyannikova IG, Thomas A, Larrabee BR, et al
    Differential durability of immune responses to measles and mumps following MMR vaccination.
    Vaccine. 2019 Feb 20. pii: S0264-410X(19)30225.
    PubMed     Abstract available


  1030. MIKAMO H, Yamagishi Y, Murata S, Yokokawa R, et al
    Efficacy, safety, and immunogenicity of a quadrivalent HPV vaccine in Japanese men: A randomized, Phase 3, placebo-controlled study.
    Vaccine. 2019 Feb 20. pii: S0264-410X(19)30154.
    PubMed     Abstract available


  1031. WANG Z, Li Z, Su X, Qiao Y, et al
    Enhanced cross-lineage protection induced by recombinant H9N2 avian influenza virus inactivated vaccine.
    Vaccine. 2019 Feb 20. pii: S0264-410X(19)30206.
    PubMed     Abstract available


  1032. HAPPE M, Samuvel DJ, Ohtola JA, Korte JE, et al
    Race-related differences in functional antibody response to pneumococcal vaccination in HIV-infected individuals.
    Vaccine. 2019 Feb 20. pii: S0264-410X(19)30182.
    PubMed     Abstract available


  1033. PARVEEN N, Fernandez MC, Haynes AM, Zhang RL, et al
    Non-pathogenic Borrelia burgdorferi expressing Treponema pallidum TprK and Tp0435 antigens as a novel approach to evaluate syphilis vaccine candidates.
    Vaccine. 2019 Feb 20. pii: S0264-410X(19)30217.
    PubMed     Abstract available


  1034. HARRO C, Louis Bourgeois A, Sack D, Walker R, et al
    Live attenuated enterotoxigenic Escherichia coli (ETEC) vaccine with dmLT adjuvant protects human volunteers against virulent experimental ETEC challenge.
    Vaccine. 2019 Feb 20. pii: S0264-410X(19)30220.
    PubMed     Abstract available


  1035. WATESKA AR, Nowalk MP, Lin CJ, Harrison LH, et al
    Cost-effectiveness of adult pneumococcal vaccination policies in underserved minorities aged 50-64years compared to the US general population.
    Vaccine. 2019 Feb 20. pii: S0264-410X(19)30012.
    PubMed     Abstract available


  1036. ABUBAKAR A, Melhem N, Malik M, Dbaibo G, et al
    Seasonal influenza vaccination policies in the Eastern Mediterranean Region: Current status and the way forward.
    Vaccine. 2019 Feb 19. pii: S0264-410X(19)30163.
    PubMed     Abstract available


  1037. ILES RA, Gatumu H, Kagundu S, Draheim C, et al
    Information sharing and willingness-to-pay for CBPP vaccine in rural Kenya.
    Vaccine. 2019 Feb 16. pii: S0264-410X(19)30157.
    PubMed     Abstract available


  1038. TAKASHIMA M, Lambert SB, Paynter S, Ware RS, et al
    Relative effectiveness of revaccination with 23-valent pneumococcal polysaccharide vaccine in preventing invasive pneumococcal disease in adult Aboriginal and Torres Strait Islander people, Australia.
    Vaccine. 2019 Feb 16. pii: S0264-410X(19)30183.
    PubMed     Abstract available


  1039. DUROUS L, Julien T, Padey B, Traversier A, et al
    SPRi-based hemagglutinin quantitative assay for influenza vaccine production monitoring.
    Vaccine. 2019 Feb 14. pii: S0264-410X(19)30181.
    PubMed     Abstract available


  1040. BOUMART Z, Daouam S, Bamouh Z, Jazouli M, et al
    Safety and immunogenicity of a live attenuated Rift Valley Fever recombinant arMP-12DeltaNSm21/384 vaccine candidate for sheep, goats and calves.
    Vaccine. 2019 Feb 14. pii: S0264-410X(19)30152.
    PubMed     Abstract available


  1041. ENCHERY F, Hamers C, Kwiatek O, Gaillardet D, et al
    Development of a PPRV challenge model in goats and its use to assess the efficacy of a PPR vaccine.
    Vaccine. 2019 Feb 13. pii: S0264-410X(19)30133.
    PubMed     Abstract available


  1042. FITZWATER SP, Ramachandran P, Kahn GD, Nedunchelian K, et al
    Impact of the introduction of the Haemophilus influenzae type b conjugate vaccine in an urban setting in southern India.
    Vaccine. 2019 Feb 13. pii: S0264-410X(19)30166.
    PubMed     Abstract available


  1043. ZEIGLER DF, Roque R, Clegg CH
    Optimization of a multivalent peptide vaccine for nicotine addiction.
    Vaccine. 2019 Feb 13. pii: S0264-410X(19)30180.
    PubMed     Abstract available


  1044. RAMSAY LC, Anyiwe K, Li M, Macdonald L, et al
    Economic evaluation of a publicly funded hepatitis A travel vaccination program in Ontario, Canada.
    Vaccine. 2019 Feb 12. pii: S0264-410X(19)30155.
    PubMed     Abstract available


  1045. HAMLET A, Jean K, Yactayo S, Benzler J, et al
    POLICI: A web application for visualising and extracting yellow fever vaccination coverage in Africa.
    Vaccine. 2019 Feb 12. pii: S0264-410X(19)30159.
    PubMed     Abstract available


  1046. ZHANG T, Cui L, Geng X, Yu X, et al
    Epidemiology study of pediatric primary intussusception aged </=24months in pre-rotavirus vaccine era of Jinan, China.
    Vaccine. 2019 Feb 12. pii: S0264-410X(19)30145.
    PubMed     Abstract available


  1047. SHARP A, Coles S, Pegorie M, Harwood C, et al
    Vaccination strategies for control of community outbreaks of hepatitis A: A comparison of two outbreaks in England.
    Vaccine. 2019 Feb 12. pii: S0264-410X(19)30089.
    PubMed     Abstract available


  1048. ZENG Y, Yuan Z, Yin J, Han Y, et al
    Factors affecting parental intention to vaccinate kindergarten children against influenza: A cross-sectional survey in China.
    Vaccine. 2019 Feb 12. pii: S0264-410X(19)30156.
    PubMed     Abstract available


  1049. AHMED MC, Heukelbach J, Weddih A, Filali-Maltouf A, et al
    Reduction of hospitalizations with diarrhea among children aged 0-5years in Nouakchott, Mauritania, following the introduction of rotavirus vaccine.
    Vaccine. 2019 Feb 11. pii: S0264-410X(19)30164.
    PubMed     Abstract available


  1050. HERRERA-RODRIGUEZ J, Signorazzi A, Holtrop M, de Vries-Idema J, et al
    Inactivated or damaged? Comparing the effect of inactivation methods on influenza virions to optimize vaccine production.
    Vaccine. 2019 Feb 11. pii: S0264-410X(19)30184.
    PubMed     Abstract available


  1051. JALLOH MF, Jalloh MB, Albert A, Wolff B, et al
    Perceptions and acceptability of an experimental Ebola vaccine among health care workers, frontline staff, and the general public during the 2014-2015 Ebola outbreak in Sierra Leone.
    Vaccine. 2019 Feb 9. pii: S0264-410X(19)30122.
    PubMed     Abstract available


  1052. ZUK P, Zuk P, Lisiewicz-Jakubaszko J
    The anti-vaccine movement in Poland: The socio-cultural conditions of the opposition to vaccination and threats to public health.
    Vaccine. 2019 Feb 9. pii: S0264-410X(19)30158.
    PubMed     Abstract available


  1053. PEPIN S, Samson SI, Alvarez FP, Dupuy M, et al
    Impact of a quadrivalent inactivated influenza vaccine on influenza-associated complications and health care use in children aged 6 to 35months: Analysis of data from a phase III trial in the Northern and Southern Hemispheres.
    Vaccine. 2019 Feb 8. pii: S0264-410X(19)30144.
    PubMed     Abstract available


  1054. YOUNG-XU Y, Snider JT, van Aalst R, Mahmud SM, et al
    Analysis of relative effectiveness of high-dose versus standard-dose influenza vaccines using an instrumental variable method.
    Vaccine. 2019 Feb 8. pii: S0264-410X(19)30148.
    PubMed     Abstract available


  1055. WASAN EK, Syeda J, Strom S, Cawthray J, et al
    A lipidic delivery system of a triple vaccine adjuvant enhances mucosal immunity following nasal administration in mice.
    Vaccine. 2019 Feb 7. pii: S0264-410X(19)30134.
    PubMed     Abstract available


  1056. HABER P, Moro PL, Ng C, Dores GM, et al
    Post-licensure surveillance of trivalent adjuvanted influenza vaccine (aIIV3; Fluad), Vaccine Adverse Event Reporting System (VAERS), United States, July 2016-June 2018.
    Vaccine. 2019 Feb 7. pii: S0264-410X(19)30128.
    PubMed     Abstract available


  1057. HARAPAN H, Mudatsir M, Yufika A, Nawawi Y, et al
    Community acceptance and willingness-to-pay for a hypothetical Zika vaccine: A cross-sectional study in Indonesia.
    Vaccine. 2019 Feb 7. pii: S0264-410X(19)30147.
    PubMed     Abstract available


  1058. DOORNEKAMP L, de Jong W, Wagener MN, Goeijenbier M, et al
    Dutch healthcare professionals' opinion on vaccination and education to prevent infections in immunocompromised patients: A mixed-method study with recommendations for daily practice.
    Vaccine. 2019 Feb 7. pii: S0264-410X(19)30160.
    PubMed     Abstract available


  1059. FORTANIER AC, Venekamp RP, Hoes AW, Schilder AGM, et al
    Does pneumococcal conjugate vaccination affect onset and risk of first acute otitis media and recurrences? A primary care-based cohort study.
    Vaccine. 2019 Feb 6. pii: S0264-410X(19)30149.
    PubMed     Abstract available


  1060. SHEN AK, Groom AV, Leach DL, Bridges CB, et al
    A pathway to developing and testing quality measures aimed at improving adult vaccination rates in the United States.
    Vaccine. 2019 Feb 6. pii: S0264-410X(19)30120.
    PubMed     Abstract available


  1061. BORGEY F, Henry L, Lebeltel J, Lescure P, et al
    Effectiveness of an intervention campaign on influenza vaccination of professionals in nursing homes: A cluster-randomized controlled trial.
    Vaccine. 2019 Feb 6. pii: S0264-410X(19)30151.
    PubMed     Abstract available


  1062. KESSELS J, Tarantola A, Salahuddin N, Blumberg L, et al
    Rabies post-exposure prophylaxis: A systematic review on abridged vaccination schedules and the effect of changing administration routes during a single course.
    Vaccine. 2019 Feb 5. pii: S0264-410X(19)30105.
    PubMed     Abstract available


  1063. RANDALL H, Kallen LE
    Using advocacy to increase investment in enteric vaccine development.
    Vaccine. 2019 Feb 5. pii: S0264-410X(18)31706.
    PubMed     Abstract available


  1064. PARKER AR, Park MA, Harding S, Abraham RS, et al
    The total IgM, IgA and IgG antibody responses to pneumococcal polysaccharide vaccination (Pneumovax(R)23) in a healthy adult population and patients diagnosed with primary immunodeficiencies.
    Vaccine. 2019 Feb 5. pii: S0264-410X(19)30098.
    PubMed     Abstract available


  1065. ROY S, Jaeson MI, Li Z, Mahboob S, et al
    Viral vector and route of administration determine the ILC and DC profiles responsible for downstream vaccine-specific immune outcomes.
    Vaccine. 2019 Feb 4. pii: S0264-410X(19)30121.
    PubMed     Abstract available


  1066. STASI C, Monnini M, Cellesi V, Salvadori M, et al
    Screening for hepatitis B virus and accelerated vaccination schedule in prison: A pilot multicenter study.
    Vaccine. 2019 Feb 4. pii: S0264-410X(19)30125.
    PubMed     Abstract available


  1067. SHEIKH S, Biundo E, Courcier S, Damm O, et al
    Corrigendum to 'A report on the status of vaccination in Europe' [Vaccine 36 (2018) 4979-4992].
    Vaccine. 2019 Feb 4. pii: S0264-410X(19)30102.
    PubMed    


  1068. NOLAN MB, Schulman ML, Botha AE, Human AM, et al
    Serum antibody immunoreactivity and safety of native porcine and recombinant zona pellucida vaccines formulated with a non-Freund's adjuvant in horses.
    Vaccine. 2019 Feb 4. pii: S0264-410X(19)30129.
    PubMed     Abstract available


  1069. DEMPSEY AF, Pyrzanowski J, Campagna EJ, Lockhart S, et al
    Parent report of provider HPV vaccine communication strategies used during a randomized, controlled trial of a provider communication intervention.
    Vaccine. 2019 Feb 4. pii: S0264-410X(19)30127.
    PubMed     Abstract available


  1070. RAO S, Alishahi M, De Crescenzo L, Dempsey AF, et al
    A population-based study of maternal and infant factors influencing influenza vaccination among young children born in Colorado from 2008 to 2016.
    Vaccine. 2019 Feb 2. pii: S0264-410X(19)30130.
    PubMed     Abstract available


  1071. ABENTE EJ, Rajao DS, Gauger PC, Vincent AL, et al
    Alphavirus-vectored hemagglutinin subunit vaccine provides partial protection against heterologous challenge in pigs.
    Vaccine. 2019 Feb 2. pii: S0264-410X(19)30052.
    PubMed     Abstract available


  1072. TRAN CH, Afriyie DO, Pham TN, Otsu S, et al
    Rabies post-exposure prophylaxis initiation and adherence among patients in Vietnam, 2014-2016.
    Vaccine. 2019 Feb 2. pii: S0264-410X(19)30093.
    PubMed     Abstract available


  1073. BEARSON SMD, Bearson BL, Sylte MJ, Looft T, et al
    Cross-protective Salmonella vaccine reduces cecal and splenic colonization of multidrug-resistant Salmonella enterica serovar Heidelberg.
    Vaccine. 2019 Feb 1. pii: S0264-410X(19)30027.
    PubMed     Abstract available


    January 2019
  1074. KIM T, Hong JK, Oem JK, Lee KN, et al
    Cross-protective efficacy of the O1 Manisa+O 3039 bivalent vaccine and the O 3039 monovalent vaccine against heterologous challenge with FMDV O/Jincheon/SKR/2014 in pig.
    Vaccine. 2019 Jan 31. pii: S0264-410X(18)31644.
    PubMed     Abstract available


  1075. MONTESINO R, Gutierrez N, Camacho F, Farnos O, et al
    Multi-antigenic recombinant subunit vaccine against Lawsonia intracellularis: The etiological agent of porcine proliferative enteropathy.
    Vaccine. 2019 Jan 30. pii: S0264-410X(19)30092.
    PubMed     Abstract available


  1076. MARECHAL C, Lal H, Poder A, Ferguson M, et al
    Corrigendum to 'Immunogenicity and safety of the adjuvanted recombinant zoster vaccine co-administered with the 23-valent pneumococcal polysaccharide vaccine in adults >/=50years of age: A randomized trial' [Vaccine 36 (2018) 4278-4286].
    Vaccine. 2019 Jan 30. pii: S0264-410X(19)30076.
    PubMed    


  1077. BORRAS E, Urbiztondo L, Carmona G, Jane M, et al
    Effectiveness and impact of the hepatitis B vaccination program in preadolescents in Catalonia 21 years after its introduction.
    Vaccine. 2019 Jan 29. pii: S0264-410X(19)30078.
    PubMed     Abstract available


  1078. XU S, Newcomer SR, Kulldorff M, Daley MF, et al
    Use of three summary measures of pediatric vaccination for studying the safety of the childhood immunization schedule.
    Vaccine. 2019 Jan 29. pii: S0264-410X(19)30104.
    PubMed     Abstract available


  1079. MOTTRAM L, Chakraborty S, Cox E, Fleckenstein J, et al
    How genomics can be used to understand host susceptibility to enteric infection, aiding in the development of vaccines and immunotherapeutic interventions.
    Vaccine. 2019 Jan 29. pii: S0264-410X(19)30069.
    PubMed     Abstract available


  1080. SHAPIRO JR, Hodgins B, Hendin HE, Patel A, et al
    Needle-free delivery of influenza vaccine using the Med-Jet(R) H4 is efficient and elicits the same humoral and cellular responses as standard IM injection: A randomized trial.
    Vaccine. 2019 Jan 29. pii: S0264-410X(19)30103.
    PubMed     Abstract available


  1081. PADMANABHA N, Kini JR, Alwani AA, Sardesai A, et al
    Acceptability of human papillomavirus vaccination among medical students in Mangalore, India.
    Vaccine. 2019 Jan 29. pii: S0264-410X(19)30095.
    PubMed     Abstract available


  1082. QUINN SC, Jamison AM, An J, Hancock GR, et al
    Measuring vaccine hesitancy, confidence, trust and flu vaccine uptake: Results of a national survey of White and African American adults.
    Vaccine. 2019 Jan 29. pii: S0264-410X(19)30096.
    PubMed     Abstract available


  1083. AMADOR-MOLINA A, Trejo-Moreno C, Romero-Rodriguez D, Sada-Ovalle I, et al
    Vaccination with human papillomavirus-18 E1 protein plus alpha-galactosyl-ceramide induces CD8(+) cytotoxic response and impairs the growth of E1-expressing tumors.
    Vaccine. 2019 Jan 28. pii: S0264-410X(18)31709.
    PubMed     Abstract available


  1084. ADDISON M, Lazzaro T, Crawford N
    Injection site abscess (ISA) following an infant vaccine.
    Vaccine. 2019 Jan 28. pii: S0264-410X(19)30079.
    PubMed    


  1085. SURYADEVARA M, Bonville CA, Cibula DA, Domachowske JB, et al
    Associations between population based voting trends during the 2016 US presidential election and adolescent vaccination rates.
    Vaccine. 2019 Jan 25. pii: S0264-410X(19)30099.
    PubMed     Abstract available


  1086. WARRELL MJ
    Rabies post-exposure vaccination in 2 visits within a week: A 4-site intradermal regimen.
    Vaccine. 2019 Jan 25. pii: S0264-410X(19)30073.
    PubMed     Abstract available


  1087. GHORBANI A, Ngunjiri JM, Xia M, Elaish M, et al
    Heterosubtypic protection against avian influenza virus by live attenuated and chimeric norovirus P-particle-M2e vaccines in chickens.
    Vaccine. 2019 Jan 25. pii: S0264-410X(19)30100.
    PubMed     Abstract available


  1088. NOLAN T, Santolaya ME, de Looze F, Marshall H, et al
    Antibody persistence and booster response in adolescents and young adults 4 and 7.5 years after immunization with 4CMenB vaccine.
    Vaccine. 2019 Jan 25. pii: S0264-410X(19)30028.
    PubMed     Abstract available


  1089. GARON J, Wuddhika IV, Sreenivasan N, Wannemuehler K, et al
    Community-based household assessment of human papillomavirus (HPV) vaccination coverage and acceptability - HPV vaccine demonstration program, Cambodia - 2017.
    Vaccine. 2019 Jan 24. pii: S0264-410X(19)30008.
    PubMed     Abstract available


  1090. WILDES TJ, Grippin A, Fasanya H, Dyson KA, et al
    Effect of atorvastatin on humoral immune response to 23-valent pneumococcal polysaccharide vaccination in healthy volunteers: The StatVax randomized clinical trial.
    Vaccine. 2019 Jan 24. pii: S0264-410X(19)30077.
    PubMed     Abstract available


  1091. SMITHSON MW, Basinki AJ, Nuismer SL, Bull JJ, et al
    Transmissible vaccines whose dissemination rates vary through time, with applications to wildlife.
    Vaccine. 2019 Jan 24. pii: S0264-410X(19)30072.
    PubMed     Abstract available


  1092. VADLAMUDI NK, Parhar K, Altre Malana KL, Kang A, et al
    Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine compared to 23-valent pneumococcal polysaccharide in immunocompetent adults: A systematic review and meta-analysis.
    Vaccine. 2019 Jan 23. pii: S0264-410X(19)30057.
    PubMed     Abstract available


  1093. COELHO CH, Gazzinelli-Guimaraes PH, Howard J, Barnafo E, et al
    Chronic helminth infection does not impair immune response to malaria transmission blocking vaccine Pfs230D1-EPA/Alhydrogel(R) in mice.
    Vaccine. 2019 Jan 23. pii: S0264-410X(19)30090.
    PubMed     Abstract available


  1094. SAHIN Z, Neeleman R, Haines J, Kayser V, et al
    Preparation-free method can enable rapid surfactant screening during industrial processing of influenza vaccines.
    Vaccine. 2019 Jan 23. pii: S0264-410X(19)30050.
    PubMed     Abstract available


  1095. MILUCKY J, Carvalho MG, Rouphael N, Bennett NM, et al
    Streptococcus pneumoniae colonization after introduction of 13-valent pneumococcal conjugate vaccine for US adults 65 years of age and older, 2015-2016.
    Vaccine. 2019 Jan 23. pii: S0264-410X(19)30070.
    PubMed     Abstract available


  1096. JENDROSSEK M, Edmunds WJ, Rohan H, Clifford S, et al
    Health care worker vaccination against Ebola: Vaccine acceptance and employment duration in Sierra Leone.
    Vaccine. 2019 Jan 23. pii: S0264-410X(19)30029.
    PubMed     Abstract available


  1097. LYONS NA, Knight-Jones TJD, Bartels C, Paton DJ, et al
    Considerations for design and implementation of vaccine field trials for novel foot-and-mouth disease vaccines.
    Vaccine. 2019 Jan 23. pii: S0264-410X(19)30043.
    PubMed     Abstract available


  1098. LU J, Luo M, Yee AZH, Sheldenkar A, et al
    Do superstitious beliefs affect influenza vaccine uptake through shaping health beliefs?
    Vaccine. 2019 Jan 22. pii: S0264-410X(19)30071.
    PubMed     Abstract available


  1099. TORISU H, Okada K
    Vaccination-associated acute disseminated encephalomyelitis.
    Vaccine. 2019 Jan 22. pii: S0264-410X(19)30075.
    PubMed     Abstract available


  1100. SHEN AK, Warnock R, Selna W, MaCurdy TE, et al
    Vaccination among Medicare-fee-for service beneficiaries: Characteristics and predictors of vaccine receipt, 2014-2017.
    Vaccine. 2019 Jan 22. pii: S0264-410X(19)30041.
    PubMed     Abstract available


  1101. WEDLOCK PT, Mitgang EA, Haidari LA, Prosser W, et al
    The value of tailoring vial sizes to populations and locations.
    Vaccine. 2019;37:637-644.
    PubMed     Abstract available


  1102. BERNSTEIN DI, Pasetti MF, Brady R, Buskirk AD, et al
    A Phase 1 dose escalating study of double mutant heat-labile toxin LTR192G/L211A (dmLT) from Enterotoxigenic Escherichia coli (ETEC) by sublingual or oral immunization.
    Vaccine. 2019;37:602-611.
    PubMed     Abstract available


  1103. ZHANG D, Jiang N, Chen Q
    Vaccination with recombinant adenoviruses expressing Toxoplasma gondii MIC3, ROP9, and SAG2 provide protective immunity against acute toxoplasmosis in mice.
    Vaccine. 2019 Jan 19. pii: S0264-410X(18)31729.
    PubMed     Abstract available


  1104. ROBERTSON CA, Hedrick J, Bassily E, Greenberg DP, et al
    Persistence of bactericidal antibodies 4years after a booster dose of quadrivalent meningococcal diphtheria toxoid conjugate vaccine (MenACWY-D).
    Vaccine. 2019 Jan 19. pii: S0264-410X(19)30039.
    PubMed     Abstract available


  1105. LEDOV VA, Golovina ME, Markina AA, Knirel YA, et al
    Highly homogenous tri-acylated S-LPS acts as a novel clinically applicable vaccine against Shigella flexneri 2a infection.
    Vaccine. 2019 Jan 19. pii: S0264-410X(19)30048.
    PubMed     Abstract available


  1106. WOUTERS I, Desmet S, Van Heirstraeten L, Blaizot S, et al
    Follow-up of serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae in child carriage after a PCV13-to-PCV10 vaccine switch in Belgium.
    Vaccine. 2019 Jan 19. pii: S0264-410X(19)30049.
    PubMed     Abstract available


  1107. WOODS CW, Sanchez AM, Swamy GK, McClain MT, et al
    An observer blinded, randomized, placebo-controlled, phase I dose escalation trial to evaluate the safety and immunogenicity of an inactivated West Nile virus Vaccine, HydroVax-001, in healthy adults.
    Vaccine. 2019 Jan 18. pii: S0264-410X(18)31699.
    PubMed     Abstract available


  1108. MARLOW R, Finn A, Rodrigues F
    Lack of impact of rotavirus vaccination on childhood seizure hospital attendances in Portugal - An interrupted time series analysis.
    Vaccine. 2019 Jan 17. pii: S0264-410X(19)30055.
    PubMed    


  1109. YUNG BS, Pugh H, Generotti AA, Phanhthilath N, et al
    Novel IFN-gamma ELISpot reveals robust T cell responses elicited after influenza nucleoprotein DNA vaccination in New Zealand White rabbits.
    Vaccine. 2019 Jan 17. pii: S0264-410X(19)30037.
    PubMed     Abstract available


  1110. KOLE S, Qadiri SSN, Shin SM, Kim WS, et al
    PLGA encapsulated inactivated-viral vaccine: Formulation and evaluation of its protective efficacy against viral haemorrhagic septicaemia virus (VHSV) infection in olive flounder (Paralichthys olivaceus) vaccinated by mucosal delivery routes.
    Vaccine. 2019 Jan 17. pii: S0264-410X(19)30042.
    PubMed     Abstract available


  1111. LALSIAMTHARA J, Senevirathne A, Lee JH
    Partial protection induced by Salmonella based Brucella vaccine candidate in pregnant guinea pigs.
    Vaccine. 2019 Jan 17. pii: S0264-410X(19)30074.
    PubMed     Abstract available


  1112. STRIJBOS E, Tannemaat MR, Alleman I, de Meel RHP, et al
    A prospective, double-blind, randomized, placebo-controlled study on the efficacy and safety of influenza vaccination in myasthenia gravis.
    Vaccine. 2019 Jan 16. pii: S0264-410X(19)30038.
    PubMed     Abstract available


  1113. LANDAZABAL CS, Moro PL, Lewis P, Omer SB, et al
    Safety of 9-valent human papillomavirus vaccine administration among pregnant women: Adverse event reports in the Vaccine Adverse Event Reporting System (VAERS), 2014-2017.
    Vaccine. 2019 Jan 16. pii: S0264-410X(18)31641.
    PubMed     Abstract available


  1114. DEGAREGE A, Krupp K, Fennie K, Srinivas V, et al
    An integrative behavior theory derived model to assess factors affecting HPV vaccine acceptance using structural equation modeling.
    Vaccine. 2019 Jan 14. pii: S0264-410X(19)30046.
    PubMed     Abstract available


  1115. BIANCO A, Mascaro V, Zucco R, Pavia M, et al
    Parent perspectives on childhood vaccination: How to deal with vaccine hesitancy and refusal?
    Vaccine. 2019 Jan 14. pii: S0264-410X(19)30033.
    PubMed     Abstract available


  1116. XU L, Li Z, Su Z, Yang Y, et al
    Development of meningococcal polysaccharide conjugate vaccine that can elicit long-lasting and strong cellular immune response with hepatitis B core antigen virus-like particles as a novel carrier protein.
    Vaccine. 2019 Jan 14. pii: S0264-410X(19)30054.
    PubMed     Abstract available


  1117. SMITH GP, Jain-Gupta N, Alqublan H, Dorneles EMS, et al
    Development of an auxotrophic, live-attenuated Brucella suis vaccine strain capable of expressing multimeric GnRH.
    Vaccine. 2019 Jan 14. pii: S0264-410X(19)30051.
    PubMed     Abstract available


  1118. BOCCALINI S, Tacconi FM, Lai PL, Bechini A, et al
    Appropriateness and preferential use of different seasonal influenza vaccines: A pilot study on the opinion of vaccinating physicians in Italy.
    Vaccine. 2019 Jan 14. pii: S0264-410X(19)30026.
    PubMed     Abstract available


  1119. MUNIRA SL, Hendriks JT, Atmosukarto II, Friede MH, et al
    A cost analysis of producing vaccines in developing countries.
    Vaccine. 2019 Jan 14. pii: S0264-410X(18)31575.
    PubMed     Abstract available


  1120. XU X, Ding Z, Yuan Q, Ding J, et al
    A genotype VII Newcastle disease virus-like particles confer full protection with reduced virus load and decreased virus shedding.
    Vaccine. 2019;37:444-451.
    PubMed     Abstract available


  1121. WALLACE AS, Wannemuehler K, Bonsu G, Wardle M, et al
    Development of a valid and reliable scale to assess parents' beliefs and attitudes about childhood vaccines and their association with vaccination uptake and delay in Ghana.
    Vaccine. 2019 Jan 11. pii: S0264-410X(19)30024.
    PubMed     Abstract available


  1122. WANG X, Tang Q, Qiu L, Yang Z, et al
    Penton-dodecahedron of fowl adenovirus serotype 4 as a vaccine candidate for the control of related diseases.
    Vaccine. 2019 Jan 11. pii: S0264-410X(18)31714.
    PubMed     Abstract available


  1123. JALLOH MF, Bennett SD, Alam D, Kouta P, et al
    Rapid behavioral assessment of barriers and opportunities to improve vaccination coverage among displaced Rohingyas in Bangladesh, January 2018.
    Vaccine. 2019 Jan 11. pii: S0264-410X(18)31715.
    PubMed     Abstract available


  1124. SOUTO FJD, de Brito WI, Fontes CJF
    Impact of the single-dose universal mass vaccination strategy against hepatitis A in Brazil.
    Vaccine. 2019 Jan 10. pii: S0264-410X(19)30010.
    PubMed     Abstract available


  1125. VANNICE KS, Cassetti MC, Eisinger RW, Hombach J, et al
    Demonstrating vaccine effectiveness during a waning epidemic: A WHO/NIH meeting report on approaches to development and licensure of Zika vaccine candidates.
    Vaccine. 2019 Jan 10. pii: S0264-410X(18)31713.
    PubMed     Abstract available


  1126. SHEN A, Khavjou O, King G, Bates L, et al
    Provider time and costs to vaccinate adult patients: Impact of time counseling without vaccination.
    Vaccine. 2019 Jan 10. pii: S0264-410X(19)30001.
    PubMed     Abstract available


  1127. KHAN AI, Islam MS, Islam MT, Ahmed A, et al
    Oral cholera vaccination strategy: Self-administration of the second dose in urban Dhaka, Bangladesh.
    Vaccine. 2019 Jan 10. pii: S0264-410X(19)30004.
    PubMed     Abstract available


  1128. LUSVAN ME, Debellut F, Clark A, Demberelsuren S, et al
    Projected impact, cost-effectiveness, and budget implications of rotavirus vaccination in Mongolia.
    Vaccine. 2019 Jan 10. pii: S0264-410X(19)30025.
    PubMed     Abstract available


  1129. BAKER SM, Pociask D, Clements JD, McLachlan JB, et al
    Intradermal vaccination with a Pseudomonas aeruginosa vaccine adjuvanted with a mutant bacterial ADP-ribosylating enterotoxin protects against acute pneumonia.
    Vaccine. 2019 Jan 9. pii: S0264-410X(19)30009.
    PubMed     Abstract available


  1130. POLKOWSKA A, Skoczynska A, Paradowska-Stankiewicz I, Stefanoff P, et al
    Pneumococcal meningitis before the introduction of 10-valent pneumococcal conjugate vaccine into the National Childhood Immunization Program in Poland.
    Vaccine. 2019 Jan 9. pii: S0264-410X(18)31701.
    PubMed     Abstract available


  1131. CHEN W, Zhao Y, Xie X, Liu J, et al
    Safety of a quadrivalent human papillomavirus vaccine in a Phase 3, randomized, double-blind, placebo-controlled clinical trial among Chinese women during 90months of follow-up.
    Vaccine. 2019 Jan 9. pii: S0264-410X(18)31703.
    PubMed     Abstract available


  1132. XIAN TH, Parasuraman S, Sinniah K, Ravichandran M, et al
    Repeated dose toxicity evaluation of a cold chain-free, live, attenuated oral cholera vaccine in Sprague Dawley rats.
    Vaccine. 2019 Jan 7. pii: S0264-410X(18)31700.
    PubMed     Abstract available


  1133. PENG X, Hu X, Salazar MA
    First case in China of vaccine-associated poliomyelitis after sequential Inactivated and bivalent oral polio vaccination.
    Vaccine. 2019 Jan 7. pii: S0264-410X(18)31693.
    PubMed     Abstract available


  1134. NAILI I, Vinot J, Baudner BC, Bernalier-Donadille A, et al
    Mixed mucosal-parenteral immunizations with the broadly conserved pathogenic Escherichia coli antigen SslE induce a robust mucosal and systemic immunity without affecting the murine intestinal microbiota.
    Vaccine. 2019;37:314-324.
    PubMed     Abstract available


  1135. PANOZZO CA, Pourmalek F, Brauchli Pernus Y, Pileggi GS, et al
    Arthritis and arthralgia as an adverse event following immunization: A systematic literature review.
    Vaccine. 2019;37:372-383.
    PubMed     Abstract available


  1136. WORLD HEALTH ORGANIZATION
    Measles vaccines: WHO position paper, April 2017 - Recommendations.
    Vaccine. 2019;37:219-222.
    PubMed     Abstract available


  1137. VU M, Luu M, Haardorfer R, Berg CJ, et al
    A multilevel analysis of factors influencing the inaccuracy of parental reports of adolescent HPV vaccination status.
    Vaccine. 2019 Jan 6. pii: S0264-410X(18)31705.
    PubMed     Abstract available


  1138. MCDONALD P, Limaye RJ, Omer SB, Buttenheim AM, et al
    Exploring California's new law eliminating personal belief exemptions to childhood vaccines and vaccine decision-making among homeschooling mothers in California.
    Vaccine. 2019 Jan 6. pii: S0264-410X(18)31678.
    PubMed     Abstract available


  1139. WANG Y, Zade J, Moon SS, Weldon W, et al
    Lack of immune interference between inactivated polio vaccine and inactivated rotavirus vaccine co-administered by intramuscular injection in two animal species.
    Vaccine. 2019 Jan 6. pii: S0264-410X(18)31716.
    PubMed     Abstract available


  1140. MORAN A, Agaliotis M, Seale H
    The views of key stakeholders around mandatory influenza vaccination of hospital and aged care staff: Examining the current climate in Australia.
    Vaccine. 2019 Jan 6. pii: S0264-410X(18)31702.
    PubMed     Abstract available


  1141. HEALY SA, Fried M, Richie T, Bok K, et al
    Malaria vaccine trials in pregnant women: An imperative without precedent.
    Vaccine. 2019 Jan 6. pii: S0264-410X(18)31698.
    PubMed     Abstract available


  1142. PRASERT K, Patumanond J, Praphasiri P, Siriluk S, et al
    Effectiveness of trivalent inactivated influenza vaccine among community-dwelling older adults in Thailand: A two-year prospective cohort study.
    Vaccine. 2019 Jan 4. pii: S0264-410X(19)30003.
    PubMed     Abstract available


  1143. ATTWELL K, Dube E, Gagneur A, Omer SB, et al
    Vaccine acceptance: Science, policy, and practice in a 'post-fact' world.
    Vaccine. 2019 Jan 4. pii: S0264-410X(18)31674.
    PubMed     Abstract available


  1144. TOIZUMI M, Vo HM, Dang DA, Moriuchi H, et al
    Clinical manifestations of congenital rubella syndrome: A review of our experience in Vietnam.
    Vaccine. 2019;37:202-209.
    PubMed     Abstract available


  1145. VERMA SK, Gupta A, Batra L, Tuteja U, et al
    Escherichia coli expressed flagellin C (FliC) of Salmonella Typhi improved the protective efficacy of YopE against plague infection.
    Vaccine. 2019;37:19-24.
    PubMed     Abstract available


  1146. BEN-SHIMOL S, Givon-Lavi N, Leibovitz E, Greenberg D, et al
    Studying PCV impact on clinical presentation of otitis media helps to understand its pathogenesis.
    Vaccine. 2019;37:1-6.
    PubMed     Abstract available


  1147. WEHBI NK, Wani RJ, Klepser DG, Murry J, et al
    Impact of implementing a technology platform in community pharmacies to increase adult immunizations rates.
    Vaccine. 2019;37:56-60.
    PubMed     Abstract available


  1148. KIM SJ, Seon SH, Luong TT, Ghosh P, et al
    Immunization with attenuated non-transformable pneumococcal pep27 and comD mutant provides serotype-independent protection against pneumococcal infection.
    Vaccine. 2019;37:90-98.
    PubMed     Abstract available


  1149. BEN FRAJ I, Smaoui H, Zghal M, Sassi O, et al
    Seroprevalence of pertussis among healthcare workers: A cross-sectional study from Tunisia.
    Vaccine. 2019;37:109-112.
    PubMed     Abstract available


  1150. NAGAI K, Domon H, Maekawa T, Hiyoshi T, et al
    Immunization with pneumococcal elongation factor Tu enhances serotype-independent protection against Streptococcus pneumoniae infection.
    Vaccine. 2019;37:160-168.
    PubMed     Abstract available


  1151. ARORA G, Lehman D, Charlu S, Ross N, et al
    Vaccine health beliefs and educational influences among pediatric residents.
    Vaccine. 2019 Jan 2. pii: S0264-410X(18)31711.
    PubMed     Abstract available


  1152. NAWA N, Fujiwara T
    Association between social capital and second dose of measles vaccination in Japan: Results from the A-CHILD study.
    Vaccine. 2019 Jan 2. pii: S0264-410X(18)31710.
    PubMed     Abstract available


  1153. YAN Z, Cui Y, Zhou W, Li W, et al
    Molecular characterization of Streptococcus pneumoniae in children living in southwest China and assessment of a potential protein vaccine, rPfbA.
    Vaccine. 2019 Jan 2. pii: S0264-410X(18)31692.
    PubMed     Abstract available


    December 2018
  1154. QUINTEL BK, Thomas A, Poer DeRaad DE, Slifka MK, et al
    Advanced oxidation technology for the development of a next-generation inactivated West Nile virus vaccine.
    Vaccine. 2018 Dec 31. pii: S0264-410X(18)31691.
    PubMed     Abstract available


  1155. REGAN AK, Gibbs R, Bloomfield L, Effler PV, et al
    Estimating influenza vaccine effectiveness using data routinely available in electronic primary care records.
    Vaccine. 2018 Dec 29. pii: S0264-410X(18)31651.
    PubMed     Abstract available


  1156. EDLER M, Fernandez A, Anderson K, Pierce JY, et al
    HPV vaccination, knowledge, and attitudes among young cervical cancer survivors in the Deep South.
    Vaccine. 2018 Dec 28. pii: S0264-410X(18)31712.
    PubMed     Abstract available


  1157. HURLEY LP, Allison MA, Kim L, O'Leary ST, et al
    Primary care physicians' perspectives on respiratory syncytial virus (RSV) disease in adults and a potential RSV vaccine for adults.
    Vaccine. 2018 Dec 28. pii: S0264-410X(18)31704.
    PubMed     Abstract available


  1158. WAGNER AL, Shenton LM, Gillespie BW, Mathew JL, et al
    Assessing the timeliness of vaccine administration in children under five years in India, 2013.
    Vaccine. 2018 Dec 27. pii: S0264-410X(18)31708.
    PubMed     Abstract available


  1159. LIN X, Shrader L, Rodgers L, Stokley S, et al
    Increasing human papillomavirus vaccination at the recommended age.
    Vaccine. 2018 Dec 24. pii: S0264-410X(18)31694.
    PubMed     Abstract available


  1160. VAN MULDER TJS, Withanage K, Beyers KCL, Vankerckhoven VVJ, et al
    Immunogenicity and safety of intradermal delivery of hepatitis B booster vaccine using the novel drug delivery device VAX-ID.
    Vaccine. 2018 Dec 23. pii: S0264-410X(18)31676.
    PubMed     Abstract available


  1161. BASTA NE, Becker AB, Li Q, Nederhoff D, et al
    Parental awareness of Meningococcal B vaccines and willingness to vaccinate their teens.
    Vaccine. 2018 Dec 23. pii: S0264-410X(18)31642.
    PubMed     Abstract available


  1162. KRISHNAMOORTHY Y, Eliyas SK, Nair NP, Sakthivel M, et al
    Impact and cost effectiveness of pneumococcal conjugate vaccine in India.
    Vaccine. 2018 Dec 23. pii: S0264-410X(18)31649.
    PubMed     Abstract available


  1163. HIRTH JM, Fuchs EL, Chang M, Fernandez ME, et al
    Variations in reason for intention not to vaccinate across time, region, and by race/ethnicity, NIS-Teen (2008-2016).
    Vaccine. 2018 Dec 21. pii: S0264-410X(18)31677.
    PubMed     Abstract available


  1164. ROCHANATHIMOKE O, Riewpaiboon A, Tharmaphornpilas P, Jiamsiri S, et al
    Economic burden of rotavirus diarrhea in Thailand: Report from a pilot study on rotavirus vaccination.
    Vaccine. 2018 Dec 19. pii: S0264-410X(18)31673.
    PubMed     Abstract available


  1165. HANSON CM, Mirza I, Kumapley R, Ogbuanu I, et al
    Response to comments on "Enhancing immunization during second year of life by reducing missed opportunities for vaccinations in 46 countries".
    Vaccine. 2018;36:7908.
    PubMed    


  1166. THYSEN SM, Fisker AB
    Reducing missed opportunities for vaccinations should be done with eyes wide open.
    Vaccine. 2018;36:7907.
    PubMed    


  1167. WEDLOCK PT, Mitgang EA, Elsheikh F, Leonard J, et al
    The potential effects of introducing microneedle patch vaccines into routine vaccine supply chains.
    Vaccine. 2018 Dec 18. pii: S0264-410X(18)31653.
    PubMed     Abstract available


  1168. FISHER H, Harding S, Hickman M, Macleod J, et al
    Barriers and enablers to adolescent self-consent for vaccination: A mixed-methods evidence synthesis.
    Vaccine. 2018 Dec 17. pii: S0264-410X(18)31652.
    PubMed     Abstract available


  1169. TAK CR, Gunning K, Kim J, Sherwin CM, et al
    The effect of a prescription order requirement for pharmacist-administered vaccination on herpes zoster vaccination rates.
    Vaccine. 2018 Dec 15. pii: S0264-410X(18)31648.
    PubMed     Abstract available


  1170. PEPIN S, Dupuy M, Borja-Tabora CFC, Montellano M, et al
    Efficacy, immunogenicity, and safety of a quadrivalent inactivated influenza vaccine in children aged 6-35months: A multi-season randomised placebo-controlled trial in the Northern and Southern Hemispheres.
    Vaccine. 2018 Dec 14. pii: S0264-410X(18)31637.
    PubMed     Abstract available


  1171. MILLER PDE, de Silva TI, Leonard H, Anthias C, et al
    A comparison of viral microneutralization and haemagglutination inhibition assays as measures of seasonal inactivated influenza vaccine immunogenicity in the first year after reduced intensity conditioning, lymphocyte depleted allogeneic haematopoieti
    Vaccine. 2018 Dec 13. pii: S0264-410X(18)31586.
    PubMed     Abstract available


  1172. BAHRI P, Rago L
    CIOMS Guide To Vaccine Safety Communication - Executive summary.
    Vaccine. 2018 Dec 13. pii: S0264-410X(18)31646.
    PubMed     Abstract available


  1173. KIMOTO T, Kim H, Sakai S, Takahashi E, et al
    Oral vaccination with influenza hemagglutinin combined with human pulmonary surfactant-mimicking synthetic adjuvant SF-10 induces efficient local and systemic immunity compared with nasal and subcutaneous vaccination and provides protective immunity i
    Vaccine. 2018 Dec 13. pii: S0264-410X(18)31647.
    PubMed     Abstract available


  1174. OSHANSKY CM, Zhou J, Gao Y, Schweinle JE, et al
    Safety and immunogenicity of influenza A(H5N1) vaccine stored up to twelve years in the National Pre-Pandemic Influenza Vaccine Stockpile (NPIVS).
    Vaccine. 2018 Dec 12. pii: S0264-410X(18)31632.
    PubMed     Abstract available


  1175. HOOK LM, Awasthi S, Dubin J, Flechtner J, et al
    A trivalent gC2/gD2/gE2 vaccine for herpes simplex virus generates antibody responses that block immune evasion domains on gC2 better than natural infection.
    Vaccine. 2018 Dec 12. pii: S0264-410X(18)31639.
    PubMed     Abstract available


  1176. BROTHERTON JM, Hawkes D, Sultana F, Malloy MJ, et al
    Age-specific HPV prevalence among 116,052 women in Australia's renewed cervical screening program: A new tool for monitoring vaccine impact.
    Vaccine. 2018 Dec 11. pii: S0264-410X(18)31638.
    PubMed     Abstract available


  1177. DENIS M, Knezevic I, Wilde H, Hemachudha T, et al
    An overview of the immunogenicity and effectiveness of current human rabies vaccines administered by intradermal route.
    Vaccine. 2018 Dec 11. pii: S0264-410X(18)31635.
    PubMed     Abstract available


  1178. VAN ZANDVOORT K, Howard N, Mounier-Jack S, Jit M, et al
    Strengthening national vaccine decision-making: Assessing the impact of SIVAC Initiative support on national immunisation technical advisory group (NITAG) functionality in 77 low and middle-income countries.
    Vaccine. 2018 Dec 10. pii: S0264-410X(18)31633.
    PubMed     Abstract available


  1179. POLLOCK KG, Wallace LA, Wrigglesworth S, McMaster D, et al
    HPV vaccine uptake in men who have sex with men in Scotland.
    Vaccine. 2018 Dec 10. pii: S0264-410X(18)31645.
    PubMed     Abstract available


  1180. HAMPSON K, Abela-Ridder B, Bharti O, Knopf L, et al
    Modelling to inform prophylaxis regimens to prevent human rabies.
    Vaccine. 2018 Dec 7. pii: S0264-410X(18)31519.
    PubMed     Abstract available


  1181. CATTAPAN A, Browne K, Halperin DM, Di Castri A, et al
    Motivation for participating in phase 1 vaccine trials: Comparison of an influenza and an Ebola randomized controlled trial.
    Vaccine. 2018 Dec 6. pii: S0264-410X(18)31527.
    PubMed     Abstract available


  1182. RATTANAVIPAPONG W, Thavorncharoensap M, Youngkong S, Genuino AJ, et al
    The impact of transmission dynamics of rabies control: Systematic review.
    Vaccine. 2018 Dec 5. pii: S0264-410X(18)31558.
    PubMed     Abstract available


  1183. LEIDNER AJ, Murthy N, Chesson HW, Biggerstaff M, et al
    Cost-effectiveness of adult vaccinations: A systematic review.
    Vaccine. 2018 Dec 4. pii: S0264-410X(18)31581.
    PubMed     Abstract available


  1184. YANG YT, Huang AL, Zhao Y
    The prevalence of hepatitis B core antibody in vaccinated Chinese children: A hospital-based study.
    Vaccine. 2018 Dec 4. pii: S0264-410X(18)31630.
    PubMed     Abstract available


  1185. O'NEILL J, Newall F, Antolovich G, Lima S, et al
    The uptake of adolescent vaccinations through the School Immunisation Program in specialist schools in Victoria, Australia.
    Vaccine. 2018 Dec 3. pii: S0264-410X(18)31557.
    PubMed     Abstract available


  1186. VALENCIA S, Gill RB, Dowdell KC, Wang Y, et al
    Comparison of vaccination with rhesus CMV (RhCMV) soluble gB with a RhCMV replication-defective virus deleted for MHC class I immune evasion genes in a RhCMV challenge model.
    Vaccine. 2018 Dec 3. pii: S0264-410X(18)31172.
    PubMed     Abstract available


    November 2018
  1187. SHIBLI R, Rishpon S, Cohen-Dar M, Kandlik Y, et al
    What affects pediatric healthcare providers to encourage receipt of routine childhood vaccinations? Results from the Northern District of Israel, 2016.
    Vaccine. 2018 Nov 30. pii: S0264-410X(18)31576.
    PubMed     Abstract available


  1188. CIRUELA P, Izquierdo C, Broner S, Munoz-Almagro C, et al
    The changing epidemiology of invasive pneumococcal disease after PCV13 vaccination in a country with intermediate vaccination coverage.
    Vaccine. 2018;36:7744-7752.
    PubMed     Abstract available


  1189. BRESEE JS, McKinlay MA, Abramson J, Klugman KP, et al
    Global Funders Consortium for Universal Influenza Vaccine Development.
    Vaccine. 2018 Nov 29. pii: S0264-410X(18)31560.
    PubMed    


  1190. FREW PM, Murden R, Mehta CC, Chamberlain AT, et al
    Development of a US trust measure to assess and monitor parental confidence in the vaccine system.
    Vaccine. 2018 Nov 29. pii: S0264-410X(18)31312.
    PubMed     Abstract available


  1191. NAKAYAMA T
    Causal relationship between immunological responses and adverse reactions following vaccination.
    Vaccine. 2018 Nov 29. pii: S0264-410X(18)31568.
    PubMed     Abstract available


  1192. DUSZYNSKI KM, Pratt NL, Lynch JW, Berry JG, et al
    Use of different combination diphtheria-tetanus-acellular pertussis vaccines does not increase risk of 30-day infant mortality. A population-based linkage cohort study using administrative data from the Australian Childhood Immunisation Register and t
    Vaccine. 2018 Nov 28. pii: S0264-410X(18)31548.
    PubMed     Abstract available


  1193. FLAXMAN A, Yamaguchi Y, van Diemen PM, Rollier C, et al
    Heterogeneous early immune responses to the S. aureus EapH2 antigen induced by gastrointestinal tract colonisation impact the response to subsequent vaccination.
    Vaccine. 2018 Nov 28. pii: S0264-410X(18)31588.
    PubMed     Abstract available


  1194. JRADI H, Bawazir A
    Knowledge, attitudes, and practices among Saudi women regarding cervical cancer, human papillomavirus (HPV) and corresponding vaccine.
    Vaccine. 2018 Nov 28. pii: S0264-410X(18)31590.
    PubMed     Abstract available


  1195. FABER MT, Duun-Henriksen AK, Dehlendorff C, Tatla MK, et al
    Adverse pregnancy outcomes and infant mortality after quadrivalent HPV vaccination during pregnancy.
    Vaccine. 2018 Nov 28. pii: S0264-410X(18)31553.
    PubMed     Abstract available


  1196. LANGEDIJK AC, van Aalst M, Meek B, van Leeuwen EMM, et al
    Long-term pneumococcal vaccine immunogenicity following allogeneic hematopoietic stem cell transplantation.
    Vaccine. 2018 Nov 27. pii: S0264-410X(18)31578.
    PubMed     Abstract available


  1197. DAWA J, Chaves SS, Ba Nguz A, Kalani R, et al
    Developing a seasonal influenza vaccine recommendation in Kenya: Process and challenges faced by the National Immunization Technical Advisory Group (NITAG).
    Vaccine. 2018 Nov 27. pii: S0264-410X(18)31587.
    PubMed     Abstract available


  1198. JEONG JH, Kim EH, Lloren KKS, Kwon JJ, et al
    Preclinical evaluation of the efficacy of an H5N8 vaccine candidate (IDCDC-RG43A) in mouse and ferret models for pandemic preparedness.
    Vaccine. 2018 Nov 27. pii: S0264-410X(18)31589.
    PubMed     Abstract available


  1199. SATZKE C, Dunne EM, Choummanivong M, Ortika BD, et al
    Pneumococcal carriage in vaccine-eligible children and unvaccinated infants in Lao PDR two years following the introduction of the 13-valent pneumococcal conjugate vaccine.
    Vaccine. 2018 Nov 27. pii: S0264-410X(18)31464.
    PubMed     Abstract available


  1200. ELSHINA E, Allen ER, Flaxman A, van Diemen PM, et al
    Vaccination with the Staphylococcus aureus secreted proteins EapH1 and EapH2 impacts both S. aureus carriage and invasive disease.
    Vaccine. 2018 Nov 27. pii: S0264-410X(18)31559.
    PubMed     Abstract available


  1201. ABI JAOUDE J, Khair D, Dagher H, Saad H, et al
    Factors associated with Human Papilloma Virus (HPV) vaccine recommendation by physicians in Lebanon, a cross-sectional study.
    Vaccine. 2018;36:7562-7567.
    PubMed     Abstract available


  1202. NAPOLITANO F, Gualdieri L, Santagati G, Angelillo IF, et al
    Knowledge and attitudes toward HPV infection and vaccination among immigrants and refugees in Italy.
    Vaccine. 2018;36:7536-7541.
    PubMed     Abstract available


  1203. REN S, Holliday E, Hure A, Peel R, et al
    Pneumococcal polysaccharide vaccine associated with reduced lengths of stay for cardiovascular events hospital admissions: Experience from the Hunter Community Study.
    Vaccine. 2018;36:7520-7524.
    PubMed     Abstract available


  1204. PASTOR Y, Camacho AI, Zuniga-Ripa A, Merchan A, et al
    Towards a subunit vaccine from a Shigella flexneri DeltatolR mutant.
    Vaccine. 2018;36:7509-7519.
    PubMed     Abstract available


  1205. VAN DE BURGWAL LHM, Ribeiro CDS, Van der Waal MB, Claassen E, et al
    Towards improved process efficiency in vaccine innovation: The Vaccine Innovation Cycle as a validated, conceptual stage-gate model.
    Vaccine. 2018;36:7496-7508.
    PubMed     Abstract available


  1206. PECENKA C, Debellut F, Bar-Zeev N, Anwari P, et al
    Re-evaluating the cost and cost-effectiveness of rotavirus vaccination in Bangladesh, Ghana, and Malawi: A comparison of three rotavirus vaccines.
    Vaccine. 2018;36:7472-7478.
    PubMed     Abstract available


  1207. KARTHIGESU SP, Chisholm JS, Coall DA
    Do grandparents influence parents' decision to vaccinate their children? A systematic review.
    Vaccine. 2018;36:7456-7462.
    PubMed     Abstract available


  1208. VAJO Z, Kalabay L, Vajo P, Balaton G, et al
    Licensing the first reduced, 6microg dose whole virion, aluminum adjuvanted seasonal influenza vaccine - A randomized-controlled multicenter trial.
    Vaccine. 2018 Nov 26. pii: S0264-410X(18)31562.
    PubMed     Abstract available


  1209. YU W, Lee LA, Liu Y, Scherpbier RW, et al
    Vaccine-preventable disease control in the People's Republic of China: 1949-2016.
    Vaccine. 2018 Nov 26. pii: S0264-410X(18)31357.
    PubMed     Abstract available


  1210. HEGAZY-HASSAN W, Zepeda-Escobar JA, Ochoa-Garcia L, Contreras-Ortiz JME, et al
    TcVac1 vaccine delivery by intradermal electroporation enhances vaccine induced immune protection against Trypanosoma cruzi infection in mice.
    Vaccine. 2018 Nov 26. pii: S0264-410X(18)31564.
    PubMed     Abstract available


  1211. KOCHHAR S, Excler JL, Bok K, Gurwith M, et al
    Defining the interval for monitoring potential adverse events following immunization (AEFIs) after receipt of live viral vectored vaccines.
    Vaccine. 2018 Nov 26. pii: S0264-410X(18)31235.
    PubMed     Abstract available


  1212. QUEENAN AM, Dowling DJ, Cheng WK, Fae K, et al
    Increasing FIM2/3 antigen-content improves efficacy of Bordetella pertussis vaccines in mice in vivo without altering vaccine-induced human reactogenicity biomarkers in vitro.
    Vaccine. 2018 Nov 23. pii: S0264-410X(18)31551.
    PubMed     Abstract available


  1213. CAMPBELL ZA, Otieno L, Shirima GM, Marsh TL, et al
    Drivers of vaccination preferences to protect a low-value livestock resource: Willingness to pay for Newcastle disease vaccines by smallholder households.
    Vaccine. 2018 Nov 23. pii: S0264-410X(18)31583.
    PubMed     Abstract available


  1214. MCCLURE DL, Jacobsen SJ, Klein NP, Naleway AL, et al
    Similar relative risks of seizures following measles containing vaccination in children born preterm compared to full-term without previous seizures or seizure-related disorders.
    Vaccine. 2018 Nov 23. pii: S0264-410X(18)31561.
    PubMed     Abstract available


  1215. PEZZOTTI P, Bellino S, Riccardo F, Lucaroni F, et al
    Vaccine preventable invasive bacterial diseases in Italy: A comparison between the national surveillance system and recorded hospitalizations, 2007-2016.
    Vaccine. 2018 Nov 23. pii: S0264-410X(18)31572.
    PubMed     Abstract available


  1216. MATYSIAK-KLOSE D, Santibanez S, Schwerdtfeger C, Koch J, et al
    Post-exposure prophylaxis for measles with immunoglobulins revised recommendations of the standing committee on vaccination in Germany.
    Vaccine. 2018 Nov 23. pii: S0264-410X(18)31455.
    PubMed     Abstract available


  1217. RIDDELL CA, Bhat N, Bont LJ, Dupont WD, et al
    Informing randomized clinical trials of respiratory syncytial virus vaccination during pregnancy to prevent recurrent childhood wheezing: A sample size analysis.
    Vaccine. 2018 Nov 22. pii: S0264-410X(18)31407.
    PubMed     Abstract available


  1218. AKHTAR M, Chowdhury MI, Bhuiyan TR, Kaim J, et al
    Evaluation of the safety and immunogenicity of the oral inactivated multivalent enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi adults in a double-blind, randomized, placebo-controlled Phase I trial using electrochemiluminescence and ELI
    Vaccine. 2018 Nov 22. pii: S0264-410X(18)31563.
    PubMed     Abstract available


  1219. TARANTOLA A, Tejiokem MC, Briggs DJ
    Evaluating new rabies post-exposure prophylaxis (PEP) regimens or vaccines.
    Vaccine. 2018 Nov 21. pii: S0264-410X(18)31542.
    PubMed     Abstract available


  1220. BOLLAERTS K, Verstraeten T, Cohet C
    Observational studies of non-specific effects of Diphtheria-Tetanus-Pertussis vaccines in low-income countries: Assessing the potential impact of study characteristics, bias and confounding through meta-regression.
    Vaccine. 2018 Nov 21. pii: S0264-410X(18)31574.
    PubMed     Abstract available


  1221. MCMORROW ML, Tempia S, Walaza S, Treurnicht FK, et al
    Prioritization of risk groups for influenza vaccination in resource limited settings - A case study from South Africa.
    Vaccine. 2018 Nov 21. pii: S0264-410X(18)31573.
    PubMed     Abstract available


  1222. BERNSTEIN DI, Pullum DA, Cardin RD, Bravo FJ, et al
    The HSV-1 live attenuated VC2 vaccine provides protection against HSV-2 genital infection in the guinea pig model of genital herpes.
    Vaccine. 2018 Nov 21. pii: S0264-410X(18)31565.
    PubMed     Abstract available


  1223. VESIKARI T, Borrow R, Da Costa X, Thomas S, et al
    Concomitant administration of a fully liquid ready-to-use DTaP-IPV-HB-PRP-T hexavalent vaccine with a meningococcal ACWY conjugate vaccine in toddlers.
    Vaccine. 2018 Nov 21. pii: S0264-410X(18)31497.
    PubMed     Abstract available


  1224. STEAD M, Critchlow N, Eadie D, Sullivan F, et al
    Mandatory policies for influenza vaccination: Views of managers and healthcare workers in England.
    Vaccine. 2018 Nov 20. pii: S0264-410X(18)31556.
    PubMed     Abstract available


  1225. CHEN J, Yu X, Zheng Q, Hou L, et al
    The immunopotentiator CVC1302 enhances immune efficacy and protective ability of foot-and-mouth disease virus vaccine in pigs.
    Vaccine. 2018 Nov 20. pii: S0264-410X(18)31523.
    PubMed     Abstract available


  1226. KOVACS E, Sahin-Toth J, Tothpal A, Kristof K, et al
    Vaccine-driven serotype-rearrangement is seen with latency in clinical isolates: Comparison of carried and clinical pneumococcal isolates from the same time period in Hungary.
    Vaccine. 2018 Nov 20. pii: S0264-410X(18)31549.
    PubMed     Abstract available


  1227. LOPEZ AL, Harris JB, Raguindin PF, Aldaba J, et al
    Introduction of inactivated poliovirus vaccine in the Philippines: Effect on health care provider and infant caregiver attitudes and practices.
    Vaccine. 2018;36:7399-7407.
    PubMed     Abstract available


  1228. CROWCROFT NS, Klein NP
    A framework for research on vaccine effectiveness.
    Vaccine. 2018;36:7286-7293.
    PubMed     Abstract available


  1229. HURLEY LP, Allison MA, Dooling KL, O'Leary ST, et al
    Primary care physicians' experience with zoster vaccine live (ZVL) and awareness and attitudes regarding the new recombinant zoster vaccine (RZV).
    Vaccine. 2018;36:7408-7414.
    PubMed     Abstract available


  1230. DEMEURE CE, Derbise A, Guillas C, Gerke C, et al
    Humoral and cellular immune correlates of protection against bubonic plague by a live Yersinia pseudotuberculosis vaccine.
    Vaccine. 2018 Nov 19. pii: S0264-410X(18)31545.
    PubMed     Abstract available


  1231. DE SERRES G, Billard MN, Gariepy MC, Rouleau I, et al
    Short-term safety of 4CMenB vaccine during a mass meningococcal B vaccination campaign in Quebec, Canada.
    Vaccine. 2018 Nov 19. pii: S0264-410X(18)31492.
    PubMed     Abstract available


  1232. DENG Y, Cai W, Li J, Li Y, et al
    Evaluation of the genetic stability of Sabin strains and the consistency of inactivated poliomyelitis vaccine made from Sabin strains using direct deep-sequencing.
    Vaccine. 2018 Nov 19. pii: S0264-410X(18)31543.
    PubMed     Abstract available


  1233. DIAMOS AG, Larios D, Brown L, Kilbourne J, et al
    Vaccine synergy with virus-like particle and immune complex platforms for delivery of human papillomavirus L2 antigen.
    Vaccine. 2018 Nov 17. pii: S0264-410X(18)31544.
    PubMed     Abstract available


  1234. SEPPALA EM, Lopez-Perea N, Torres de Mier MV, Echevarria JE, et al
    Last cases of rubella and congenital rubella syndrome in Spain, 1997-2016: The success of a vaccination program.
    Vaccine. 2018 Nov 16. pii: S0264-410X(18)31539.
    PubMed     Abstract available


  1235. TUCKERMAN J, Misan S, Salih S, Joseph Xavier B, et al
    Influenza vaccination: Uptake and associations in a cross-sectional study of children with special risk medical conditions.
    Vaccine. 2018 Nov 16. pii: S0264-410X(18)31299.
    PubMed     Abstract available


  1236. TARANTOLA A, Ly S, Chan M, In S, et al
    Intradermal rabies post-exposure prophylaxis can be abridged with no measurable impact on clinical outcome in Cambodia, 2003-2014.
    Vaccine. 2018 Nov 16. pii: S0264-410X(18)31420.
    PubMed     Abstract available


  1237. DONG B, Wang L, Nie S, Li X, et al
    Anti-glioma effect of intracranial vaccination with tumor cell lysate plus flagellin in mice.
    Vaccine. 2018 Nov 15. pii: S0264-410X(18)30550.
    PubMed     Abstract available


  1238. NAGASHIMA S, Yamamoto C, Ko K, Chuon C, et al
    Acquisition rate of antibody to hepatitis B surface antigen among medical and dental students in Japan after three-dose hepatitis B vaccination.
    Vaccine. 2018 Nov 15. pii: S0264-410X(18)31541.
    PubMed     Abstract available


  1239. MILLIGAN GN, Schnierle BS, McAuley AJ, Beasley DWC, et al
    Defining a correlate of protection for chikungunya virus vaccines.
    Vaccine. 2018 Nov 15. pii: S0264-410X(18)31399.
    PubMed     Abstract available


  1240. BIELECKI K, Kirolos A, Willocks LJ, Pollock KG, et al
    Low uptake of nasal influenza vaccine in polish and other ethnic minority children in Edinburgh, Scotland.
    Vaccine. 2018 Nov 15. pii: S0264-410X(18)31552.
    PubMed     Abstract available


  1241. ESPOSITO D, Titievsky L, Beachler DC, Hawes JCL, et al
    Incidence of outcomes relevant to vaccine safety monitoring in a US commercially-insured population.
    Vaccine. 2018 Nov 15. pii: S0264-410X(18)31418.
    PubMed     Abstract available


  1242. KUROVA N, Timofeeva EV, Guiso N, Macina D, et al
    A cross-sectional study of Bordetella pertussis seroprevalence and estimated duration of vaccine protection against pertussis in St. Petersburg, Russia.
    Vaccine. 2018 Nov 15. pii: S0264-410X(18)31516.
    PubMed     Abstract available


  1243. YUE X, Black CL, Williams WW, Lu PJ, et al
    Influenza vaccination among adults living with persons at high-risk for complications from influenza during early 2016-17 influenza season.
    Vaccine. 2018 Nov 14. pii: S0264-410X(18)31499.
    PubMed     Abstract available


  1244. VALENTINI S, Santoro G, Baffetta F, Franceschi S, et al
    Monocyte-activation test to reliably measure the pyrogenic content of a vaccine: An in vitro pyrogen test to overcome in vivo limitations.
    Vaccine. 2018 Nov 14. pii: S0264-410X(18)31469.
    PubMed     Abstract available


  1245. KAHN KE, Santibanez TA, Zhai Y, Bridges CB, et al
    Association between patient reminders and influenza vaccination status among children.
    Vaccine. 2018 Nov 14. pii: S0264-410X(18)31395.
    PubMed     Abstract available


  1246. WON SY, Hunt K, Guak H, Hasaj B, et al
    Characterization of the innate stimulatory capacity of plant-derived virus-like particles bearing influenza hemagglutinin.
    Vaccine. 2018 Nov 14. pii: S0264-410X(18)31496.
    PubMed     Abstract available


  1247. BACCI JL, Hansen R, Ree C, Reynolds MJ, et al
    The effects of vaccination forecasts and value-based payment on adult immunizations by community pharmacists.
    Vaccine. 2018 Nov 13. pii: S0264-410X(18)31540.
    PubMed     Abstract available


  1248. PAN WK, Seidman JC, Ali A, Hoest C, et al
    Oral polio vaccine response in the MAL-ED birth cohort study: Considerations for polio eradication strategies.
    Vaccine. 2018 Nov 12. pii: S0264-410X(18)30746.
    PubMed     Abstract available


  1249. GIORGAKOUDI K, O'Sullivan C, Heath PT, Ladhani S, et al
    Cost-effectiveness analysis of maternal immunisation against group B Streptococcus (GBS) disease: A modelling study.
    Vaccine. 2018;36:7033-7042.
    PubMed     Abstract available



  1250. Dengue vaccine: WHO position paper, September 2018 - Recommendations.
    Vaccine. 2018 Nov 10. pii: S0264-410X(18)31339.
    PubMed     Abstract available


  1251. SHANG M, Chung JR, Jackson ML, Jackson LA, et al
    Influenza vaccine effectiveness among patients with high-risk medical conditions in the United States, 2012-2016.
    Vaccine. 2018 Nov 9. pii: S0264-410X(18)31490.
    PubMed     Abstract available


  1252. HUANG H, Gao P, Gao Z, Wang L, et al
    A big pertussis outbreak in a primary school with high vaccination coverage in northern China: An evidence of the emerging of the disease in China.
    Vaccine. 2018 Nov 9. pii: S0264-410X(18)31518.
    PubMed     Abstract available


  1253. CHEN S, Lin F, Chen S, Hu Q, et al
    Development of a live attenuated vaccine against Muscovy duck reovirus infection.
    Vaccine. 2018 Nov 9. pii: S0264-410X(18)31502.
    PubMed     Abstract available


  1254. RATHI N, Desai S, Kawade A, Venkatramanan P, et al
    A Phase III open-label, randomized, active controlled clinical study to assess safety, immunogenicity and lot-to-lot consistency of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants.
    Vaccine. 2018 Nov 9. pii: S0264-410X(18)31515.
    PubMed     Abstract available


  1255. IVES A, Dieuzy-Labaye I, Abela-Ridder B
    Global characteristics of the rabies biologics market in 2017.
    Vaccine. 2018 Nov 9. pii: S0264-410X(18)31364.
    PubMed     Abstract available


  1256. HOEVE CE, van Haren A, Sturkenboom MCJM, Straus SMJM, et al
    Spontaneous reports of vaccination errors in the European regulatory database EudraVigilance: A descriptive study.
    Vaccine. 2018 Nov 8. pii: S0264-410X(18)31501.
    PubMed     Abstract available


  1257. MUNOZ FM, Jackson LA, Swamy GK, Edwards KM, et al
    Safety and immunogenicity of seasonal trivalent inactivated influenza vaccines in pregnant women.
    Vaccine. 2018 Nov 8. pii: S0264-410X(18)31475.
    PubMed     Abstract available


  1258. ADETIFA IMO, Karia B, Mutuku A, Bwanaali T, et al
    Coverage and timeliness of vaccination and the validity of routine estimates: Insights from a vaccine registry in Kenya.
    Vaccine. 2018 Nov 8. pii: S0264-410X(18)31504.
    PubMed     Abstract available


  1259. MACIAS PARRA M, Gentile A, Vazquez Narvaez JA, Capdevila A, et al
    Immunogenicity and safety of the 4CMenB and MenACWY-CRM meningococcal vaccines administered concomitantly in infants: A phase 3b, randomized controlled trial.
    Vaccine. 2018 Nov 7. pii: S0264-410X(18)31493.
    PubMed     Abstract available


  1260. BURNETT E, Van Trang N, Rayamajhi A, Yousafzai MT, et al
    Preparing for safety monitoring after rotavirus vaccine introduction - Assessment of baseline epidemiology of intussusception among children <2years of age in four Asian countries.
    Vaccine. 2018 Nov 7. pii: S0264-410X(18)31500.
    PubMed     Abstract available


  1261. WOOD ME, Griebel P, Huizenga ML, Lockwood S, et al
    Accelerated onset of chronic wasting disease in elk (Cervus canadensis) vaccinated with a PrP(Sc)-specific vaccine and housed in a prion contaminated environment.
    Vaccine. 2018 Nov 7. pii: S0264-410X(18)31425.
    PubMed     Abstract available


  1262. WILCOX CR, Bottrell K, Paterson P, Schulz WS, et al
    Influenza and pertussis vaccination in pregnancy: Portrayal in online media articles and perceptions of pregnant women and healthcare professionals.
    Vaccine. 2018 Nov 3. pii: S0264-410X(18)31489.
    PubMed     Abstract available


  1263. WANG X, Li M, Lin Z, Pan H, et al
    Multifaceted characterization of recombinant protein-based vaccines: An immunochemical toolbox for epitope-specific analyses of the hepatitis E vaccine.
    Vaccine. 2018 Nov 2. pii: S0264-410X(18)31486.
    PubMed     Abstract available


  1264. HAATVEIT HM, Hodneland K, Braaen S, Hansen EF, et al
    DNA vaccine expressing the non-structural proteins of Piscine orthoreovirus delay the kinetics of PRV infection and induces moderate protection against heart -and skeletal muscle inflammation in Atlantic salmon (Salmo salar).
    Vaccine. 2018 Nov 2. pii: S0264-410X(18)31491.
    PubMed     Abstract available


  1265. POLLOCK KG, Tait B, Tait J, Bielecki K, et al
    Evidence of decreased HPV vaccine acceptance in Polish communities within Scotland.
    Vaccine. 2018 Nov 2. pii: S0264-410X(18)31494.
    PubMed     Abstract available


  1266. DESAI S, Schanzer DL, Silva A, Rotondo J, et al
    Trends in Canadian infant pertussis hospitalizations in the pre- and post-acellular vaccine era, 1981-2016.
    Vaccine. 2018 Nov 1. pii: S0264-410X(18)31413.
    PubMed     Abstract available


  1267. TRUMBO SP, Silver D, Domenti O, Gasoyan H, et al
    Strengthening legal frameworks for vaccination: The experiences of Armenia, Georgia, and Moldova.
    Vaccine. 2018 Nov 1. pii: S0264-410X(18)31454.
    PubMed     Abstract available


    October 2018
  1268. BOCQUIER A, Fressard L, Cortaredona S, Zaytseva A, et al
    Social differentiation of vaccine hesitancy among French parents and the mediating role of trust and commitment to health: A nationwide cross-sectional study.
    Vaccine. 2018 Oct 31. pii: S0264-410X(18)31472.
    PubMed     Abstract available


  1269. YANG X, Zhang D, Ou W
    Pneumococcal vaccination patterns among persons aged 65years or older in the United States: A retrospective database analysis.
    Vaccine. 2018 Oct 31. pii: S0264-410X(18)31367.
    PubMed     Abstract available


  1270. SHEDRAWY J, Henriksson M, Hergens MP, Askling HH, et al
    Estimating costs and health outcomes of publicly funded tick-born encephalitis vaccination: A cost-effectiveness analysis.
    Vaccine. 2018 Oct 30. pii: S0264-410X(18)31473.
    PubMed     Abstract available


  1271. GILBERT BE, Patel N, Lu H, Liu Y, et al
    Respiratory syncytial virus fusion nanoparticle vaccine immune responses target multiple neutralizing epitopes that contribute to protection against wild-type and palivizumab-resistant mutant virus challenge.
    Vaccine. 2018 Oct 30. pii: S0264-410X(18)31458.
    PubMed     Abstract available


  1272. MARTIRE B, Azzari C, Badolato R, Canessa C, et al
    Corrigendum to: "Vaccination in immunocompromised host: Recommendations of Italian Primary Immunodeficiency Network Centers (IPINET)" [Vaccine 36 (2018) Pages 3541-3542].
    Vaccine. 2018 Oct 30. pii: S0264-410X(18)31424.
    PubMed    


  1273. AHMED N, Quinn SC, Hancock GR, Freimuth VS, et al
    Social media use and influenza vaccine uptake among White and African American adults.
    Vaccine. 2018 Oct 30. pii: S0264-410X(18)31415.
    PubMed     Abstract available


  1274. WILLAME C, Lin L, Vetter V, Baril L, et al
    Reply to Lee et al.'s letter to the editor pertaining to our publication entitled "Pain caused by measles, mumps, and rubella vaccines: A systematic literature review".
    Vaccine. 2018;36:6589-6590.
    PubMed    


  1275. LEE AW, Saldutti LP, Wolfson LJ, Stek JE, et al
    To the editor: Response to Willame, et al., published in Vaccine 35 (2017) 5551-5558, entitled "Pain caused by measles, mumps, and rubella vaccines: A systematic literature review".
    Vaccine. 2018;36:6587-6588.
    PubMed    


  1276. DATEY A, Shreenivas M, Chandrasekharan G, Joseph J, et al
    Rewiring of one carbon metabolism in Salmonella serves as an excellent live vaccine against systemic salmonellosis.
    Vaccine. 2018 Oct 29. pii: S0264-410X(18)31466.
    PubMed     Abstract available


  1277. GIUFRE M, Fabiani M, Cardines R, Riccardo F, et al
    Increasing trend in invasive non-typeable Haemophilus influenzae disease and molecular characterization of the isolates, Italy, 2012-2016.
    Vaccine. 2018;36:6615-6622.
    PubMed     Abstract available


  1278. ARAUJO IL, Dummer LA, Rodrigues PRC, Dos Santos AG Jr, et al
    Immune responses in bovines to recombinant glycoprotein D of bovine herpesvirus type 5 as vaccine antigen.
    Vaccine. 2018 Oct 28. pii: S0264-410X(18)31467.
    PubMed     Abstract available


  1279. MOSAHEB M, Wetzler LM
    Meningococcal PorB induces a robust and diverse antigen specific T cell response as a vaccine adjuvant.
    Vaccine. 2018 Oct 28. pii: S0264-410X(18)31459.
    PubMed     Abstract available


  1280. SCHURINK-VAN 'T KLOOSTER TM, Donken R, Schepp RM, van der Klis FRM, et al
    Persistence of immune response following bivalent HPV vaccination: A follow-up study among girls routinely vaccinated with a two-dose schedule.
    Vaccine. 2018 Oct 27. pii: S0264-410X(18)31370.
    PubMed     Abstract available


  1281. BOIGARD H, Cimica V, Galarza JM
    Dengue-2 virus-like particle (VLP) based vaccine elicits the highest titers of neutralizing antibodies when produced at reduced temperature.
    Vaccine. 2018 Oct 27. pii: S0264-410X(18)31457.
    PubMed     Abstract available


  1282. HIRTH J, McGrath CJ, Kuo YF, Rupp RE, et al
    Impact of human papillomavirus vaccination on racial/ethnic disparities in vaccine-type human papillomavirus prevalence among 14-26year old females in the U.S.
    Vaccine. 2018 Oct 27. pii: S0264-410X(18)31462.
    PubMed     Abstract available


  1283. PERCIACCANTE A, Coralli A, Bianucci R
    Vaccines: The oxymoron of Italian health policy.
    Vaccine. 2018 Oct 23. pii: S0264-410X(18)31404.
    PubMed    


  1284. BERKLEY S
    Political will and vaccine legislation.
    Vaccine. 2018 Oct 23. pii: S0264-410X(18)31402.
    PubMed    


  1285. LOVRIC MAKARIC Z, Kolaric B, Tomljenovic M, Posavec M, et al
    Attitudes and beliefs related to childhood vaccinations among parents of 6years old children in Zagreb, Croatia.
    Vaccine. 2018 Oct 23. pii: S0264-410X(18)31421.
    PubMed     Abstract available


  1286. IKILEZI G, Zlavog B, Augusto OJ, Sherr K, et al
    Tracking donor funding towards achieving the Global Vaccine Action Plan (GVAP) goals: A landscape analysis (1990-2016).
    Vaccine. 2018 Oct 23. pii: S0264-410X(18)31430.
    PubMed     Abstract available


  1287. CALO WA, Gilkey MB, Malo TL, Robichaud M, et al
    A content analysis of HPV vaccination messages available online.
    Vaccine. 2018 Oct 23. pii: S0264-410X(18)31419.
    PubMed     Abstract available


  1288. BEKKAT-BERKANI R, Romano-Mazzotti L
    Understanding the unique characteristics of seasonal influenza illness to improve vaccine uptake in the US.
    Vaccine. 2018 Oct 23. pii: S0264-410X(18)31393.
    PubMed     Abstract available


  1289. ZHANG H, Wen W, Zhao Z, Wang J, et al
    Enhanced protective immunity to CSFV E2 subunit vaccine by using IFN-gamma as immunoadjuvant in weaning piglets.
    Vaccine. 2018 Oct 23. pii: S0264-410X(18)31396.
    PubMed     Abstract available


  1290. GAGNEUR A, Gosselin V, Dube E
    Motivational interviewing: A promising tool to address vaccine hesitancy.
    Vaccine. 2018;36:6553-6555.
    PubMed    


  1291. ZHAI Y, Santibanez TA, Kahn KE, Black CL, et al
    Paid sick leave benefits, influenza vaccination, and taking sick days due to influenza-like illness among U.S. workers.
    Vaccine. 2018 Oct 22. pii: S0264-410X(18)31405.
    PubMed     Abstract available


  1292. LOEB M, Russell ML, Neupane B, Thanabalan V, et al
    A randomized, blinded, placebo-controlled trial comparing antibody responses to homeopathic and conventional vaccines in university students.
    Vaccine. 2018 Oct 20. pii: S0264-410X(18)31232.
    PubMed     Abstract available


  1293. HEINSBROEK E, Tafatatha T, Phiri A, Swarthout TD, et al
    Pneumococcal carriage in households in Karonga District, Malawi, before and after introduction of 13-valent pneumococcal conjugate vaccination.
    Vaccine. 2018 Oct 20. pii: S0264-410X(18)31387.
    PubMed     Abstract available


  1294. VAUGHN AR, Johnson ML
    Communicating and enhancing teachers' attitudes and understanding of influenza using refutational text.
    Vaccine. 2018 Oct 17. pii: S0264-410X(18)31406.
    PubMed     Abstract available


  1295. O'BRIEN KL, Nolan T
    The WHO position on rabies immunization - 2018 updates.
    Vaccine. 2018 Oct 17. pii: S0264-410X(18)31366.
    PubMed    


  1296. WANG Q, Yue N, Zheng M, Wang D, et al
    Influenza vaccination coverage of population and the factors influencing influenza vaccination in mainland China: A meta-analysis.
    Vaccine. 2018 Oct 16. pii: S0264-410X(18)31411.
    PubMed     Abstract available


  1297. D'ALESSIO F, Koopman G, Houard S, Remarque EJ, et al
    Workshop report: Experimental animal models for universal influenza vaccines.
    Vaccine. 2018 Oct 16. pii: S0264-410X(18)31390.
    PubMed     Abstract available


  1298. THOMAS LF, Bellet C, Rushton J
    Using economic and social data to improve veterinary vaccine development: Learning lessons from human vaccinology.
    Vaccine. 2018 Oct 16. pii: S0264-410X(18)31410.
    PubMed     Abstract available


  1299. MCGAVIN ZA, Wagner AL, Carlson BF, Power LE, et al
    Childhood full and under-vaccination in Nigeria, 2013.
    Vaccine. 2018 Oct 16. pii: S0264-410X(18)31409.
    PubMed     Abstract available


  1300. ZHANG L, Durr E, Galli JD, Cosmi S, et al
    Design and characterization of a fusion glycoprotein vaccine for Respiratory Syncytial Virus with improved stability.
    Vaccine. 2018 Oct 16. pii: S0264-410X(18)31398.
    PubMed     Abstract available


  1301. SANTIBANEZ TA, Kahn KE, Bridges CB
    Do parents prefer inactivated or live attenuated influenza vaccine for their children?
    Vaccine. 2018 Oct 16. pii: S0264-410X(18)31408.
    PubMed     Abstract available


  1302. CANNON JW, Jack S, Wu Y, Zhang J, et al
    An economic case for a vaccine to prevent group A streptococcus skin infections.
    Vaccine. 2018 Oct 16. pii: S0264-410X(18)31352.
    PubMed     Abstract available


  1303. CHIDO-AMAJUOYI OG, Wonodi C, Mantey D, Perez A, et al
    Prevalence and correlates of never vaccinated Nigerian children, aged 1-5years.
    Vaccine. 2018 Oct 16. pii: S0264-410X(18)31358.
    PubMed     Abstract available


  1304. HRABER P, Bradfute S, Clarke E, Ye C, et al
    Amphiphilic block copolymer delivery of a DNA vaccine against Zika virus.
    Vaccine. 2018 Oct 15. pii: S0264-410X(18)31388.
    PubMed     Abstract available


  1305. SALAT J, Formanova P, Hunady M, Eyer L, et al
    Development and testing of a new tick-borne encephalitis virus vaccine candidate for veterinary use.
    Vaccine. 2018 Oct 15. pii: S0264-410X(18)31400.
    PubMed     Abstract available


  1306. THANG HV, Huong VM, Victor JC, Van CB, et al
    Safety and immunogenicity of inactivated monovalent influenza A/H1N1 vaccine candidate manufactured in Vietnam.
    Vaccine. 2018 Oct 15. pii: S0264-410X(18)31365.
    PubMed     Abstract available


  1307. ATTWELL K, Navin MC, Lopalco PL, Jestin C, et al
    Recent vaccine mandates in the United States, Europe and Australia: A comparative study.
    Vaccine. 2018 Oct 15. pii: S0264-410X(18)31371.
    PubMed     Abstract available


  1308. HAQUE W, Haque J, Barai D, Rahman S, et al
    Distribution of rotavirus genotypes in Dhaka, Bangladesh, 2012-2016: Re-emergence of G3P[8] after over a decade of interval.
    Vaccine. 2018;36:6393-6400.
    PubMed     Abstract available


  1309. TOKARS JI, Rolfes MA, Foppa IM, Reed C, et al
    An evaluation and update of methods for estimating the number of influenza cases averted by vaccination in the United States.
    Vaccine. 2018 Oct 13. pii: S0264-410X(18)31392.
    PubMed     Abstract available


  1310. BARRERA J, Brake DA, Schutta C, Ettyreddy D, et al
    Versatility of the adenovirus-vectored foot-and-mouth disease vaccine platform across multiple foot-and-mouth disease virus serotypes and topotypes using a vaccine dose representative of the AdtA24 conditionally licensed vaccine.
    Vaccine. 2018 Oct 13. pii: S0264-410X(18)31397.
    PubMed     Abstract available


  1311. NUGENT G, Yockney IJ, Cross ML, Buddle BM, et al
    Low-dose BCG vaccination protects free-ranging cattle against naturally-acquired bovine tuberculosis.
    Vaccine. 2018 Oct 13. pii: S0264-410X(18)31391.
    PubMed     Abstract available


  1312. YEOLEKAR LR, Ganguly M, Tyagi P, Ingle NB, et al
    Immunogenicity and efficacy of the monovalent, trivalent and quadrivalent intranasal live attenuated influenza vaccines containing different pdmH1N1 strains.
    Vaccine. 2018 Oct 12. pii: S0264-410X(18)31354.
    PubMed     Abstract available


  1313. GERRETSEN HE, Capone S, Vitelli A, Reyes LS, et al
    Antibodies in lymphocyte supernatants can distinguish between neutralising antibodies induced by RSV vaccination and pre-existing antibodies induced by natural infection.
    Vaccine. 2018 Oct 11. pii: S0264-410X(18)31351.
    PubMed     Abstract available


  1314. SASAKI E, Momose H, Hiradate Y, Mizukami T, et al
    Establishment of a novel safety assessment method for vaccine adjuvant development.
    Vaccine. 2018 Oct 11. pii: S0264-410X(18)31361.
    PubMed     Abstract available


  1315. PIRCON JY, Talarico CA, Bollaerts K, Hausdorff WP, et al
    The choice of analytical methodology can alter conclusions regarding herd effects of paediatric pneumococcal vaccination programmes.
    Vaccine. 2018 Oct 10. pii: S0264-410X(18)31355.
    PubMed     Abstract available


  1316. ZHANG Z, Dong Z, Wang Q, Carr MJ, et al
    Characterization of an inactivated whole-virus bivalent vaccine that induces balanced protective immunity against coxsackievirus A6 and A10 in mice.
    Vaccine. 2018 Oct 10. pii: S0264-410X(18)31350.
    PubMed     Abstract available


  1317. GILCA V, Sauvageau C, Panicker G, De Serres G, et al
    Immunogenicity and safety of a mixed vaccination schedule with one dose of nonavalent and one dose of bivalent HPV vaccine versus two doses of nonavalent vaccine - A randomized clinical trial.
    Vaccine. 2018 Oct 9. pii: S0264-410X(18)31326.
    PubMed     Abstract available


  1318. ODEVALL L, Hong D, Digilio L, Sahastrabuddhe S, et al
    The Euvichol story - Development and licensure of a safe, effective and affordable oral cholera vaccine through global public private partnerships.
    Vaccine. 2018 Oct 9. pii: S0264-410X(18)31276.
    PubMed     Abstract available


  1319. SCHAEFERS MM, Duan B, Mizrahi B, Lu R, et al
    PLGA-encapsulation of the Pseudomonas aeruginosa PopB vaccine antigen improves Th17 responses and confers protection against experimental acute pneumonia.
    Vaccine. 2018 Oct 9. pii: S0264-410X(18)31362.
    PubMed     Abstract available


  1320. BOCKSTAL V, Tiemessen MM, Achterberg R, Van Wordragen C, et al
    An inactivated poliovirus vaccine using Sabin strains produced on the serum-free PER.C6(R) cell culture platform is immunogenic and safe in a non-human primate model.
    Vaccine. 2018 Oct 9. pii: S0264-410X(18)31349.
    PubMed     Abstract available


  1321. HADDISON EC, Ngono D, Kouamen GT, Kagina BM, et al
    Successful polio supplementary immunisation activities in a security compromised zone - Experiences from the Southwest region of Cameroon.
    Vaccine. 2018 Oct 9. pii: S0264-410X(18)31356.
    PubMed     Abstract available


  1322. LI AJ, Sreenivasan N, Siddiqi UR, Tahmina S, et al
    Descriptive assessment of rabies post-exposure prophylaxis procurement, distribution, monitoring, and reporting in four Asian countries: Bangladesh, Bhutan, Cambodia, and Sri Lanka, 2017-2018.
    Vaccine. 2018 Oct 9. pii: S0264-410X(18)31363.
    PubMed     Abstract available


  1323. CHANGALUCHA J, Steenson R, Grieve E, Cleaveland S, et al
    The need to improve access to rabies post-exposure vaccines: Lessons from Tanzania.
    Vaccine. 2018 Oct 8. pii: S0264-410X(18)31243.
    PubMed     Abstract available


  1324. WUTZLER P, Casabona G, Cnops J, Akpo EIH, et al
    Herpes zoster in the context of varicella vaccination - An equation with several variables.
    Vaccine. 2018 Oct 8. pii: S0264-410X(18)31262.
    PubMed     Abstract available


  1325. AKSULAR M, Calvo-Pinilla E, Marin-Lopez A, Ortego J, et al
    A single dose of African horse sickness virus (AHSV) VP2 based vaccines provides complete clinical protection in a mouse model.
    Vaccine. 2018 Oct 8. pii: S0264-410X(18)31341.
    PubMed     Abstract available


  1326. LEE VY, Booy R, Skinner SR, Fong J, et al
    The effect of exercise on local and systemic adverse reactions after vaccinations - Outcomes of two randomized controlled trials.
    Vaccine. 2018 Oct 6. pii: S0264-410X(18)31345.
    PubMed     Abstract available


  1327. ABEBE A, Getahun M, Mapaseka SL, Beyene B, et al
    Impact of rotavirus vaccine introduction and genotypic characteristics of rotavirus strains in children less than 5years of age with gastroenteritis in Ethiopia: 2011-2016.
    Vaccine. 2018 Oct 6. pii: S0264-410X(18)31317.
    PubMed     Abstract available


  1328. MUGO NR, Eckert L, Magaret AS, Cheng A, et al
    Quadrivalent HPV vaccine in HIV-1-infected early adolescent girls and boys in Kenya: Month 7 and 12 post vaccine immunogenicity and correlation with immune status.
    Vaccine. 2018 Oct 5. pii: S0264-410X(18)31328.
    PubMed     Abstract available


  1329. GROMIS A, Liu K
    The roles of neighborhood composition and autism prevalence on vaccination exemption pockets: A population-wide study.
    Vaccine. 2018 Oct 5. pii: S0264-410X(18)31298.
    PubMed     Abstract available


  1330. IBRAHIM R, Ali SA, Kazi AM, Rizvi A, et al
    Impact of maternally derived pertussis antibody titers on infant whole-cell pertussis vaccine response in a low income setting.
    Vaccine. 2018 Oct 5. pii: S0264-410X(18)31314.
    PubMed     Abstract available


  1331. BARTSCH SM, Taitel MS, DePasse JV, Cox SN, et al
    Epidemiologic and economic impact of pharmacies as vaccination locations during an influenza epidemic.
    Vaccine. 2018 Oct 5. pii: S0264-410X(18)31300.
    PubMed     Abstract available


  1332. HUNGERFORD D, Vivancos R, Read JM, Bonnett LJ, et al
    Mitigating bias in observational vaccine effectiveness studies using simulated comparator populations: Application to rotavirus vaccination in the UK.
    Vaccine. 2018 Oct 4. pii: S0264-410X(18)31320.
    PubMed     Abstract available


  1333. TIFREA DF, Pal S, Le Bon C, Giusti F, et al
    Co-delivery of amphipol-conjugated adjuvant with antigen, and adjuvant combinations, enhance immune protection elicited by a membrane protein-based vaccine against a mucosal challenge with Chlamydia.
    Vaccine. 2018 Oct 4. pii: S0264-410X(18)31324.
    PubMed     Abstract available


  1334. SALMONS B, Lim PY, Djurup R, Cardosa J, et al
    Non-clinical safety assessment of repeated intramuscular administration of an EV-A71 VLP vaccine in rabbits.
    Vaccine. 2018 Oct 4. pii: S0264-410X(18)31331.
    PubMed     Abstract available


  1335. MUKERJI R, Hendrickson C, Genschmer KR, Park SS, et al
    The diversity of the proline-rich domain of pneumococcal surface protein A (PspA): Potential relevance to a broad-spectrum vaccine.
    Vaccine. 2018 Oct 4. pii: S0264-410X(18)31174.
    PubMed     Abstract available


  1336. TSUZUKI S, Schwehm M, Eichner M
    Corrigendum to "Simulation studies to assess the long-term effects of Japan's change from trivalent to quadrivalent influenza vaccination" [Vaccine 36 (2018) 624-630].
    Vaccine. 2018 Oct 3. pii: S0264-410X(18)31315.
    PubMed    


  1337. ROBISON SG, Thomas AR
    Assessing the effectiveness of high-dose influenza vaccine in preventing hospitalization among seniors, and observations on the limitations of effectiveness study design.
    Vaccine. 2018 Oct 1. pii: S0264-410X(18)31319.
    PubMed     Abstract available


  1338. ZHANG C, Huang X, Chen S, Li Y, et al
    Epitope clustering analysis for vaccine-induced human antibodies in relationship to a panel of murine monoclonal antibodies against HPV16 viral capsid.
    Vaccine. 2018 Oct 1. pii: S0264-410X(18)31295.
    PubMed     Abstract available


  1339. RAGONNAUD E, Schroedel S, Mariya S, Iskandriati D, et al
    Replication deficient human adenovirus vector serotype 19a/64: Immunogenicity in mice and female cynomolgus macaques.
    Vaccine. 2018;36:6212-6222.
    PubMed     Abstract available


    September 2018
  1340. BORG K, Sutton K, Beasley M, Tull F, et al
    Communication-based interventions for increasing influenza vaccination rates among Aboriginal children: A randomised controlled trial.
    Vaccine. 2018 Sep 29. pii: S0264-410X(18)31269.
    PubMed     Abstract available


  1341. GORDON CL, Hutchings CL, Highton AJ, Colston JM, et al
    Memory inflation following adenoviral vaccination depends on IL-21.
    Vaccine. 2018 Sep 29. pii: S0264-410X(18)31330.
    PubMed     Abstract available


  1342. MIYAMOTO N, Mochizuki S, Kobiyama K, Ishii KJ, et al
    Corrigendum to "Designing an immunocyte-targeting delivery system by use of beta-glucan" [Vaccine 36 (2018) 186-189].
    Vaccine. 2018 Sep 29. pii: S0264-410X(18)31316.
    PubMed    


  1343. HAYASHI T, Lynch HE, Geyer S, Yoshida K, et al
    Impact of early life exposure to ionizing radiation on influenza vaccine response in an elderly Japanese cohort.
    Vaccine. 2018 Sep 28. pii: S0264-410X(18)31323.
    PubMed     Abstract available


  1344. HAN Y, Peng X, Li K, Jiang X, et al
    Potent effect of KISS1-54 DNA vaccine compared with KISS1-10 DNA vaccine in inhibiting the fertility of female rats.
    Vaccine. 2018 Sep 28. pii: S0264-410X(18)31322.
    PubMed     Abstract available


  1345. FERLITO C, Biselli R, Mariotti S, von Hunolstein C, et al
    Tetanus-diphtheria vaccination in adults: the long-term persistence of antibodies is not dependent on polyclonal B-cell activation and the defective response to diphtheria toxoid re-vaccination is associated to HLADRB1 *01.
    Vaccine. 2018 Sep 27. pii: S0264-410X(18)31301.
    PubMed     Abstract available


  1346. LAIRD RM, Ma Z, Dorabawila N, Pequegnat B, et al
    Evaluation of a conjugate vaccine platform against enterotoxigenic Escherichia coli (ETEC), Campylobacter jejuni and Shigella.
    Vaccine. 2018 Sep 27. pii: S0264-410X(18)31321.
    PubMed     Abstract available


  1347. HARRIS SL, Tan C, Andrew L, Hao L, et al
    The bivalent factor H binding protein meningococcal serogroup B vaccine elicits bactericidal antibodies against representative non-serogroup B meningococci.
    Vaccine. 2018 Sep 27. pii: S0264-410X(18)30747.
    PubMed     Abstract available


  1348. KIELY M, Billard MN, Toth E, Zafack JG, et al
    Investigation of an increase in large local reactions following vaccine schedule change to include DTaP-HB-IPV-Hib (Infanrix-hexa(R)) and MMRV (ProQuad(R)) at 18months of age.
    Vaccine. 2018 Sep 27. pii: S0264-410X(18)31318.
    PubMed     Abstract available


  1349. SCHNEIDER K, Gronhoj C, Hahn CH, von Buchwald C, et al
    Therapeutic human papillomavirus vaccines in head and neck cancer: A systematic review of current clinical trials.
    Vaccine. 2018 Sep 26. pii: S0264-410X(18)31277.
    PubMed     Abstract available


  1350. TENG Z, Sun S, Chen H, Huang J, et al
    Golden-star nanoparticles as adjuvant effectively promotes immune response to foot-and-mouth disease virus-like particles vaccine.
    Vaccine. 2018 Sep 26. pii: S0264-410X(18)31290.
    PubMed     Abstract available


  1351. GOLDFARB IT, Jaffe E, James K, Drapkin Lyerly A, et al
    Pregnant women's attitudes toward Zika virus vaccine trial participation.
    Vaccine. 2018 Sep 26. pii: S0264-410X(18)31311.
    PubMed     Abstract available


  1352. JUAN-GINER A, Tchaton M, Jemmy JP, Soumah A, et al
    Safety of the rVSV ZEBOV vaccine against Ebola Zaire among frontline workers in Guinea.
    Vaccine. 2018 Sep 25. pii: S0264-410X(18)31246.
    PubMed     Abstract available


  1353. SAYEDAHMED EE, Kumari R, Shukla S, Hassan AO, et al
    Longevity of adenovirus vector immunity in mice and its implications for vaccine efficacy.
    Vaccine. 2018 Sep 25. pii: S0264-410X(18)31291.
    PubMed     Abstract available


  1354. DOKE K, Fitzgerald SA, Barral RL, Griffin P, et al
    Concomitant HPV and MenACWY vaccination among sixth and seventh graders receiving Tdap.
    Vaccine. 2018 Sep 25. pii: S0264-410X(18)31216.
    PubMed     Abstract available


  1355. STUURMAN AL, Riera M, Lamprianou S, Perez-Vilar S, et al
    Vaccine safety surveillance in pregnancy in low- and middle-income countries using GAIA case definitions: A feasibility assessment.
    Vaccine. 2018 Sep 25. pii: S0264-410X(18)31293.
    PubMed     Abstract available


  1356. TILEY KS, White JM, Andrews N, Ramsay M, et al
    Inequalities in childhood vaccination timing and completion in London.
    Vaccine. 2018 Sep 25. pii: S0264-410X(18)31292.
    PubMed     Abstract available


  1357. REN Z, Zhao Y, Liu J, Ji X, et al
    Inclusion of membrane-anchored LTB or flagellin protein in H5N1 virus-like particles enhances protective responses following intramuscular and oral immunization of mice.
    Vaccine. 2018;36:5990-5998.
    PubMed     Abstract available


  1358. SURAGH TA, Lamprianou S, MacDonald NE, Loharikar AR, et al
    Cluster anxiety-related adverse events following immunization (AEFI): An assessment of reports detected in social media and those identified using an online search engine.
    Vaccine. 2018;36:5949-5954.
    PubMed     Abstract available


  1359. BURKHARDT M, Reiter K, Nguyen V, Suzuki M, et al
    Assessment of the impact of manufacturing changes on the physicochemical properties of the recombinant vaccine carrier ExoProtein A.
    Vaccine. 2018 Sep 24. pii: S0264-410X(18)31297.
    PubMed     Abstract available


  1360. WANG Y, Resch T, Esona MD, Moon SS, et al
    A DS-1 like G9P[6] human strain CDC-6 as a new rotavirus vaccine candidate.
    Vaccine. 2018 Sep 24. pii: S0264-410X(18)31184.
    PubMed     Abstract available


  1361. MCCOY JD, Painter JE, Jacobsen KH
    Perceptions of vaccination within a Christian homeschooling community in Pennsylvania.
    Vaccine. 2018 Sep 22. pii: S0264-410X(18)31296.
    PubMed     Abstract available


  1362. CHU K, Ying Z, Wang L, Hu Y, et al
    Safety and immunogenicity of inactivated poliovirus vaccine made from Sabin strains: A phase II, randomized, dose-finding trial.
    Vaccine. 2018 Sep 21. pii: S0264-410X(18)31272.
    PubMed     Abstract available


  1363. GREENBERG D, Hoover PA, Vesikari T, Peltier C, et al
    Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV15) in healthy infants.
    Vaccine. 2018 Sep 20. pii: S0264-410X(18)30323.
    PubMed     Abstract available


  1364. FISCHER T, Spohn M, Olearo F, Zinser ME, et al
    Dynamic changes of circulating miRNAs induced by the Ebola virus vaccine VSV-EBOV.
    Vaccine. 2018 Sep 20. pii: S0264-410X(18)31265.
    PubMed     Abstract available


  1365. HENRY O, Brzostek J, Czajka H, Leviniene G, et al
    Corrigendum to "One or two doses of live varicella virus-containing vaccines: Efficacy, persistence of immune responses, and safety six years after administration in healthy children during their second year of life" [Vaccine 36 (2018) 381-387].
    Vaccine. 2018 Sep 20. pii: S0264-410X(18)31271.
    PubMed    


  1366. SCHURINK-VAN'T KLOOSTER TM, Kemmeren JM, van der Maas NAT, van de Putte EM, et al
    No evidence found for an increased risk of long-term fatigue following human papillomavirus vaccination of adolescent girls.
    Vaccine. 2018 Sep 19. pii: S0264-410X(18)31268.
    PubMed     Abstract available


  1367. MOMOSE H, Sasaki E, Kuramitsu M, Hamaguchi I, et al
    Gene expression profiling toward the next generation safety control of influenza vaccines and adjuvants in Japan.
    Vaccine. 2018 Sep 19. pii: S0264-410X(18)31270.
    PubMed     Abstract available


  1368. DEHLENDORFF C, Sparen P, Baldur-Felskov B, Herweijer E, et al
    Effectiveness of varying number of doses and timing between doses of quadrivalent HPV vaccine against severe cervical lesions.
    Vaccine. 2018 Sep 18. pii: S0264-410X(18)31258.
    PubMed     Abstract available


  1369. BERTRAN K, Lee DH, Criado MF, Balzli CL, et al
    Maternal antibody inhibition of recombinant Newcastle disease virus vectored vaccine in a primary or booster avian influenza vaccination program of broiler chickens.
    Vaccine. 2018 Sep 18. pii: S0264-410X(18)31264.
    PubMed     Abstract available


  1370. ALI M, Chang BA, Johnson KW, Morris SK, et al
    Incidence and aetiology of bacterial meningitis among children aged 1-59months in South Asia: systematic review and meta-analysis.
    Vaccine. 2018;36:5846-5857.
    PubMed     Abstract available


  1371. WISE LD, Wolf JJ, Plitnick LM
    Evaluation of a 9-valent HPV vaccine in Sprague-Dawley rats: Nonclinical studies assessing general, reproductive, and developmental toxicity.
    Vaccine. 2018 Sep 17. pii: S0264-410X(18)31211.
    PubMed     Abstract available


  1372. HOSSAIN A, Politi C, Mandalia N, Cohen AL, et al
    Expenditures on vaccine-preventable disease surveillance: Analysis and evaluation of comprehensive multi-year plans (cMYPs) for immunization.
    Vaccine. 2018 Sep 17. pii: S0264-410X(18)31077.
    PubMed     Abstract available


  1373. EDOUARD S, Al-Tawfiq JA, Memish ZA, Yezli S, et al
    Impact of the Hajj on pneumococcal carriage and the effect of various pneumococcal vaccines.
    Vaccine. 2018 Sep 17. pii: S0264-410X(18)31266.
    PubMed     Abstract available


  1374. RICHARDSON JS, Messonnier ML, Prosser LA
    Preferences for health economics presentations among vaccine policymakers and researchers.
    Vaccine. 2018 Sep 17. pii: S0264-410X(18)31178.
    PubMed     Abstract available


  1375. VERMA A, Burns DL
    Improving the stability of recombinant anthrax protective antigen vaccine.
    Vaccine. 2018 Sep 15. pii: S0264-410X(18)31261.
    PubMed     Abstract available


  1376. MARIA DE SOUZA MORAIS S, Ferreira Rodigues N, Ingrid Oliveira da Silva N, Aparecido Salvador E, et al
    Serum albumin nanoparticles vaccine provides protection against a lethal Pseudomonas aeruginosa challenge.
    Vaccine. 2018 Sep 15. pii: S0264-410X(18)31210.
    PubMed     Abstract available


  1377. SMITH MA, Hall M, Lew JB, Canfell K, et al
    Potential for HPV vaccination and primary HPV screening to reduce cervical cancer disparities: Example from New Zealand.
    Vaccine. 2018 Sep 14. pii: S0264-410X(18)31202.
    PubMed     Abstract available


  1378. DIALLO A, Victor JC, Feser J, Ortiz JR, et al
    Immunogenicity and safety of MF59-adjuvanted and full-dose unadjuvanted trivalent inactivated influenza vaccines among vaccine-naive children in a randomized clinical trial in rural Senegal.
    Vaccine. 2018 Sep 14. pii: S0264-410X(18)31158.
    PubMed     Abstract available


  1379. DEDIEGO ML, Chiem K, Topham DJ
    Directed selection of amino acid changes in the influenza hemagglutinin and neuraminidase affecting protein antigenicity.
    Vaccine. 2018 Sep 14. pii: S0264-410X(18)31240.
    PubMed     Abstract available


  1380. TOEPP A, Larson M, Wilson G, Grinnage-Pulley T, et al
    Randomized, controlled, double-blinded field trial to assess Leishmania vaccine effectiveness as immunotherapy for canine leishmaniosis.
    Vaccine. 2018 Sep 12. pii: S0264-410X(18)31245.
    PubMed     Abstract available


  1381. MIYAZAKI A, Kandasamy S, Michael H, Langel SN, et al
    Protein deficiency reduces efficacy of oral attenuated human rotavirus vaccine in a human infant fecal microbiota transplanted gnotobiotic pig model.
    Vaccine. 2018 Sep 12. pii: S0264-410X(18)31244.
    PubMed     Abstract available


  1382. FORTNER KB, Swamy GK, Broder KR, Jimenez-Truque N, et al
    Reactogenicity and immunogenicity of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant and nonpregnant women.
    Vaccine. 2018 Sep 12. pii: S0264-410X(18)30942.
    PubMed     Abstract available


  1383. CARRELL RK, Stanton RA, Ethier SP, LaRue AC, et al
    ICOSL-augmented adenoviral-based vaccination induces a bipolar Th17/Th1 T cell response against unglycosylated MUC1 antigen.
    Vaccine. 2018 Sep 12. pii: S0264-410X(18)31257.
    PubMed     Abstract available


  1384. DENDLE C, Stuart RL, Mulley WR, Holdsworth SR, et al
    Pneumococcal vaccination in adult solid organ transplant recipients: A review of current evidence.
    Vaccine. 2018 Sep 11. pii: S0264-410X(18)31209.
    PubMed     Abstract available


  1385. KHATOON N, Ojha R, Mishra A, Prajapati VK, et al
    Examination of antigenic proteins of Trypanosoma cruzi to fabricate an epitope-based subunit vaccine by exploiting epitope mapping mechanism.
    Vaccine. 2018 Sep 11. pii: S0264-410X(18)31239.
    PubMed     Abstract available


  1386. CAO Z, Chen D, Yang Y, Zhang D, et al
    Effectiveness of post-exposure prophylaxis during varicella outbreaks among primary and middle school students in Shanghai: An analysis of three-year surveillance data.
    Vaccine. 2018;36:5754-5759.
    PubMed     Abstract available


  1387. KHAN MN, Pryharski K, Pichichero ME
    Immunogenicity and protective efficacy of monovalent PCVs containing 22F and 33F polysaccharides in mouse models of colonization and co-infection.
    Vaccine. 2018;36:5701-5708.
    PubMed     Abstract available


  1388. CHEN C, Beutels P, Wood J, Menzies R, et al
    Retrospective cost-effectiveness of the 23-valent pneumococcal polysaccharide vaccination program in Australia.
    Vaccine. 2018 Sep 10. pii: S0264-410X(18)31234.
    PubMed     Abstract available


  1389. BARTHOLOMEUS E, De Neuter N, Meysman P, Suls A, et al
    Transcriptome profiling in blood before and after hepatitis B vaccination shows significant differences in gene expression between responders and non-responders.
    Vaccine. 2018 Sep 8. pii: S0264-410X(18)31236.
    PubMed     Abstract available


  1390. THOMSON A, Vallee-Tourangeau G, Suggs LS
    Strategies to increase vaccine acceptance and uptake: From behavioral insights to context-specific, culturally-appropriate, evidence-based communications and interventions.
    Vaccine. 2018 Sep 7. pii: S0264-410X(18)31140.
    PubMed    


  1391. ULENDORF JACOBSEN S, Valentiner-Branth P, Molbak K
    Examining determinants for reporting suspected adverse events following HPV vaccination in Denmark.
    Vaccine. 2018 Sep 7. pii: S0264-410X(18)31190.
    PubMed     Abstract available


  1392. ZHANG C, Li LH, Wang J, Zhao Z, et al
    Enhanced protective immunity against spring viremia of carp virus infection can be induced by recombinant subunit vaccine conjugated to single-walled carbon nanotubes.
    Vaccine. 2018 Sep 7. pii: S0264-410X(18)31110.
    PubMed     Abstract available


  1393. PNIEWSKI T, Milczarek M, Wojas-Turek J, Pajtasz-Piasecka E, et al
    Plant lyophilisate carrying S-HBsAg as an oral booster vaccine against HBV.
    Vaccine. 2018 Sep 6. pii: S0264-410X(18)31241.
    PubMed     Abstract available


  1394. ALBANESE GA, Lee DH, Cheng IN, Hilt DA, et al
    Biological and molecular characterization of ArkGA: A novel Arkansas serotype vaccine that is highly attenuated, efficacious, and protective against homologous challenge.
    Vaccine. 2018 Sep 6. pii: S0264-410X(18)31228.
    PubMed     Abstract available


  1395. BRANDON D, Kimmel M, Kuriyakose SO, Kostanyan L, et al
    Antibody persistence and safety and immunogenicity of a second booster dose nine years after a first booster vaccination with a reduced antigen diphtheria-tetanus-acellular pertussis vaccine (Tdap) in adults.
    Vaccine. 2018 Sep 6. pii: S0264-410X(18)31180.
    PubMed     Abstract available


  1396. PEZZOTTI P, Bellino S, Prestinaci F, Iacchini S, et al
    Reply to letters to the Editor: Bellavite P. Factors that influenced the historical trends of tetanus and diphtheria. Donzelli A, Duca P. More than 70,000 deaths prevented by vaccination against three diseases in about 75years? The estimation seems ex
    Vaccine. 2018;36:5508-5509.
    PubMed    


  1397. DONZELLI A, Duca P
    More than 70,000 deaths prevented by vaccination against three diseases in about 75years? The estimation seems exaggerated.
    Vaccine. 2018;36:5507.
    PubMed    


  1398. SU QD, He SH, Yi Y, Qiu F, et al
    Intranasal vaccination with ebola virus GP amino acids 258-601 protects mice against lethal challenge.
    Vaccine. 2018 Sep 5. pii: S0264-410X(18)31238.
    PubMed     Abstract available


  1399. MATTHEWS I, Lu X, Dawson H, Bricout H, et al
    Assessing the effectiveness of zoster vaccine live: A retrospective cohort study using primary care data in the United Kingdom.
    Vaccine. 2018 Sep 5. pii: S0264-410X(18)31166.
    PubMed     Abstract available


  1400. MUHSEN IN, Aljurf M, Wingard JR, Poland GA, et al
    Vaccinating donors for hematopoietic cell transplantation: A systematic review and future perspectives.
    Vaccine. 2018 Sep 5. pii: S0264-410X(18)31173.
    PubMed     Abstract available


  1401. FISKER AB, Thysen SM
    Non-live pentavalent vaccines after live measles vaccine may increase mortality.
    Vaccine. 2018 Sep 5. pii: S0264-410X(18)31233.
    PubMed     Abstract available


  1402. MCGRATH LJ, Layton JB, Krueger WS, Kshirsagar AV, et al
    High-dose influenza vaccine use among patients receiving hemodialysis in the United States, 2010-2013.
    Vaccine. 2018 Sep 5. pii: S0264-410X(18)31229.
    PubMed     Abstract available


  1403. HORSINGTON J, Nfon C, Gonzales JL, Singanallur N, et al
    Protection in sheep against heterologous challenge with serotype Asia-1 foot-and-mouth disease virus using high potency vaccine.
    Vaccine. 2018 Sep 5. pii: S0264-410X(18)31213.
    PubMed     Abstract available


  1404. MOKADDAS EM, Shibl AM, Elgouhary A, Elsobky M, et al
    Effect of the introduction of pneumococcal conjugate vaccines on serotype prevalence in Kuwait and Saudi Arabia.
    Vaccine. 2018 Sep 5. pii: S0264-410X(18)31076.
    PubMed     Abstract available


  1405. MORGENSTERN K, Xie Y, Palladino G, Barr JR, et al
    Reference antigen-free and antibody-free LTD-IDMS assay for influenza H7N9 vaccine in vitro potency determination.
    Vaccine. 2018 Sep 4. pii: S0264-410X(18)31204.
    PubMed     Abstract available


  1406. GROOM HC, Irving SA, Koppolu P, Smith N, et al
    Uptake and safety of Hepatitis B vaccination during pregnancy: A Vaccine Safety Datalink study.
    Vaccine. 2018 Sep 4. pii: S0264-410X(18)31214.
    PubMed     Abstract available


  1407. TAM YH, Ng TWY, Chu DKW, Fang VJ, et al
    The effectiveness of influenza vaccination against medically-attended illnesses in Hong Kong across three years with different degrees of vaccine match, 2014-17.
    Vaccine. 2018 Sep 3. pii: S0264-410X(18)31215.
    PubMed     Abstract available


  1408. NZOLO D, Engo Biongo A, Kuemmerle A, Lusakibanza M, et al
    Safety profile of fractional dosing of the 17DD Yellow Fever Vaccine among males and females: Experience of a community-based pharmacovigilance in Kinshasa, DR Congo.
    Vaccine. 2018 Sep 3. pii: S0264-410X(18)31181.
    PubMed     Abstract available


  1409. SOUZA CK, Rajao DS, Sandbulte MR, Lopes S, et al
    The type of adjuvant in whole inactivated influenza a virus vaccines impacts vaccine-associated enhanced respiratory disease.
    Vaccine. 2018 Sep 1. pii: S0264-410X(18)31212.
    PubMed     Abstract available


  1410. ROOZBEHANI M, Falak R, Mohammadi M, Hemphill A, et al
    Characterization of a multi-epitope peptide with selective MHC-binding capabilities encapsulated in PLGA nanoparticles as a novel vaccine candidate against Toxoplasma gondii infection.
    Vaccine. 2018 Sep 1. pii: S0264-410X(18)31208.
    PubMed     Abstract available


  1411. MOMBELLI M, Rettby N, Perreau M, Pascual M, et al
    Immunogenicity and safety of double versus standard dose of the seasonal influenza vaccine in solid-organ transplant recipients: A randomized controlled trial.
    Vaccine. 2018 Sep 1. pii: S0264-410X(18)31186.
    PubMed     Abstract available


    August 2018
  1412. CHIU HT, Shen LJ, Chen YC, Lin JH, et al
    Effect of statin use on the risk of medically attended acute respiratory illness among influenza vaccinated elderly.
    Vaccine. 2018 Aug 30. pii: S0264-410X(18)31206.
    PubMed     Abstract available


  1413. WESTFALL J, Yates JL, Van Slyke G, Ehrbar D, et al
    Thermal stability and epitope integrity of a lyophilized ricin toxin subunit vaccine.
    Vaccine. 2018 Aug 29. pii: S0264-410X(18)31188.
    PubMed     Abstract available


  1414. MOHANTY S, Leader AE, Gibeau E, Johnson C, et al
    Using Facebook to reach adolescents for human papillomavirus (HPV) vaccination.
    Vaccine. 2018 Aug 29. pii: S0264-410X(18)31189.
    PubMed     Abstract available


  1415. BRUXELLE JF, Tsapis N, Hoys S, Collignon A, et al
    Protection against Clostridium difficile infection in a hamster model by oral vaccination using flagellin FliC-loaded pectin beads.
    Vaccine. 2018 Aug 29. pii: S0264-410X(18)31122.
    PubMed     Abstract available


  1416. ESPOSITO S, Pugni L, Mosca F, Principi N, et al
    Rotarix(R) and RotaTeq(R) administration to preterm infants in the neonatal intensive care unit: Review of available evidence.
    Vaccine. 2018;36:5430-5434.
    PubMed     Abstract available


  1417. VILCA LM, Esposito S
    The crucial role of maternal care providers as vaccinators for pregnant women.
    Vaccine. 2018;36:5379-5384.
    PubMed     Abstract available


  1418. BONANNI P, Bonaccorsi G, Lorini C, Santomauro F, et al
    Focusing on the implementation of 21st century vaccines for adults.
    Vaccine. 2018;36:5358-5365.
    PubMed     Abstract available


  1419. MAVER PJ, Poljak M
    Progress in prophylactic human papillomavirus (HPV) vaccination in 2016: A literature review.
    Vaccine. 2018;36:5416-5423.
    PubMed     Abstract available


  1420. ESPOSITO S, Principi N
    Herpes zoster prevention: A difficult problem to solve.
    Vaccine. 2018;36:5442-5448.
    PubMed     Abstract available


  1421. VENKATRAMAN N, Silman D, Folegatti PM, Hill AVS, et al
    Vaccines against Ebola virus.
    Vaccine. 2018;36:5454-5459.
    PubMed     Abstract available


  1422. WILKINS AL, Snape MD
    Emerging clinical experience with vaccines against group B meningococcal disease.
    Vaccine. 2018;36:5470-5476.
    PubMed     Abstract available


  1423. POLAND GA, Ovsyannikova IG, Kennedy RB
    Personalized vaccinology: A review.
    Vaccine. 2018;36:5350-5357.
    PubMed     Abstract available


  1424. KOWALZIK F, Faber J, Knuf M
    MMR and MMRV vaccines.
    Vaccine. 2018;36:5402-5407.
    PubMed     Abstract available


  1425. OBANDO-PACHECO P, Rivero-Calle I, Gomez-Rial J, Rodriguez-Tenreiro Sanchez C, et al
    New perspectives for hexavalent vaccines.
    Vaccine. 2018;36:5485-5494.
    PubMed     Abstract available


  1426. LUCERO Y, Vidal R, O'Ryan G M
    Norovirus vaccines under development.
    Vaccine. 2018;36:5435-5441.
    PubMed     Abstract available


  1427. DATTA SS, O'Connor PM, Jankovic D, Muscat M, et al
    Progress and challenges in measles and rubella elimination in the WHO European Region.
    Vaccine. 2018;36:5408-5415.
    PubMed